data_2l41_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l41 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 CA-C-O 120.372 0.072 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.16 50.1 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.335 -0.853 . . . . 0.0 111.739 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -158.27 150.7 22.09 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.918 2.087 . . . . 0.0 108.718 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -126.04 152.33 45.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.591 0.632 . . . . 0.0 112.25 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.68 125.36 41.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.273 1.429 . . . . 0.0 108.904 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -104.14 136.51 43.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.661 1.984 . . . . 0.0 110.262 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.28 137.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.324 1.05 . . . . 0.0 109.561 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.93 -175.1 3.61 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 122.316 0.953 . . . . 0.0 113.194 169.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -83.93 13.24 5.11 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.18 -44.32 99.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.456 1.502 . . . . 0.0 114.723 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.93 21.93 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.914 2.409 . . . . 0.0 113.186 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.59 59.31 1.49 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.532 1.533 . . . . 0.0 110.389 174.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -153.27 31.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.73 2.812 . . . . 0.0 110.795 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 m120 58.42 146.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.431 2.692 . . . . 0.0 114.055 -157.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.16 153.02 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.367 1.067 . . . . 0.0 110.652 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.0 m -135.45 166.06 24.05 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.636 1.974 . . . . 0.0 110.217 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -52.35 -32.94 40.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.194 -0.941 . . . . 0.0 111.465 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.51 -21.7 65.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.181 1.792 . . . . 0.0 115.014 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.83 -47.5 62.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.204 0.911 . . . . 0.0 109.514 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.22 -29.23 62.64 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.497 -1.377 . . . . 0.0 112.051 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -61.82 -46.65 88.58 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.002 0.921 . . . . 0.0 111.687 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.91 -39.1 90.84 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.523 -0.735 . . . . 0.0 110.321 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.73 -76.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 109.113 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -119.52 123.87 45.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.841 1.201 . . . . 0.0 111.747 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 15.4 m -157.9 -41.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 126.085 1.754 . . . . 0.0 112.846 167.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 25' ' ' SER . 53.9 Cg_endo -81.01 43.44 1.55 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.65 2.233 . . . . 0.0 112.562 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.07 146.15 46.74 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.416 1.486 . . . . 0.0 110.655 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.74 -161.11 28.28 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -96.67 -2.14 45.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.185 0.994 . . . . 0.0 112.95 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp 62.22 167.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 126.803 2.041 . . . . 0.0 114.168 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.9 mtm -152.12 -71.59 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.943 -1.098 . . . . 0.0 110.508 162.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -156.53 155.8 32.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.012 0.925 . . . . 0.0 113.394 -171.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tp -101.75 135.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.737 2.015 . . . . 0.0 110.046 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -127.02 68.85 1.27 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.924 1.289 . . . . 0.0 109.931 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.07 137.67 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -124.14 145.78 49.07 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.639 1.576 . . . . 0.0 108.643 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -70.42 -8.91 54.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -167.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.17 -59.52 1.94 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.756 1.162 . . . . 0.0 110.93 166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.46 131.97 14.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.998 1.719 . . . . 0.0 110.17 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 171.0 52.19 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.81 154.2 39.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.489 1.515 . . . . 0.0 110.972 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.63 151.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.87 1.668 . . . . 0.0 108.58 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.38 108.25 7.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.573 0.749 . . . . 0.0 109.164 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -127.33 158.82 36.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.497 1.519 . . . . 0.0 112.772 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -90.08 147.49 23.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.905 1.282 . . . . 0.0 110.61 170.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 66.6 86.79 0.13 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 129.585 3.154 . . . . 0.0 115.321 -162.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.45 -30.75 93.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.561 2.841 . . . . 0.0 114.851 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.62 -36.15 80.28 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.577 1.081 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -67.85 -37.64 82.12 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.8 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.684 0.793 . . . . 0.0 110.083 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.21 -31.63 72.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.252 1.021 . . . . 0.0 111.664 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.94 68.88 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.147 -0.971 . . . . 0.0 112.534 173.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.1 mt -60.51 -49.53 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.83 1.196 . . . . 0.0 110.594 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.07 -16.81 61.47 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.76 -58.88 3.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.214 1.406 . . . . 0.0 111.27 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.94 -45.09 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.543 -0.723 . . . . 0.0 111.83 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.77 15.97 0.76 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.031 1.332 . . . . 0.0 113.107 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 121.088 -1.007 . . . . 0.0 110.607 178.197 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -130.3 138.96 50.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.282 2.233 . . . . 0.0 108.889 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -141.47 130.96 23.83 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.757 0.823 . . . . 0.0 111.869 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.73 134.45 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.577 -0.702 . . . . 0.0 111.166 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.56 99.46 8.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.791 1.636 . . . . 0.0 108.526 161.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.473 0.676 0 C-N-CA 125.15 1.38 . . . . 0.0 114.06 -170.138 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.539 0.76 0 CA-C-O 120.089 -0.046 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -152.15 145.5 24.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -163.38 168.58 20.18 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.404 1.882 . . . . 0.0 110.01 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -140.63 153.16 45.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 171.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.3 121.35 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 108.435 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -100.66 133.85 44.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.386 1.074 . . . . 0.0 111.311 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.2 mm -90.48 99.43 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.755 0.822 . . . . 0.0 108.831 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.01 156.23 47.82 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.091 0.377 . . . . 0.0 112.663 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -51.03 98.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.15 1.78 . . . . 0.0 112.912 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.8 tm? -150.11 -56.64 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.486 1.514 . . . . 0.0 112.462 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 65.9 Cg_endo -72.94 -48.0 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.931 1.725 . . . . 0.0 113.348 -168.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 mp 57.02 -15.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -129.88 143.98 51.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.216 1.806 . . . . 0.0 111.721 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.61 29.13 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.368 2.267 . . . . 0.0 115.414 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -69.28 138.27 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.015 0.912 . . . . 0.0 111.241 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.9 p -143.71 156.84 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.534 1.133 . . . . 0.0 111.061 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.87 -25.84 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.086 -1.009 . . . . 0.0 111.758 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.83 -28.59 69.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.847 1.259 . . . . 0.0 114.012 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -67.61 -43.11 81.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.99 1.723 . . . . 0.0 111.476 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.01 -45.07 95.22 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.917 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -69.73 -37.92 76.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.494 1.118 . . . . 0.0 113.764 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -31.59 66.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.568 -1.332 . . . . 0.0 111.574 176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -64.14 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.468 1.107 . . . . 0.0 108.727 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -124.5 111.89 16.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.988 1.267 . . . . 0.0 110.71 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.41 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 47.7 t -155.61 -49.76 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 25' ' ' SER . 64.6 Cg_endo -84.47 8.68 4.49 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.024 2.483 . . . . 0.0 115.139 -173.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -84.7 15.05 4.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.848 1.259 . . . . 0.0 113.547 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.14 -15.16 9.13 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.148 -1.595 . . . . 0.0 115.375 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.88 133.91 34.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.319 1.559 . . . . 0.0 111.724 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.45 152.5 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.317 0.647 . . . . 0.0 112.234 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.4 mtm -162.03 -67.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.761 2.024 . . . . 0.0 109.001 151.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -148.43 155.63 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.203 1.401 . . . . 0.0 112.744 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -130.04 145.22 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.791 1.236 . . . . 0.0 111.119 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -136.96 157.16 47.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.052 1.341 . . . . 0.0 111.466 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.22 159.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -132.87 167.46 20.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.619 2.368 . . . . 0.0 110.95 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.42 -16.48 36.28 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.43 -10.04 5.16 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -160.64 -177.76 6.41 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.017 1.727 . . . . 0.0 111.132 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.27 170.29 36.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 120.527 -1.358 . . . . 0.0 115.285 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -130.69 128.09 40.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.378 1.471 . . . . 0.0 111.869 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mt -97.74 139.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.724 1.61 . . . . 0.0 108.544 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -130.56 94.09 3.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.273 1.429 . . . . 0.0 107.735 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -127.13 154.12 45.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.702 1.601 . . . . 0.0 113.941 -162.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.84 161.87 28.63 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.281 -0.887 . . . . 0.0 111.348 163.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 61.87 78.59 0.3 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.053 2.541 . . . . 0.0 115.639 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -24.28 51.5 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.089 2.526 . . . . 0.0 114.698 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -77.32 -37.09 53.28 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.092 -1.005 . . . . 0.0 112.522 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -70.41 -33.01 70.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.707 0.23 . . . . 0.0 111.091 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.9 t -65.2 -44.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 174.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -58.01 -48.19 80.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 111.419 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.49 -33.53 66.07 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.825 0.85 . . . . 0.0 112.983 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.77 -27.08 36.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -50.4 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 120.692 1.587 . . . . 0.0 110.074 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.0 -4.1 15.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.044 1.338 . . . . 0.0 113.603 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 87.8 m -108.2 -7.93 15.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.502 1.521 . . . . 0.0 113.879 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -137.23 -55.39 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.174 0.897 . . . . 0.0 112.61 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.021 -1.05 . . . . 0.0 112.465 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 CA--C 1.545 0.785 0 C-N-CA 125.811 1.644 . . . . 0.0 112.838 175.551 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.4 mt -119.95 133.96 55.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.595 0.758 . . . . 0.0 110.838 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -134.21 130.58 37.41 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.591 1.156 . . . . 0.0 110.994 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.74 143.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.913 0.885 . . . . 0.0 111.93 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 t -140.38 153.99 46.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.117 1.767 . . . . 0.0 110.849 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 125.236 1.414 . . . . 0.0 110.806 166.427 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.533 0.473 0 CA-C-O 121.084 0.368 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.28 146.01 51.83 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -160.98 147.84 15.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.601 1.56 . . . . 0.0 109.634 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -127.23 149.97 49.76 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.777 0.831 . . . . 0.0 110.734 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.57 124.99 31.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -104.26 137.23 42.47 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.755 1.622 . . . . 0.0 111.401 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -95.7 96.3 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.561 1.144 . . . . 0.0 110.281 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -8.51 74.36 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.889 1.233 . . . . 0.0 115.123 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -78.16 30.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.784 2.292 . . . . 0.0 114.179 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 33.14 66.75 1.15 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.595 2.358 . . . . 0.0 114.459 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.44 56.1 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.593 3.529 . . . . 0.0 113.964 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.93 -2.26 11.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.566 2.747 . . . . 0.0 112.985 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.33 150.14 51.7 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.607 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -12.49 96.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.61 3.164 . . . . 0.0 115.349 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 152.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.611 1.564 . . . . 0.0 111.256 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.1 p -137.7 166.72 23.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.543 1.937 . . . . 0.0 110.538 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -55.49 -25.16 35.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.316 0.646 . . . . 0.0 112.172 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -63.01 -27.29 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.303 1.441 . . . . 0.0 113.143 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.83 -48.74 23.55 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.418 -0.801 . . . . 0.0 110.938 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.76 -34.96 79.07 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.609 -1.307 . . . . 0.0 111.329 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -69.2 -35.71 76.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.986 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -37.37 78.77 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.9 1.227 . . . . 0.0 110.887 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.87 -79.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -120.79 108.27 13.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.245 0.93 . . . . 0.0 110.818 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.498 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 60.7 p -135.09 -30.46 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.821 -1.561 . . . . 0.0 114.658 160.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.498 ' CD ' ' H ' ' A' ' 25' ' ' SER . 19.2 Cg_endo -88.65 10.75 3.24 Favored 'Trans proline' 0 C--N 1.356 0.956 0 CA-C-N 122.988 2.103 . . . . 0.0 113.623 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -105.7 142.38 35.53 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.817 1.247 . . . . 0.0 111.332 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.23 -161.24 45.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.967 0.794 . . . . 0.0 114.744 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -98.94 -0.95 41.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.0 0.92 . . . . 0.0 113.387 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 63.56 158.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.744 2.017 . . . . 0.0 115.451 168.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.4 mtm -151.72 -79.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.58 1.152 . . . . 0.0 108.555 162.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -142.0 157.39 44.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -114.68 131.41 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.853 1.661 . . . . 0.0 108.954 168.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -127.1 90.18 3.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.983 1.313 . . . . 0.0 110.415 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.91 138.69 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.626 -0.671 . . . . 0.0 110.354 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -133.56 145.94 50.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.214 1.806 . . . . 0.0 108.693 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.67 25.04 0.81 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.429 1.492 . . . . 0.0 112.827 -168.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 -56.68 0.36 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.568 1.947 . . . . 0.0 110.772 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -142.78 101.16 3.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 110.152 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.34 156.43 48.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.692 0.663 . . . . 0.0 113.77 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.86 152.03 50.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.751 1.262 . . . . 0.0 112.607 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 145.51 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.113 1.765 . . . . 0.0 108.416 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -135.03 90.1 2.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.132 1.773 . . . . 0.0 107.999 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -121.34 160.17 24.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.092 1.357 . . . . 0.0 114.204 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -92.25 156.29 17.4 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.997 1.319 . . . . 0.0 110.229 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 67.63 76.79 0.26 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 129.158 2.983 . . . . 0.0 113.714 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -58.38 -33.85 98.18 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.9 3.066 . . . . 0.0 113.551 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -58.08 -45.26 87.44 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.253 0.933 . . . . 0.0 111.178 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -71.81 -28.37 63.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.53 -42.48 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.733 1.151 . . . . 0.0 110.639 170.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -67.86 -44.06 78.0 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 112.131 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.28 -33.5 69.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.065 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.94 64.06 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.263 -0.898 . . . . 0.0 113.044 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.47 -50.38 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.395 -1.441 . . . . 0.0 109.7 171.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.41 -6.05 32.8 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.4 t -85.23 -50.36 7.44 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.906 1.282 . . . . 0.0 111.982 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -109.0 -47.15 3.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.24 1.016 . . . . 0.0 113.693 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -67.63 -21.42 65.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.13 0.972 . . . . 0.0 112.025 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 126.726 2.011 . . . . 0.0 111.811 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 mt -126.44 134.91 50.85 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.583 1.153 . . . . 0.0 108.567 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.68 133.5 41.94 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.9 137.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.589 1.556 . . . . 0.0 111.325 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -143.59 168.52 19.68 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.766 2.027 . . . . 0.0 111.004 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 124.529 1.132 . . . . 0.0 109.539 178.089 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.636 0.975 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -122.21 97.97 5.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.691 2.396 . . . . 0.0 108.583 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.73 95.35 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.396 1.479 . . . . 0.0 109.332 -164.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -86.57 151.77 23.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.655 0.74 . . . . 0.0 112.241 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.3 126.43 38.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.877 1.671 . . . . 0.0 108.983 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -104.1 136.66 43.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.704 1.602 . . . . 0.0 111.424 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.62 99.01 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.784 0.834 . . . . 0.0 110.245 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.94 -7.26 86.44 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.423 -0.798 . . . . 0.0 114.702 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -77.08 50.07 0.72 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.69 1.596 . . . . 0.0 112.662 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.5 mt 38.45 66.74 2.46 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.334 2.254 . . . . 0.0 113.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.83 15.82 0.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 125.198 3.932 . . . . 0.0 115.262 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.4 32.68 0.34 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.316 1.447 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -127.53 52.0 1.87 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.821 2.048 . . . . 0.0 112.622 -164.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 44.45 55.89 5.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.468 1.507 . . . . 0.0 113.357 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.16 161.15 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.87 0.868 . . . . 0.0 111.606 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -147.06 154.61 41.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 112.377 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -62.31 -29.37 70.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -66.44 -22.08 66.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.29 -38.97 49.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.979 0.912 . . . . 0.0 110.686 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.22 -44.12 80.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.175 0.99 . . . . 0.0 111.205 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.24 -45.08 96.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.064 1.345 . . . . 0.0 111.855 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -29.21 65.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.404 -0.81 . . . . 0.0 112.262 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.36 -73.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -120.87 117.97 28.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.553 1.07 . . . . 0.0 111.923 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.459 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 16.5 p -162.48 -31.36 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 163.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 25' ' ' SER . 30.0 Cg_endo -93.85 0.89 3.21 Favored 'Trans proline' 0 C--N 1.357 1.015 0 CA-C-N 122.932 2.083 . . . . 0.0 114.633 -170.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -78.59 179.45 7.1 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.292 1.837 . . . . 0.0 111.735 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.39 19.34 0.27 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.384 1.468 . . . . 0.0 116.598 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -141.47 140.05 33.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 112.564 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -163.68 153.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.811 2.044 . . . . 0.0 108.672 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.7 tpp -166.08 -57.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.73 1.15 . . . . 0.0 110.897 154.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -156.21 147.12 22.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.96 144.08 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.953 1.301 . . . . 0.0 108.105 169.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.83 86.36 1.93 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 110.498 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tt -103.18 146.29 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -172.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -132.05 149.85 52.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.301 1.84 . . . . 0.0 109.45 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -72.79 39.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.929 1.692 . . . . 0.0 114.3 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.82 -43.64 0.09 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.404 2.282 . . . . 0.0 110.718 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.25 128.67 34.33 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.87 0.868 . . . . 0.0 111.747 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.35 126.55 7.91 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.68 0.657 . . . . 0.0 112.382 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -139.16 150.97 46.23 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.898 1.332 . . . . 0.0 113.84 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 152.86 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.243 2.217 . . . . 0.0 108.978 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -140.14 90.31 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.234 1.414 . . . . 0.0 108.576 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -111.68 164.4 13.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.273 1.429 . . . . 0.0 112.402 -170.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -103.21 148.38 25.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.62 -1.3 . . . . 0.0 110.033 172.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.0 t30 69.69 105.34 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 129.05 2.94 . . . . 0.0 114.438 -156.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.89 -26.9 6.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.496 2.797 . . . . 0.0 113.393 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -65.26 -34.8 79.21 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.235 -0.916 . . . . 0.0 111.996 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.7 m -82.31 -20.07 38.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.77 -1.109 . . . . 0.0 113.578 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.92 -51.64 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.314 1.415 . . . . 0.0 108.979 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -71.25 -28.19 64.0 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.3 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -66.74 -47.95 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.619 1.099 . . . . 0.0 111.761 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.95 66.37 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.947 -1.096 . . . . 0.0 112.328 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.03 -53.33 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.139 0.881 . . . . 0.0 110.198 167.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.96 -18.47 62.62 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.42 1.464 . . . . 0.0 113.532 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.15 -36.62 47.49 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 113.35 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -115.06 -42.38 3.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.503 1.121 . . . . 0.0 113.113 -169.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -72.55 23.53 0.06 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.693 1.997 . . . . 0.0 114.09 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 126.573 1.949 . . . . 0.0 111.404 175.395 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 mt -134.63 144.26 47.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.968 1.707 . . . . 0.0 109.74 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.48 138.95 46.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.29 140.79 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.918 1.287 . . . . 0.0 110.481 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -140.43 143.77 35.77 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 167.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.7 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.703 0.764 . . . . 0.0 111.709 -172.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.539 0.764 0 N-CA-C 111.276 -0.317 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 125.82 29.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 111.972 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -138.74 95.02 2.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 109.363 -164.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.01 149.04 43.61 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.442 -0.787 . . . . 0.0 111.183 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.96 122.23 29.7 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.065 1.346 . . . . 0.0 108.93 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -96.44 130.36 43.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.172 1.789 . . . . 0.0 110.859 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.84 91.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.181 0.993 . . . . 0.0 109.318 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.93 4.88 56.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.997 1.284 . . . . 0.0 115.397 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -64.48 -162.98 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.58 1.952 . . . . 0.0 111.818 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -119.66 42.11 0.46 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -77.19 54.83 4.81 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.087 3.191 . . . . 0.0 112.318 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.6 50.46 1.32 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.806 2.042 . . . . 0.0 109.376 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -142.49 168.74 19.02 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.086 2.554 . . . . 0.0 109.297 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -61.76 110.01 1.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.395 -0.816 . . . . 0.0 110.205 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.72 155.21 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.082 0.953 . . . . 0.0 112.41 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.1 m -133.55 155.17 50.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.149 1.779 . . . . 0.0 111.333 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.01 -25.68 22.43 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.924 1.29 . . . . 0.0 114.22 -167.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -53.65 -27.32 26.67 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 0.0 113.32 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.13 -49.95 17.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.896 1.225 . . . . 0.0 112.379 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.11 -28.1 69.84 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.045 -1.659 . . . . 0.0 111.514 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.06 -34.95 71.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.31 1.444 . . . . 0.0 113.335 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -35.07 79.52 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.984 1.265 . . . . 0.0 110.91 170.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.26 -77.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.828 1.251 . . . . 0.0 107.96 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -120.53 116.17 24.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.126 1.33 . . . . 0.0 111.122 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.5 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 p -158.66 -29.88 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 162.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.5 ' HD2' ' H ' ' A' ' 25' ' ' SER . 41.2 Cg_endo -86.82 0.17 7.82 Favored 'Trans proline' 0 C--N 1.357 0.977 0 CA-C-N 123.283 2.208 . . . . 0.0 113.995 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -79.36 171.91 14.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.467 1.507 . . . . 0.0 111.638 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.64 -15.7 80.51 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -87.04 121.21 29.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.873 1.337 . . . . 0.0 111.904 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 tp -154.54 146.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.26 0.624 . . . . 0.0 111.74 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mtm -159.84 -73.09 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.458 1.903 . . . . 0.0 110.129 162.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -143.8 160.63 40.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.965 1.706 . . . . 0.0 114.1 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -133.15 124.67 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.113 1.765 . . . . 0.0 110.105 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -129.28 74.05 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.616 1.167 . . . . 0.0 112.012 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 tt -65.73 146.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.062 -1.024 . . . . 0.0 111.326 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -145.01 147.21 32.37 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.809 2.043 . . . . 0.0 108.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.96 143.35 51.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.785 0.434 . . . . 0.0 110.639 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.87 -53.87 0.31 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.609 1.964 . . . . 0.0 115.84 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -141.32 73.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.049 0.928 . . . . 0.0 112.289 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.93 51.66 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.544 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.77 160.44 38.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 122.839 1.304 . . . . 0.0 112.642 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -122.97 155.84 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.98 1.712 . . . . 0.0 109.024 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -136.3 88.69 2.4 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.941 1.296 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.84 175.0 5.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.819 0.848 . . . . 0.0 111.296 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -117.02 151.89 35.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.145 1.778 . . . . 0.0 109.096 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.9 t30 66.51 92.24 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 127.537 2.335 . . . . 0.0 113.812 -160.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.58 -21.46 45.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.779 2.319 . . . . 0.0 113.34 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.99 -30.97 68.44 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.387 -0.821 . . . . 0.0 112.001 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -89.24 -25.08 21.92 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 117.719 -1.134 . . . . 0.0 113.478 168.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.29 -48.01 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 120.434 1.47 . . . . 0.0 109.274 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.92 -41.65 95.38 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.171 -0.919 . . . . 0.0 113.061 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.12 -38.25 79.17 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.638 1.108 . . . . 0.0 112.479 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -27.5 61.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.66 -58.49 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.598 1.09 . . . . 0.0 109.441 168.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.27 -19.17 65.22 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.42 -44.98 14.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.42 1.888 . . . . 0.0 114.409 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -106.41 -24.74 12.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.79 1.236 . . . . 0.0 113.753 -169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -72.63 35.78 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.328 2.251 . . . . 0.0 112.497 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 127.982 2.513 . . . . 0.0 109.216 -175.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.14 141.75 47.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.328 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.2 134.91 33.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.807 1.185 . . . . 0.0 113.291 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -90.29 146.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.769 1.228 . . . . 0.0 110.551 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 155.73 44.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.692 0.797 . . . . 0.0 110.276 165.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 123.431 0.692 . . . . 0.0 109.922 166.062 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 CA--C 1.535 0.531 0 CA-C-O 120.681 0.2 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 142.63 49.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.142 1.377 . . . . 0.0 111.673 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 t -142.93 140.48 31.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.954 1.702 . . . . 0.0 109.184 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -113.59 145.56 41.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.618 0.767 . . . . 0.0 110.31 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -131.72 126.12 33.73 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.644 1.577 . . . . 0.0 109.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.3 132.28 54.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.37 94.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.15 43.25 2.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.708 1.147 . . . . 0.0 112.911 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -114.45 32.92 5.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.586 1.554 . . . . 0.0 113.132 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.8 tp 43.08 72.53 1.14 Allowed Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.885 2.874 . . . . 0.0 113.986 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.5 1.52 6.76 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.67 2.913 . . . . 0.0 113.091 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.18 32.15 0.18 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 114.421 -172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -146.71 -56.61 0.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.805 -1.184 . . . . 0.0 111.583 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -145.07 134.42 23.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 110.843 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -157.01 149.84 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.208 1.003 . . . . 0.0 111.084 169.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -135.63 155.84 49.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.098 1.759 . . . . 0.0 110.172 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -50.04 -33.8 19.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.154 1.382 . . . . 0.0 114.101 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.3 -23.29 47.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.92 -48.54 58.12 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.017 -1.052 . . . . 0.0 111.581 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.91 -33.62 68.45 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.037 -1.04 . . . . 0.0 111.099 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -61.18 -43.81 98.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -27.23 62.69 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.185 -0.947 . . . . 0.0 111.839 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.22 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.789 0.835 . . . . 0.0 109.525 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -122.1 114.8 21.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.794 1.179 . . . . 0.0 111.037 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -151.81 -40.54 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.654 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -96.6 15.91 0.79 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.26 2.64 . . . . 0.0 114.125 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.42 22.87 0.32 Allowed 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.455 -1.403 . . . . 0.0 114.4 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.26 -13.93 13.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.476 1.988 . . . . 0.0 116.517 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.51 156.17 49.33 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.114 1.366 . . . . 0.0 110.307 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -165.14 165.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.01 0.924 . . . . 0.0 110.811 -161.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -155.68 -69.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 156.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -143.36 165.04 28.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.451 1.5 . . . . 0.0 113.671 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 tp -113.83 133.84 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.709 2.004 . . . . 0.0 110.018 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -129.9 55.53 1.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 110.416 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.2 tt -70.05 146.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.672 -1.267 . . . . 0.0 111.225 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -134.49 156.52 48.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.797 1.639 . . . . 0.0 110.254 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.51 10.73 0.75 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.766 1.226 . . . . 0.0 113.698 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.68 -60.82 0.44 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.832 1.253 . . . . 0.0 112.238 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -141.89 101.58 3.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.207 1.403 . . . . 0.0 109.457 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.27 152.93 42.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.78 0.705 . . . . 0.0 113.514 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -131.93 157.49 43.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.875 1.27 . . . . 0.0 112.406 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.55 150.38 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.143 1.777 . . . . 0.0 108.53 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -140.15 102.68 4.43 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.226 0.466 . . . . 0.0 110.268 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -119.26 161.01 21.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.249 1.419 . . . . 0.0 112.841 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -78.12 161.86 27.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.745 0.818 . . . . 0.0 109.999 164.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 53.89 90.04 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.769 2.028 . . . . 0.0 113.937 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.99 -25.65 81.87 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.078 2.519 . . . . 0.0 114.523 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -72.69 -25.47 61.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.923 0.783 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -66.73 -42.63 85.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.29 0.95 . . . . 0.0 111.462 167.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.31 -42.79 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.603 1.161 . . . . 0.0 110.952 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -66.49 -45.39 79.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.668 0.787 . . . . 0.0 111.931 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.72 -34.63 74.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.59 0.756 . . . . 0.0 112.357 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.8 -27.62 63.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.68 -48.54 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.958 -1.714 . . . . 0.0 110.505 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.32 2.3 7.8 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.7 t -98.99 -33.05 10.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.877 1.671 . . . . 0.0 112.899 169.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -122.11 -28.26 4.42 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 t -88.08 12.67 12.95 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.954 1.302 . . . . 0.0 112.314 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 126.693 1.997 . . . . 0.0 110.399 177.548 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.8 mt -124.94 138.21 54.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.193 1.397 . . . . 0.0 108.917 165.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -132.36 131.31 41.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.178 0.991 . . . . 0.0 110.799 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.75 140.38 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.214 1.006 . . . . 0.0 111.485 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.1 t -134.99 117.64 15.98 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.354 1.062 . . . . 0.0 110.126 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 123.866 0.866 . . . . 0.0 112.28 178.619 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 CA--C 1.533 0.474 0 N-CA-C 112.954 0.328 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 105.06 5.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.227 1.011 . . . . 0.0 110.013 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -128.74 140.39 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.143 0.977 . . . . 0.0 111.294 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -112.25 150.41 30.96 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.952 0.901 . . . . 0.0 112.169 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.07 122.89 35.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.425 1.89 . . . . 0.0 108.707 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -103.59 148.36 26.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.843 1.657 . . . . 0.0 111.524 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.09 135.48 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.537 1.535 . . . . 0.0 110.447 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.41 172.56 2.66 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.568 1.08 . . . . 0.0 113.756 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.67 33.66 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 -161.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.59 -32.97 0.39 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 126.4 1.88 . . . . 0.0 115.307 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.05 -7.23 20.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 123.612 2.326 . . . . 0.0 114.271 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.72 -5.41 8.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.87 1.268 . . . . 0.0 113.254 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -122.68 -38.54 2.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.635 1.974 . . . . 0.0 113.959 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -146.47 127.88 14.95 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.472 1.509 . . . . 0.0 109.113 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.39 127.94 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.438 0.695 . . . . 0.0 111.611 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -152.8 143.32 22.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.093 1.357 . . . . 0.0 109.972 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -57.21 -30.08 64.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.419 1.009 . . . . 0.0 112.426 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.09 -28.95 68.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.896 1.678 . . . . 0.0 113.235 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.43 -45.65 58.65 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.423 1.089 . . . . 0.0 111.514 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.82 -40.93 97.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.496 -0.752 . . . . 0.0 110.252 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.4 -45.28 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.422 1.089 . . . . 0.0 112.424 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.17 82.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.347 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.9 mt -61.02 -74.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.92 1.288 . . . . 0.0 108.494 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -124.53 124.42 42.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.528 1.058 . . . . 0.0 111.444 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.484 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 4.3 m -157.93 -34.31 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 156.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 25' ' ' SER . 56.8 Cg_endo -85.25 5.17 6.33 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 CA-C-N 122.902 2.072 . . . . 0.0 113.686 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.46 -21.34 30.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.08 -157.76 12.87 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 120.084 1.311 . . . . 0.0 116.0 -171.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -68.93 -25.99 64.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.269 1.4 mp 63.72 167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.213 1.405 . . . . 0.0 113.731 170.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.1 mtm -153.04 -72.74 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.388 -1.445 . . . . 0.0 109.889 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.01 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.538 1.135 . . . . 0.0 113.281 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.7 mt -82.46 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 161.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -135.73 66.12 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.423 1.106 . . . . 0.0 111.074 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 tt -83.19 150.96 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.11 0.964 . . . . 0.0 111.883 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -114.4 -175.98 2.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.379 1.872 . . . . 0.0 111.299 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -79.59 -15.03 58.39 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.03 -10.65 2.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.41 159.2 35.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 112.837 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.03 124.36 5.99 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.427 -0.651 . . . . 0.0 111.584 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -128.62 149.19 50.75 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.829 1.299 . . . . 0.0 111.802 164.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.95 149.33 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 126.617 1.967 . . . . 0.0 107.818 166.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -137.08 100.66 4.34 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.049 0.94 . . . . 0.0 108.631 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -124.19 153.91 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.027 1.731 . . . . 0.0 112.837 -167.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -81.36 155.34 26.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.274 0.629 . . . . 0.0 110.695 166.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 59.99 95.65 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 130.226 3.41 . . . . 0.0 116.333 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -67.26 -18.03 50.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.449 2.766 . . . . 0.0 113.46 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -74.76 -27.83 60.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.433 1.015 . . . . 0.0 111.636 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -75.47 -39.24 58.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.562 0.619 . . . . 0.0 111.914 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.21 -41.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.919 0.487 . . . . 0.0 110.598 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -61.91 -49.16 77.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.307 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -55.7 -41.82 74.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.833 0.742 . . . . 0.0 111.591 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.35 -34.34 77.76 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.399 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.2 mt -63.42 -50.49 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.509 1.504 . . . . 0.0 111.025 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.1 -12.49 61.23 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.15 -20.72 17.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.377 1.471 . . . . 0.0 113.241 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -125.48 -29.56 3.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -91.32 -1.53 57.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.766 1.226 . . . . 0.0 112.927 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 108.872 -172.502 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 mt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.5 mt -134.9 140.68 45.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.259 1.824 . . . . 0.0 108.503 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.2 137.75 34.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.98 0.809 . . . . 0.0 112.841 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.81 142.0 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.742 1.217 . . . . 0.0 112.606 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t -143.29 171.6 13.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.723 2.009 . . . . 0.0 109.826 171.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.1 m . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 125.257 1.423 . . . . 0.0 111.268 176.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.536 0.62 0 N-CA-C 112.615 0.198 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.45 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.865 2.066 . . . . 0.0 108.2 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -135.27 123.67 23.32 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.375 1.07 . . . . 0.0 109.75 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -88.48 151.72 22.35 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.842 0.829 . . . . 0.0 112.197 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.38 129.46 53.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.23 1.812 . . . . 0.0 107.541 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -109.86 134.78 51.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.208 1.403 . . . . 0.0 110.555 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mm -94.93 116.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.345 1.058 . . . . 0.0 108.712 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.82 149.51 25.09 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 119.566 -0.575 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -55.32 72.02 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.628 2.771 . . . . 0.0 115.148 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.432 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 94.9 mt -126.19 -37.75 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.911 2.485 . . . . 0.0 113.832 170.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 40.8 Cg_endo -83.8 59.47 6.22 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.782 2.321 . . . . 0.0 112.119 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.126 1.37 . . . . 0.0 113.021 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.93 146.84 45.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.042 1.337 . . . . 0.0 113.43 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.8 t30 35.83 59.82 0.84 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.237 2.215 . . . . 0.0 114.289 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.49 138.34 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.871 0.843 . . . . 0.0 111.789 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -120.08 159.96 23.78 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.862 1.665 . . . . 0.0 110.263 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -17.54 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.05 -1.031 . . . . 0.0 113.173 161.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -74.26 -23.45 59.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.326 1.051 . . . . 0.0 112.999 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.19 -35.95 63.99 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.803 -1.185 . . . . 0.0 110.732 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.32 -43.51 98.65 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.685 -1.26 . . . . 0.0 110.639 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.11 -44.2 96.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.091 0.956 . . . . 0.0 112.554 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -64.0 -36.64 84.65 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.13 -0.981 . . . . 0.0 111.574 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.67 -70.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.154 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.86 125.14 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.136 1.334 . . . . 0.0 111.394 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.465 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 17.5 m -158.73 -37.77 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.027 1.731 . . . . 0.0 113.588 164.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.2 Cg_endo -83.84 34.53 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.469 2.113 . . . . 0.0 113.311 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.33 123.35 16.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.643 1.577 . . . . 0.0 110.722 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.35 -160.1 53.93 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.581 0.61 . . . . 0.0 113.487 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -107.24 -5.08 18.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.934 1.294 . . . . 0.0 113.904 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 1.6 mp 67.57 154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.771 2.028 . . . . 0.0 114.404 171.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.5 mmt -151.66 -56.44 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.758 1.623 . . . . 0.0 110.5 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -159.12 148.65 18.78 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.626 1.103 . . . . 0.0 113.645 -170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 147.7 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.191 0.996 . . . . 0.0 111.169 163.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -147.66 101.85 3.37 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.298 0.954 . . . . 0.0 111.688 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.47 149.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.312 -1.493 . . . . 0.0 113.056 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -123.88 156.12 36.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.115 1.366 . . . . 0.0 111.329 167.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -65.39 22.91 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 127.395 2.278 . . . . 0.0 116.941 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.08 -33.11 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.485 1.514 . . . . 0.0 112.667 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -152.82 156.04 38.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.865 1.666 . . . . 0.0 110.217 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.23 152.44 18.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.657 0.646 . . . . 0.0 113.699 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.74 156.21 34.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 123.254 1.502 . . . . 0.0 111.683 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.65 152.86 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.98 2.112 . . . . 0.0 107.334 166.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -136.14 101.27 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -121.52 155.0 35.92 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.943 1.297 . . . . 0.0 112.024 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -75.47 157.01 34.65 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.937 0.495 . . . . 0.0 111.218 164.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 68.34 82.29 0.19 Allowed Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 128.797 2.839 . . . . 0.0 115.517 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -57.93 -37.71 95.07 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.592 2.861 . . . . 0.0 113.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -66.59 -34.31 77.61 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.197 -0.939 . . . . 0.0 112.822 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.7 m -87.06 -21.48 26.04 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -43.98 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.205 0.911 . . . . 0.0 109.836 162.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -63.03 -40.37 97.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.984 0.914 . . . . 0.0 112.461 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.24 -35.96 74.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.263 0.625 . . . . 0.0 112.374 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.64 61.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.611 0.764 . . . . 0.0 112.778 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.66 -53.11 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.485 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -67.02 -9.54 40.17 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.76 -33.13 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.122 1.769 . . . . 0.0 113.966 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 59' ' ' GLN . 5.9 tp10 -127.83 -15.91 4.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 t -74.97 33.2 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 111.519 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 57' ' ' GLU . 6.4 pt20 . . . . . 0 C--N 1.328 -0.333 0 C-N-CA 128.324 2.65 . . . . 0.0 108.021 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 mt -128.92 143.24 50.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.44 1.896 . . . . 0.0 109.057 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -140.09 135.36 32.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.03 0.832 . . . . 0.0 112.59 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.16 144.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.95 0.9 . . . . 0.0 111.095 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.31 129.61 23.84 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.846 1.258 . . . . 0.0 110.46 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 124.207 1.003 . . . . 0.0 112.784 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.546 1.106 0 N-CA-C 115.773 1.413 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt 65.12 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.191 2.597 . . . . 0.0 116.586 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -147.9 172.56 13.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.975 1.71 . . . . 0.0 111.412 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -135.08 161.58 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.153 1.381 . . . . 0.0 113.285 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.19 129.65 31.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.937 1.695 . . . . 0.0 110.309 -171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -111.12 141.69 44.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.781 1.632 . . . . 0.0 111.92 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 mm -101.6 96.76 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.709 1.604 . . . . 0.0 110.291 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 -3.66 84.84 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.409 1.481 . . . . 0.0 115.404 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 47.02 0.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.02 1.91 . . . . 0.0 113.664 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 40.93 59.35 8.24 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.392 1.877 . . . . 0.0 113.589 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.45 25.88 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.027 3.818 . . . . 0.0 114.543 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 -12.99 46.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.26 1.424 . . . . 0.0 113.252 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.64 137.16 51.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.837 1.655 . . . . 0.0 112.303 -167.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 50.95 48.65 22.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.304 1.442 . . . . 0.0 114.062 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 m -112.45 146.15 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 122.574 1.178 . . . . 0.0 113.135 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -146.7 166.76 25.61 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 109.694 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 25.2 mmtp -50.45 -32.04 16.79 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.266 -0.896 . . . . 0.0 112.752 172.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.23 -20.66 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.456 1.102 . . . . 0.0 113.459 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.89 -48.26 32.2 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.629 1.104 . . . . 0.0 110.848 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.61 -35.79 79.61 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -71.52 -40.25 70.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.904 0.882 . . . . 0.0 112.989 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -25.53 60.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.627 1.103 . . . . 0.0 112.527 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.38 -74.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -124.14 125.39 44.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.626 1.557 . . . . 0.0 112.13 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -149.62 -54.25 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 161.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.06 22.47 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.203 2.602 . . . . 0.0 114.085 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -90.39 -33.03 16.19 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.328 -1.483 . . . . 0.0 114.844 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.07 11.9 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 119.122 0.874 . . . . 0.0 114.16 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.14 -24.56 63.19 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp 66.91 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.36 -59.37 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.622 -1.299 . . . . 0.0 111.019 161.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -145.29 138.98 26.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.148 0.979 . . . . 0.0 111.918 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tt -123.38 127.31 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.74 1.616 . . . . 0.0 110.056 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 5.2 p30 -128.8 152.81 48.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.767 1.227 . . . . 0.0 111.616 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -141.87 154.07 19.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.083 -1.011 . . . . 0.0 112.154 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' H ' HD12 ' A' ' 35' ' ' ILE . 42.1 tptt -149.38 146.99 27.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.301 1.441 . . . . 0.0 110.91 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -57.34 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 128.539 2.736 . . . . 0.0 116.872 168.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.95 -63.9 0.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.778 1.631 . . . . 0.0 110.669 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -141.46 111.82 6.92 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.985 0.914 . . . . 0.0 110.96 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.72 151.28 33.84 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.549 0.595 . . . . 0.0 112.482 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.37 156.08 46.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.714 1.245 . . . . 0.0 111.83 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.67 143.55 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.942 0.897 . . . . 0.0 109.221 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -127.67 98.44 5.2 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.582 1.153 . . . . 0.0 108.142 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -120.78 151.24 39.83 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.595 1.158 . . . . 0.0 111.672 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.03 159.99 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.756 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 64.74 82.73 0.21 Allowed Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 127.701 2.4 . . . . 0.0 112.818 -160.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.69 -33.05 47.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.14 3.227 . . . . 0.0 113.887 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -77.11 -23.38 51.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.838 0.855 . . . . 0.0 112.942 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -69.91 -41.98 73.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 163.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.76 -43.33 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.047 0.539 . . . . 0.0 110.569 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.97 -43.77 67.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.168 0.895 . . . . 0.0 113.234 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.41 -33.65 75.2 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.37 0.986 . . . . 0.0 111.731 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.18 68.88 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.287 -0.883 . . . . 0.0 112.97 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.65 -53.0 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.298 1.408 . . . . 0.0 110.4 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.45 -15.92 63.93 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.4 m -84.22 -45.72 12.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.645 1.178 . . . . 0.0 113.68 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -104.0 -29.31 11.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 t -74.89 1.28 13.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.71 0.804 . . . . 0.0 111.598 164.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 CA--C 1.536 0.413 0 O-C-N 120.937 -1.102 . . . . 0.0 110.832 174.606 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 mt -127.25 139.96 52.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.542 1.137 . . . . 0.0 109.354 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -131.64 138.13 48.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.451 0.569 . . . . 0.0 112.303 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.07 130.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -133.97 148.79 51.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.151 . . . . 0.0 109.632 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.538 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 N-CA-C 111.409 -0.266 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 134.69 41.7 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.905 0.882 . . . . 0.0 111.554 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -146.87 155.76 42.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.63 1.572 . . . . 0.0 109.304 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -121.14 161.13 22.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.755 0.788 . . . . 0.0 112.663 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.8 121.89 19.04 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.478 1.911 . . . . 0.0 108.291 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -104.35 134.64 47.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.738 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 mm -91.49 132.18 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.742 0.817 . . . . 0.0 108.834 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -155.38 5.63 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.044 0.831 . . . . 0.0 113.104 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.6 83.39 0.43 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.217 -1.166 . . . . 0.0 111.591 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.418 ' H ' ' CD ' ' A' ' 11' ' ' PRO . 58.2 tp -139.44 -41.71 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.996 1.718 . . . . 0.0 115.011 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.418 ' CD ' ' H ' ' A' ' 10' ' ' LEU . 21.4 Cg_endo -93.51 17.75 1.03 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.255 1.97 . . . . 0.0 114.488 -162.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.33 22.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 131.75 27.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.267 2.227 . . . . 0.0 110.754 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 t30 40.15 47.71 2.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.353 1.461 . . . . 0.0 113.728 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.61 125.9 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 123.7 0.8 . . . . 0.0 110.965 -161.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -159.83 151.41 20.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.365 1.466 . . . . 0.0 110.599 -167.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -61.4 -16.73 49.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -69.73 -33.78 72.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.485 0.584 . . . . 0.0 112.345 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.2 -35.78 74.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.207 1.367 . . . . 0.0 112.036 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.42 -39.46 71.07 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -61.95 -38.42 88.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.994 0.918 . . . . 0.0 112.392 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -36.4 82.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.687 0.795 . . . . 0.0 110.938 174.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.36 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -122.53 121.08 35.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.854 1.206 . . . . 0.0 111.717 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.58 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.9 p -150.51 -30.1 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 159.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 25' ' ' SER . 44.5 Cg_endo -81.92 26.2 0.63 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.242 2.194 . . . . 0.0 113.265 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -121.62 137.24 54.82 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.592 1.957 . . . . 0.0 110.67 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.1 -159.42 49.7 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 121.841 0.69 . . . . 0.0 114.431 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -100.8 -7.68 23.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.229 1.012 . . . . 0.0 113.543 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 67.85 142.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.025 2.13 . . . . 0.0 115.372 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 mmt -138.73 -81.71 0.31 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.953 1.301 . . . . 0.0 111.018 170.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -137.55 162.18 34.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.301 1.841 . . . . 0.0 113.583 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 tt -149.64 121.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.728 1.211 . . . . 0.0 110.977 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.87 101.92 6.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.472 1.109 . . . . 0.0 111.556 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.16 135.95 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.63 0.772 . . . . 0.0 112.114 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -120.88 165.95 14.48 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.209 1.803 . . . . 0.0 110.38 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -78.15 -18.82 55.1 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 -4.94 9.35 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -164.36 179.54 6.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.25 1.82 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.57 159.02 27.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 120.573 -1.329 . . . . 0.0 114.763 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.36 149.85 51.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.532 1.533 . . . . 0.0 112.084 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.8 150.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 127.024 2.13 . . . . 0.0 108.334 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -132.9 113.99 13.51 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 167.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -125.96 155.54 41.2 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.532 1.158 . . . . 0.0 112.308 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -80.3 144.53 32.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.686 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 80.03 82.03 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.382 3.073 . . . . 0.0 115.155 -170.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.53 -38.68 88.65 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.22 3.28 . . . . 0.0 114.494 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.01 -29.18 67.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.98 -1.075 . . . . 0.0 111.855 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -68.76 -35.0 76.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.49 -40.1 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.437 0.695 . . . . 0.0 109.691 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -65.81 -40.1 91.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.527 170.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.85 -38.34 81.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.2 0.909 . . . . 0.0 111.191 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.41 70.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.529 0.731 . . . . 0.0 112.693 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.27 -50.38 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.265 1.393 . . . . 0.0 110.395 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.22 -12.27 61.53 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.323 0.965 . . . . 0.0 113.393 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -96.86 -28.86 14.04 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -108.53 -56.3 2.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.398 1.479 . . . . 0.0 111.994 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -14.34 58.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.737 1.215 . . . . 0.0 113.151 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 125.802 1.641 . . . . 0.0 112.733 -179.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 mt -129.49 148.49 51.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.298 2.239 . . . . 0.0 107.536 166.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -142.42 130.17 21.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.81 138.9 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.406 1.482 . . . . 0.0 112.664 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.3 t -135.38 148.76 49.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 112.766 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 125.169 1.387 . . . . 0.0 112.49 167.624 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.541 0.855 0 CA-C-O 120.102 -0.041 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.66 140.43 40.82 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.117 0.967 . . . . 0.0 113.209 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 141.89 15.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.575 1.55 . . . . 0.0 110.355 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -116.77 145.73 43.3 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.946 0.898 . . . . 0.0 111.717 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.88 124.42 44.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.533 1.533 . . . . 0.0 108.739 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -108.86 135.83 49.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.2 mm -90.72 80.17 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.089 1.356 . . . . 0.0 110.776 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 -4.3 12.28 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.18 1.371 . . . . 0.0 115.164 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.19 -10.81 34.43 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.649 1.98 . . . . 0.0 114.248 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.6 mt 48.53 63.79 9.76 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.066 1.746 . . . . 0.0 113.803 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.99 45.25 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 125.663 4.242 . . . . 0.0 113.679 -173.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -50.43 -23.69 2.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.023 2.129 . . . . 0.0 115.998 -166.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.05 2.8 5.88 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.538 2.335 . . . . 0.0 114.075 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -135.67 61.62 1.65 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 110.8 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.58 117.89 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.789 1.235 . . . . 0.0 110.965 -173.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 t -155.38 151.95 28.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -50.59 -34.09 24.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.549 1.14 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -68.69 -22.38 64.37 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.09 -35.14 64.18 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.339 -1.475 . . . . 0.0 111.24 174.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.55 -40.89 69.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.376 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -69.29 -38.45 78.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.825 0.85 . . . . 0.0 113.184 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -28.1 65.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.68 -77.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.638 1.175 . . . . 0.0 108.526 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -117.53 112.36 20.49 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.693 1.133 . . . . 0.0 111.588 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.413 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 42.8 t -159.95 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.665 1.586 . . . . 0.0 112.294 167.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD2' ' H ' ' A' ' 25' ' ' SER . 50.4 Cg_endo -87.96 17.15 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 115.358 -171.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -90.29 1.32 56.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.542 1.137 . . . . 0.0 114.043 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.45 19.47 76.32 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.474 1.034 . . . . 0.0 113.905 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -137.75 137.43 38.27 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.595 1.158 . . . . 0.0 110.066 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 tp -158.28 163.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.543 1.137 . . . . 0.0 109.517 -170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.5 tpp -164.59 -67.35 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.668 0.787 . . . . 0.0 110.49 150.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -139.81 144.19 37.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 111.953 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 pt -107.85 141.85 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.107 0.963 . . . . 0.0 110.846 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -145.31 72.36 1.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.684 1.193 . . . . 0.0 110.464 -172.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 tt -90.78 138.11 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.863 -1.148 . . . . 0.0 113.118 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.85 157.0 30.74 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 110.371 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.02 8.53 0.53 Allowed 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -168.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.8 -51.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.349 1.46 . . . . 0.0 111.901 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.73 138.32 23.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.396 1.078 . . . . 0.0 110.738 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.99 160.09 30.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -127.18 152.71 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.898 1.279 . . . . 0.0 111.632 167.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.33 145.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.615 1.566 . . . . 0.0 108.246 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -130.42 87.94 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.633 1.573 . . . . 0.0 107.088 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -115.13 169.68 8.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.619 1.568 . . . . 0.0 112.573 -167.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -91.35 177.52 6.22 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.181 1.393 . . . . 0.0 111.333 168.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 49.15 81.03 0.27 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.741 2.416 . . . . 0.0 114.423 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.29 -29.65 89.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.497 2.798 . . . . 0.0 114.242 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -73.79 -33.94 64.42 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.468 -0.77 . . . . 0.0 111.597 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -70.65 -31.2 68.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.3 0.955 . . . . 0.0 112.622 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.66 -48.1 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.425 0.69 . . . . 0.0 110.518 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -64.66 -44.47 90.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.714 0.688 . . . . 0.0 112.546 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.94 -38.23 72.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.552 1.141 . . . . 0.0 112.322 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.03 -26.22 62.12 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.572 -0.705 . . . . 0.0 112.891 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.39 -51.61 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.045 1.293 . . . . 0.0 110.392 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.89 -17.95 65.01 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.79 -60.11 2.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.312 0.645 . . . . 0.0 111.973 167.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.02 -35.84 20.09 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.322 1.449 . . . . 0.0 114.722 -166.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -85.55 -3.98 59.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.612 1.565 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 124.508 1.123 . . . . 0.0 109.403 163.498 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.62 139.44 53.92 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.92 1.688 . . . . 0.0 108.525 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -132.7 134.77 45.22 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.243 0.929 . . . . 0.0 112.154 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.65 137.92 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.384 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 m -139.67 167.25 22.54 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.089 1.756 . . . . 0.0 110.773 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.468 0.451 0 O-C-N 121.269 -0.895 . . . . 0.0 111.578 -174.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 112.914 0.313 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.53 156.02 18.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.307 1.843 . . . . 0.0 111.956 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -159.05 167.04 30.3 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.049 0.939 . . . . 0.0 111.468 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -130.1 165.01 23.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.93 126.11 42.69 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.291 2.236 . . . . 0.0 109.117 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -106.68 143.1 35.26 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.662 1.585 . . . . 0.0 111.498 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.7 101.7 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.668 1.587 . . . . 0.0 110.96 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 7.52 75.59 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.038 1.304 . . . . 0.0 114.909 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -74.29 15.32 0.34 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.25 80.96 0.27 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.373 2.269 . . . . 0.0 112.677 -163.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.39 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.059 3.173 . . . . 0.0 111.892 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 mp 53.15 22.95 2.81 Favored 'General case' 0 CA--C 1.557 1.214 0 O-C-N 120.408 -1.432 . . . . 0.0 113.837 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -150.9 150.11 30.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.341 2.256 . . . . 0.0 110.469 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 m120 45.36 39.67 4.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.291 1.437 . . . . 0.0 113.224 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.77 34.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.739 1.615 . . . . 0.0 113.488 -157.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -90.68 147.53 23.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.898 1.279 . . . . 0.0 110.801 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.33 -32.29 10.88 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -62.97 -12.73 27.67 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.96 -43.71 70.98 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.983 -1.073 . . . . 0.0 111.893 168.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.68 -36.7 65.34 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.641 -0.662 . . . . 0.0 110.73 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.07 -45.52 91.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.491 0.716 . . . . 0.0 112.045 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -28.08 64.09 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.608 -0.682 . . . . 0.0 112.798 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.83 -75.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -123.85 126.58 46.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.843 1.201 . . . . 0.0 111.137 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 3.7 m -157.78 -20.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 160.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 25' ' ' SER . 29.4 Cg_endo -91.85 15.27 1.66 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 123.558 2.306 . . . . 0.0 113.166 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -105.58 154.68 20.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.563 1.145 . . . . 0.0 113.472 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 -146.28 43.43 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.699 1.143 . . . . 0.0 115.761 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.46 -0.6 27.74 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.177 1.391 . . . . 0.0 112.784 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.271 1.3 tp 63.5 171.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 128.376 2.67 . . . . 0.0 116.435 166.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mtm -171.6 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.692 1.597 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -142.63 136.99 29.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.273 1.429 . . . . 0.0 112.457 -164.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tt -85.2 139.31 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.056 0.942 . . . . 0.0 109.929 163.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -143.4 77.83 1.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.921 0.782 . . . . 0.0 111.665 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -88.15 138.71 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 122.076 0.941 . . . . 0.0 111.62 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -130.49 147.22 52.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.679 1.592 . . . . 0.0 108.336 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -75.0 35.86 0.11 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.37 -57.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.103 1.761 . . . . 0.0 109.52 166.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.84 126.58 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.133 1.373 . . . . 0.0 110.22 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.21 149.12 24.77 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 122.604 0.145 . . . . 0.0 112.926 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -134.37 162.41 32.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.324 1.45 . . . . 0.0 111.501 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.95 149.13 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 108.602 167.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -131.98 97.96 4.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.799 1.24 . . . . 0.0 107.936 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.51 145.53 50.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 112.284 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -73.75 154.15 39.71 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 166.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 64.34 86.98 0.13 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.477 2.711 . . . . 0.0 114.638 -166.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.0 -24.48 65.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.753 2.302 . . . . 0.0 114.423 174.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -68.54 -43.38 76.84 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.328 0.967 . . . . 0.0 110.719 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.7 m -72.8 -29.67 63.46 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.19 -46.03 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.873 0.76 . . . . 0.0 109.867 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -63.91 -37.54 87.8 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.288 1.035 . . . . 0.0 112.812 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.15 -45.19 94.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.305 0.642 . . . . 0.0 111.139 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 -31.34 72.45 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.563 -0.711 . . . . 0.0 112.322 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.24 -54.92 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.911 1.232 . . . . 0.0 110.58 172.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -71.67 -16.07 62.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -89.44 -36.17 15.59 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -103.13 -24.29 13.6 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.059 1.344 . . . . 0.0 113.911 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.3 p -68.51 -5.8 21.6 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.129 -1.607 . . . . 0.0 113.221 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.925 1.69 . . . . 0.0 112.84 -170.616 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 121.713 0.768 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -128.79 143.03 50.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.546 2.339 . . . . 0.0 106.623 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -136.19 132.25 35.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.266 1.394 . . . . 0.0 112.446 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.4 144.1 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.021 0.928 . . . . 0.0 110.654 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 t -140.95 147.99 39.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.432 1.093 . . . . 0.0 110.87 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.7 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.407 0.622 . . . . 0.0 111.267 170.544 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 CA--C 1.537 0.66 0 N-CA-C 114.311 0.85 . . . . 0.0 114.311 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.35 148.9 52.22 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.847 2.059 . . . . 0.0 110.006 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 p -162.94 161.68 25.81 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.285 1.434 . . . . 0.0 109.992 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.25 156.24 44.96 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.309 1.043 . . . . 0.0 111.395 160.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.35 117.78 23.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.199 2.199 . . . . 0.0 107.988 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -100.42 147.02 26.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.715 1.206 . . . . 0.0 111.501 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mm -103.29 131.56 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.84 1.256 . . . . 0.0 109.117 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.44 -176.49 4.82 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 121.399 0.444 . . . . 0.0 113.386 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.69 47.51 0.51 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.508 1.523 . . . . 0.0 114.911 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -119.02 -25.28 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 127.261 2.224 . . . . 0.0 115.518 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.9 38.6 0.76 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.92 2.414 . . . . 0.0 112.595 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.7 49.36 1.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.353 1.861 . . . . 0.0 110.183 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.45 37.58 1.69 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.301 1.84 . . . . 0.0 113.168 -161.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 51.36 61.08 3.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.053 1.741 . . . . 0.0 112.399 -172.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.19 149.35 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.089 0.956 . . . . 0.0 113.157 -167.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -138.78 164.43 29.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.109 2.563 . . . . 0.0 109.328 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -49.57 -32.44 12.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.468 1.107 . . . . 0.0 113.136 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -49.55 -36.56 23.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.549 1.539 . . . . 0.0 113.931 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.93 -39.59 50.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 111.94 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.01 -39.67 95.44 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.502 -0.749 . . . . 0.0 110.279 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.12 -36.67 74.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.985 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -69.28 -36.13 76.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.059 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.9 mt -63.1 -77.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.154 0.982 . . . . 0.0 108.871 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -120.3 121.08 37.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.97 1.259 . . . . 0.0 112.304 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.563 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.4 t -152.14 -38.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 112.98 165.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.563 ' HD2' ' H ' ' A' ' 25' ' ' SER . 47.4 Cg_endo -83.92 46.4 2.01 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.632 2.221 . . . . 0.0 112.18 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.96 145.63 49.72 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.491 1.116 . . . . 0.0 111.51 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.77 -155.4 33.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -97.71 0.89 47.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.686 0.794 . . . . 0.0 112.648 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tp 60.95 175.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.133 2.173 . . . . 0.0 113.7 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 mtm -166.11 -73.56 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.393 1.477 . . . . 0.0 109.051 160.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -144.22 153.53 42.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.663 1.185 . . . . 0.0 112.364 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 tt -122.49 130.93 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 126.292 1.837 . . . . 0.0 109.425 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.06 146.48 50.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.484 1.114 . . . . 0.0 112.316 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.14 148.79 23.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.135 1.374 . . . . 0.0 110.812 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -136.08 -176.44 4.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.639 1.576 . . . . 0.0 109.736 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -65.4 122.95 18.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.65 0.78 . . . . 0.0 110.661 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.44 10.03 0.44 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -157.04 157.64 35.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.529 1.532 . . . . 0.0 110.881 171.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.17 161.7 28.8 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.507 -0.746 . . . . 0.0 113.08 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -140.15 116.93 10.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.833 1.253 . . . . 0.0 110.865 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.98 148.5 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.858 -1.151 . . . . 0.0 108.939 164.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -137.19 98.28 3.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.859 0.864 . . . . 0.0 109.316 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -123.06 153.81 39.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 112.951 -169.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -81.06 153.66 27.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.408 1.083 . . . . 0.0 110.525 164.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 67.81 75.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 128.762 2.825 . . . . 0.0 113.852 -164.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -52.32 -35.77 65.74 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.982 3.121 . . . . 0.0 114.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -64.82 -39.37 93.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.004 0.82 . . . . 0.0 111.857 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -63.86 -31.26 72.38 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 -43.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.944 0.898 . . . . 0.0 109.942 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.74 -45.39 85.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.981 0.81 . . . . 0.0 111.675 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -62.48 -40.03 95.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.722 0.809 . . . . 0.0 112.257 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.04 72.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.379 0.672 . . . . 0.0 112.238 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.66 -51.08 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.517 1.053 . . . . 0.0 110.431 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.61 -15.39 63.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.81 -39.7 15.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.415 1.486 . . . . 0.0 114.141 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.15 -30.95 6.79 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -68.87 -3.16 11.57 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.562 -1.336 . . . . 0.0 113.623 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 . . . . . 0 CA--C 1.546 0.794 0 C-N-CA 128.026 2.531 . . . . 0.0 112.015 178.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -129.31 141.78 51.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.438 1.895 . . . . 0.0 109.601 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.36 135.29 30.33 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.2 p -102.18 137.67 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.325 1.05 . . . . 0.0 112.057 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -143.66 141.11 30.41 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.873 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.242 1.017 . . . . 0.0 112.905 173.582 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.532 0.415 0 N-CA-C 113.559 0.561 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HB3' HE22 ' A' ' 43' ' ' GLN . 0.6 OUTLIER -131.44 118.56 20.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.765 2.026 . . . . 0.0 109.506 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -136.42 108.06 7.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.468 1.107 . . . . 0.0 110.118 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -84.98 149.26 25.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.369 0.604 . . . . 0.0 110.855 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.57 120.22 29.05 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.475 1.51 . . . . 0.0 108.117 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -99.18 136.26 39.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.537 1.535 . . . . 0.0 110.744 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -93.13 107.14 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 109.799 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.17 0.83 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.332 1.444 . . . . 0.0 113.947 173.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.65 148.86 39.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.321 1.848 . . . . 0.0 111.207 166.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.9 tp -110.28 90.72 10.35 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.43 1.892 . . . . 0.0 109.341 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.54 -23.62 23.14 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.367 2.711 . . . . 0.0 112.615 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . 0.283 1.6 tt 55.25 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.965 3.306 . . . . 0.0 114.236 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -97.78 -2.69 40.51 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.5 17.99 13.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.572 1.149 . . . . 0.0 113.457 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.12 126.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.786 1.634 . . . . 0.0 113.538 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 t -155.5 142.65 19.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 112.438 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.1 -32.13 71.81 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.754 -0.591 . . . . 0.0 111.019 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.06 -24.57 67.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.557 1.143 . . . . 0.0 112.828 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.09 -41.35 50.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.357 0.98 . . . . 0.0 111.739 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.95 -39.58 87.32 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 110.983 172.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -63.95 -43.79 94.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.172 0.989 . . . . 0.0 112.03 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.714 -1.241 . . . . 0.0 111.397 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.6 mt -58.71 -71.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.402 1.081 . . . . 0.0 109.483 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -124.63 114.56 19.52 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.748 1.158 . . . . 0.0 110.838 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.474 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 33.1 t -155.94 -43.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HD2' ' H ' ' A' ' 25' ' ' SER . 89.9 Cg_endo -83.04 11.38 3.29 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.435 2.09 . . . . 0.0 115.521 -173.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -80.07 16.91 1.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.16 -14.63 32.37 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.555 1.074 . . . . 0.0 115.6 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.482 ' CE1' HD21 ' A' ' 46' ' ' ASN . 47.8 m-70 -135.97 141.1 44.39 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.404 1.882 . . . . 0.0 108.64 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 tp -153.37 161.48 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.449 0.699 . . . . 0.0 111.061 -162.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -151.9 -65.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.497 152.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -152.95 153.31 32.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.393 0.997 . . . . 0.0 113.434 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.53 140.2 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.26 1.424 . . . . 0.0 108.891 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -129.84 65.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.735 1.255 . . . . 0.0 110.679 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.35 138.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.821 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -125.82 155.42 41.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.517 1.527 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.83 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -165.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.91 -42.75 0.31 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.943 1.297 . . . . 0.0 112.767 167.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -148.91 146.77 28.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.84 1.256 . . . . 0.0 110.254 171.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.86 164.46 17.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -170.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -130.0 163.65 26.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.496 1.518 . . . . 0.0 110.543 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.96 155.12 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 109.238 166.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.401 HE22 ' HB3' ' A' ' 2' ' ' LYS . 42.3 tp60 -140.93 92.24 2.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.544 1.538 . . . . 0.0 108.28 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -112.33 165.83 11.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.23 1.412 . . . . 0.0 112.815 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.16 163.67 18.6 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.291 1.036 . . . . 0.0 111.062 164.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.482 HD21 ' CE1' ' A' ' 29' ' ' HIS . 56.5 t-20 51.41 91.28 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.851 2.46 . . . . 0.0 114.076 -172.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.56 -24.21 75.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.85 1.7 . . . . 0.0 113.969 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -67.28 -35.66 79.94 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.935 0.789 . . . . 0.0 111.587 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.9 m -71.17 -35.73 71.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.336 0.654 . . . . 0.0 112.273 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.34 -41.25 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.889 -0.507 . . . . 0.0 110.424 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -69.53 -36.53 76.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.116 -0.99 . . . . 0.0 112.879 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.33 -35.99 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.212 0.915 . . . . 0.0 111.692 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.02 66.68 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.615 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.14 -52.31 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.475 1.489 . . . . 0.0 110.279 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.14 1.78 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 46.2 t -107.62 -52.69 2.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.23 1.812 . . . . 0.0 112.855 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -88.83 -40.78 12.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.775 1.23 . . . . 0.0 112.501 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -71.09 -3.32 19.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.091 -1.006 . . . . 0.0 112.448 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 128.212 2.605 . . . . 0.0 111.589 179.112 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tp . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 mt -119.98 134.87 55.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.334 1.454 . . . . 0.0 108.001 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.75 128.31 45.12 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.92 142.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.514 1.126 . . . . 0.0 110.598 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 t -141.6 121.05 13.21 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.395 1.078 . . . . 0.0 110.105 171.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 124.781 1.232 . . . . 0.0 111.297 -173.641 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 CA--C 1.547 1.134 0 CA-C-O 121.064 0.36 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.8 123.29 20.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.602 1.161 . . . . 0.0 110.475 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -137.82 114.38 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.855 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -93.0 141.57 28.25 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.703 -0.623 . . . . 0.0 112.529 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.76 133.44 53.98 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.867 2.067 . . . . 0.0 108.36 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -117.57 138.56 51.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.758 2.023 . . . . 0.0 110.773 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -103.13 144.28 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.26 -162.51 1.67 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 122.022 0.79 . . . . 0.0 114.422 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -82.39 19.38 1.25 Allowed 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.601 -1.529 . . . . 0.0 114.675 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.59 -36.83 10.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.619 173.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 13' ' ' LYS . 32.1 Cg_exo -72.54 18.08 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.322 3.348 . . . . 0.0 116.696 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.4 mt -71.96 19.61 0.07 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.012 1.325 . . . . 0.0 113.249 170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 11' ' ' PRO . 22.5 ptmt -126.24 -178.7 4.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 110.409 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -52.16 122.33 8.39 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.311 0.505 . . . . 0.0 111.692 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.11 146.01 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.817 0.818 . . . . 0.0 112.526 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -133.9 168.12 19.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.866 1.667 . . . . 0.0 111.298 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -57.8 -32.51 67.62 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.084 -1.01 . . . . 0.0 111.452 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -64.01 -25.15 67.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.56 -48.19 56.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.624 1.102 . . . . 0.0 110.21 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.27 -38.34 86.39 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.153 -0.967 . . . . 0.0 111.496 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.22 -40.31 93.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.891 1.677 . . . . 0.0 112.16 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -28.4 60.48 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.539 -1.351 . . . . 0.0 113.176 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.0 -45.31 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -137.68 102.26 4.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.178 1.791 . . . . 0.0 111.644 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.452 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.0 t -164.56 -48.56 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.819 1.648 . . . . 0.0 111.923 166.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD2' ' H ' ' A' ' 25' ' ' SER . 83.8 Cg_endo -78.19 20.23 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.984 2.456 . . . . 0.0 115.679 -169.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.23 15.37 22.96 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.421 1.488 . . . . 0.0 114.217 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.2 5.46 62.52 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.523 1.535 . . . . 0.0 116.422 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.444 ' CE1' HD21 ' A' ' 46' ' ' ASN . 87.7 m-70 -143.57 126.32 16.1 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.981 1.712 . . . . 0.0 109.005 -171.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -151.36 160.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -156.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 40.0 mtm -158.01 -84.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.184 2.194 . . . . 0.0 108.122 152.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -135.05 155.94 49.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.684 1.594 . . . . 0.0 114.073 -168.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -109.64 136.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.699 1.6 . . . . 0.0 110.469 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.58 72.09 1.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.524 1.13 . . . . 0.0 111.114 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.4 134.29 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.615 -1.303 . . . . 0.0 110.099 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -134.93 143.1 46.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.736 1.615 . . . . 0.0 109.011 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.1 46.42 0.4 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.41 -41.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.308 1.443 . . . . 0.0 112.283 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.51 151.2 37.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.208 1.403 . . . . 0.0 109.588 168.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 147.28 18.7 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.392 0.52 . . . . 0.0 113.481 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -125.82 155.34 41.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.825 1.298 . . . . 0.0 111.596 164.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.21 155.41 32.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 107.578 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.22 109.37 7.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 167.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -115.08 161.01 18.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.261 1.824 . . . . 0.0 111.125 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.57 146.37 25.17 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.247 -0.908 . . . . 0.0 110.691 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.444 HD21 ' CE1' ' A' ' 29' ' ' HIS . 50.1 t30 68.74 107.58 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 127.722 2.409 . . . . 0.0 114.969 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.87 -19.0 21.28 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.752 1.635 . . . . 0.0 113.329 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.57 -41.39 98.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.31 1.413 . . . . 0.0 113.103 -172.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -82.45 -18.02 43.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.17 -41.68 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.163 0.892 . . . . 0.0 109.705 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -62.83 -44.31 96.48 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.089 -1.007 . . . . 0.0 111.689 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.81 -41.68 91.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.631 0.65 . . . . 0.0 112.03 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.66 90.35 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.42 -0.8 . . . . 0.0 112.575 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.08 -52.67 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.708 1.14 . . . . 0.0 110.716 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.31 -17.74 56.18 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.6 t -73.53 -49.11 28.18 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.239 1.816 . . . . 0.0 111.976 166.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -101.28 -28.51 12.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -162.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -71.49 -18.32 62.3 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.594 1.088 . . . . 0.0 113.373 173.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 110.33 -172.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.17 133.94 44.81 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.052 2.141 . . . . 0.0 107.94 165.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -144.12 131.88 21.33 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.503 1.047 . . . . 0.0 113.775 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.57 141.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.168 0.587 . . . . 0.0 112.038 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.7 m -133.53 127.14 32.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.83 2.052 . . . . 0.0 108.535 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.672 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.476 0.472 0 CA-C-O 119.706 -0.206 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -114.12 111.84 22.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.45 1.1 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -126.42 100.22 6.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.98 0.912 . . . . 0.0 111.162 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.22 153.88 24.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.53 0.681 . . . . 0.0 111.445 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.07 126.12 29.47 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.765 1.626 . . . . 0.0 108.918 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -103.46 137.98 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.788 1.235 . . . . 0.0 111.633 171.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.78 98.55 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.182 0.993 . . . . 0.0 108.97 168.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.52 176.19 50.69 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.736 0.684 . . . . 0.0 111.571 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.91 40.15 24.37 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.312 -1.111 . . . . 0.0 111.724 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.81 123.47 89.6 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.916 1.287 . . . . 0.0 110.566 -162.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.15 107.3 1.67 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.645 2.897 . . . . 0.0 110.009 168.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.15 7.79 1.97 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.478 -1.389 . . . . 0.0 112.771 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -114.78 128.16 56.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.479 2.311 . . . . 0.0 110.876 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 47.56 35.07 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.98 132.76 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 120.767 -1.208 . . . . 0.0 109.537 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.0 p -133.07 163.23 29.72 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 111.461 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -61.15 -24.63 66.43 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.189 -0.944 . . . . 0.0 112.801 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.33 -31.7 70.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.907 0.883 . . . . 0.0 112.1 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.02 -47.08 84.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.95 0.796 . . . . 0.0 110.42 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.76 -40.66 93.33 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.518 -0.739 . . . . 0.0 111.122 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -68.96 -41.41 78.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.336 1.054 . . . . 0.0 113.327 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -22.36 60.25 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 120.665 -1.272 . . . . 0.0 113.275 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 mt -83.55 -41.15 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.347 0.659 . . . . 0.0 109.696 170.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.7 91.58 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.534 1.534 . . . . 0.0 111.888 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 t -157.88 -49.75 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 165.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.35 27.67 0.49 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.205 2.603 . . . . 0.0 114.033 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.77 14.87 25.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.718 1.607 . . . . 0.0 113.381 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.18 -101.31 2.71 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.439 1.019 . . . . 0.0 113.479 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -64.1 135.27 56.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.784 0.834 . . . . 0.0 112.747 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 tp -140.5 163.87 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.314 1.046 . . . . 0.0 112.0 -161.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.0 mtm -152.22 -76.9 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.485 1.114 . . . . 0.0 109.79 152.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -142.73 156.61 45.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.738 1.215 . . . . 0.0 113.807 -166.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mt -119.2 137.15 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.962 2.105 . . . . 0.0 109.642 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.96 84.04 2.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.946 1.299 . . . . 0.0 110.075 -175.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -88.33 135.25 26.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 165.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -132.89 147.75 52.29 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.862 2.065 . . . . 0.0 108.432 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -62.48 -9.42 8.49 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.3 -24.43 11.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -152.94 145.41 24.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.335 1.425 . . . . 0.0 114.035 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.46 131.15 10.47 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.862 1.22 . . . . 0.0 113.035 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -137.33 156.07 48.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.632 1.573 . . . . 0.0 111.95 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.82 154.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.535 1.534 . . . . 0.0 109.256 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -136.01 113.37 10.7 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -117.2 158.37 24.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.117 1.767 . . . . 0.0 112.339 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.05 151.56 31.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 109.87 164.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 48.8 101.67 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 128.103 2.561 . . . . 0.0 114.439 -172.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -55.96 -11.84 6.18 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.34 2.694 . . . . 0.0 115.357 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -61.62 -36.0 79.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.599 1.09 . . . . 0.0 113.701 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.6 p -69.49 -39.95 77.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 111.335 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.61 -45.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.385 1.074 . . . . 0.0 110.483 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -63.92 -40.83 97.39 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 111.829 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.71 -35.32 80.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -40.29 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.439 1.096 . . . . 0.0 112.239 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -58.86 -48.65 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 120.207 1.367 . . . . 0.0 110.707 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.67 -15.03 63.1 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.0 t -89.0 -55.37 3.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.429 1.092 . . . . 0.0 111.5 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -87.43 -36.85 17.49 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.124 1.77 . . . . 0.0 113.804 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -67.42 -22.57 65.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.274 1.397 . . . . 0.0 111.879 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 124.413 1.085 . . . . 0.0 112.032 170.216 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mm . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.9 mt -125.03 129.33 50.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.306 0.642 . . . . 0.0 110.991 -171.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -133.06 127.09 33.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.9 144.87 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.704 1.202 . . . . 0.0 110.957 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.3 t -143.03 150.57 39.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.208 1.403 . . . . 0.0 109.293 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 C--O 1.237 0.446 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 CA-C-O 119.623 -0.24 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.79 120.63 22.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 112.321 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -129.4 159.02 37.54 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.856 1.262 . . . . 0.0 111.533 173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.37 149.34 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.654 1.582 . . . . 0.0 110.247 168.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.64 117.76 19.12 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.691 1.596 . . . . 0.0 107.979 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -97.76 132.5 43.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.677 1.591 . . . . 0.0 110.511 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.36 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.848 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.03 -178.47 0.34 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 123.99 0.805 . . . . 0.0 113.697 166.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -76.75 26.61 0.14 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 120.124 -1.81 . . . . 0.0 113.739 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.19 66.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.468 1.507 . . . . 0.0 112.113 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -63.36 6.32 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.332 3.355 . . . . 0.0 117.604 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.15 -9.05 14.41 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -117.14 -27.02 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.518 1.527 . . . . 0.0 114.241 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.6 127.66 14.63 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.789 1.635 . . . . 0.0 110.259 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.59 89.17 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.201 1.4 . . . . 0.0 111.908 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -139.87 148.74 42.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.486 1.114 . . . . 0.0 109.301 163.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -60.01 -21.01 60.77 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.537 1.062 . . . . 0.0 112.714 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -55.49 -24.33 30.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.72 1.208 . . . . 0.0 113.6 169.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.47 -53.53 7.98 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.043 0.937 . . . . 0.0 111.603 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.16 -36.63 70.98 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.393 -1.442 . . . . 0.0 111.133 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -70.1 -22.84 62.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.438 1.495 . . . . 0.0 114.108 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.13 58.3 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.448 -1.407 . . . . 0.0 111.674 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.51 -45.1 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.855 0.862 . . . . 0.0 109.662 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.89 118.16 14.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.437 1.495 . . . . 0.0 111.251 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.542 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.6 p -154.54 -37.93 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.823 -1.561 . . . . 0.0 114.987 162.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 25' ' ' SER . 82.9 Cg_endo -76.46 -2.28 12.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.155 2.162 . . . . 0.0 113.329 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -93.16 141.55 28.29 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.328 1.051 . . . . 0.0 112.43 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.77 -164.1 43.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 124.643 1.115 . . . . 0.0 114.743 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -87.67 -12.83 44.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.231 1.012 . . . . 0.0 112.776 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 66.57 157.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.188 2.195 . . . . 0.0 113.965 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 38.0 tpp -156.7 -79.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.293 -0.879 . . . . 0.0 111.534 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -138.7 153.27 48.51 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.049 1.295 . . . . 0.0 113.946 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.85 130.73 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.751 1.62 . . . . 0.0 110.625 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -145.32 127.86 16.05 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.819 0.819 . . . . 0.0 113.043 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.33 144.45 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.718 -1.239 . . . . 0.0 112.028 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -128.88 156.07 44.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.356 1.462 . . . . 0.0 110.406 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -72.32 7.44 1.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.23 -35.38 2.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.134 1.333 . . . . 0.0 113.219 163.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -154.22 148.73 26.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.512 1.525 . . . . 0.0 110.448 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.96 165.26 12.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.342 -0.849 . . . . 0.0 114.202 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.33 133.52 51.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.901 1.81 . . . . 0.0 112.683 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 mt -104.88 139.65 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.546 1.538 . . . . 0.0 107.152 167.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -134.61 84.77 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -115.17 153.42 30.85 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.562 1.145 . . . . 0.0 112.489 -169.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.67 151.91 24.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.424 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 65.6 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 128.771 2.828 . . . . 0.0 114.699 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.39 -23.77 58.11 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.242 2.628 . . . . 0.0 114.479 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -64.86 -40.72 95.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 111.182 -175.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 m -73.83 -31.06 63.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.038 0.935 . . . . 0.0 112.631 174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.01 -44.25 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.686 -0.634 . . . . 0.0 109.92 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -65.22 -41.47 94.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.781 0.833 . . . . 0.0 112.152 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -59.51 -38.95 82.3 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.773 0.829 . . . . 0.0 112.198 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.94 58.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.076 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 mt -57.44 -51.52 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 121.007 1.73 . . . . 0.0 109.674 165.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.94 2.54 8.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -105.84 -26.86 11.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.574 1.55 . . . . 0.0 113.526 171.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -127.05 -26.76 3.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.467 1.107 . . . . 0.0 113.309 -166.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -76.57 40.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.185 1.794 . . . . 0.0 112.276 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 128.015 2.526 . . . . 0.0 108.566 -176.562 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -127.0 131.03 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.969 1.708 . . . . 0.0 107.985 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -128.07 122.13 31.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -92.13 141.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.945 0.898 . . . . 0.0 111.225 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.0 t -136.78 150.46 48.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 108.392 166.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 123.567 0.747 . . . . 0.0 110.254 -173.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.664 0 CA-C-O 119.385 -0.339 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.16 137.89 33.87 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.004 1.322 . . . . 0.0 112.879 -173.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 t -133.0 162.96 30.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 110.922 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -132.4 161.52 33.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.634 0.73 . . . . 0.0 112.15 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -143.74 130.29 20.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.026 1.73 . . . . 0.0 108.872 -166.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -110.99 141.76 44.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.921 1.688 . . . . 0.0 112.013 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -94.7 100.55 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.093 0.957 . . . . 0.0 111.156 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.96 4.37 53.96 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.047 1.784 . . . . 0.0 115.728 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -82.23 30.15 0.41 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.323 1.449 . . . . 0.0 114.031 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.9 tp 50.71 63.77 9.34 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.71 2.004 . . . . 0.0 114.024 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.89 26.48 0.36 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.365 2.71 . . . . 0.0 115.427 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -78.89 51.2 1.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 109.879 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -147.59 147.07 29.67 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 128.399 2.68 . . . . 0.0 108.544 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -53.75 115.79 2.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.192 0.997 . . . . 0.0 111.573 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.47 148.09 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.308 1.043 . . . . 0.0 111.29 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -118.61 158.97 24.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.0 1.72 . . . . 0.0 111.989 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -52.35 -30.25 27.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.695 1.598 . . . . 0.0 113.819 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.41 -29.61 69.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.002 0.921 . . . . 0.0 113.274 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.89 -43.46 98.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.205 0.911 . . . . 0.0 111.121 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.52 -36.38 63.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.377 1.071 . . . . 0.0 111.612 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.12 -35.53 80.74 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.33 0.652 . . . . 0.0 112.559 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -18.84 59.13 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -72.06 -80.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -116.34 117.49 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.151 0.977 . . . . 0.0 110.747 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.541 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 76.8 p -148.2 -27.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.734 1.613 . . . . 0.0 113.772 158.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' CD ' ' H ' ' A' ' 25' ' ' SER . 10.2 Cg_endo -96.46 19.84 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 CA-C-N 122.899 2.071 . . . . 0.0 114.111 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -120.77 143.9 48.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.628 1.571 . . . . 0.0 111.929 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 -152.61 40.85 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.78 -0.575 . . . . 0.0 114.352 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -88.6 -25.77 22.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.024 -0.988 . . . . 0.0 113.257 -171.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mm 64.78 153.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.154 1.782 . . . . 0.0 112.206 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.0 tpp -154.91 -57.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.439 -1.413 . . . . 0.0 113.758 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -156.34 155.69 32.65 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.523 1.129 . . . . 0.0 113.911 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.91 151.89 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.173 1.389 . . . . 0.0 112.281 168.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.25 98.34 3.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.444 1.498 . . . . 0.0 110.525 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tt -106.41 138.84 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -130.64 153.55 48.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.013 1.325 . . . . 0.0 110.371 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -76.78 49.41 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.992 1.317 . . . . 0.0 112.387 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.26 -51.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.744 2.418 . . . . 0.0 110.333 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -149.69 144.39 26.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.521 1.528 . . . . 0.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.14 140.83 15.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.119 0.866 . . . . 0.0 112.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.58 148.69 50.5 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.73 1.253 . . . . 0.0 112.43 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -129.88 138.35 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.745 1.618 . . . . 0.0 107.775 176.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.05 97.68 5.35 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.449 1.1 . . . . 0.0 108.415 175.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -118.53 152.81 35.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.031 0.932 . . . . 0.0 111.655 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.28 162.47 21.14 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.654 167.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 69.88 74.42 0.27 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 127.968 2.507 . . . . 0.0 113.357 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.0 -36.89 97.74 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.659 2.906 . . . . 0.0 114.709 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -62.86 -34.43 77.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.158 1.344 . . . . 0.0 111.817 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.5 m -77.45 -33.88 54.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.72 -42.92 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.178 0.899 . . . . 0.0 109.987 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.01 -39.98 87.18 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.301 1.04 . . . . 0.0 112.711 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.1 -32.23 73.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.994 0.816 . . . . 0.0 112.596 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.49 63.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.294 0.638 . . . . 0.0 112.05 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.67 -54.86 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.956 1.253 . . . . 0.0 110.514 171.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.44 -20.41 63.08 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.601 1.092 . . . . 0.0 112.811 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 t -90.98 -24.44 20.11 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.843 1.257 . . . . 0.0 114.321 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -126.49 -19.18 4.67 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.501 -1.374 . . . . 0.0 113.651 -172.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -86.96 21.3 2.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.382 1.873 . . . . 0.0 112.804 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 CA--C 1.532 0.25 0 C-N-CA 125.083 1.353 . . . . 0.0 109.694 -170.0 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.1 mt . . . . . 0 N--CA 1.461 0.111 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.48 150.89 51.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.785 1.634 . . . . 0.0 109.776 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.13 137.82 31.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.696 -0.627 . . . . 0.0 111.592 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -93.63 145.47 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.042 0.937 . . . . 0.0 111.044 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.4 t -135.67 146.95 48.34 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.587 1.155 . . . . 0.0 110.757 168.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.328 -0.363 0 C-N-CA 123.975 0.91 . . . . 0.0 111.901 175.489 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.535 0.535 0 N-CA-C 112.21 0.042 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 133.47 33.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.207 1.003 . . . . 0.0 112.571 176.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -151.52 155.01 37.62 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.438 0.695 . . . . 0.0 110.833 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -120.59 149.84 41.83 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.304 1.442 . . . . 0.0 111.004 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -120.03 128.17 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.42 1.888 . . . . 0.0 108.459 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -115.49 141.67 47.75 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.754 1.622 . . . . 0.0 111.169 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.69 114.93 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.576 1.15 . . . . 0.0 109.798 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.92 -4.98 86.69 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.716 1.627 . . . . 0.0 114.462 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -77.52 31.88 0.16 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.749 1.275 . . . . 0.0 113.466 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt 44.8 76.26 0.56 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.716 2.006 . . . . 0.0 114.188 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.85 26.8 0.18 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.008 3.139 . . . . 0.0 115.419 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -76.2 16.25 0.47 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.133 2.573 . . . . 0.0 112.683 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -127.81 157.62 39.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 129.11 2.964 . . . . 0.0 110.983 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -43.74 120.98 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.045 1.738 . . . . 0.0 112.338 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.96 159.84 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.085 0.954 . . . . 0.0 111.594 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -133.59 161.61 34.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.845 1.658 . . . . 0.0 111.747 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -52.58 -33.86 47.99 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.329 -0.857 . . . . 0.0 111.728 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.62 -21.01 65.41 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.12 -38.04 63.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.911 1.232 . . . . 0.0 112.302 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.96 -37.91 64.37 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.061 -1.024 . . . . 0.0 110.534 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -64.84 -43.85 91.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -29.88 69.75 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.291 0.95 . . . . 0.0 112.145 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.06 -78.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 167.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.16 120.64 35.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.462 1.483 . . . . 0.0 111.752 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.435 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 13.3 p -158.1 -33.35 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.219 167.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' H ' ' A' ' 25' ' ' SER . 31.5 Cg_endo -91.62 43.1 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.686 2.257 . . . . 0.0 111.201 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -133.33 153.8 51.27 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.215 1.806 . . . . 0.0 110.386 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.18 -157.89 35.38 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 163.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -103.02 -4.76 24.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 65.49 170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.141 1.776 . . . . 0.0 113.941 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.5 mtm -157.65 -75.7 0.09 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.931 -1.106 . . . . 0.0 109.517 163.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -145.42 155.3 43.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.654 1.182 . . . . 0.0 113.995 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 tt -115.6 134.05 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.044 1.738 . . . . 0.0 108.788 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.02 121.44 9.66 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.211 1.005 . . . . 0.0 111.622 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.6 147.07 31.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.879 0.871 . . . . 0.0 111.4 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.64 154.79 43.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.825 1.25 . . . . 0.0 110.211 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -68.8 44.36 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.058 1.743 . . . . 0.0 113.058 171.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.01 -40.71 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.345 2.258 . . . . 0.0 111.993 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -144.97 143.38 30.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.904 1.282 . . . . 0.0 109.923 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.11 136.61 11.73 Favored Glycine 0 N--CA 1.463 0.488 0 C-N-CA 123.884 0.755 . . . . 0.0 112.515 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -139.37 159.58 41.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 123.221 1.486 . . . . 0.0 112.42 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -136.28 148.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.29 1.836 . . . . 0.0 107.523 171.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -134.3 104.84 6.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -124.88 155.27 39.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.493 1.517 . . . . 0.0 112.714 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -90.0 153.5 20.53 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.02 1.328 . . . . 0.0 111.037 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 66.32 79.87 0.23 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.903 2.881 . . . . 0.0 113.705 -159.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -53.11 -33.24 62.9 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.074 3.183 . . . . 0.0 114.635 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -70.58 -35.85 73.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.066 0.848 . . . . 0.0 111.8 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -65.9 -31.75 72.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.88 -38.11 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.697 0.799 . . . . 0.0 110.223 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.39 -42.24 98.79 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.421 -0.799 . . . . 0.0 112.105 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.46 -38.15 90.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.87 0.759 . . . . 0.0 112.239 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.18 77.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.974 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.19 -53.34 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.817 1.19 . . . . 0.0 110.399 171.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.06 -29.7 70.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.306 0.957 . . . . 0.0 112.664 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -77.15 -38.12 52.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -94.87 -26.97 15.96 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 t -72.53 -20.78 61.28 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.152 0.981 . . . . 0.0 112.496 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 125.963 1.705 . . . . 0.0 111.097 170.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 mt -138.64 139.1 38.39 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.757 1.223 . . . . 0.0 108.922 -165.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -133.74 125.89 29.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.88 139.81 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.096 0.959 . . . . 0.0 111.149 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -143.82 144.57 31.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.744 1.618 . . . . 0.0 110.663 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.468 0.437 0 C-N-CA 124.014 0.926 . . . . 0.0 110.217 178.804 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.539 0.742 0 N-CA-C 113.77 0.642 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 98.59 5.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.079 1.752 . . . . 0.0 109.64 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -128.06 99.82 5.64 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.997 0.919 . . . . 0.0 110.338 -162.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -84.51 154.08 22.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 112.382 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.71 127.76 41.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.003 1.721 . . . . 0.0 108.79 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -104.36 138.74 40.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.376 1.471 . . . . 0.0 112.132 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -97.21 97.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.181 1.392 . . . . 0.0 110.289 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.72 -23.0 65.42 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.147 0.88 . . . . 0.0 115.018 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.96 58.17 0.47 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.212 1.805 . . . . 0.0 115.483 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp 46.37 55.7 15.91 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 127.321 2.248 . . . . 0.0 113.754 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.47 4.42 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.471 3.447 . . . . 0.0 115.112 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.03 1.14 2.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.053 2.141 . . . . 0.0 116.198 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -139.77 -28.95 0.74 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -150.39 99.24 2.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.872 1.269 . . . . 0.0 110.117 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.44 149.52 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.48 0.712 . . . . 0.0 110.621 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -146.22 164.26 32.84 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.699 1.2 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -58.36 -29.76 66.24 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.144 -0.972 . . . . 0.0 112.48 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.34 -18.91 63.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -77.68 -47.18 19.83 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.909 -1.119 . . . . 0.0 109.946 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.15 -41.57 75.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.05 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -68.63 -43.21 76.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.484 1.514 . . . . 0.0 112.905 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -34.6 77.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.182 0.901 . . . . 0.0 111.152 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.93 -70.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.004 1.322 . . . . 0.0 108.747 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -124.2 112.7 17.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 111.168 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 11.8 m -160.57 -22.15 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.364 1.866 . . . . 0.0 113.355 157.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' CD ' ' H ' ' A' ' 25' ' ' SER . 32.5 Cg_exo -73.43 16.22 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.149 2.566 . . . . 0.0 116.4 171.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -134.06 154.95 50.83 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.228 1.411 . . . . 0.0 111.129 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.45 -165.5 31.95 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.334 0.969 . . . . 0.0 115.093 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -91.12 -17.87 25.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.3 mm 64.71 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.785 1.634 . . . . 0.0 112.801 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.5 tpp -153.44 -58.13 0.13 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.3 -0.875 . . . . 0.0 112.466 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -147.8 145.02 28.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.674 1.189 . . . . 0.0 112.967 -171.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -117.68 127.52 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.185 1.794 . . . . 0.0 109.839 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -137.02 87.52 2.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.981 0.896 . . . . 0.0 111.24 -164.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.3 139.43 21.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.078 0.951 . . . . 0.0 110.944 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.31 153.41 46.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.195 2.198 . . . . 0.0 109.082 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -76.81 28.0 0.13 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.53 -41.77 0.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.807 2.043 . . . . 0.0 111.378 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -137.83 146.93 44.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.388 1.075 . . . . 0.0 112.703 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.31 133.33 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 123.976 0.798 . . . . 0.0 112.222 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -131.27 154.83 48.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.25 1.5 . . . . 0.0 112.569 171.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.031 1.732 . . . . 0.0 108.352 167.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -140.72 80.44 1.75 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.383 1.873 . . . . 0.0 108.046 -172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -111.72 165.93 11.62 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.759 -1.213 . . . . 0.0 113.828 -166.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -96.19 153.37 17.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.03 0.932 . . . . 0.0 110.419 166.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 66.95 85.61 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.902 2.881 . . . . 0.0 115.249 -166.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.45 -30.35 72.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.633 2.888 . . . . 0.0 113.331 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -53.91 -41.27 67.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.572 0.624 . . . . 0.0 110.939 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 m -87.47 -23.71 24.36 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.83 -45.86 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.759 1.163 . . . . 0.0 109.105 164.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -65.16 -42.77 93.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.949 0.9 . . . . 0.0 112.755 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.488 1.04 . . . . 0.0 112.197 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.75 -32.58 62.13 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.28 -52.71 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.343 1.429 . . . . 0.0 109.51 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.19 -10.76 60.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -89.06 -23.42 22.55 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.787 -1.196 . . . . 0.0 113.68 170.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -128.96 -37.12 1.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -165.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 t -76.63 -13.2 60.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.826 1.25 . . . . 0.0 113.251 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 123.983 0.913 . . . . 0.0 112.093 178.102 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -121.92 140.46 52.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.394 1.478 . . . . 0.0 110.45 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.19 140.53 37.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.45 140.81 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.136 1.374 . . . . 0.0 111.136 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.9 t -152.88 153.72 33.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.606 1.162 . . . . 0.0 111.615 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 124.987 1.315 . . . . 0.0 112.07 173.776 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 CA-C-O 120.372 0.072 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.16 50.1 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.335 -0.853 . . . . 0.0 111.739 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -158.27 150.7 22.09 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.918 2.087 . . . . 0.0 108.718 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -126.04 152.33 45.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.591 0.632 . . . . 0.0 112.25 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.68 125.36 41.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.273 1.429 . . . . 0.0 108.904 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -104.14 136.51 43.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.661 1.984 . . . . 0.0 110.262 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.28 137.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.324 1.05 . . . . 0.0 109.561 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.93 -175.1 3.61 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 122.316 0.953 . . . . 0.0 113.194 169.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -83.93 13.24 5.11 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.18 -44.32 99.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.456 1.502 . . . . 0.0 114.723 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.93 21.93 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.914 2.409 . . . . 0.0 113.186 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.59 59.31 1.49 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.532 1.533 . . . . 0.0 110.389 174.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -153.27 31.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.73 2.812 . . . . 0.0 110.795 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 m120 58.42 146.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.431 2.692 . . . . 0.0 114.055 -157.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.16 153.02 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.367 1.067 . . . . 0.0 110.652 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.0 m -135.45 166.06 24.05 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.636 1.974 . . . . 0.0 110.217 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -52.35 -32.94 40.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.194 -0.941 . . . . 0.0 111.465 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.51 -21.7 65.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.181 1.792 . . . . 0.0 115.014 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.83 -47.5 62.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.204 0.911 . . . . 0.0 109.514 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.22 -29.23 62.64 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.497 -1.377 . . . . 0.0 112.051 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -61.82 -46.65 88.58 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.002 0.921 . . . . 0.0 111.687 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.91 -39.1 90.84 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.523 -0.735 . . . . 0.0 110.321 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.73 -76.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 109.113 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -119.52 123.87 45.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.841 1.201 . . . . 0.0 111.747 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 15.4 m -157.9 -41.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 126.085 1.754 . . . . 0.0 112.846 167.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' H ' ' A' ' 25' ' ' SER . 53.9 Cg_endo -81.01 43.44 1.55 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.65 2.233 . . . . 0.0 112.562 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.07 146.15 46.74 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.416 1.486 . . . . 0.0 110.655 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.74 -161.11 28.28 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -96.67 -2.14 45.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.185 0.994 . . . . 0.0 112.95 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp 62.22 167.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 126.803 2.041 . . . . 0.0 114.168 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.9 mtm -152.12 -71.59 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.943 -1.098 . . . . 0.0 110.508 162.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -156.53 155.8 32.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.012 0.925 . . . . 0.0 113.394 -171.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tp -101.75 135.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.737 2.015 . . . . 0.0 110.046 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -127.02 68.85 1.27 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.924 1.289 . . . . 0.0 109.931 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.07 137.67 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -124.14 145.78 49.07 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.639 1.576 . . . . 0.0 108.643 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -70.42 -8.91 54.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -167.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.17 -59.52 1.94 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.756 1.162 . . . . 0.0 110.93 166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.46 131.97 14.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.998 1.719 . . . . 0.0 110.17 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 171.0 52.19 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.81 154.2 39.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.489 1.515 . . . . 0.0 110.972 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.63 151.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.87 1.668 . . . . 0.0 108.58 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.38 108.25 7.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.573 0.749 . . . . 0.0 109.164 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -127.33 158.82 36.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.497 1.519 . . . . 0.0 112.772 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -90.08 147.49 23.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.905 1.282 . . . . 0.0 110.61 170.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 66.6 86.79 0.13 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 129.585 3.154 . . . . 0.0 115.321 -162.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.45 -30.75 93.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.561 2.841 . . . . 0.0 114.851 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.62 -36.15 80.28 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.577 1.081 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -67.85 -37.64 82.12 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.8 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.684 0.793 . . . . 0.0 110.083 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.21 -31.63 72.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.252 1.021 . . . . 0.0 111.664 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.94 68.88 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.147 -0.971 . . . . 0.0 112.534 173.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.1 mt -60.51 -49.53 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.83 1.196 . . . . 0.0 110.594 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.07 -16.81 61.47 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.76 -58.88 3.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.214 1.406 . . . . 0.0 111.27 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.94 -45.09 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.543 -0.723 . . . . 0.0 111.83 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.77 15.97 0.76 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.031 1.332 . . . . 0.0 113.107 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -57.84 140.32 52.1 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.088 -1.007 . . . . 0.0 110.607 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -133.94 130.27 37.47 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.106 0.962 . . . . 0.0 113.549 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.6 ttm -98.29 166.13 11.54 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.267 1.827 . . . . 0.0 110.079 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -75.6 50.57 0.55 Allowed 'General case' 0 CA--C 1.553 1.095 0 O-C-N 120.437 -1.414 . . . . 0.0 114.135 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.35 31.87 5.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.661 2.384 . . . . 0.0 111.326 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.75 -168.96 52.95 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.039 1.304 . . . . 0.0 115.644 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.4 98.69 3.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.08 1.352 . . . . 0.0 111.76 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -105.62 -23.84 12.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.644 1.578 . . . . 0.0 113.904 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -143.55 142.46 31.12 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.477 1.511 . . . . 0.0 110.76 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.55 109.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.359 1.463 . . . . 0.0 109.293 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -130.3 138.96 50.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.282 2.233 . . . . 0.0 108.889 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -141.47 130.96 23.83 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.757 0.823 . . . . 0.0 111.869 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.73 134.45 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.577 -0.702 . . . . 0.0 111.166 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.56 99.46 8.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.791 1.636 . . . . 0.0 108.526 161.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.2 m -77.43 34.18 0.17 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.15 1.38 . . . . 0.0 114.06 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -61.37 102.97 0.26 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.537 1.535 . . . . 0.0 110.756 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.12 37.62 0.32 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.363 1.465 . . . . 0.0 111.795 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.76 145.38 42.37 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.363 2.265 . . . . 0.0 110.344 -173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.221 1.408 . . . . 0.0 112.383 -174.705 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 O4'-C1'-N19 112.172 3.972 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 110.953 2.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.234 1 O4'-C1'-N19 112.569 4.369 . 0.101 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.578 -2.429 1 O4'-C1'-N19 113.3 5.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.539 0.76 0 CA-C-O 120.089 -0.046 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -152.15 145.5 24.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -163.38 168.58 20.18 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.404 1.882 . . . . 0.0 110.01 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -140.63 153.16 45.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 171.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.3 121.35 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 108.435 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -100.66 133.85 44.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.386 1.074 . . . . 0.0 111.311 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.2 mm -90.48 99.43 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.755 0.822 . . . . 0.0 108.831 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.01 156.23 47.82 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.091 0.377 . . . . 0.0 112.663 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -51.03 98.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.15 1.78 . . . . 0.0 112.912 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.8 tm? -150.11 -56.64 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.486 1.514 . . . . 0.0 112.462 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 65.9 Cg_endo -72.94 -48.0 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.931 1.725 . . . . 0.0 113.348 -168.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 mp 57.02 -15.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -129.88 143.98 51.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.216 1.806 . . . . 0.0 111.721 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.61 29.13 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.368 2.267 . . . . 0.0 115.414 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -69.28 138.27 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.015 0.912 . . . . 0.0 111.241 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.9 p -143.71 156.84 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.534 1.133 . . . . 0.0 111.061 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.87 -25.84 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.086 -1.009 . . . . 0.0 111.758 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.83 -28.59 69.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.847 1.259 . . . . 0.0 114.012 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -67.61 -43.11 81.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.99 1.723 . . . . 0.0 111.476 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.01 -45.07 95.22 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.917 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -69.73 -37.92 76.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.494 1.118 . . . . 0.0 113.764 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -31.59 66.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.568 -1.332 . . . . 0.0 111.574 176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -64.14 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.468 1.107 . . . . 0.0 108.727 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -124.5 111.89 16.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.988 1.267 . . . . 0.0 110.71 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.41 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 47.7 t -155.61 -49.76 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 25' ' ' SER . 64.6 Cg_endo -84.47 8.68 4.49 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.024 2.483 . . . . 0.0 115.139 -173.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -84.7 15.05 4.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.848 1.259 . . . . 0.0 113.547 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.14 -15.16 9.13 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.148 -1.595 . . . . 0.0 115.375 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.88 133.91 34.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.319 1.559 . . . . 0.0 111.724 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.45 152.5 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.317 0.647 . . . . 0.0 112.234 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.4 mtm -162.03 -67.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.761 2.024 . . . . 0.0 109.001 151.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -148.43 155.63 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.203 1.401 . . . . 0.0 112.744 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.8 pt -130.04 145.22 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.791 1.236 . . . . 0.0 111.119 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -136.96 157.16 47.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.052 1.341 . . . . 0.0 111.466 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.22 159.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -132.87 167.46 20.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.619 2.368 . . . . 0.0 110.95 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.42 -16.48 36.28 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.43 -10.04 5.16 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -160.64 -177.76 6.41 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.017 1.727 . . . . 0.0 111.132 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.27 170.29 36.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 120.527 -1.358 . . . . 0.0 115.285 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -130.69 128.09 40.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.378 1.471 . . . . 0.0 111.869 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mt -97.74 139.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.724 1.61 . . . . 0.0 108.544 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -130.56 94.09 3.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.273 1.429 . . . . 0.0 107.735 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -127.13 154.12 45.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.702 1.601 . . . . 0.0 113.941 -162.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.84 161.87 28.63 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.281 -0.887 . . . . 0.0 111.348 163.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 61.87 78.59 0.3 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.053 2.541 . . . . 0.0 115.639 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -24.28 51.5 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.089 2.526 . . . . 0.0 114.698 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -77.32 -37.09 53.28 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.092 -1.005 . . . . 0.0 112.522 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -70.41 -33.01 70.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.707 0.23 . . . . 0.0 111.091 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.9 t -65.2 -44.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 174.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -58.01 -48.19 80.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 111.419 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.49 -33.53 66.07 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.825 0.85 . . . . 0.0 112.983 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.77 -27.08 36.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -50.4 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 120.692 1.587 . . . . 0.0 110.074 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.0 -4.1 15.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.044 1.338 . . . . 0.0 113.603 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 87.8 m -108.2 -7.93 15.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.502 1.521 . . . . 0.0 113.879 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -137.23 -55.39 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.174 0.897 . . . . 0.0 112.61 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.021 -1.05 . . . . 0.0 112.465 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -113.07 14.75 19.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.811 1.644 . . . . 0.0 112.838 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -79.71 37.29 0.35 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.503 -1.373 . . . . 0.0 112.325 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.16 140.88 19.03 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.234 1.814 . . . . 0.0 107.759 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -116.31 138.29 51.44 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.497 1.119 . . . . 0.0 111.74 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.1 t80 54.03 36.13 23.82 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.851 1.26 . . . . 0.0 113.395 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.9 -145.12 5.78 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.155 -0.966 . . . . 0.0 112.345 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -153.73 158.75 41.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.136 0.974 . . . . 0.0 113.111 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -136.77 -37.7 0.66 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.407 1.883 . . . . 0.0 112.714 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -145.88 172.32 13.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.081 1.353 . . . . 0.0 111.073 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.29 106.41 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.4 mt -119.95 133.96 55.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.595 0.758 . . . . 0.0 110.838 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -134.21 130.58 37.41 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.591 1.156 . . . . 0.0 110.994 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.74 143.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.913 0.885 . . . . 0.0 111.93 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 t -140.38 153.99 46.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.117 1.767 . . . . 0.0 110.849 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m -129.31 29.26 5.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.236 1.414 . . . . 0.0 110.806 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.5 m -75.04 145.94 41.96 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.915 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -138.27 1.69 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.68 1.592 . . . . 0.0 114.152 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.04 159.87 41.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.733 2.013 . . . . 0.0 109.92 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -170.597 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.294 0 O4'-C1'-N19 111.953 3.753 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 O4'-C1'-N19 110.817 2.617 . 0.286 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O5'-C5'-C4' 113.448 2.32 . 0.124 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 O4'-C1'-N19 112.0 3.8 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.533 0.473 0 CA-C-O 121.084 0.368 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.28 146.01 51.83 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -160.98 147.84 15.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.601 1.56 . . . . 0.0 109.634 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -127.23 149.97 49.76 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.777 0.831 . . . . 0.0 110.734 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.57 124.99 31.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -104.26 137.23 42.47 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.755 1.622 . . . . 0.0 111.401 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -95.7 96.3 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.561 1.144 . . . . 0.0 110.281 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -8.51 74.36 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.889 1.233 . . . . 0.0 115.123 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -78.16 30.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.784 2.292 . . . . 0.0 114.179 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 33.14 66.75 1.15 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.595 2.358 . . . . 0.0 114.459 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.44 56.1 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.593 3.529 . . . . 0.0 113.964 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.93 -2.26 11.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.566 2.747 . . . . 0.0 112.985 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.33 150.14 51.7 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.607 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -12.49 96.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.61 3.164 . . . . 0.0 115.349 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 152.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.611 1.564 . . . . 0.0 111.256 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.1 p -137.7 166.72 23.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.543 1.937 . . . . 0.0 110.538 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -55.49 -25.16 35.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.316 0.646 . . . . 0.0 112.172 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -63.01 -27.29 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.303 1.441 . . . . 0.0 113.143 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.83 -48.74 23.55 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.418 -0.801 . . . . 0.0 110.938 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.76 -34.96 79.07 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.609 -1.307 . . . . 0.0 111.329 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -69.2 -35.71 76.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.986 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -37.37 78.77 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.9 1.227 . . . . 0.0 110.887 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.87 -79.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -120.79 108.27 13.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.245 0.93 . . . . 0.0 110.818 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.498 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 60.7 p -135.09 -30.46 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.821 -1.561 . . . . 0.0 114.658 160.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.498 ' CD ' ' H ' ' A' ' 25' ' ' SER . 19.2 Cg_endo -88.65 10.75 3.24 Favored 'Trans proline' 0 C--N 1.356 0.956 0 CA-C-N 122.988 2.103 . . . . 0.0 113.623 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -105.7 142.38 35.53 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.817 1.247 . . . . 0.0 111.332 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.23 -161.24 45.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.967 0.794 . . . . 0.0 114.744 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -98.94 -0.95 41.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.0 0.92 . . . . 0.0 113.387 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 63.56 158.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.744 2.017 . . . . 0.0 115.451 168.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.4 mtm -151.72 -79.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.58 1.152 . . . . 0.0 108.555 162.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -142.0 157.39 44.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -114.68 131.41 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.853 1.661 . . . . 0.0 108.954 168.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -127.1 90.18 3.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.983 1.313 . . . . 0.0 110.415 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.91 138.69 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.626 -0.671 . . . . 0.0 110.354 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -133.56 145.94 50.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.214 1.806 . . . . 0.0 108.693 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.67 25.04 0.81 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.429 1.492 . . . . 0.0 112.827 -168.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 -56.68 0.36 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.568 1.947 . . . . 0.0 110.772 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -142.78 101.16 3.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 110.152 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.34 156.43 48.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.692 0.663 . . . . 0.0 113.77 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.86 152.03 50.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.751 1.262 . . . . 0.0 112.607 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 145.51 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.113 1.765 . . . . 0.0 108.416 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -135.03 90.1 2.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.132 1.773 . . . . 0.0 107.999 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -121.34 160.17 24.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.092 1.357 . . . . 0.0 114.204 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -92.25 156.29 17.4 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.997 1.319 . . . . 0.0 110.229 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 67.63 76.79 0.26 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 129.158 2.983 . . . . 0.0 113.714 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -58.38 -33.85 98.18 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.9 3.066 . . . . 0.0 113.551 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -58.08 -45.26 87.44 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.253 0.933 . . . . 0.0 111.178 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -71.81 -28.37 63.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.53 -42.48 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.733 1.151 . . . . 0.0 110.639 170.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -67.86 -44.06 78.0 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 112.131 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.28 -33.5 69.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.065 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.94 64.06 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.263 -0.898 . . . . 0.0 113.044 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.47 -50.38 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.395 -1.441 . . . . 0.0 109.7 171.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.41 -6.05 32.8 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.4 t -85.23 -50.36 7.44 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.906 1.282 . . . . 0.0 111.982 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -109.0 -47.15 3.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.24 1.016 . . . . 0.0 113.693 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -67.63 -21.42 65.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.13 0.972 . . . . 0.0 112.025 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -118.78 23.6 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.726 2.011 . . . . 0.0 111.811 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.04 146.78 54.57 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.13 14.86 0.26 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.742 1.617 . . . . 0.0 115.26 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -77.28 162.52 27.27 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.523 -1.361 . . . . 0.0 113.461 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -76.86 154.61 33.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.898 1.279 . . . . 0.0 112.203 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.39 -154.39 34.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.321 1.438 . . . . 0.0 112.233 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -69.74 157.68 36.85 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 111.29 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -121.71 151.61 40.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.091 1.356 . . . . 0.0 110.917 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.06 138.16 57.58 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.82 -0.55 . . . . 0.0 110.626 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.1 mt -102.38 106.08 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 mt -126.44 134.91 50.85 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.583 1.153 . . . . 0.0 108.567 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.68 133.5 41.94 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.9 137.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.589 1.556 . . . . 0.0 111.325 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -143.59 168.52 19.68 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.766 2.027 . . . . 0.0 111.004 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.5 m -145.8 136.6 24.41 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.529 1.132 . . . . 0.0 109.539 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -64.73 112.27 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.012 0.824 . . . . 0.0 109.345 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -142.64 134.41 26.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.341 1.056 . . . . 0.0 110.588 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.83 141.09 58.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.565 0.698 . . . . 0.0 112.129 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.878 -1.534 . . . . 0.0 111.47 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.248 0 C5'-C4'-C3' 109.804 -3.798 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 O4'-C1'-N19 111.402 3.202 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 1 O4'-C1'-N19 112.375 4.175 OUTLIER-EPSILON 0.058 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 1 P-O3'-C3' 125.647 4.956 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.636 0.975 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -122.21 97.97 5.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.691 2.396 . . . . 0.0 108.583 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.73 95.35 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.396 1.479 . . . . 0.0 109.332 -164.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -86.57 151.77 23.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.655 0.74 . . . . 0.0 112.241 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.3 126.43 38.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.877 1.671 . . . . 0.0 108.983 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -104.1 136.66 43.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.704 1.602 . . . . 0.0 111.424 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.62 99.01 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.784 0.834 . . . . 0.0 110.245 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.94 -7.26 86.44 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.423 -0.798 . . . . 0.0 114.702 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -77.08 50.07 0.72 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.69 1.596 . . . . 0.0 112.662 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.5 mt 38.45 66.74 2.46 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.334 2.254 . . . . 0.0 113.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.83 15.82 0.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 125.198 3.932 . . . . 0.0 115.262 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.4 32.68 0.34 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.316 1.447 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -127.53 52.0 1.87 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.821 2.048 . . . . 0.0 112.622 -164.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 44.45 55.89 5.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.468 1.507 . . . . 0.0 113.357 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.16 161.15 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.87 0.868 . . . . 0.0 111.606 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -147.06 154.61 41.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 112.377 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -62.31 -29.37 70.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -66.44 -22.08 66.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.29 -38.97 49.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.979 0.912 . . . . 0.0 110.686 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.22 -44.12 80.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.175 0.99 . . . . 0.0 111.205 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.24 -45.08 96.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.064 1.345 . . . . 0.0 111.855 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -29.21 65.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.404 -0.81 . . . . 0.0 112.262 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.36 -73.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -120.87 117.97 28.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.553 1.07 . . . . 0.0 111.923 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.459 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 16.5 p -162.48 -31.36 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 163.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 25' ' ' SER . 30.0 Cg_endo -93.85 0.89 3.21 Favored 'Trans proline' 0 C--N 1.357 1.015 0 CA-C-N 122.932 2.083 . . . . 0.0 114.633 -170.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -78.59 179.45 7.1 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.292 1.837 . . . . 0.0 111.735 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.39 19.34 0.27 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.384 1.468 . . . . 0.0 116.598 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -141.47 140.05 33.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 112.564 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -163.68 153.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.811 2.044 . . . . 0.0 108.672 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.7 tpp -166.08 -57.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.73 1.15 . . . . 0.0 110.897 154.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -156.21 147.12 22.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.96 144.08 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.953 1.301 . . . . 0.0 108.105 169.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.83 86.36 1.93 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 110.498 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tt -103.18 146.29 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -172.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -132.05 149.85 52.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.301 1.84 . . . . 0.0 109.45 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -72.79 39.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.929 1.692 . . . . 0.0 114.3 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.82 -43.64 0.09 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.404 2.282 . . . . 0.0 110.718 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.25 128.67 34.33 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.87 0.868 . . . . 0.0 111.747 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.35 126.55 7.91 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.68 0.657 . . . . 0.0 112.382 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -139.16 150.97 46.23 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.898 1.332 . . . . 0.0 113.84 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 152.86 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.243 2.217 . . . . 0.0 108.978 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -140.14 90.31 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.234 1.414 . . . . 0.0 108.576 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -111.68 164.4 13.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.273 1.429 . . . . 0.0 112.402 -170.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -103.21 148.38 25.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.62 -1.3 . . . . 0.0 110.033 172.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.0 t30 69.69 105.34 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 129.05 2.94 . . . . 0.0 114.438 -156.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.89 -26.9 6.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.496 2.797 . . . . 0.0 113.393 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -65.26 -34.8 79.21 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.235 -0.916 . . . . 0.0 111.996 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.7 m -82.31 -20.07 38.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.77 -1.109 . . . . 0.0 113.578 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.92 -51.64 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.314 1.415 . . . . 0.0 108.979 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -71.25 -28.19 64.0 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.3 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -66.74 -47.95 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.619 1.099 . . . . 0.0 111.761 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.95 66.37 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.947 -1.096 . . . . 0.0 112.328 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.03 -53.33 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.139 0.881 . . . . 0.0 110.198 167.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.96 -18.47 62.62 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.42 1.464 . . . . 0.0 113.532 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.15 -36.62 47.49 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 113.35 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -115.06 -42.38 3.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.503 1.121 . . . . 0.0 113.113 -169.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -72.55 23.53 0.06 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.693 1.997 . . . . 0.0 114.09 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -136.81 8.96 3.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.573 1.949 . . . . 0.0 111.404 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -93.76 116.69 29.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.6 mtt -123.08 141.47 51.92 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.565 1.146 . . . . 0.0 111.859 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -133.05 171.58 13.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.521 1.528 . . . . 0.0 110.099 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.58 119.16 7.04 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.455 -0.778 . . . . 0.0 111.894 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.87 3.26 73.5 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -154.38 152.62 30.42 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.952 1.876 . . . . 0.0 113.968 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -147.43 148.69 31.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.274 1.43 . . . . 0.0 110.719 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.98 134.31 35.67 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.779 0.323 . . . . 0.0 110.571 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.7 mm -132.86 117.8 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.455 1.902 . . . . 0.0 107.701 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 mt -134.63 144.26 47.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.968 1.707 . . . . 0.0 109.74 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.48 138.95 46.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.29 140.79 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.918 1.287 . . . . 0.0 110.481 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -140.43 143.77 35.77 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 167.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.7 p -149.34 142.4 24.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.703 0.764 . . . . 0.0 111.709 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.1 p -154.43 167.99 28.17 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.358 1.063 . . . . 0.0 110.405 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -148.48 141.9 25.28 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.969 0.508 . . . . 0.0 111.555 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.82 10.68 7.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.191 1.796 . . . . 0.0 113.116 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.643 1.577 . . . . 0.0 109.936 168.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 1 O4'-C1'-N19 112.312 4.112 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.579 -2.321 1 O4'-C1'-N19 113.042 4.842 . 0.167 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.73 0 P-O3'-C3' 123.804 3.42 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.253 0 O4'-C1'-C2' 102.427 -2.838 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.539 0.764 0 N-CA-C 111.276 -0.317 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 125.82 29.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 111.972 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -138.74 95.02 2.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 109.363 -164.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.01 149.04 43.61 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.442 -0.787 . . . . 0.0 111.183 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.96 122.23 29.7 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.065 1.346 . . . . 0.0 108.93 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -96.44 130.36 43.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.172 1.789 . . . . 0.0 110.859 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.84 91.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.181 0.993 . . . . 0.0 109.318 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.93 4.88 56.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.997 1.284 . . . . 0.0 115.397 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -64.48 -162.98 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.58 1.952 . . . . 0.0 111.818 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -119.66 42.11 0.46 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -77.19 54.83 4.81 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.087 3.191 . . . . 0.0 112.318 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.6 50.46 1.32 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.806 2.042 . . . . 0.0 109.376 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -142.49 168.74 19.02 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.086 2.554 . . . . 0.0 109.297 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -61.76 110.01 1.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.395 -0.816 . . . . 0.0 110.205 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.72 155.21 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.082 0.953 . . . . 0.0 112.41 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.1 m -133.55 155.17 50.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.149 1.779 . . . . 0.0 111.333 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.01 -25.68 22.43 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.924 1.29 . . . . 0.0 114.22 -167.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -53.65 -27.32 26.67 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 0.0 113.32 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.13 -49.95 17.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.896 1.225 . . . . 0.0 112.379 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.11 -28.1 69.84 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.045 -1.659 . . . . 0.0 111.514 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.06 -34.95 71.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.31 1.444 . . . . 0.0 113.335 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -35.07 79.52 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.984 1.265 . . . . 0.0 110.91 170.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.26 -77.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.828 1.251 . . . . 0.0 107.96 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -120.53 116.17 24.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.126 1.33 . . . . 0.0 111.122 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.5 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 p -158.66 -29.88 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 162.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.5 ' HD2' ' H ' ' A' ' 25' ' ' SER . 41.2 Cg_endo -86.82 0.17 7.82 Favored 'Trans proline' 0 C--N 1.357 0.977 0 CA-C-N 123.283 2.208 . . . . 0.0 113.995 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -79.36 171.91 14.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.467 1.507 . . . . 0.0 111.638 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.64 -15.7 80.51 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -87.04 121.21 29.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.873 1.337 . . . . 0.0 111.904 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 tp -154.54 146.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.26 0.624 . . . . 0.0 111.74 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mtm -159.84 -73.09 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.458 1.903 . . . . 0.0 110.129 162.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -143.8 160.63 40.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.965 1.706 . . . . 0.0 114.1 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -133.15 124.67 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.113 1.765 . . . . 0.0 110.105 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -129.28 74.05 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.616 1.167 . . . . 0.0 112.012 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 tt -65.73 146.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.062 -1.024 . . . . 0.0 111.326 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -145.01 147.21 32.37 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.809 2.043 . . . . 0.0 108.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.96 143.35 51.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.785 0.434 . . . . 0.0 110.639 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.87 -53.87 0.31 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.609 1.964 . . . . 0.0 115.84 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -141.32 73.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.049 0.928 . . . . 0.0 112.289 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.93 51.66 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.544 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.77 160.44 38.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 122.839 1.304 . . . . 0.0 112.642 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -122.97 155.84 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.98 1.712 . . . . 0.0 109.024 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -136.3 88.69 2.4 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.941 1.296 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.84 175.0 5.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.819 0.848 . . . . 0.0 111.296 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -117.02 151.89 35.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.145 1.778 . . . . 0.0 109.096 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.9 t30 66.51 92.24 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 127.537 2.335 . . . . 0.0 113.812 -160.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.58 -21.46 45.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.779 2.319 . . . . 0.0 113.34 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.99 -30.97 68.44 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.387 -0.821 . . . . 0.0 112.001 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -89.24 -25.08 21.92 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 117.719 -1.134 . . . . 0.0 113.478 168.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.29 -48.01 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 120.434 1.47 . . . . 0.0 109.274 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.92 -41.65 95.38 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.171 -0.919 . . . . 0.0 113.061 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.12 -38.25 79.17 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.638 1.108 . . . . 0.0 112.479 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -27.5 61.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.66 -58.49 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.598 1.09 . . . . 0.0 109.441 168.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.27 -19.17 65.22 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.42 -44.98 14.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.42 1.888 . . . . 0.0 114.409 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -106.41 -24.74 12.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.79 1.236 . . . . 0.0 113.753 -169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -72.63 35.78 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.328 2.251 . . . . 0.0 112.497 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -153.72 148.92 26.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.982 2.513 . . . . 0.0 109.216 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -135.27 -18.03 1.77 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.847 1.259 . . . . 0.0 111.32 164.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.9 mmt -126.75 162.93 24.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.989 2.515 . . . . 0.0 111.503 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -91.05 13.11 17.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.82 1.248 . . . . 0.0 112.395 168.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -142.02 142.2 32.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.691 1.196 . . . . 0.0 111.141 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.17 -160.27 46.11 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.793 0.711 . . . . 0.0 113.653 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -132.79 132.22 41.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.394 1.478 . . . . 0.0 110.665 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -128.53 -33.27 2.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.179 1.392 . . . . 0.0 112.915 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.93 122.69 36.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 108.71 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.49 109.15 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.351 1.461 . . . . 0.0 108.158 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.14 141.75 47.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.328 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.2 134.91 33.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.807 1.185 . . . . 0.0 113.291 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -90.29 146.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.769 1.228 . . . . 0.0 110.551 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 155.73 44.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.692 0.797 . . . . 0.0 110.276 165.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -103.6 158.66 16.21 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.431 0.692 . . . . 0.0 109.922 166.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -73.16 173.51 9.31 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 112.108 172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -98.53 14.4 28.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.991 0.916 . . . . 0.0 111.905 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.7 172.53 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.176 1.79 . . . . 0.0 111.873 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 116.859 -1.543 . . . . 0.0 113.677 -176.095 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 111.292 3.092 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.467 0 O4'-C1'-N19 111.44 3.24 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.154 0 O4'-C1'-N19 111.551 3.351 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.595 0 O4'-C4'-C3' 108.72 2.3 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 CA--C 1.535 0.531 0 CA-C-O 120.681 0.2 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 142.63 49.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.142 1.377 . . . . 0.0 111.673 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 t -142.93 140.48 31.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.954 1.702 . . . . 0.0 109.184 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -113.59 145.56 41.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.618 0.767 . . . . 0.0 110.31 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -131.72 126.12 33.73 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.644 1.577 . . . . 0.0 109.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.3 132.28 54.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.37 94.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.15 43.25 2.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.708 1.147 . . . . 0.0 112.911 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -114.45 32.92 5.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.586 1.554 . . . . 0.0 113.132 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.8 tp 43.08 72.53 1.14 Allowed Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.885 2.874 . . . . 0.0 113.986 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.5 1.52 6.76 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.67 2.913 . . . . 0.0 113.091 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.18 32.15 0.18 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 114.421 -172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -146.71 -56.61 0.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.805 -1.184 . . . . 0.0 111.583 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -145.07 134.42 23.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 110.843 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -157.01 149.84 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.208 1.003 . . . . 0.0 111.084 169.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -135.63 155.84 49.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.098 1.759 . . . . 0.0 110.172 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -50.04 -33.8 19.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.154 1.382 . . . . 0.0 114.101 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.3 -23.29 47.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.92 -48.54 58.12 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.017 -1.052 . . . . 0.0 111.581 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.91 -33.62 68.45 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.037 -1.04 . . . . 0.0 111.099 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -61.18 -43.81 98.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -27.23 62.69 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.185 -0.947 . . . . 0.0 111.839 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.22 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.789 0.835 . . . . 0.0 109.525 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -122.1 114.8 21.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.794 1.179 . . . . 0.0 111.037 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -151.81 -40.54 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.654 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -96.6 15.91 0.79 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.26 2.64 . . . . 0.0 114.125 -172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.42 22.87 0.32 Allowed 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.455 -1.403 . . . . 0.0 114.4 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.26 -13.93 13.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.476 1.988 . . . . 0.0 116.517 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.51 156.17 49.33 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.114 1.366 . . . . 0.0 110.307 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -165.14 165.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.01 0.924 . . . . 0.0 110.811 -161.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -155.68 -69.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 156.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -143.36 165.04 28.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.451 1.5 . . . . 0.0 113.671 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 tp -113.83 133.84 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.709 2.004 . . . . 0.0 110.018 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -129.9 55.53 1.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 110.416 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.2 tt -70.05 146.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.672 -1.267 . . . . 0.0 111.225 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -134.49 156.52 48.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.797 1.639 . . . . 0.0 110.254 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.51 10.73 0.75 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.766 1.226 . . . . 0.0 113.698 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.68 -60.82 0.44 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.832 1.253 . . . . 0.0 112.238 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -141.89 101.58 3.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.207 1.403 . . . . 0.0 109.457 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.27 152.93 42.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.78 0.705 . . . . 0.0 113.514 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -131.93 157.49 43.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.875 1.27 . . . . 0.0 112.406 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.55 150.38 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.143 1.777 . . . . 0.0 108.53 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -140.15 102.68 4.43 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.226 0.466 . . . . 0.0 110.268 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -119.26 161.01 21.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.249 1.419 . . . . 0.0 112.841 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -78.12 161.86 27.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.745 0.818 . . . . 0.0 109.999 164.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 53.89 90.04 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.769 2.028 . . . . 0.0 113.937 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.99 -25.65 81.87 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.078 2.519 . . . . 0.0 114.523 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -72.69 -25.47 61.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.923 0.783 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -66.73 -42.63 85.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.29 0.95 . . . . 0.0 111.462 167.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.31 -42.79 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.603 1.161 . . . . 0.0 110.952 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -66.49 -45.39 79.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.668 0.787 . . . . 0.0 111.931 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.72 -34.63 74.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.59 0.756 . . . . 0.0 112.357 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.8 -27.62 63.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.68 -48.54 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.958 -1.714 . . . . 0.0 110.505 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.32 2.3 7.8 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.7 t -98.99 -33.05 10.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.877 1.671 . . . . 0.0 112.899 169.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -122.11 -28.26 4.42 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 t -88.08 12.67 12.95 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.954 1.302 . . . . 0.0 112.314 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -147.1 140.82 25.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.693 1.997 . . . . 0.0 110.399 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.19 169.29 20.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 111.73 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttt -136.43 -4.86 2.06 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -118.04 -17.5 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.121 1.768 . . . . 0.0 113.495 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -133.42 134.06 43.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.336 1.454 . . . . 0.0 111.063 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.46 125.45 10.45 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.77 0.7 . . . . 0.0 111.685 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.94 143.62 50.86 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.905 0.882 . . . . 0.0 112.069 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -127.83 12.82 6.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.756 2.022 . . . . 0.0 113.469 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 pp -69.88 154.25 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.382 0.673 . . . . 0.0 111.543 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -124.29 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.593 1.157 . . . . 0.0 109.708 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.8 mt -124.94 138.21 54.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.193 1.397 . . . . 0.0 108.917 165.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -132.36 131.31 41.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.178 0.991 . . . . 0.0 110.799 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.75 140.38 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.214 1.006 . . . . 0.0 111.485 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.1 t -134.99 117.64 15.98 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.354 1.062 . . . . 0.0 110.126 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -151.86 161.69 42.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.866 0.866 . . . . 0.0 112.28 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.6 t -129.15 141.33 51.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.005 0.922 . . . . 0.0 112.22 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -144.28 173.21 11.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.699 1.999 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.32 148.44 48.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.213 1.005 . . . . 0.0 112.129 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.524 1.53 . . . . 0.0 111.162 -176.118 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.254 1 O4'-C1'-N19 112.652 4.452 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.485 1 O4'-C1'-N19 112.489 4.289 . 0.093 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.409 -3.686 0 O4'-C1'-N19 111.169 2.969 . 0.01 4g . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.571 -2.982 1 O4'-C1'-N19 113.398 5.198 . 0.159 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 CA--C 1.533 0.474 0 N-CA-C 112.954 0.328 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 105.06 5.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.227 1.011 . . . . 0.0 110.013 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -128.74 140.39 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.143 0.977 . . . . 0.0 111.294 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -112.25 150.41 30.96 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.952 0.901 . . . . 0.0 112.169 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.07 122.89 35.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.425 1.89 . . . . 0.0 108.707 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -103.59 148.36 26.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.843 1.657 . . . . 0.0 111.524 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.09 135.48 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.537 1.535 . . . . 0.0 110.447 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.41 172.56 2.66 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.568 1.08 . . . . 0.0 113.756 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.67 33.66 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 -161.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.59 -32.97 0.39 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 126.4 1.88 . . . . 0.0 115.307 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.05 -7.23 20.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 123.612 2.326 . . . . 0.0 114.271 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.72 -5.41 8.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.87 1.268 . . . . 0.0 113.254 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -122.68 -38.54 2.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.635 1.974 . . . . 0.0 113.959 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -146.47 127.88 14.95 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.472 1.509 . . . . 0.0 109.113 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.39 127.94 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.438 0.695 . . . . 0.0 111.611 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -152.8 143.32 22.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.093 1.357 . . . . 0.0 109.972 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -57.21 -30.08 64.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.419 1.009 . . . . 0.0 112.426 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.09 -28.95 68.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.896 1.678 . . . . 0.0 113.235 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.43 -45.65 58.65 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.423 1.089 . . . . 0.0 111.514 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.82 -40.93 97.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.496 -0.752 . . . . 0.0 110.252 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.4 -45.28 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.422 1.089 . . . . 0.0 112.424 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.17 82.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.347 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.9 mt -61.02 -74.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.92 1.288 . . . . 0.0 108.494 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -124.53 124.42 42.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.528 1.058 . . . . 0.0 111.444 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.484 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 4.3 m -157.93 -34.31 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 156.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 25' ' ' SER . 56.8 Cg_endo -85.25 5.17 6.33 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 CA-C-N 122.902 2.072 . . . . 0.0 113.686 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.46 -21.34 30.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.08 -157.76 12.87 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 120.084 1.311 . . . . 0.0 116.0 -171.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -68.93 -25.99 64.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.269 1.4 mp 63.72 167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.213 1.405 . . . . 0.0 113.731 170.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.1 mtm -153.04 -72.74 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.388 -1.445 . . . . 0.0 109.889 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.01 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.538 1.135 . . . . 0.0 113.281 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.7 mt -82.46 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 161.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -135.73 66.12 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.423 1.106 . . . . 0.0 111.074 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 tt -83.19 150.96 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.11 0.964 . . . . 0.0 111.883 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -114.4 -175.98 2.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.379 1.872 . . . . 0.0 111.299 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -79.59 -15.03 58.39 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.03 -10.65 2.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.41 159.2 35.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 112.837 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.03 124.36 5.99 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.427 -0.651 . . . . 0.0 111.584 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' CE2' ' C6 ' ' B' ' 80' ' ' ' U' . 7.9 m-85 -128.62 149.19 50.75 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.829 1.299 . . . . 0.0 111.802 164.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.95 149.33 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 126.617 1.967 . . . . 0.0 107.818 166.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -137.08 100.66 4.34 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.049 0.94 . . . . 0.0 108.631 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -124.19 153.91 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.027 1.731 . . . . 0.0 112.837 -167.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -81.36 155.34 26.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.274 0.629 . . . . 0.0 110.695 166.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 59.99 95.65 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 130.226 3.41 . . . . 0.0 116.333 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -67.26 -18.03 50.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.449 2.766 . . . . 0.0 113.46 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -74.76 -27.83 60.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.433 1.015 . . . . 0.0 111.636 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -75.47 -39.24 58.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.562 0.619 . . . . 0.0 111.914 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.21 -41.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.919 0.487 . . . . 0.0 110.598 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -61.91 -49.16 77.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.307 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -55.7 -41.82 74.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.833 0.742 . . . . 0.0 111.591 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.35 -34.34 77.76 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.399 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.2 mt -63.42 -50.49 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.509 1.504 . . . . 0.0 111.025 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.1 -12.49 61.23 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.15 -20.72 17.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.377 1.471 . . . . 0.0 113.241 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -125.48 -29.56 3.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -91.32 -1.53 57.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.766 1.226 . . . . 0.0 112.927 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.71 152.09 47.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 108.872 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 56.43 90.19 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.278 1.431 . . . . 0.0 112.896 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -76.12 23.37 0.14 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.567 1.547 . . . . 0.0 113.992 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -130.12 12.75 5.64 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.862 2.465 . . . . 0.0 112.385 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -150.49 -27.38 0.23 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.782 1.633 . . . . 0.0 112.501 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.05 -151.98 12.41 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.046 2.26 . . . . 0.0 111.675 154.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -122.19 165.83 15.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.45 2.3 . . . . 0.0 110.889 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -69.33 10.11 0.37 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.38 131.3 41.7 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.393 1.077 . . . . 0.0 111.088 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.15 129.29 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.5 mt -134.9 140.68 45.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.259 1.824 . . . . 0.0 108.503 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.2 137.75 34.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.98 0.809 . . . . 0.0 112.841 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.81 142.0 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.742 1.217 . . . . 0.0 112.606 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t -143.29 171.6 13.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.723 2.009 . . . . 0.0 109.826 171.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.1 m -142.84 36.89 1.43 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.257 1.423 . . . . 0.0 111.268 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.1 t -146.24 137.89 24.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.094 0.957 . . . . 0.0 113.169 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.77 11.92 35.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.471 1.509 . . . . 0.0 113.519 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.62 158.87 28.32 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.037 -1.039 . . . . 0.0 111.487 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 C--O 1.248 1.017 0 C-N-CA 125.778 1.631 . . . . 0.0 112.024 -175.372 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C3'-C2'-C1' 99.283 -2.463 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.816 0 O4'-C1'-N19 111.514 3.314 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . 0.408 ' C6 ' ' CE2' ' A' ' 41' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.414 1 O4'-C1'-N19 112.276 4.076 . 0.236 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.285 1 O4'-C1'-N19 114.056 5.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.536 0.62 0 N-CA-C 112.615 0.198 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.45 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.865 2.066 . . . . 0.0 108.2 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -135.27 123.67 23.32 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.375 1.07 . . . . 0.0 109.75 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -88.48 151.72 22.35 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.842 0.829 . . . . 0.0 112.197 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.38 129.46 53.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.23 1.812 . . . . 0.0 107.541 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -109.86 134.78 51.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.208 1.403 . . . . 0.0 110.555 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mm -94.93 116.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.345 1.058 . . . . 0.0 108.712 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.82 149.51 25.09 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 119.566 -0.575 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -55.32 72.02 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.628 2.771 . . . . 0.0 115.148 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 94.9 mt -126.19 -37.75 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.911 2.485 . . . . 0.0 113.832 170.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 40.8 Cg_endo -83.8 59.47 6.22 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.782 2.321 . . . . 0.0 112.119 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.126 1.37 . . . . 0.0 113.021 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.93 146.84 45.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.042 1.337 . . . . 0.0 113.43 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.8 t30 35.83 59.82 0.84 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.237 2.215 . . . . 0.0 114.289 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.49 138.34 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.871 0.843 . . . . 0.0 111.789 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -120.08 159.96 23.78 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.862 1.665 . . . . 0.0 110.263 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -17.54 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.05 -1.031 . . . . 0.0 113.173 161.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -74.26 -23.45 59.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.326 1.051 . . . . 0.0 112.999 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.19 -35.95 63.99 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.803 -1.185 . . . . 0.0 110.732 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.32 -43.51 98.65 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.685 -1.26 . . . . 0.0 110.639 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.11 -44.2 96.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.091 0.956 . . . . 0.0 112.554 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -64.0 -36.64 84.65 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.13 -0.981 . . . . 0.0 111.574 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.67 -70.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.154 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.86 125.14 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.136 1.334 . . . . 0.0 111.394 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.465 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 17.5 m -158.73 -37.77 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.027 1.731 . . . . 0.0 113.588 164.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.2 Cg_endo -83.84 34.53 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.469 2.113 . . . . 0.0 113.311 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.33 123.35 16.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.643 1.577 . . . . 0.0 110.722 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.35 -160.1 53.93 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.581 0.61 . . . . 0.0 113.487 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -107.24 -5.08 18.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.934 1.294 . . . . 0.0 113.904 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 1.6 mp 67.57 154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.771 2.028 . . . . 0.0 114.404 171.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.5 mmt -151.66 -56.44 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.758 1.623 . . . . 0.0 110.5 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -159.12 148.65 18.78 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.626 1.103 . . . . 0.0 113.645 -170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 147.7 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.191 0.996 . . . . 0.0 111.169 163.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -147.66 101.85 3.37 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.298 0.954 . . . . 0.0 111.688 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.47 149.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.312 -1.493 . . . . 0.0 113.056 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -123.88 156.12 36.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.115 1.366 . . . . 0.0 111.329 167.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -65.39 22.91 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 127.395 2.278 . . . . 0.0 116.941 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.08 -33.11 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.485 1.514 . . . . 0.0 112.667 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -152.82 156.04 38.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.865 1.666 . . . . 0.0 110.217 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.23 152.44 18.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.657 0.646 . . . . 0.0 113.699 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.74 156.21 34.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 123.254 1.502 . . . . 0.0 111.683 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.65 152.86 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.98 2.112 . . . . 0.0 107.334 166.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -136.14 101.27 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -121.52 155.0 35.92 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.943 1.297 . . . . 0.0 112.024 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -75.47 157.01 34.65 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.937 0.495 . . . . 0.0 111.218 164.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 68.34 82.29 0.19 Allowed Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 128.797 2.839 . . . . 0.0 115.517 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -57.93 -37.71 95.07 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.592 2.861 . . . . 0.0 113.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -66.59 -34.31 77.61 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.197 -0.939 . . . . 0.0 112.822 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.7 m -87.06 -21.48 26.04 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -43.98 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.205 0.911 . . . . 0.0 109.836 162.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -63.03 -40.37 97.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.984 0.914 . . . . 0.0 112.461 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.24 -35.96 74.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.263 0.625 . . . . 0.0 112.374 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.64 61.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.611 0.764 . . . . 0.0 112.778 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.66 -53.11 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.485 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -67.02 -9.54 40.17 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.76 -33.13 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.122 1.769 . . . . 0.0 113.966 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 59' ' ' GLN . 5.9 tp10 -127.83 -15.91 4.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 t -74.97 33.2 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 111.519 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 57' ' ' GLU . 6.4 pt20 -147.73 143.72 27.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.324 2.65 . . . . 0.0 108.021 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.61 162.75 32.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.501 1.12 . . . . 0.0 109.352 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -58.08 140.82 51.85 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 110.449 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -66.57 103.43 1.07 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.109 0.564 . . . . 0.0 111.888 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -153.77 26.5 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.909 1.684 . . . . 0.0 111.986 -170.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.56 12.13 83.93 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 120.647 -1.283 . . . . 0.0 115.078 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -141.36 151.1 43.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.81 1.644 . . . . 0.0 114.42 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -156.41 136.35 12.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.98 1.712 . . . . 0.0 110.702 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -79.73 142.68 35.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.258 0.935 . . . . 0.0 111.192 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.4 123.82 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.033 1.333 . . . . 0.0 109.317 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 mt -128.92 143.24 50.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.44 1.896 . . . . 0.0 109.057 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -140.09 135.36 32.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.03 0.832 . . . . 0.0 112.59 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.16 144.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.95 0.9 . . . . 0.0 111.095 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.31 129.61 23.84 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.846 1.258 . . . . 0.0 110.46 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -125.13 17.7 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.207 1.003 . . . . 0.0 112.784 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -149.91 151.43 33.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.155 1.382 . . . . 0.0 110.659 170.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -66.92 142.73 57.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.459 1.104 . . . . 0.0 112.955 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.99 21.46 0.88 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.869 1.268 . . . . 0.0 113.342 -168.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 124.871 1.268 . . . . 0.0 112.538 -176.485 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.551 3.351 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 0 O4'-C1'-N19 111.702 3.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O5'-C5'-C4' 114.184 2.846 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.339 0 O4'-C1'-N19 111.358 3.158 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.546 1.106 0 N-CA-C 115.773 1.413 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt 65.12 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.191 2.597 . . . . 0.0 116.586 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -147.9 172.56 13.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.975 1.71 . . . . 0.0 111.412 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -135.08 161.58 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.153 1.381 . . . . 0.0 113.285 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.19 129.65 31.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.937 1.695 . . . . 0.0 110.309 -171.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -111.12 141.69 44.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.781 1.632 . . . . 0.0 111.92 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 mm -101.6 96.76 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.709 1.604 . . . . 0.0 110.291 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 -3.66 84.84 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.409 1.481 . . . . 0.0 115.404 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 47.02 0.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.02 1.91 . . . . 0.0 113.664 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 40.93 59.35 8.24 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.392 1.877 . . . . 0.0 113.589 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.45 25.88 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.027 3.818 . . . . 0.0 114.543 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 -12.99 46.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.26 1.424 . . . . 0.0 113.252 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.64 137.16 51.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.837 1.655 . . . . 0.0 112.303 -167.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 50.95 48.65 22.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.304 1.442 . . . . 0.0 114.062 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 m -112.45 146.15 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 122.574 1.178 . . . . 0.0 113.135 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -146.7 166.76 25.61 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 109.694 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 25.2 mmtp -50.45 -32.04 16.79 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.266 -0.896 . . . . 0.0 112.752 172.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.23 -20.66 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.456 1.102 . . . . 0.0 113.459 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.89 -48.26 32.2 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.629 1.104 . . . . 0.0 110.848 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.61 -35.79 79.61 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -71.52 -40.25 70.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.904 0.882 . . . . 0.0 112.989 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -25.53 60.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.627 1.103 . . . . 0.0 112.527 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.38 -74.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -124.14 125.39 44.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.626 1.557 . . . . 0.0 112.13 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -149.62 -54.25 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 161.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.06 22.47 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.203 2.602 . . . . 0.0 114.085 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -90.39 -33.03 16.19 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.328 -1.483 . . . . 0.0 114.844 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.07 11.9 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 119.122 0.874 . . . . 0.0 114.16 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.14 -24.56 63.19 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp 66.91 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.36 -59.37 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.622 -1.299 . . . . 0.0 111.019 161.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -145.29 138.98 26.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.148 0.979 . . . . 0.0 111.918 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tt -123.38 127.31 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.74 1.616 . . . . 0.0 110.056 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 5.2 p30 -128.8 152.81 48.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.767 1.227 . . . . 0.0 111.616 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -141.87 154.07 19.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.083 -1.011 . . . . 0.0 112.154 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' H ' HD12 ' A' ' 35' ' ' ILE . 42.1 tptt -149.38 146.99 27.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.301 1.441 . . . . 0.0 110.91 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -57.34 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 128.539 2.736 . . . . 0.0 116.872 168.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.95 -63.9 0.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.778 1.631 . . . . 0.0 110.669 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -141.46 111.82 6.92 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.985 0.914 . . . . 0.0 110.96 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.72 151.28 33.84 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.549 0.595 . . . . 0.0 112.482 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.37 156.08 46.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.714 1.245 . . . . 0.0 111.83 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.67 143.55 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.942 0.897 . . . . 0.0 109.221 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -127.67 98.44 5.2 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.582 1.153 . . . . 0.0 108.142 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -120.78 151.24 39.83 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.595 1.158 . . . . 0.0 111.672 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.03 159.99 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.756 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 64.74 82.73 0.21 Allowed Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 127.701 2.4 . . . . 0.0 112.818 -160.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.69 -33.05 47.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.14 3.227 . . . . 0.0 113.887 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -77.11 -23.38 51.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.838 0.855 . . . . 0.0 112.942 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -69.91 -41.98 73.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 163.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.76 -43.33 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.047 0.539 . . . . 0.0 110.569 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.97 -43.77 67.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.168 0.895 . . . . 0.0 113.234 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.41 -33.65 75.2 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.37 0.986 . . . . 0.0 111.731 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.18 68.88 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.287 -0.883 . . . . 0.0 112.97 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.65 -53.0 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.298 1.408 . . . . 0.0 110.4 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.45 -15.92 63.93 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.4 m -84.22 -45.72 12.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.645 1.178 . . . . 0.0 113.68 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -104.0 -29.31 11.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 t -74.89 1.28 13.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.71 0.804 . . . . 0.0 111.598 164.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.77 128.96 38.06 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.937 -1.102 . . . . 0.0 110.832 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.24 138.12 43.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.499 0.72 . . . . 0.0 111.785 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.0 mtt -140.37 155.67 46.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.613 1.565 . . . . 0.0 111.597 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -65.51 157.78 28.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.811 0.844 . . . . 0.0 111.943 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 57.7 38.11 27.46 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.586 1.954 . . . . 0.0 113.75 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -164.05 19.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -170.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -123.9 138.94 54.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.413 1.885 . . . . 0.0 111.155 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -74.02 115.21 13.22 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.89 146.82 45.89 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.623 0.769 . . . . 0.0 109.219 171.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.4 107.74 19.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 mt -127.25 139.96 52.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.542 1.137 . . . . 0.0 109.354 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -131.64 138.13 48.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.451 0.569 . . . . 0.0 112.303 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.07 130.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -133.97 148.79 51.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.151 . . . . 0.0 109.632 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.2 m -132.63 135.82 46.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 p -101.98 14.1 32.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.731 2.013 . . . . 0.0 112.674 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -69.52 148.54 49.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.592 1.557 . . . . 0.0 110.681 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.27 143.74 56.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.622 -0.674 . . . . 0.0 111.835 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.21 -1.853 . . . . 0.0 111.735 -179.318 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.301 0 O4'-C1'-N19 111.897 3.697 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 0 O4'-C1'-N19 110.815 2.615 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.018 0 C3'-C2'-C1' 99.335 -2.406 . 0.41 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.303 0 O4'-C1'-N19 111.964 3.764 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 N-CA-C 111.409 -0.266 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 134.69 41.7 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.905 0.882 . . . . 0.0 111.554 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -146.87 155.76 42.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.63 1.572 . . . . 0.0 109.304 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -121.14 161.13 22.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.755 0.788 . . . . 0.0 112.663 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.8 121.89 19.04 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.478 1.911 . . . . 0.0 108.291 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -104.35 134.64 47.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.738 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 mm -91.49 132.18 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.742 0.817 . . . . 0.0 108.834 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -155.38 5.63 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.044 0.831 . . . . 0.0 113.104 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.6 83.39 0.43 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.217 -1.166 . . . . 0.0 111.591 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' H ' ' CD ' ' A' ' 11' ' ' PRO . 58.2 tp -139.44 -41.71 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.996 1.718 . . . . 0.0 115.011 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' CD ' ' H ' ' A' ' 10' ' ' LEU . 21.4 Cg_endo -93.51 17.75 1.03 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.255 1.97 . . . . 0.0 114.488 -162.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.33 22.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 131.75 27.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.267 2.227 . . . . 0.0 110.754 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 t30 40.15 47.71 2.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.353 1.461 . . . . 0.0 113.728 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.61 125.9 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 123.7 0.8 . . . . 0.0 110.965 -161.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -159.83 151.41 20.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.365 1.466 . . . . 0.0 110.599 -167.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -61.4 -16.73 49.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -69.73 -33.78 72.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.485 0.584 . . . . 0.0 112.345 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.2 -35.78 74.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.207 1.367 . . . . 0.0 112.036 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.42 -39.46 71.07 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -61.95 -38.42 88.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.994 0.918 . . . . 0.0 112.392 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -36.4 82.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.687 0.795 . . . . 0.0 110.938 174.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.36 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -122.53 121.08 35.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.854 1.206 . . . . 0.0 111.717 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.58 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.9 p -150.51 -30.1 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 159.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 25' ' ' SER . 44.5 Cg_endo -81.92 26.2 0.63 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.242 2.194 . . . . 0.0 113.265 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -121.62 137.24 54.82 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.592 1.957 . . . . 0.0 110.67 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.1 -159.42 49.7 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 121.841 0.69 . . . . 0.0 114.431 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -100.8 -7.68 23.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.229 1.012 . . . . 0.0 113.543 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 67.85 142.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.025 2.13 . . . . 0.0 115.372 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 mmt -138.73 -81.71 0.31 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.953 1.301 . . . . 0.0 111.018 170.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -137.55 162.18 34.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.301 1.841 . . . . 0.0 113.583 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 tt -149.64 121.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.728 1.211 . . . . 0.0 110.977 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.87 101.92 6.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.472 1.109 . . . . 0.0 111.556 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.16 135.95 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.63 0.772 . . . . 0.0 112.114 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -120.88 165.95 14.48 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.209 1.803 . . . . 0.0 110.38 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -78.15 -18.82 55.1 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 -4.94 9.35 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -164.36 179.54 6.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.25 1.82 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.57 159.02 27.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 120.573 -1.329 . . . . 0.0 114.763 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.36 149.85 51.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.532 1.533 . . . . 0.0 112.084 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.8 150.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 127.024 2.13 . . . . 0.0 108.334 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -132.9 113.99 13.51 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 167.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -125.96 155.54 41.2 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.532 1.158 . . . . 0.0 112.308 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -80.3 144.53 32.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.686 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 80.03 82.03 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.382 3.073 . . . . 0.0 115.155 -170.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.53 -38.68 88.65 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.22 3.28 . . . . 0.0 114.494 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.01 -29.18 67.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.98 -1.075 . . . . 0.0 111.855 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -68.76 -35.0 76.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.49 -40.1 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.437 0.695 . . . . 0.0 109.691 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -65.81 -40.1 91.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.527 170.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.85 -38.34 81.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.2 0.909 . . . . 0.0 111.191 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.41 70.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.529 0.731 . . . . 0.0 112.693 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.27 -50.38 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.265 1.393 . . . . 0.0 110.395 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.22 -12.27 61.53 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.323 0.965 . . . . 0.0 113.393 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -96.86 -28.86 14.04 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -108.53 -56.3 2.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.398 1.479 . . . . 0.0 111.994 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -14.34 58.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.737 1.215 . . . . 0.0 113.151 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.33 10.48 8.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.802 1.641 . . . . 0.0 112.733 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -78.71 137.38 37.75 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.835 -1.165 . . . . 0.0 110.714 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.5 ttt 56.42 34.54 24.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.93 1.292 . . . . 0.0 112.51 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -58.72 -7.66 1.06 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.535 1.934 . . . . 0.0 115.714 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -104.32 -2.9 24.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.642 1.577 . . . . 0.0 113.27 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.18 -27.76 1.08 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.715 1.626 . . . . 0.0 114.898 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -148.96 156.75 42.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.181 2.193 . . . . 0.0 110.551 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -125.8 137.15 53.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 112.572 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.31 137.3 51.89 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.314 1.446 . . . . 0.0 109.993 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.35 114.09 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.487 1.115 . . . . 0.0 108.986 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 mt -129.49 148.49 51.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.298 2.239 . . . . 0.0 107.536 166.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -142.42 130.17 21.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.81 138.9 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.406 1.482 . . . . 0.0 112.664 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.3 t -135.38 148.76 49.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 112.766 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.4 p -133.91 16.97 3.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.169 1.387 . . . . 0.0 112.49 167.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.9 m -94.43 16.17 15.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.304 1.442 . . . . 0.0 113.726 -173.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -93.97 14.6 19.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.379 1.872 . . . . 0.0 112.651 -173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.83 13.94 7.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.866 1.666 . . . . 0.0 112.024 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 127.182 2.193 . . . . 0.0 113.742 -175.096 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 O4'-C1'-N19 111.061 2.861 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 C5'-C4'-C3' 110.423 -3.385 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.595 1 O4'-C1'-N19 112.522 4.322 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0a' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 O4'-C1'-N19 111.181 2.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.541 0.855 0 CA-C-O 120.102 -0.041 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.66 140.43 40.82 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.117 0.967 . . . . 0.0 113.209 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 141.89 15.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.575 1.55 . . . . 0.0 110.355 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -116.77 145.73 43.3 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.946 0.898 . . . . 0.0 111.717 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.88 124.42 44.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.533 1.533 . . . . 0.0 108.739 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -108.86 135.83 49.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.2 mm -90.72 80.17 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.089 1.356 . . . . 0.0 110.776 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 -4.3 12.28 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.18 1.371 . . . . 0.0 115.164 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.19 -10.81 34.43 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.649 1.98 . . . . 0.0 114.248 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.6 mt 48.53 63.79 9.76 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.066 1.746 . . . . 0.0 113.803 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.99 45.25 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 125.663 4.242 . . . . 0.0 113.679 -173.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -50.43 -23.69 2.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.023 2.129 . . . . 0.0 115.998 -166.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.05 2.8 5.88 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.538 2.335 . . . . 0.0 114.075 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -135.67 61.62 1.65 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 110.8 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.58 117.89 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.789 1.235 . . . . 0.0 110.965 -173.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 t -155.38 151.95 28.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -50.59 -34.09 24.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.549 1.14 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -68.69 -22.38 64.37 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.09 -35.14 64.18 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.339 -1.475 . . . . 0.0 111.24 174.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.55 -40.89 69.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.376 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -69.29 -38.45 78.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.825 0.85 . . . . 0.0 113.184 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -28.1 65.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.68 -77.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.638 1.175 . . . . 0.0 108.526 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -117.53 112.36 20.49 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.693 1.133 . . . . 0.0 111.588 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.413 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 42.8 t -159.95 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.665 1.586 . . . . 0.0 112.294 167.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD2' ' H ' ' A' ' 25' ' ' SER . 50.4 Cg_endo -87.96 17.15 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 115.358 -171.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -90.29 1.32 56.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.542 1.137 . . . . 0.0 114.043 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.45 19.47 76.32 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.474 1.034 . . . . 0.0 113.905 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -137.75 137.43 38.27 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.595 1.158 . . . . 0.0 110.066 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 tp -158.28 163.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.543 1.137 . . . . 0.0 109.517 -170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.5 tpp -164.59 -67.35 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.668 0.787 . . . . 0.0 110.49 150.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -139.81 144.19 37.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 111.953 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 pt -107.85 141.85 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.107 0.963 . . . . 0.0 110.846 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -145.31 72.36 1.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.684 1.193 . . . . 0.0 110.464 -172.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 tt -90.78 138.11 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.863 -1.148 . . . . 0.0 113.118 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.85 157.0 30.74 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 110.371 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.02 8.53 0.53 Allowed 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -168.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.8 -51.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.349 1.46 . . . . 0.0 111.901 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.73 138.32 23.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.396 1.078 . . . . 0.0 110.738 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.99 160.09 30.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -127.18 152.71 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.898 1.279 . . . . 0.0 111.632 167.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.33 145.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.615 1.566 . . . . 0.0 108.246 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -130.42 87.94 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.633 1.573 . . . . 0.0 107.088 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -115.13 169.68 8.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.619 1.568 . . . . 0.0 112.573 -167.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -91.35 177.52 6.22 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.181 1.393 . . . . 0.0 111.333 168.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 49.15 81.03 0.27 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.741 2.416 . . . . 0.0 114.423 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.29 -29.65 89.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.497 2.798 . . . . 0.0 114.242 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -73.79 -33.94 64.42 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.468 -0.77 . . . . 0.0 111.597 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -70.65 -31.2 68.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.3 0.955 . . . . 0.0 112.622 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.66 -48.1 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.425 0.69 . . . . 0.0 110.518 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -64.66 -44.47 90.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.714 0.688 . . . . 0.0 112.546 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.94 -38.23 72.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.552 1.141 . . . . 0.0 112.322 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.03 -26.22 62.12 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.572 -0.705 . . . . 0.0 112.891 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.39 -51.61 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.045 1.293 . . . . 0.0 110.392 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.89 -17.95 65.01 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.79 -60.11 2.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.312 0.645 . . . . 0.0 111.973 167.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.02 -35.84 20.09 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.322 1.449 . . . . 0.0 114.722 -166.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -85.55 -3.98 59.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.612 1.565 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -75.82 71.88 2.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.508 1.123 . . . . 0.0 109.403 163.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -144.38 138.0 27.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.434 1.894 . . . . 0.0 109.64 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.0 ttp -140.61 139.62 34.94 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.684 1.194 . . . . 0.0 110.538 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -149.0 161.3 42.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 110.73 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.54 53.25 1.05 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.0 -148.13 6.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 128.149 2.785 . . . . 0.0 109.673 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.94 158.5 1.39 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.27 1.028 . . . . 0.0 113.589 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -117.52 144.58 44.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.672 1.989 . . . . 0.0 111.305 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.1 tp -74.57 70.72 1.82 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.409 -0.807 . . . . 0.0 111.324 169.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.31 123.89 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.525 0.73 . . . . 0.0 109.904 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.62 139.44 53.92 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.92 1.688 . . . . 0.0 108.525 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -132.7 134.77 45.22 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.243 0.929 . . . . 0.0 112.154 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.65 137.92 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.384 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 m -139.67 167.25 22.54 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.089 1.756 . . . . 0.0 110.773 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.8 t -153.93 153.07 31.37 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -0.895 . . . . 0.0 111.578 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 m -68.52 -0.5 5.13 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.059 1.344 . . . . 0.0 113.432 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -54.66 112.46 1.02 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.481 1.912 . . . . 0.0 110.83 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.74 49.68 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.211 1.804 . . . . 0.0 111.08 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.551 1.54 . . . . 0.0 113.481 -172.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.431 -1.823 1 O4'-C1'-N19 114.462 6.262 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.58 -2.213 0 O4'-C1'-N19 112.17 3.97 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.241 0 C5'-C4'-C3' 110.923 -3.051 . 0.061 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.573 -2.809 0 O4'-C1'-N19 111.961 3.761 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 112.914 0.313 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.53 156.02 18.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.307 1.843 . . . . 0.0 111.956 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -159.05 167.04 30.3 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.049 0.939 . . . . 0.0 111.468 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -130.1 165.01 23.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.93 126.11 42.69 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.291 2.236 . . . . 0.0 109.117 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -106.68 143.1 35.26 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.662 1.585 . . . . 0.0 111.498 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.7 101.7 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.668 1.587 . . . . 0.0 110.96 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 7.52 75.59 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.038 1.304 . . . . 0.0 114.909 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -74.29 15.32 0.34 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.25 80.96 0.27 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.373 2.269 . . . . 0.0 112.677 -163.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.39 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.059 3.173 . . . . 0.0 111.892 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 mp 53.15 22.95 2.81 Favored 'General case' 0 CA--C 1.557 1.214 0 O-C-N 120.408 -1.432 . . . . 0.0 113.837 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -150.9 150.11 30.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.341 2.256 . . . . 0.0 110.469 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 m120 45.36 39.67 4.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.291 1.437 . . . . 0.0 113.224 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.77 34.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.739 1.615 . . . . 0.0 113.488 -157.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -90.68 147.53 23.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.898 1.279 . . . . 0.0 110.801 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.33 -32.29 10.88 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -62.97 -12.73 27.67 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.96 -43.71 70.98 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.983 -1.073 . . . . 0.0 111.893 168.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.68 -36.7 65.34 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.641 -0.662 . . . . 0.0 110.73 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.07 -45.52 91.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.491 0.716 . . . . 0.0 112.045 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -28.08 64.09 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.608 -0.682 . . . . 0.0 112.798 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.83 -75.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -123.85 126.58 46.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.843 1.201 . . . . 0.0 111.137 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 3.7 m -157.78 -20.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 160.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 25' ' ' SER . 29.4 Cg_endo -91.85 15.27 1.66 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 123.558 2.306 . . . . 0.0 113.166 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -105.58 154.68 20.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.563 1.145 . . . . 0.0 113.472 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 -146.28 43.43 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.699 1.143 . . . . 0.0 115.761 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.46 -0.6 27.74 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.177 1.391 . . . . 0.0 112.784 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.271 1.3 tp 63.5 171.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 128.376 2.67 . . . . 0.0 116.435 166.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mtm -171.6 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.692 1.597 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -142.63 136.99 29.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.273 1.429 . . . . 0.0 112.457 -164.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tt -85.2 139.31 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.056 0.942 . . . . 0.0 109.929 163.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -143.4 77.83 1.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.921 0.782 . . . . 0.0 111.665 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -88.15 138.71 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 122.076 0.941 . . . . 0.0 111.62 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -130.49 147.22 52.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.679 1.592 . . . . 0.0 108.336 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -75.0 35.86 0.11 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.37 -57.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.103 1.761 . . . . 0.0 109.52 166.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.84 126.58 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.133 1.373 . . . . 0.0 110.22 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.21 149.12 24.77 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 122.604 0.145 . . . . 0.0 112.926 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -134.37 162.41 32.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.324 1.45 . . . . 0.0 111.501 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.95 149.13 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 108.602 167.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -131.98 97.96 4.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.799 1.24 . . . . 0.0 107.936 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.51 145.53 50.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 112.284 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -73.75 154.15 39.71 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 166.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 64.34 86.98 0.13 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.477 2.711 . . . . 0.0 114.638 -166.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.0 -24.48 65.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.753 2.302 . . . . 0.0 114.423 174.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -68.54 -43.38 76.84 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.328 0.967 . . . . 0.0 110.719 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.7 m -72.8 -29.67 63.46 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.19 -46.03 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.873 0.76 . . . . 0.0 109.867 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -63.91 -37.54 87.8 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.288 1.035 . . . . 0.0 112.812 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.15 -45.19 94.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.305 0.642 . . . . 0.0 111.139 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 -31.34 72.45 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.563 -0.711 . . . . 0.0 112.322 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.24 -54.92 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.911 1.232 . . . . 0.0 110.58 172.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -71.67 -16.07 62.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -89.44 -36.17 15.59 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -103.13 -24.29 13.6 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.059 1.344 . . . . 0.0 113.911 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.3 p -68.51 -5.8 21.6 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.129 -1.607 . . . . 0.0 113.221 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -145.13 23.69 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.925 1.69 . . . . 0.0 112.84 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -82.77 83.5 7.68 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.156 -1.59 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 80.7 mtp 58.96 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.723 1.609 . . . . 0.0 113.716 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -74.26 166.96 22.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.78 1.632 . . . . 0.0 112.873 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.29 160.06 33.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 113.346 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 68.24 -169.68 39.48 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.2 0.905 . . . . 0.0 113.062 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -134.09 18.6 3.76 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -92.18 23.26 3.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.771 1.228 . . . . 0.0 112.594 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -121.51 129.44 52.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.685 1.194 . . . . 0.0 111.23 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 tp -157.28 154.06 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.204 1.002 . . . . 0.0 110.602 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -128.79 143.03 50.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.546 2.339 . . . . 0.0 106.623 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -136.19 132.25 35.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.266 1.394 . . . . 0.0 112.446 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.4 144.1 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.021 0.928 . . . . 0.0 110.654 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 t -140.95 147.99 39.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.432 1.093 . . . . 0.0 110.87 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.7 t -75.69 146.12 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.407 0.622 . . . . 0.0 111.267 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 p -107.34 5.88 27.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.455 1.502 . . . . 0.0 112.386 166.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -141.9 52.67 1.49 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.477 1.911 . . . . 0.0 111.388 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.0 157.62 37.4 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.399 0 C-N-CA 126.638 1.975 . . . . 0.0 114.18 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C3'-C2'-C1' 98.996 -2.782 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.375 1 O4'-C1'-N19 112.608 4.408 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.118 0 C3'-C2'-C1' 103.857 2.619 . 0.102 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.031 0 O4'-C1'-N19 111.733 3.533 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 CA--C 1.537 0.66 0 N-CA-C 114.311 0.85 . . . . 0.0 114.311 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.35 148.9 52.22 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.847 2.059 . . . . 0.0 110.006 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 p -162.94 161.68 25.81 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.285 1.434 . . . . 0.0 109.992 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.25 156.24 44.96 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.309 1.043 . . . . 0.0 111.395 160.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.35 117.78 23.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.199 2.199 . . . . 0.0 107.988 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -100.42 147.02 26.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.715 1.206 . . . . 0.0 111.501 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mm -103.29 131.56 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.84 1.256 . . . . 0.0 109.117 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.44 -176.49 4.82 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 121.399 0.444 . . . . 0.0 113.386 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.69 47.51 0.51 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.508 1.523 . . . . 0.0 114.911 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -119.02 -25.28 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 127.261 2.224 . . . . 0.0 115.518 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.9 38.6 0.76 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.92 2.414 . . . . 0.0 112.595 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.7 49.36 1.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.353 1.861 . . . . 0.0 110.183 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.45 37.58 1.69 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.301 1.84 . . . . 0.0 113.168 -161.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 51.36 61.08 3.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.053 1.741 . . . . 0.0 112.399 -172.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.19 149.35 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.089 0.956 . . . . 0.0 113.157 -167.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -138.78 164.43 29.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.109 2.563 . . . . 0.0 109.328 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -49.57 -32.44 12.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.468 1.107 . . . . 0.0 113.136 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -49.55 -36.56 23.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.549 1.539 . . . . 0.0 113.931 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.93 -39.59 50.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 111.94 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.01 -39.67 95.44 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.502 -0.749 . . . . 0.0 110.279 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.12 -36.67 74.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.985 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -69.28 -36.13 76.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.059 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.9 mt -63.1 -77.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.154 0.982 . . . . 0.0 108.871 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -120.3 121.08 37.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.97 1.259 . . . . 0.0 112.304 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.563 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.4 t -152.14 -38.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 112.98 165.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.563 ' HD2' ' H ' ' A' ' 25' ' ' SER . 47.4 Cg_endo -83.92 46.4 2.01 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.632 2.221 . . . . 0.0 112.18 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.96 145.63 49.72 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.491 1.116 . . . . 0.0 111.51 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.77 -155.4 33.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -97.71 0.89 47.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.686 0.794 . . . . 0.0 112.648 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tp 60.95 175.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.133 2.173 . . . . 0.0 113.7 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 mtm -166.11 -73.56 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.393 1.477 . . . . 0.0 109.051 160.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -144.22 153.53 42.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.663 1.185 . . . . 0.0 112.364 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 tt -122.49 130.93 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 126.292 1.837 . . . . 0.0 109.425 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.06 146.48 50.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.484 1.114 . . . . 0.0 112.316 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.14 148.79 23.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.135 1.374 . . . . 0.0 110.812 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -136.08 -176.44 4.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.639 1.576 . . . . 0.0 109.736 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -65.4 122.95 18.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.65 0.78 . . . . 0.0 110.661 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.44 10.03 0.44 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -157.04 157.64 35.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.529 1.532 . . . . 0.0 110.881 171.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.17 161.7 28.8 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.507 -0.746 . . . . 0.0 113.08 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -140.15 116.93 10.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.833 1.253 . . . . 0.0 110.865 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.98 148.5 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.858 -1.151 . . . . 0.0 108.939 164.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -137.19 98.28 3.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.859 0.864 . . . . 0.0 109.316 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -123.06 153.81 39.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 112.951 -169.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -81.06 153.66 27.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.408 1.083 . . . . 0.0 110.525 164.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 67.81 75.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 128.762 2.825 . . . . 0.0 113.852 -164.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -52.32 -35.77 65.74 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.982 3.121 . . . . 0.0 114.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -64.82 -39.37 93.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.004 0.82 . . . . 0.0 111.857 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -63.86 -31.26 72.38 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 -43.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.944 0.898 . . . . 0.0 109.942 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.74 -45.39 85.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.981 0.81 . . . . 0.0 111.675 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -62.48 -40.03 95.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.722 0.809 . . . . 0.0 112.257 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.04 72.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.379 0.672 . . . . 0.0 112.238 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.66 -51.08 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.517 1.053 . . . . 0.0 110.431 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.61 -15.39 63.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.81 -39.7 15.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.415 1.486 . . . . 0.0 114.141 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.15 -30.95 6.79 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -68.87 -3.16 11.57 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.562 -1.336 . . . . 0.0 113.623 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -115.69 11.12 15.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.026 2.531 . . . . 0.0 112.015 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -57.48 158.48 5.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.036 0.934 . . . . 0.0 112.253 172.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 58.1 mtt -113.28 22.01 14.68 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.48 -40.67 97.72 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.153 -0.967 . . . . 0.0 112.69 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.26 120.55 4.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 112.432 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.78 78.27 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.001 -1.062 . . . . 0.0 114.744 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 54.71 13.29 0.68 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.627 2.371 . . . . 0.0 117.165 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -160.4 140.61 11.47 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.547 1.939 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.3 110.33 12.28 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.29 119.93 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.943 0.897 . . . . 0.0 110.425 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -129.31 141.78 51.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.438 1.895 . . . . 0.0 109.601 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.36 135.29 30.33 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.2 p -102.18 137.67 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.325 1.05 . . . . 0.0 112.057 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -143.66 141.11 30.41 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.873 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 t -130.37 21.89 5.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.242 1.017 . . . . 0.0 112.905 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -149.45 97.99 2.72 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.645 1.178 . . . . 0.0 109.919 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -126.32 10.51 7.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.39 1.476 . . . . 0.0 112.412 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.25 152.86 51.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.665 1.986 . . . . 0.0 110.695 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.846 1.259 . . . . 0.0 109.817 173.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 O4'-C1'-N19 111.773 3.573 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . 0.421 HO2' ' P ' ' B' ' 80' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.464 0 O4'-C1'-N19 111.863 3.663 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . 0.421 ' P ' HO2' ' B' ' 79' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O4'-C1'-N19 111.853 3.653 . 0.072 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.089 1 O4'-C1'-N19 113.954 5.754 . 0.084 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.532 0.415 0 N-CA-C 113.559 0.561 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HB3' HE22 ' A' ' 43' ' ' GLN . 0.6 OUTLIER -131.44 118.56 20.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.765 2.026 . . . . 0.0 109.506 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -136.42 108.06 7.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.468 1.107 . . . . 0.0 110.118 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -84.98 149.26 25.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.369 0.604 . . . . 0.0 110.855 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.57 120.22 29.05 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.475 1.51 . . . . 0.0 108.117 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -99.18 136.26 39.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.537 1.535 . . . . 0.0 110.744 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -93.13 107.14 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 109.799 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.17 0.83 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.332 1.444 . . . . 0.0 113.947 173.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.65 148.86 39.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.321 1.848 . . . . 0.0 111.207 166.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.9 tp -110.28 90.72 10.35 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.43 1.892 . . . . 0.0 109.341 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.54 -23.62 23.14 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.367 2.711 . . . . 0.0 112.615 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . 0.283 1.6 tt 55.25 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.965 3.306 . . . . 0.0 114.236 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -97.78 -2.69 40.51 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.5 17.99 13.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.572 1.149 . . . . 0.0 113.457 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.12 126.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.786 1.634 . . . . 0.0 113.538 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 t -155.5 142.65 19.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 112.438 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.1 -32.13 71.81 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.754 -0.591 . . . . 0.0 111.019 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.06 -24.57 67.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.557 1.143 . . . . 0.0 112.828 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.09 -41.35 50.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.357 0.98 . . . . 0.0 111.739 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.95 -39.58 87.32 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 110.983 172.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -63.95 -43.79 94.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.172 0.989 . . . . 0.0 112.03 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.714 -1.241 . . . . 0.0 111.397 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.6 mt -58.71 -71.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.402 1.081 . . . . 0.0 109.483 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -124.63 114.56 19.52 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.748 1.158 . . . . 0.0 110.838 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.474 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 33.1 t -155.94 -43.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HD2' ' H ' ' A' ' 25' ' ' SER . 89.9 Cg_endo -83.04 11.38 3.29 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.435 2.09 . . . . 0.0 115.521 -173.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -80.07 16.91 1.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.16 -14.63 32.37 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.555 1.074 . . . . 0.0 115.6 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.482 ' CE1' HD21 ' A' ' 46' ' ' ASN . 47.8 m-70 -135.97 141.1 44.39 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.404 1.882 . . . . 0.0 108.64 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 tp -153.37 161.48 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.449 0.699 . . . . 0.0 111.061 -162.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -151.9 -65.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.497 152.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -152.95 153.31 32.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.393 0.997 . . . . 0.0 113.434 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.53 140.2 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.26 1.424 . . . . 0.0 108.891 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -129.84 65.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.735 1.255 . . . . 0.0 110.679 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.35 138.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.821 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -125.82 155.42 41.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.517 1.527 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.83 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -165.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.91 -42.75 0.31 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.943 1.297 . . . . 0.0 112.767 167.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -148.91 146.77 28.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.84 1.256 . . . . 0.0 110.254 171.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.86 164.46 17.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -170.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -130.0 163.65 26.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.496 1.518 . . . . 0.0 110.543 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.96 155.12 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 109.238 166.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.401 HE22 ' HB3' ' A' ' 2' ' ' LYS . 42.3 tp60 -140.93 92.24 2.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.544 1.538 . . . . 0.0 108.28 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -112.33 165.83 11.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.23 1.412 . . . . 0.0 112.815 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.16 163.67 18.6 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.291 1.036 . . . . 0.0 111.062 164.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.482 HD21 ' CE1' ' A' ' 29' ' ' HIS . 56.5 t-20 51.41 91.28 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.851 2.46 . . . . 0.0 114.076 -172.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.56 -24.21 75.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.85 1.7 . . . . 0.0 113.969 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -67.28 -35.66 79.94 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.935 0.789 . . . . 0.0 111.587 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.9 m -71.17 -35.73 71.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.336 0.654 . . . . 0.0 112.273 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.34 -41.25 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.889 -0.507 . . . . 0.0 110.424 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -69.53 -36.53 76.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.116 -0.99 . . . . 0.0 112.879 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.33 -35.99 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.212 0.915 . . . . 0.0 111.692 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.02 66.68 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.615 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.14 -52.31 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.475 1.489 . . . . 0.0 110.279 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.14 1.78 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 46.2 t -107.62 -52.69 2.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.23 1.812 . . . . 0.0 112.855 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -88.83 -40.78 12.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.775 1.23 . . . . 0.0 112.501 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -71.09 -3.32 19.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.091 -1.006 . . . . 0.0 112.448 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -130.79 27.06 4.96 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.212 2.605 . . . . 0.0 111.589 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.5 157.0 24.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.43 -1.419 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 75.4 mtm -73.91 61.94 0.82 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.963 1.705 . . . . 0.0 113.185 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -135.21 136.97 42.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.749 1.62 . . . . 0.0 110.065 171.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -77.32 140.93 40.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.876 0.846 . . . . 0.0 111.613 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.47 170.04 17.82 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.126 0.87 . . . . 0.0 113.103 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -132.04 15.22 4.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.518 1.927 . . . . 0.0 113.962 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -120.2 6.23 10.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.694 1.998 . . . . 0.0 115.532 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.9 tp -118.4 104.64 10.91 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.47 1.508 . . . . 0.0 109.366 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.433 1.093 . . . . 0.0 109.609 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 mt -119.98 134.87 55.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.334 1.454 . . . . 0.0 108.001 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.75 128.31 45.12 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.92 142.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.514 1.126 . . . . 0.0 110.598 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 t -141.6 121.05 13.21 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.395 1.078 . . . . 0.0 110.105 171.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.8 p -119.54 144.61 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.781 1.232 . . . . 0.0 111.297 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.7 m 53.49 32.5 14.2 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -97.13 154.75 17.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.765 1.226 . . . . 0.0 110.642 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.94 33.4 14.49 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.868 1.667 . . . . 0.0 113.238 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 . . . . . 0 C--O 1.257 1.485 0 C-N-CA 126.982 2.113 . . . . 0.0 112.215 -177.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.008 1 O4'-C1'-N19 115.135 6.935 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.383 1 O4'-C1'-N19 112.607 4.407 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.521 1 O4'-C1'-N19 112.919 4.719 . 0.315 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.228 1 O4'-C1'-N19 112.589 4.389 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 CA--C 1.547 1.134 0 CA-C-O 121.064 0.36 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.8 123.29 20.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.602 1.161 . . . . 0.0 110.475 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -137.82 114.38 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.855 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -93.0 141.57 28.25 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.703 -0.623 . . . . 0.0 112.529 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.76 133.44 53.98 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.867 2.067 . . . . 0.0 108.36 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -117.57 138.56 51.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.758 2.023 . . . . 0.0 110.773 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -103.13 144.28 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.26 -162.51 1.67 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 122.022 0.79 . . . . 0.0 114.422 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -82.39 19.38 1.25 Allowed 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.601 -1.529 . . . . 0.0 114.675 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.59 -36.83 10.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.619 173.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 13' ' ' LYS . 32.1 Cg_exo -72.54 18.08 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.322 3.348 . . . . 0.0 116.696 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.4 mt -71.96 19.61 0.07 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.012 1.325 . . . . 0.0 113.249 170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 11' ' ' PRO . 22.5 ptmt -126.24 -178.7 4.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 110.409 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -52.16 122.33 8.39 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.311 0.505 . . . . 0.0 111.692 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.11 146.01 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.817 0.818 . . . . 0.0 112.526 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -133.9 168.12 19.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.866 1.667 . . . . 0.0 111.298 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -57.8 -32.51 67.62 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.084 -1.01 . . . . 0.0 111.452 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -64.01 -25.15 67.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.56 -48.19 56.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.624 1.102 . . . . 0.0 110.21 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.27 -38.34 86.39 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.153 -0.967 . . . . 0.0 111.496 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.22 -40.31 93.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.891 1.677 . . . . 0.0 112.16 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -28.4 60.48 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.539 -1.351 . . . . 0.0 113.176 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.0 -45.31 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -137.68 102.26 4.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.178 1.791 . . . . 0.0 111.644 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.452 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.0 t -164.56 -48.56 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.819 1.648 . . . . 0.0 111.923 166.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD2' ' H ' ' A' ' 25' ' ' SER . 83.8 Cg_endo -78.19 20.23 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.984 2.456 . . . . 0.0 115.679 -169.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.23 15.37 22.96 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.421 1.488 . . . . 0.0 114.217 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.2 5.46 62.52 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.523 1.535 . . . . 0.0 116.422 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.444 ' CE1' HD21 ' A' ' 46' ' ' ASN . 87.7 m-70 -143.57 126.32 16.1 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.981 1.712 . . . . 0.0 109.005 -171.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -151.36 160.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -156.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 40.0 mtm -158.01 -84.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.184 2.194 . . . . 0.0 108.122 152.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -135.05 155.94 49.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.684 1.594 . . . . 0.0 114.073 -168.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -109.64 136.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.699 1.6 . . . . 0.0 110.469 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.58 72.09 1.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.524 1.13 . . . . 0.0 111.114 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.4 134.29 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.615 -1.303 . . . . 0.0 110.099 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -134.93 143.1 46.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.736 1.615 . . . . 0.0 109.011 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.1 46.42 0.4 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.41 -41.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.308 1.443 . . . . 0.0 112.283 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.51 151.2 37.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.208 1.403 . . . . 0.0 109.588 168.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 147.28 18.7 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.392 0.52 . . . . 0.0 113.481 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -125.82 155.34 41.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.825 1.298 . . . . 0.0 111.596 164.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.21 155.41 32.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 107.578 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.22 109.37 7.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 167.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -115.08 161.01 18.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.261 1.824 . . . . 0.0 111.125 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.57 146.37 25.17 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.247 -0.908 . . . . 0.0 110.691 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.444 HD21 ' CE1' ' A' ' 29' ' ' HIS . 50.1 t30 68.74 107.58 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 127.722 2.409 . . . . 0.0 114.969 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.87 -19.0 21.28 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.752 1.635 . . . . 0.0 113.329 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.57 -41.39 98.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.31 1.413 . . . . 0.0 113.103 -172.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -82.45 -18.02 43.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.17 -41.68 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.163 0.892 . . . . 0.0 109.705 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -62.83 -44.31 96.48 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.089 -1.007 . . . . 0.0 111.689 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.81 -41.68 91.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.631 0.65 . . . . 0.0 112.03 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.66 90.35 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.42 -0.8 . . . . 0.0 112.575 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.08 -52.67 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.708 1.14 . . . . 0.0 110.716 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.31 -17.74 56.18 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.6 t -73.53 -49.11 28.18 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.239 1.816 . . . . 0.0 111.976 166.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -101.28 -28.51 12.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -162.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -71.49 -18.32 62.3 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.594 1.088 . . . . 0.0 113.373 173.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -122.84 144.09 49.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 110.33 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -148.22 89.25 1.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.807 1.243 . . . . 0.0 111.0 -172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 58.69 12.39 2.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.045 1.738 . . . . 0.0 115.219 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -142.03 163.97 31.45 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.693 1.997 . . . . 0.0 109.747 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -74.68 157.9 34.52 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.075 -1.016 . . . . 0.0 112.618 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.14 -159.83 53.95 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.741 1.162 . . . . 0.0 113.725 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -124.05 129.19 50.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.292 1.437 . . . . 0.0 113.322 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -78.92 -16.23 57.26 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.58 1.552 . . . . 0.0 114.15 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -156.65 162.45 39.84 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.488 1.915 . . . . 0.0 110.506 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mm -87.13 123.34 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.252 1.021 . . . . 0.0 111.068 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.17 133.94 44.81 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.052 2.141 . . . . 0.0 107.94 165.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -144.12 131.88 21.33 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.503 1.047 . . . . 0.0 113.775 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.57 141.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.168 0.587 . . . . 0.0 112.038 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.7 m -133.53 127.14 32.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.83 2.052 . . . . 0.0 108.535 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -147.19 156.95 43.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 3.04 2.82 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 112.972 167.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -114.92 5.4 15.07 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.897 . . . . 0.0 113.214 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.89 154.78 38.32 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.113 -0.992 . . . . 0.0 112.751 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.498 1.919 . . . . 0.0 112.881 175.93 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.362 1 O4'-C1'-N19 113.397 5.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.579 -2.354 0 O4'-C1'-N19 111.998 3.798 . 0.034 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.334 1 C3'-C2'-C1' 105.383 4.315 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0a' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 O4'-C1'-N19 110.265 2.065 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.476 0.472 0 CA-C-O 119.706 -0.206 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -114.12 111.84 22.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.45 1.1 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -126.42 100.22 6.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.98 0.912 . . . . 0.0 111.162 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.22 153.88 24.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.53 0.681 . . . . 0.0 111.445 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.07 126.12 29.47 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.765 1.626 . . . . 0.0 108.918 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -103.46 137.98 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.788 1.235 . . . . 0.0 111.633 171.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.78 98.55 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.182 0.993 . . . . 0.0 108.97 168.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.52 176.19 50.69 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.736 0.684 . . . . 0.0 111.571 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.91 40.15 24.37 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.312 -1.111 . . . . 0.0 111.724 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.81 123.47 89.6 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.916 1.287 . . . . 0.0 110.566 -162.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.15 107.3 1.67 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.645 2.897 . . . . 0.0 110.009 168.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.15 7.79 1.97 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.478 -1.389 . . . . 0.0 112.771 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -114.78 128.16 56.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.479 2.311 . . . . 0.0 110.876 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 47.56 35.07 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.98 132.76 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 120.767 -1.208 . . . . 0.0 109.537 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.0 p -133.07 163.23 29.72 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 111.461 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -61.15 -24.63 66.43 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.189 -0.944 . . . . 0.0 112.801 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.33 -31.7 70.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.907 0.883 . . . . 0.0 112.1 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.02 -47.08 84.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.95 0.796 . . . . 0.0 110.42 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.76 -40.66 93.33 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.518 -0.739 . . . . 0.0 111.122 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -68.96 -41.41 78.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.336 1.054 . . . . 0.0 113.327 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -22.36 60.25 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 120.665 -1.272 . . . . 0.0 113.275 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 mt -83.55 -41.15 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.347 0.659 . . . . 0.0 109.696 170.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.7 91.58 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.534 1.534 . . . . 0.0 111.888 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 t -157.88 -49.75 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 165.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.35 27.67 0.49 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.205 2.603 . . . . 0.0 114.033 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.77 14.87 25.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.718 1.607 . . . . 0.0 113.381 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.18 -101.31 2.71 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.439 1.019 . . . . 0.0 113.479 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -64.1 135.27 56.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.784 0.834 . . . . 0.0 112.747 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 tp -140.5 163.87 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.314 1.046 . . . . 0.0 112.0 -161.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.0 mtm -152.22 -76.9 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.485 1.114 . . . . 0.0 109.79 152.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -142.73 156.61 45.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.738 1.215 . . . . 0.0 113.807 -166.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mt -119.2 137.15 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.962 2.105 . . . . 0.0 109.642 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.96 84.04 2.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.946 1.299 . . . . 0.0 110.075 -175.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -88.33 135.25 26.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 165.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -132.89 147.75 52.29 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.862 2.065 . . . . 0.0 108.432 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -62.48 -9.42 8.49 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.3 -24.43 11.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -152.94 145.41 24.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.335 1.425 . . . . 0.0 114.035 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.46 131.15 10.47 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.862 1.22 . . . . 0.0 113.035 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -137.33 156.07 48.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.632 1.573 . . . . 0.0 111.95 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.82 154.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.535 1.534 . . . . 0.0 109.256 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -136.01 113.37 10.7 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -117.2 158.37 24.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.117 1.767 . . . . 0.0 112.339 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.05 151.56 31.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 109.87 164.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 48.8 101.67 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 128.103 2.561 . . . . 0.0 114.439 -172.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -55.96 -11.84 6.18 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.34 2.694 . . . . 0.0 115.357 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -61.62 -36.0 79.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.599 1.09 . . . . 0.0 113.701 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.6 p -69.49 -39.95 77.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 111.335 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.61 -45.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.385 1.074 . . . . 0.0 110.483 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -63.92 -40.83 97.39 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 111.829 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.71 -35.32 80.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -40.29 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.439 1.096 . . . . 0.0 112.239 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -58.86 -48.65 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 120.207 1.367 . . . . 0.0 110.707 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.67 -15.03 63.1 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.0 t -89.0 -55.37 3.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.429 1.092 . . . . 0.0 111.5 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -87.43 -36.85 17.49 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.124 1.77 . . . . 0.0 113.804 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -67.42 -22.57 65.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.274 1.397 . . . . 0.0 111.879 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.47 140.21 58.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.413 1.085 . . . . 0.0 112.032 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 13.3 tp10 -145.43 152.28 39.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.943 1.297 . . . . 0.0 111.135 174.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.65 25.98 5.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.209 1.003 . . . . 0.0 111.903 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.442 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 60.2 t-20 -129.48 147.65 51.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.63 3.172 . . . . 0.0 108.542 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -79.61 26.32 0.31 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.123 -0.986 . . . . 0.0 113.232 173.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.4 176.71 44.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.885 2.183 . . . . 0.0 111.934 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt 50.12 30.18 4.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.423 1.889 . . . . 0.0 114.149 -174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -85.76 162.4 18.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.169 1.388 . . . . 0.0 112.083 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.71 174.04 11.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.419 1.488 . . . . 0.0 111.376 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mm -133.93 127.55 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.541 1.136 . . . . 0.0 109.169 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.9 mt -125.03 129.33 50.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.306 0.642 . . . . 0.0 110.991 -171.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -133.06 127.09 33.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.9 144.87 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.704 1.202 . . . . 0.0 110.957 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.499 ' HB2' ' H41' ' B' ' 79' ' ' ' C' . 41.3 t -143.03 150.57 39.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.208 1.403 . . . . 0.0 109.293 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 p -138.27 155.35 48.7 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 94.8 p -118.95 153.94 33.81 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 110.367 167.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.02 28.87 2.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.404 1.082 . . . . 0.0 111.58 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.92 10.5 1.34 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.976 1.71 . . . . 0.0 113.591 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 127.686 2.394 . . . . 0.0 109.27 -176.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 1 O4'-C1'-N19 112.345 4.145 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . 0.499 ' H41' ' HB2' ' A' ' 72' ' ' SER . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 O4'-C4'-C3' 108.786 2.347 . 0.023 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.049 0 O4'-C1'-N19 111.62 3.42 . 0.07 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 O4'-C1'-N19 110.879 2.679 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 CA-C-O 119.623 -0.24 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.79 120.63 22.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 112.321 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -129.4 159.02 37.54 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.856 1.262 . . . . 0.0 111.533 173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.37 149.34 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.654 1.582 . . . . 0.0 110.247 168.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.64 117.76 19.12 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.691 1.596 . . . . 0.0 107.979 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -97.76 132.5 43.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.677 1.591 . . . . 0.0 110.511 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.36 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.848 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.03 -178.47 0.34 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 123.99 0.805 . . . . 0.0 113.697 166.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -76.75 26.61 0.14 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 120.124 -1.81 . . . . 0.0 113.739 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.19 66.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.468 1.507 . . . . 0.0 112.113 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -63.36 6.32 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.332 3.355 . . . . 0.0 117.604 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.15 -9.05 14.41 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -117.14 -27.02 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.518 1.527 . . . . 0.0 114.241 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.6 127.66 14.63 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.789 1.635 . . . . 0.0 110.259 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.59 89.17 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.201 1.4 . . . . 0.0 111.908 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -139.87 148.74 42.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.486 1.114 . . . . 0.0 109.301 163.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -60.01 -21.01 60.77 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.537 1.062 . . . . 0.0 112.714 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -55.49 -24.33 30.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.72 1.208 . . . . 0.0 113.6 169.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.47 -53.53 7.98 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.043 0.937 . . . . 0.0 111.603 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.16 -36.63 70.98 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.393 -1.442 . . . . 0.0 111.133 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -70.1 -22.84 62.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.438 1.495 . . . . 0.0 114.108 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.13 58.3 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.448 -1.407 . . . . 0.0 111.674 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.51 -45.1 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.855 0.862 . . . . 0.0 109.662 -177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.89 118.16 14.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.437 1.495 . . . . 0.0 111.251 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.542 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.6 p -154.54 -37.93 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.823 -1.561 . . . . 0.0 114.987 162.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 25' ' ' SER . 82.9 Cg_endo -76.46 -2.28 12.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.155 2.162 . . . . 0.0 113.329 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -93.16 141.55 28.29 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.328 1.051 . . . . 0.0 112.43 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.77 -164.1 43.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 124.643 1.115 . . . . 0.0 114.743 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -87.67 -12.83 44.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.231 1.012 . . . . 0.0 112.776 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 66.57 157.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.188 2.195 . . . . 0.0 113.965 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 38.0 tpp -156.7 -79.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.293 -0.879 . . . . 0.0 111.534 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -138.7 153.27 48.51 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.049 1.295 . . . . 0.0 113.946 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.85 130.73 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.751 1.62 . . . . 0.0 110.625 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -145.32 127.86 16.05 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.819 0.819 . . . . 0.0 113.043 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.33 144.45 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.718 -1.239 . . . . 0.0 112.028 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -128.88 156.07 44.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.356 1.462 . . . . 0.0 110.406 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -72.32 7.44 1.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.23 -35.38 2.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.134 1.333 . . . . 0.0 113.219 163.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -154.22 148.73 26.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.512 1.525 . . . . 0.0 110.448 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.96 165.26 12.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.342 -0.849 . . . . 0.0 114.202 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.33 133.52 51.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.901 1.81 . . . . 0.0 112.683 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 mt -104.88 139.65 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.546 1.538 . . . . 0.0 107.152 167.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -134.61 84.77 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -115.17 153.42 30.85 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.562 1.145 . . . . 0.0 112.489 -169.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.67 151.91 24.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.424 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 65.6 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 128.771 2.828 . . . . 0.0 114.699 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.39 -23.77 58.11 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.242 2.628 . . . . 0.0 114.479 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -64.86 -40.72 95.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 111.182 -175.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 m -73.83 -31.06 63.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.038 0.935 . . . . 0.0 112.631 174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.01 -44.25 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.686 -0.634 . . . . 0.0 109.92 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -65.22 -41.47 94.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.781 0.833 . . . . 0.0 112.152 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -59.51 -38.95 82.3 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.773 0.829 . . . . 0.0 112.198 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.94 58.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.076 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 mt -57.44 -51.52 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 121.007 1.73 . . . . 0.0 109.674 165.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.94 2.54 8.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -105.84 -26.86 11.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.574 1.55 . . . . 0.0 113.526 171.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -127.05 -26.76 3.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.467 1.107 . . . . 0.0 113.309 -166.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -76.57 40.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.185 1.794 . . . . 0.0 112.276 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -142.65 140.73 31.71 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.015 2.526 . . . . 0.0 108.566 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.5 158.67 43.8 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.938 1.295 . . . . 0.0 109.184 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.1 151.8 34.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.59 0.756 . . . . 0.0 111.435 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -79.15 37.17 0.31 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.836 -1.165 . . . . 0.0 112.976 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -87.23 10.28 17.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.058 2.143 . . . . 0.0 112.567 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.89 116.97 1.06 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.657 -1.277 . . . . 0.0 110.544 -164.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.95 153.13 30.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.037 1.335 . . . . 0.0 111.773 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -153.03 13.39 0.51 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.73 133.91 56.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.613 0.765 . . . . 0.0 109.158 168.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 tp -142.23 144.49 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.662 1.185 . . . . 0.0 109.769 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -127.0 131.03 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.969 1.708 . . . . 0.0 107.985 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -128.07 122.13 31.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -92.13 141.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.945 0.898 . . . . 0.0 111.225 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.0 t -136.78 150.46 48.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 108.392 166.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -135.78 144.09 45.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.567 0.747 . . . . 0.0 110.254 -173.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -74.95 154.9 37.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.861 0.464 . . . . 0.0 111.668 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -58.02 126.68 28.49 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.311 0.577 . . . . 0.0 109.598 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.64 157.75 39.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.131 1.373 . . . . 0.0 111.436 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 110.96 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 O4'-C1'-N19 111.959 3.759 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.092 0 O4'-C1'-N19 111.656 3.456 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 O4'-C1'-N19 111.199 2.999 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 O4'-C1'-N19 111.232 3.032 . 0.24 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.664 0 CA-C-O 119.385 -0.339 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.16 137.89 33.87 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.004 1.322 . . . . 0.0 112.879 -173.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 t -133.0 162.96 30.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 110.922 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -132.4 161.52 33.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.634 0.73 . . . . 0.0 112.15 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -143.74 130.29 20.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.026 1.73 . . . . 0.0 108.872 -166.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -110.99 141.76 44.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.921 1.688 . . . . 0.0 112.013 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -94.7 100.55 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.093 0.957 . . . . 0.0 111.156 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.96 4.37 53.96 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.047 1.784 . . . . 0.0 115.728 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -82.23 30.15 0.41 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.323 1.449 . . . . 0.0 114.031 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.9 tp 50.71 63.77 9.34 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.71 2.004 . . . . 0.0 114.024 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.89 26.48 0.36 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.365 2.71 . . . . 0.0 115.427 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -78.89 51.2 1.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 109.879 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -147.59 147.07 29.67 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 128.399 2.68 . . . . 0.0 108.544 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -53.75 115.79 2.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.192 0.997 . . . . 0.0 111.573 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.47 148.09 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.308 1.043 . . . . 0.0 111.29 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -118.61 158.97 24.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.0 1.72 . . . . 0.0 111.989 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -52.35 -30.25 27.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.695 1.598 . . . . 0.0 113.819 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.41 -29.61 69.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.002 0.921 . . . . 0.0 113.274 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.89 -43.46 98.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.205 0.911 . . . . 0.0 111.121 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.52 -36.38 63.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.377 1.071 . . . . 0.0 111.612 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.12 -35.53 80.74 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.33 0.652 . . . . 0.0 112.559 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -18.84 59.13 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -72.06 -80.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -116.34 117.49 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.151 0.977 . . . . 0.0 110.747 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.541 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 76.8 p -148.2 -27.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.734 1.613 . . . . 0.0 113.772 158.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' CD ' ' H ' ' A' ' 25' ' ' SER . 10.2 Cg_endo -96.46 19.84 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 CA-C-N 122.899 2.071 . . . . 0.0 114.111 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -120.77 143.9 48.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.628 1.571 . . . . 0.0 111.929 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 -152.61 40.85 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.78 -0.575 . . . . 0.0 114.352 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -88.6 -25.77 22.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.024 -0.988 . . . . 0.0 113.257 -171.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mm 64.78 153.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.154 1.782 . . . . 0.0 112.206 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.0 tpp -154.91 -57.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.439 -1.413 . . . . 0.0 113.758 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -156.34 155.69 32.65 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.523 1.129 . . . . 0.0 113.911 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.91 151.89 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.173 1.389 . . . . 0.0 112.281 168.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.25 98.34 3.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.444 1.498 . . . . 0.0 110.525 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tt -106.41 138.84 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HE2' " H1'" ' B' ' 80' ' ' ' U' . 31.5 mtmt -130.64 153.55 48.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.013 1.325 . . . . 0.0 110.371 169.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -76.78 49.41 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.992 1.317 . . . . 0.0 112.387 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.26 -51.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.744 2.418 . . . . 0.0 110.333 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -149.69 144.39 26.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.521 1.528 . . . . 0.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.14 140.83 15.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.119 0.866 . . . . 0.0 112.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.58 148.69 50.5 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.73 1.253 . . . . 0.0 112.43 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -129.88 138.35 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.745 1.618 . . . . 0.0 107.775 176.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.05 97.68 5.35 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.449 1.1 . . . . 0.0 108.415 175.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -118.53 152.81 35.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.031 0.932 . . . . 0.0 111.655 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.28 162.47 21.14 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.654 167.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 69.88 74.42 0.27 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 127.968 2.507 . . . . 0.0 113.357 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.0 -36.89 97.74 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.659 2.906 . . . . 0.0 114.709 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -62.86 -34.43 77.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.158 1.344 . . . . 0.0 111.817 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.5 m -77.45 -33.88 54.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.72 -42.92 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.178 0.899 . . . . 0.0 109.987 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.01 -39.98 87.18 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.301 1.04 . . . . 0.0 112.711 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.1 -32.23 73.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.994 0.816 . . . . 0.0 112.596 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.49 63.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.294 0.638 . . . . 0.0 112.05 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.67 -54.86 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.956 1.253 . . . . 0.0 110.514 171.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.44 -20.41 63.08 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.601 1.092 . . . . 0.0 112.811 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 t -90.98 -24.44 20.11 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.843 1.257 . . . . 0.0 114.321 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -126.49 -19.18 4.67 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.501 -1.374 . . . . 0.0 113.651 -172.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -86.96 21.3 2.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.382 1.873 . . . . 0.0 112.804 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.11 119.29 9.47 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.083 1.353 . . . . 0.0 109.694 -170.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 21.0 tt0 -148.28 141.7 25.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.567 0.747 . . . . 0.0 111.437 169.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -87.02 -5.43 59.08 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 33.9 m120 -115.36 155.74 26.8 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.786 1.634 . . . . 0.0 110.699 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -78.38 51.2 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.374 0.669 . . . . 0.0 112.327 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.78 -149.59 6.41 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.195 0.902 . . . . 0.0 113.381 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -77.8 41.09 0.33 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.044 1.337 . . . . 0.0 109.757 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -68.82 147.83 51.17 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.114 1.366 . . . . 0.0 111.295 -169.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -127.06 158.53 36.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.695 0.759 . . . . 0.0 112.486 -162.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.1 mt -119.46 126.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 167.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.48 150.89 51.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.785 1.634 . . . . 0.0 109.776 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.13 137.82 31.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.696 -0.627 . . . . 0.0 111.592 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -93.63 145.47 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.042 0.937 . . . . 0.0 111.044 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.4 t -135.67 146.95 48.34 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.587 1.155 . . . . 0.0 110.757 168.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -63.24 156.5 25.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.975 0.91 . . . . 0.0 111.901 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.0 t -125.44 65.76 1.16 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.365 1.079 . . . . 0.0 109.345 164.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.66 137.87 31.93 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.833 -172.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.96 122.06 21.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.143 0.577 . . . . 0.0 110.244 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.17 -176.058 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.671 0 O4'-C1'-N19 111.865 3.665 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 0 O4'-C1'-N19 111.129 2.929 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . 0.473 " H1'" ' HE2' ' A' ' 36' ' ' LYS . . . . . . . . 0 P--O3' 1.572 -2.931 0 O4'-C1'-N19 111.373 3.173 . 0.474 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 N19-C1'-C2' 118.115 2.947 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.535 0.535 0 N-CA-C 112.21 0.042 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 133.47 33.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.207 1.003 . . . . 0.0 112.571 176.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -151.52 155.01 37.62 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.438 0.695 . . . . 0.0 110.833 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -120.59 149.84 41.83 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.304 1.442 . . . . 0.0 111.004 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -120.03 128.17 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.42 1.888 . . . . 0.0 108.459 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -115.49 141.67 47.75 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.754 1.622 . . . . 0.0 111.169 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.69 114.93 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.576 1.15 . . . . 0.0 109.798 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.92 -4.98 86.69 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.716 1.627 . . . . 0.0 114.462 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -77.52 31.88 0.16 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.749 1.275 . . . . 0.0 113.466 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt 44.8 76.26 0.56 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.716 2.006 . . . . 0.0 114.188 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.85 26.8 0.18 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.008 3.139 . . . . 0.0 115.419 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -76.2 16.25 0.47 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.133 2.573 . . . . 0.0 112.683 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -127.81 157.62 39.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 129.11 2.964 . . . . 0.0 110.983 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -43.74 120.98 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.045 1.738 . . . . 0.0 112.338 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.96 159.84 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.085 0.954 . . . . 0.0 111.594 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -133.59 161.61 34.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.845 1.658 . . . . 0.0 111.747 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -52.58 -33.86 47.99 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.329 -0.857 . . . . 0.0 111.728 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.62 -21.01 65.41 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.12 -38.04 63.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.911 1.232 . . . . 0.0 112.302 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.96 -37.91 64.37 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.061 -1.024 . . . . 0.0 110.534 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -64.84 -43.85 91.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -29.88 69.75 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.291 0.95 . . . . 0.0 112.145 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.06 -78.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 167.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.16 120.64 35.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.462 1.483 . . . . 0.0 111.752 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.435 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 13.3 p -158.1 -33.35 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.219 167.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' H ' ' A' ' 25' ' ' SER . 31.5 Cg_endo -91.62 43.1 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.686 2.257 . . . . 0.0 111.201 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -133.33 153.8 51.27 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.215 1.806 . . . . 0.0 110.386 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.18 -157.89 35.38 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 163.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -103.02 -4.76 24.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 65.49 170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.141 1.776 . . . . 0.0 113.941 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.5 mtm -157.65 -75.7 0.09 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.931 -1.106 . . . . 0.0 109.517 163.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -145.42 155.3 43.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.654 1.182 . . . . 0.0 113.995 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 tt -115.6 134.05 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.044 1.738 . . . . 0.0 108.788 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.02 121.44 9.66 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.211 1.005 . . . . 0.0 111.622 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.6 147.07 31.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.879 0.871 . . . . 0.0 111.4 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.64 154.79 43.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.825 1.25 . . . . 0.0 110.211 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -68.8 44.36 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.058 1.743 . . . . 0.0 113.058 171.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.01 -40.71 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.345 2.258 . . . . 0.0 111.993 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -144.97 143.38 30.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.904 1.282 . . . . 0.0 109.923 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.11 136.61 11.73 Favored Glycine 0 N--CA 1.463 0.488 0 C-N-CA 123.884 0.755 . . . . 0.0 112.515 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -139.37 159.58 41.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 123.221 1.486 . . . . 0.0 112.42 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -136.28 148.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.29 1.836 . . . . 0.0 107.523 171.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -134.3 104.84 6.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -124.88 155.27 39.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.493 1.517 . . . . 0.0 112.714 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -90.0 153.5 20.53 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.02 1.328 . . . . 0.0 111.037 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 66.32 79.87 0.23 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.903 2.881 . . . . 0.0 113.705 -159.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -53.11 -33.24 62.9 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.074 3.183 . . . . 0.0 114.635 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -70.58 -35.85 73.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.066 0.848 . . . . 0.0 111.8 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -65.9 -31.75 72.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.88 -38.11 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.697 0.799 . . . . 0.0 110.223 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.39 -42.24 98.79 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.421 -0.799 . . . . 0.0 112.105 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.46 -38.15 90.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.87 0.759 . . . . 0.0 112.239 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.18 77.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.974 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.19 -53.34 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.817 1.19 . . . . 0.0 110.399 171.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.06 -29.7 70.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.306 0.957 . . . . 0.0 112.664 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -77.15 -38.12 52.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -94.87 -26.97 15.96 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 t -72.53 -20.78 61.28 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.152 0.981 . . . . 0.0 112.496 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -51.69 125.44 14.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.963 1.705 . . . . 0.0 111.097 170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.29 134.8 38.44 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.386 -0.821 . . . . 0.0 110.661 168.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.5 mtm -130.0 172.77 11.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 109.662 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -72.29 8.79 1.2 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -123.63 24.67 8.44 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.834 1.654 . . . . 0.0 113.154 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.46 -150.68 13.86 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.957 -1.089 . . . . 0.0 113.364 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.98 -179.02 4.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.669 1.988 . . . . 0.0 111.993 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -66.19 133.69 51.17 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.82 -0.55 . . . . 0.0 110.235 165.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.2 mt -91.32 142.62 27.5 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.755 166.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.71 115.5 48.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.686 1.595 . . . . 0.0 106.964 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 mt -138.64 139.1 38.39 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.757 1.223 . . . . 0.0 108.922 -165.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -133.74 125.89 29.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.88 139.81 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.096 0.959 . . . . 0.0 111.149 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -143.82 144.57 31.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.744 1.618 . . . . 0.0 110.663 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -114.35 124.78 52.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.014 0.926 . . . . 0.0 110.217 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 m -80.42 147.86 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.363 0.665 . . . . 0.0 112.224 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 53.21 22.07 2.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.46 1.904 . . . . 0.0 113.842 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.66 161.51 29.53 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.755 1.222 . . . . 0.0 113.316 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 127.893 2.477 . . . . 0.0 111.687 -178.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.985 0 O4'-C1'-N19 112.055 3.855 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 O4'-C1'-N19 110.838 2.638 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.567 -3.347 0 O4'-C1'-N19 112.035 3.835 . 0.233 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.127 1 O4'-C1'-N19 112.657 4.457 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.539 0.742 0 N-CA-C 113.77 0.642 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 98.59 5.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.079 1.752 . . . . 0.0 109.64 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -128.06 99.82 5.64 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.997 0.919 . . . . 0.0 110.338 -162.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -84.51 154.08 22.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 112.382 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.71 127.76 41.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.003 1.721 . . . . 0.0 108.79 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -104.36 138.74 40.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.376 1.471 . . . . 0.0 112.132 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -97.21 97.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.181 1.392 . . . . 0.0 110.289 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.72 -23.0 65.42 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.147 0.88 . . . . 0.0 115.018 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.96 58.17 0.47 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.212 1.805 . . . . 0.0 115.483 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp 46.37 55.7 15.91 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 127.321 2.248 . . . . 0.0 113.754 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.47 4.42 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.471 3.447 . . . . 0.0 115.112 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.03 1.14 2.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.053 2.141 . . . . 0.0 116.198 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -139.77 -28.95 0.74 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -150.39 99.24 2.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.872 1.269 . . . . 0.0 110.117 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.44 149.52 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.48 0.712 . . . . 0.0 110.621 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -146.22 164.26 32.84 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.699 1.2 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -58.36 -29.76 66.24 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.144 -0.972 . . . . 0.0 112.48 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.34 -18.91 63.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -77.68 -47.18 19.83 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.909 -1.119 . . . . 0.0 109.946 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.15 -41.57 75.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.05 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -68.63 -43.21 76.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.484 1.514 . . . . 0.0 112.905 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -34.6 77.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.182 0.901 . . . . 0.0 111.152 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.93 -70.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.004 1.322 . . . . 0.0 108.747 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -124.2 112.7 17.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 111.168 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 11.8 m -160.57 -22.15 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.364 1.866 . . . . 0.0 113.355 157.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' CD ' ' H ' ' A' ' 25' ' ' SER . 32.5 Cg_exo -73.43 16.22 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.149 2.566 . . . . 0.0 116.4 171.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -134.06 154.95 50.83 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.228 1.411 . . . . 0.0 111.129 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.45 -165.5 31.95 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.334 0.969 . . . . 0.0 115.093 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -91.12 -17.87 25.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.3 mm 64.71 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.785 1.634 . . . . 0.0 112.801 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.5 tpp -153.44 -58.13 0.13 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.3 -0.875 . . . . 0.0 112.466 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -147.8 145.02 28.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.674 1.189 . . . . 0.0 112.967 -171.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -117.68 127.52 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.185 1.794 . . . . 0.0 109.839 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -137.02 87.52 2.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.981 0.896 . . . . 0.0 111.24 -164.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.3 139.43 21.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.078 0.951 . . . . 0.0 110.944 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.31 153.41 46.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.195 2.198 . . . . 0.0 109.082 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -76.81 28.0 0.13 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.53 -41.77 0.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.807 2.043 . . . . 0.0 111.378 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -137.83 146.93 44.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.388 1.075 . . . . 0.0 112.703 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.31 133.33 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 123.976 0.798 . . . . 0.0 112.222 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -131.27 154.83 48.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.25 1.5 . . . . 0.0 112.569 171.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.031 1.732 . . . . 0.0 108.352 167.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -140.72 80.44 1.75 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.383 1.873 . . . . 0.0 108.046 -172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -111.72 165.93 11.62 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.759 -1.213 . . . . 0.0 113.828 -166.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -96.19 153.37 17.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.03 0.932 . . . . 0.0 110.419 166.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 66.95 85.61 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.902 2.881 . . . . 0.0 115.249 -166.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.45 -30.35 72.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.633 2.888 . . . . 0.0 113.331 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -53.91 -41.27 67.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.572 0.624 . . . . 0.0 110.939 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 m -87.47 -23.71 24.36 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.83 -45.86 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.759 1.163 . . . . 0.0 109.105 164.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -65.16 -42.77 93.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.949 0.9 . . . . 0.0 112.755 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.488 1.04 . . . . 0.0 112.197 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.75 -32.58 62.13 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.28 -52.71 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.343 1.429 . . . . 0.0 109.51 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.19 -10.76 60.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -89.06 -23.42 22.55 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.787 -1.196 . . . . 0.0 113.68 170.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -128.96 -37.12 1.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -165.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 t -76.63 -13.2 60.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.826 1.25 . . . . 0.0 113.251 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -73.06 171.06 13.59 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.983 0.913 . . . . 0.0 112.093 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -106.55 138.04 43.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.593 1.157 . . . . 0.0 109.001 171.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -118.41 21.32 12.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.869 1.268 . . . . 0.0 113.855 -170.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 60.39 26.57 16.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.368 2.267 . . . . 0.0 113.711 -169.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -159.77 131.89 6.38 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.371 1.068 . . . . 0.0 111.833 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.95 -174.38 46.61 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.958 1.266 . . . . 0.0 114.927 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.27 158.45 23.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.306 1.042 . . . . 0.0 111.363 168.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -99.83 169.2 9.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.111 0.964 . . . . 0.0 113.48 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.5 mt -108.85 161.14 15.41 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.523 1.529 . . . . 0.0 110.539 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.27 104.22 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -121.92 140.46 52.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.394 1.478 . . . . 0.0 110.45 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.19 140.53 37.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.45 140.81 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.136 1.374 . . . . 0.0 111.136 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.9 t -152.88 153.72 33.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.606 1.162 . . . . 0.0 111.615 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 m -114.02 9.7 17.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.987 1.315 . . . . 0.0 112.07 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -66.5 140.09 57.98 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.24 1.016 . . . . 0.0 109.872 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.39 144.05 28.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.972 -1.08 . . . . 0.0 110.986 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.29 142.84 27.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.297 1.039 . . . . 0.0 110.808 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.376 -1.297 . . . . 0.0 110.811 -179.376 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.154 1 O4'-C1'-N19 112.418 4.218 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 0 O4'-C1'-N19 111.258 3.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 111.933 3.733 . 0.381 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.172 0 O4'-C1'-N19 110.916 2.716 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 CA-C-O 120.372 0.072 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.16 50.1 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.335 -0.853 . . . . 0.0 111.739 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -158.27 150.7 22.09 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.918 2.087 . . . . 0.0 108.718 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -126.04 152.33 45.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.591 0.632 . . . . 0.0 112.25 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.68 125.36 41.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.273 1.429 . . . . 0.0 108.904 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -104.14 136.51 43.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.661 1.984 . . . . 0.0 110.262 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.28 137.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.324 1.05 . . . . 0.0 109.561 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.93 -175.1 3.61 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 122.316 0.953 . . . . 0.0 113.194 169.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -83.93 13.24 5.11 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.18 -44.32 99.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.456 1.502 . . . . 0.0 114.723 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.93 21.93 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.914 2.409 . . . . 0.0 113.186 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.59 59.31 1.49 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.532 1.533 . . . . 0.0 110.389 174.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -153.27 31.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.73 2.812 . . . . 0.0 110.795 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 m120 58.42 146.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.431 2.692 . . . . 0.0 114.055 -157.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.16 153.02 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.367 1.067 . . . . 0.0 110.652 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.0 m -135.45 166.06 24.05 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.636 1.974 . . . . 0.0 110.217 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -52.35 -32.94 40.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.194 -0.941 . . . . 0.0 111.465 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.51 -21.7 65.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.181 1.792 . . . . 0.0 115.014 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.83 -47.5 62.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.204 0.911 . . . . 0.0 109.514 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.22 -29.23 62.64 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.497 -1.377 . . . . 0.0 112.051 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -61.82 -46.65 88.58 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.002 0.921 . . . . 0.0 111.687 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.91 -39.1 90.84 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.523 -0.735 . . . . 0.0 110.321 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.73 -76.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 109.113 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -119.52 123.87 45.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.841 1.201 . . . . 0.0 111.747 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.64 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 15.4 m -157.9 -41.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 126.085 1.754 . . . . 0.0 112.846 167.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HD2' ' H ' ' A' ' 25' ' ' SER . 53.9 Cg_endo -81.01 43.44 1.55 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.65 2.233 . . . . 0.0 112.562 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.07 146.15 46.74 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.416 1.486 . . . . 0.0 110.655 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.74 -161.11 28.28 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -96.67 -2.14 45.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.185 0.994 . . . . 0.0 112.95 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp 62.22 167.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 126.803 2.041 . . . . 0.0 114.168 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.9 mtm -152.12 -71.59 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.943 -1.098 . . . . 0.0 110.508 162.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -156.53 155.8 32.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.012 0.925 . . . . 0.0 113.394 -171.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tp -101.75 135.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.737 2.015 . . . . 0.0 110.046 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -127.02 68.85 1.27 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.924 1.289 . . . . 0.0 109.931 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.07 137.67 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 26.0 mmmt -124.14 145.78 49.07 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.639 1.576 . . . . 0.0 108.643 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -70.42 -8.91 54.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -167.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.17 -59.52 1.94 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.756 1.162 . . . . 0.0 110.93 166.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.46 131.97 14.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.998 1.719 . . . . 0.0 110.17 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 36' ' ' LYS . . . -81.82 171.0 52.19 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.81 154.2 39.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.489 1.515 . . . . 0.0 110.972 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.63 151.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.87 1.668 . . . . 0.0 108.58 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.38 108.25 7.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.573 0.749 . . . . 0.0 109.164 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -127.33 158.82 36.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.497 1.519 . . . . 0.0 112.772 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -90.08 147.49 23.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.905 1.282 . . . . 0.0 110.61 170.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 66.6 86.79 0.13 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 129.585 3.154 . . . . 0.0 115.321 -162.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.45 -30.75 93.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.561 2.841 . . . . 0.0 114.851 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.62 -36.15 80.28 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.577 1.081 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -67.85 -37.64 82.12 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.8 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.684 0.793 . . . . 0.0 110.083 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.21 -31.63 72.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.252 1.021 . . . . 0.0 111.664 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.94 68.88 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.147 -0.971 . . . . 0.0 112.534 173.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.1 mt -60.51 -49.53 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.83 1.196 . . . . 0.0 110.594 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.07 -16.81 61.47 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.76 -58.88 3.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.214 1.406 . . . . 0.0 111.27 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.94 -45.09 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.543 -0.723 . . . . 0.0 111.83 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.77 15.97 0.76 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.031 1.332 . . . . 0.0 113.107 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 121.088 -1.007 . . . . 0.0 110.607 178.197 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -130.3 138.96 50.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.282 2.233 . . . . 0.0 108.889 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -141.47 130.96 23.83 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.757 0.823 . . . . 0.0 111.869 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.73 134.45 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.577 -0.702 . . . . 0.0 111.166 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.56 99.46 8.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.791 1.636 . . . . 0.0 108.526 161.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.473 0.676 0 C-N-CA 125.15 1.38 . . . . 0.0 114.06 -170.138 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.539 0.76 0 CA-C-O 120.089 -0.046 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -152.15 145.5 24.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -163.38 168.58 20.18 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.404 1.882 . . . . 0.0 110.01 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -140.63 153.16 45.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 171.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.3 121.35 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 108.435 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -100.66 133.85 44.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.386 1.074 . . . . 0.0 111.311 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.2 mm -90.48 99.43 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.755 0.822 . . . . 0.0 108.831 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.01 156.23 47.82 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.091 0.377 . . . . 0.0 112.663 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -51.03 98.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.15 1.78 . . . . 0.0 112.912 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.8 tm? -150.11 -56.64 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.486 1.514 . . . . 0.0 112.462 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 65.9 Cg_endo -72.94 -48.0 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.931 1.725 . . . . 0.0 113.348 -168.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 mp 57.02 -15.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -129.88 143.98 51.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.216 1.806 . . . . 0.0 111.721 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.61 29.13 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.368 2.267 . . . . 0.0 115.414 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -69.28 138.27 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.015 0.912 . . . . 0.0 111.241 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.9 p -143.71 156.84 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.534 1.133 . . . . 0.0 111.061 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.87 -25.84 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.086 -1.009 . . . . 0.0 111.758 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.83 -28.59 69.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.847 1.259 . . . . 0.0 114.012 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -67.61 -43.11 81.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.99 1.723 . . . . 0.0 111.476 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.01 -45.07 95.22 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.917 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -69.73 -37.92 76.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.494 1.118 . . . . 0.0 113.764 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -31.59 66.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.568 -1.332 . . . . 0.0 111.574 176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -64.14 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.468 1.107 . . . . 0.0 108.727 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -124.5 111.89 16.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.988 1.267 . . . . 0.0 110.71 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.475 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 47.7 t -155.61 -49.76 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 25' ' ' SER . 64.6 Cg_endo -84.47 8.68 4.49 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.024 2.483 . . . . 0.0 115.139 -173.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -84.7 15.05 4.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.848 1.259 . . . . 0.0 113.547 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.14 -15.16 9.13 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.148 -1.595 . . . . 0.0 115.375 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.88 133.91 34.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.319 1.559 . . . . 0.0 111.724 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.45 152.5 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.317 0.647 . . . . 0.0 112.234 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.4 mtm -162.03 -67.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.761 2.024 . . . . 0.0 109.001 151.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -148.43 155.63 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.203 1.401 . . . . 0.0 112.744 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 HG12 ' A' ' 42' ' ' ILE . 16.8 pt -130.04 145.22 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.791 1.236 . . . . 0.0 111.119 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -136.96 157.16 47.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.052 1.341 . . . . 0.0 111.466 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.22 159.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -132.87 167.46 20.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.619 2.368 . . . . 0.0 110.95 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.42 -16.48 36.28 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.43 -10.04 5.16 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -160.64 -177.76 6.41 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.017 1.727 . . . . 0.0 111.132 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.27 170.29 36.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 120.527 -1.358 . . . . 0.0 115.285 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -130.69 128.09 40.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.378 1.471 . . . . 0.0 111.869 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.434 HG12 HG22 ' A' ' 33' ' ' ILE . 1.8 mt -97.74 139.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.724 1.61 . . . . 0.0 108.544 169.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -130.56 94.09 3.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.273 1.429 . . . . 0.0 107.735 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -127.13 154.12 45.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.702 1.601 . . . . 0.0 113.941 -162.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.84 161.87 28.63 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.281 -0.887 . . . . 0.0 111.348 163.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 61.87 78.59 0.3 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.053 2.541 . . . . 0.0 115.639 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -24.28 51.5 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.089 2.526 . . . . 0.0 114.698 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -77.32 -37.09 53.28 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.092 -1.005 . . . . 0.0 112.522 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -70.41 -33.01 70.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.707 0.23 . . . . 0.0 111.091 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.9 t -65.2 -44.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 174.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -58.01 -48.19 80.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 111.419 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.49 -33.53 66.07 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.825 0.85 . . . . 0.0 112.983 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.77 -27.08 36.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -50.4 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 120.692 1.587 . . . . 0.0 110.074 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.0 -4.1 15.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.044 1.338 . . . . 0.0 113.603 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 87.8 m -108.2 -7.93 15.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.502 1.521 . . . . 0.0 113.879 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -137.23 -55.39 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.174 0.897 . . . . 0.0 112.61 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.021 -1.05 . . . . 0.0 112.465 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 CA--C 1.545 0.785 0 C-N-CA 125.811 1.644 . . . . 0.0 112.838 175.551 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.4 mt -119.95 133.96 55.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.595 0.758 . . . . 0.0 110.838 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -134.21 130.58 37.41 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.591 1.156 . . . . 0.0 110.994 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.74 143.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.913 0.885 . . . . 0.0 111.93 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 t -140.38 153.99 46.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.117 1.767 . . . . 0.0 110.849 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 125.236 1.414 . . . . 0.0 110.806 166.427 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.533 0.473 0 CA-C-O 121.084 0.368 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.28 146.01 51.83 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -160.98 147.84 15.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.601 1.56 . . . . 0.0 109.634 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -127.23 149.97 49.76 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.777 0.831 . . . . 0.0 110.734 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.57 124.99 31.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -104.26 137.23 42.47 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.755 1.622 . . . . 0.0 111.401 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -95.7 96.3 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.561 1.144 . . . . 0.0 110.281 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -8.51 74.36 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.889 1.233 . . . . 0.0 115.123 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.557 HD22 ' N ' ' A' ' 68' ' ' ILE . 56.1 m-80 -78.16 30.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.784 2.292 . . . . 0.0 114.179 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 33.14 66.75 1.15 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.595 2.358 . . . . 0.0 114.459 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.44 56.1 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.593 3.529 . . . . 0.0 113.964 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.93 -2.26 11.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.566 2.747 . . . . 0.0 112.985 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.33 150.14 51.7 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.607 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -12.49 96.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.61 3.164 . . . . 0.0 115.349 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 152.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.611 1.564 . . . . 0.0 111.256 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.1 p -137.7 166.72 23.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.543 1.937 . . . . 0.0 110.538 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -55.49 -25.16 35.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.316 0.646 . . . . 0.0 112.172 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -63.01 -27.29 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.303 1.441 . . . . 0.0 113.143 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.83 -48.74 23.55 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.418 -0.801 . . . . 0.0 110.938 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.76 -34.96 79.07 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.609 -1.307 . . . . 0.0 111.329 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -69.2 -35.71 76.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.986 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -37.37 78.77 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.9 1.227 . . . . 0.0 110.887 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.87 -79.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -120.79 108.27 13.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.245 0.93 . . . . 0.0 110.818 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 60.7 p -135.09 -30.46 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.821 -1.561 . . . . 0.0 114.658 160.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 25' ' ' SER . 19.2 Cg_endo -88.65 10.75 3.24 Favored 'Trans proline' 0 C--N 1.356 0.956 0 CA-C-N 122.988 2.103 . . . . 0.0 113.623 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -105.7 142.38 35.53 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.817 1.247 . . . . 0.0 111.332 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.23 -161.24 45.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.967 0.794 . . . . 0.0 114.744 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -98.94 -0.95 41.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.0 0.92 . . . . 0.0 113.387 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 63.56 158.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.744 2.017 . . . . 0.0 115.451 168.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.4 mtm -151.72 -79.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.58 1.152 . . . . 0.0 108.555 162.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -142.0 157.39 44.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -114.68 131.41 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.853 1.661 . . . . 0.0 108.954 168.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -127.1 90.18 3.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.983 1.313 . . . . 0.0 110.415 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.91 138.69 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.626 -0.671 . . . . 0.0 110.354 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -133.56 145.94 50.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.214 1.806 . . . . 0.0 108.693 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.67 25.04 0.81 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.429 1.492 . . . . 0.0 112.827 -168.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 -56.68 0.36 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.568 1.947 . . . . 0.0 110.772 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -142.78 101.16 3.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 110.152 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.34 156.43 48.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.692 0.663 . . . . 0.0 113.77 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.86 152.03 50.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.751 1.262 . . . . 0.0 112.607 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 145.51 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.113 1.765 . . . . 0.0 108.416 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -135.03 90.1 2.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.132 1.773 . . . . 0.0 107.999 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -121.34 160.17 24.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.092 1.357 . . . . 0.0 114.204 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -92.25 156.29 17.4 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.997 1.319 . . . . 0.0 110.229 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 67.63 76.79 0.26 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 129.158 2.983 . . . . 0.0 113.714 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -58.38 -33.85 98.18 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.9 3.066 . . . . 0.0 113.551 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -58.08 -45.26 87.44 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.253 0.933 . . . . 0.0 111.178 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -71.81 -28.37 63.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.53 -42.48 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.733 1.151 . . . . 0.0 110.639 170.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -67.86 -44.06 78.0 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 112.131 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.28 -33.5 69.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.065 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.94 64.06 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.263 -0.898 . . . . 0.0 113.044 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.47 -50.38 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.395 -1.441 . . . . 0.0 109.7 171.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.41 -6.05 32.8 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.4 t -85.23 -50.36 7.44 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.906 1.282 . . . . 0.0 111.982 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -109.0 -47.15 3.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.24 1.016 . . . . 0.0 113.693 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -67.63 -21.42 65.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.13 0.972 . . . . 0.0 112.025 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 126.726 2.011 . . . . 0.0 111.811 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.557 ' N ' HD22 ' A' ' 9' ' ' ASN . 75.1 mt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 mt -126.44 134.91 50.85 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.583 1.153 . . . . 0.0 108.567 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.68 133.5 41.94 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.9 137.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.589 1.556 . . . . 0.0 111.325 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -143.59 168.52 19.68 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.766 2.027 . . . . 0.0 111.004 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 124.529 1.132 . . . . 0.0 109.539 178.089 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.636 0.975 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -122.21 97.97 5.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.691 2.396 . . . . 0.0 108.583 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.73 95.35 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.396 1.479 . . . . 0.0 109.332 -164.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -86.57 151.77 23.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.655 0.74 . . . . 0.0 112.241 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.3 126.43 38.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.877 1.671 . . . . 0.0 108.983 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -104.1 136.66 43.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.704 1.602 . . . . 0.0 111.424 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.62 99.01 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.784 0.834 . . . . 0.0 110.245 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.94 -7.26 86.44 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.423 -0.798 . . . . 0.0 114.702 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -77.08 50.07 0.72 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.69 1.596 . . . . 0.0 112.662 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.5 mt 38.45 66.74 2.46 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.334 2.254 . . . . 0.0 113.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.83 15.82 0.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 125.198 3.932 . . . . 0.0 115.262 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.4 32.68 0.34 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.316 1.447 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -127.53 52.0 1.87 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.821 2.048 . . . . 0.0 112.622 -164.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 44.45 55.89 5.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.468 1.507 . . . . 0.0 113.357 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.16 161.15 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.87 0.868 . . . . 0.0 111.606 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -147.06 154.61 41.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 112.377 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -62.31 -29.37 70.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -66.44 -22.08 66.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.29 -38.97 49.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.979 0.912 . . . . 0.0 110.686 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.22 -44.12 80.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.175 0.99 . . . . 0.0 111.205 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.24 -45.08 96.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.064 1.345 . . . . 0.0 111.855 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -29.21 65.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.404 -0.81 . . . . 0.0 112.262 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.36 -73.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -120.87 117.97 28.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.553 1.07 . . . . 0.0 111.923 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 16.5 p -162.48 -31.36 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 163.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' CD ' ' H ' ' A' ' 25' ' ' SER . 30.0 Cg_endo -93.85 0.89 3.21 Favored 'Trans proline' 0 C--N 1.357 1.015 0 CA-C-N 122.932 2.083 . . . . 0.0 114.633 -170.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -78.59 179.45 7.1 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.292 1.837 . . . . 0.0 111.735 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.39 19.34 0.27 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.384 1.468 . . . . 0.0 116.598 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -141.47 140.05 33.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 112.564 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -163.68 153.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.811 2.044 . . . . 0.0 108.672 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.7 tpp -166.08 -57.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.73 1.15 . . . . 0.0 110.897 154.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -156.21 147.12 22.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.96 144.08 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.953 1.301 . . . . 0.0 108.105 169.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.83 86.36 1.93 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 110.498 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tt -103.18 146.29 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -172.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -132.05 149.85 52.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.301 1.84 . . . . 0.0 109.45 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -72.79 39.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.929 1.692 . . . . 0.0 114.3 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.82 -43.64 0.09 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.404 2.282 . . . . 0.0 110.718 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.25 128.67 34.33 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.87 0.868 . . . . 0.0 111.747 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.35 126.55 7.91 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.68 0.657 . . . . 0.0 112.382 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -139.16 150.97 46.23 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.898 1.332 . . . . 0.0 113.84 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 152.86 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.243 2.217 . . . . 0.0 108.978 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -140.14 90.31 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.234 1.414 . . . . 0.0 108.576 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -111.68 164.4 13.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.273 1.429 . . . . 0.0 112.402 -170.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -103.21 148.38 25.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.62 -1.3 . . . . 0.0 110.033 172.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.0 t30 69.69 105.34 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 129.05 2.94 . . . . 0.0 114.438 -156.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.89 -26.9 6.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.496 2.797 . . . . 0.0 113.393 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -65.26 -34.8 79.21 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.235 -0.916 . . . . 0.0 111.996 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.7 m -82.31 -20.07 38.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.77 -1.109 . . . . 0.0 113.578 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.92 -51.64 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.314 1.415 . . . . 0.0 108.979 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -71.25 -28.19 64.0 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.3 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -66.74 -47.95 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.619 1.099 . . . . 0.0 111.761 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.95 66.37 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.947 -1.096 . . . . 0.0 112.328 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.03 -53.33 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.139 0.881 . . . . 0.0 110.198 167.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.96 -18.47 62.62 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.42 1.464 . . . . 0.0 113.532 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.15 -36.62 47.49 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 113.35 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -115.06 -42.38 3.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.503 1.121 . . . . 0.0 113.113 -169.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -72.55 23.53 0.06 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.693 1.997 . . . . 0.0 114.09 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 126.573 1.949 . . . . 0.0 111.404 175.395 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 mt -134.63 144.26 47.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.968 1.707 . . . . 0.0 109.74 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.48 138.95 46.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.29 140.79 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.918 1.287 . . . . 0.0 110.481 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -140.43 143.77 35.77 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 167.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.7 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.703 0.764 . . . . 0.0 111.709 -172.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.539 0.764 0 N-CA-C 111.276 -0.317 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 125.82 29.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 111.972 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -138.74 95.02 2.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 109.363 -164.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.01 149.04 43.61 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.442 -0.787 . . . . 0.0 111.183 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.96 122.23 29.7 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.065 1.346 . . . . 0.0 108.93 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t80 -96.44 130.36 43.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.172 1.789 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.84 91.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.181 0.993 . . . . 0.0 109.318 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 6' ' ' PHE . . . -77.93 4.88 56.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.997 1.284 . . . . 0.0 115.397 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -64.48 -162.98 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.58 1.952 . . . . 0.0 111.818 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -119.66 42.11 0.46 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -77.19 54.83 4.81 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.087 3.191 . . . . 0.0 112.318 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.6 50.46 1.32 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.806 2.042 . . . . 0.0 109.376 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -142.49 168.74 19.02 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.086 2.554 . . . . 0.0 109.297 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -61.76 110.01 1.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.395 -0.816 . . . . 0.0 110.205 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.72 155.21 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.082 0.953 . . . . 0.0 112.41 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.1 m -133.55 155.17 50.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.149 1.779 . . . . 0.0 111.333 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.01 -25.68 22.43 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.924 1.29 . . . . 0.0 114.22 -167.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -53.65 -27.32 26.67 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 0.0 113.32 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.13 -49.95 17.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.896 1.225 . . . . 0.0 112.379 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.11 -28.1 69.84 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.045 -1.659 . . . . 0.0 111.514 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.06 -34.95 71.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.31 1.444 . . . . 0.0 113.335 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -35.07 79.52 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.984 1.265 . . . . 0.0 110.91 170.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.26 -77.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.828 1.251 . . . . 0.0 107.96 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -120.53 116.17 24.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.126 1.33 . . . . 0.0 111.122 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.577 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 p -158.66 -29.88 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 162.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 25' ' ' SER . 41.2 Cg_endo -86.82 0.17 7.82 Favored 'Trans proline' 0 C--N 1.357 0.977 0 CA-C-N 123.283 2.208 . . . . 0.0 113.995 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -79.36 171.91 14.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.467 1.507 . . . . 0.0 111.638 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.64 -15.7 80.51 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -87.04 121.21 29.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.873 1.337 . . . . 0.0 111.904 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 tp -154.54 146.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.26 0.624 . . . . 0.0 111.74 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mtm -159.84 -73.09 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.458 1.903 . . . . 0.0 110.129 162.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -143.8 160.63 40.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.965 1.706 . . . . 0.0 114.1 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -133.15 124.67 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.113 1.765 . . . . 0.0 110.105 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -129.28 74.05 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.616 1.167 . . . . 0.0 112.012 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 tt -65.73 146.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.062 -1.024 . . . . 0.0 111.326 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -145.01 147.21 32.37 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.809 2.043 . . . . 0.0 108.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.96 143.35 51.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.785 0.434 . . . . 0.0 110.639 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.87 -53.87 0.31 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.609 1.964 . . . . 0.0 115.84 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -141.32 73.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.049 0.928 . . . . 0.0 112.289 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.93 51.66 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.544 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.77 160.44 38.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 122.839 1.304 . . . . 0.0 112.642 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -122.97 155.84 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.98 1.712 . . . . 0.0 109.024 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -136.3 88.69 2.4 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.941 1.296 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.84 175.0 5.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.819 0.848 . . . . 0.0 111.296 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -117.02 151.89 35.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.145 1.778 . . . . 0.0 109.096 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.9 t30 66.51 92.24 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 127.537 2.335 . . . . 0.0 113.812 -160.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.58 -21.46 45.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.779 2.319 . . . . 0.0 113.34 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.99 -30.97 68.44 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.387 -0.821 . . . . 0.0 112.001 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -89.24 -25.08 21.92 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 117.719 -1.134 . . . . 0.0 113.478 168.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.29 -48.01 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 120.434 1.47 . . . . 0.0 109.274 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.92 -41.65 95.38 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.171 -0.919 . . . . 0.0 113.061 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.12 -38.25 79.17 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.638 1.108 . . . . 0.0 112.479 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -27.5 61.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.66 -58.49 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.598 1.09 . . . . 0.0 109.441 168.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.27 -19.17 65.22 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.42 -44.98 14.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.42 1.888 . . . . 0.0 114.409 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -106.41 -24.74 12.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.79 1.236 . . . . 0.0 113.753 -169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -72.63 35.78 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.328 2.251 . . . . 0.0 112.497 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 127.982 2.513 . . . . 0.0 109.216 -175.745 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.14 141.75 47.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.328 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.2 134.91 33.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.807 1.185 . . . . 0.0 113.291 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -90.29 146.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.769 1.228 . . . . 0.0 110.551 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 155.73 44.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.692 0.797 . . . . 0.0 110.276 165.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 123.431 0.692 . . . . 0.0 109.922 166.062 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 CA--C 1.535 0.531 0 CA-C-O 120.681 0.2 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 142.63 49.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.142 1.377 . . . . 0.0 111.673 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 t -142.93 140.48 31.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.954 1.702 . . . . 0.0 109.184 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -113.59 145.56 41.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.618 0.767 . . . . 0.0 110.31 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -131.72 126.12 33.73 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.644 1.577 . . . . 0.0 109.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.3 132.28 54.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.37 94.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.15 43.25 2.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.708 1.147 . . . . 0.0 112.911 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -114.45 32.92 5.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.586 1.554 . . . . 0.0 113.132 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.8 tp 43.08 72.53 1.14 Allowed Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.885 2.874 . . . . 0.0 113.986 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.5 1.52 6.76 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.67 2.913 . . . . 0.0 113.091 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.18 32.15 0.18 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 114.421 -172.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -146.71 -56.61 0.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.805 -1.184 . . . . 0.0 111.583 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -145.07 134.42 23.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 110.843 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -157.01 149.84 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.208 1.003 . . . . 0.0 111.084 169.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -135.63 155.84 49.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.098 1.759 . . . . 0.0 110.172 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -50.04 -33.8 19.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.154 1.382 . . . . 0.0 114.101 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.3 -23.29 47.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.92 -48.54 58.12 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.017 -1.052 . . . . 0.0 111.581 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.91 -33.62 68.45 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.037 -1.04 . . . . 0.0 111.099 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -61.18 -43.81 98.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -27.23 62.69 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.185 -0.947 . . . . 0.0 111.839 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.22 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.789 0.835 . . . . 0.0 109.525 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -122.1 114.8 21.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.794 1.179 . . . . 0.0 111.037 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.453 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 23.1 t -151.81 -40.54 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.654 170.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' H ' ' A' ' 25' ' ' SER . 22.7 Cg_endo -96.6 15.91 0.79 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.26 2.64 . . . . 0.0 114.125 -172.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.42 22.87 0.32 Allowed 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.455 -1.403 . . . . 0.0 114.4 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.26 -13.93 13.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.476 1.988 . . . . 0.0 116.517 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.51 156.17 49.33 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.114 1.366 . . . . 0.0 110.307 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -165.14 165.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.01 0.924 . . . . 0.0 110.811 -161.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -155.68 -69.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 156.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -143.36 165.04 28.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.451 1.5 . . . . 0.0 113.671 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 tp -113.83 133.84 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.709 2.004 . . . . 0.0 110.018 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -129.9 55.53 1.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 110.416 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.2 tt -70.05 146.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.672 -1.267 . . . . 0.0 111.225 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -134.49 156.52 48.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.797 1.639 . . . . 0.0 110.254 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.51 10.73 0.75 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.766 1.226 . . . . 0.0 113.698 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.68 -60.82 0.44 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.832 1.253 . . . . 0.0 112.238 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -141.89 101.58 3.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.207 1.403 . . . . 0.0 109.457 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.27 152.93 42.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.78 0.705 . . . . 0.0 113.514 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -131.93 157.49 43.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.875 1.27 . . . . 0.0 112.406 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.55 150.38 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.143 1.777 . . . . 0.0 108.53 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -140.15 102.68 4.43 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.226 0.466 . . . . 0.0 110.268 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -119.26 161.01 21.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.249 1.419 . . . . 0.0 112.841 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -78.12 161.86 27.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.745 0.818 . . . . 0.0 109.999 164.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 53.89 90.04 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.769 2.028 . . . . 0.0 113.937 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.99 -25.65 81.87 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.078 2.519 . . . . 0.0 114.523 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -72.69 -25.47 61.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.923 0.783 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -66.73 -42.63 85.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.29 0.95 . . . . 0.0 111.462 167.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.31 -42.79 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.603 1.161 . . . . 0.0 110.952 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -66.49 -45.39 79.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.668 0.787 . . . . 0.0 111.931 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.72 -34.63 74.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.59 0.756 . . . . 0.0 112.357 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.8 -27.62 63.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.68 -48.54 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.958 -1.714 . . . . 0.0 110.505 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.32 2.3 7.8 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.7 t -98.99 -33.05 10.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.877 1.671 . . . . 0.0 112.899 169.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -122.11 -28.26 4.42 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 t -88.08 12.67 12.95 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.954 1.302 . . . . 0.0 112.314 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 126.693 1.997 . . . . 0.0 110.399 177.548 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.8 mt -124.94 138.21 54.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.193 1.397 . . . . 0.0 108.917 165.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -132.36 131.31 41.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.178 0.991 . . . . 0.0 110.799 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.75 140.38 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.214 1.006 . . . . 0.0 111.485 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.1 t -134.99 117.64 15.98 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.354 1.062 . . . . 0.0 110.126 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 123.866 0.866 . . . . 0.0 112.28 178.619 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 CA--C 1.533 0.474 0 N-CA-C 112.954 0.328 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 105.06 5.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.227 1.011 . . . . 0.0 110.013 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -128.74 140.39 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.143 0.977 . . . . 0.0 111.294 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -112.25 150.41 30.96 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.952 0.901 . . . . 0.0 112.169 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.07 122.89 35.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.425 1.89 . . . . 0.0 108.707 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -103.59 148.36 26.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.843 1.657 . . . . 0.0 111.524 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.09 135.48 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.537 1.535 . . . . 0.0 110.447 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.41 172.56 2.66 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.568 1.08 . . . . 0.0 113.756 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.67 33.66 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 -161.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.59 -32.97 0.39 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 126.4 1.88 . . . . 0.0 115.307 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.05 -7.23 20.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 123.612 2.326 . . . . 0.0 114.271 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.72 -5.41 8.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.87 1.268 . . . . 0.0 113.254 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -122.68 -38.54 2.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.635 1.974 . . . . 0.0 113.959 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -146.47 127.88 14.95 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.472 1.509 . . . . 0.0 109.113 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.39 127.94 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.438 0.695 . . . . 0.0 111.611 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -152.8 143.32 22.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.093 1.357 . . . . 0.0 109.972 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -57.21 -30.08 64.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.419 1.009 . . . . 0.0 112.426 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.09 -28.95 68.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.896 1.678 . . . . 0.0 113.235 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.43 -45.65 58.65 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.423 1.089 . . . . 0.0 111.514 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.82 -40.93 97.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.496 -0.752 . . . . 0.0 110.252 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.4 -45.28 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.422 1.089 . . . . 0.0 112.424 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.17 82.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.347 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.9 mt -61.02 -74.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.92 1.288 . . . . 0.0 108.494 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 8.8 m-30 -124.53 124.42 42.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.528 1.058 . . . . 0.0 111.444 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.594 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 4.3 m -157.93 -34.31 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 156.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 25' ' ' SER . 56.8 Cg_endo -85.25 5.17 6.33 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 CA-C-N 122.902 2.072 . . . . 0.0 113.686 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.46 -21.34 30.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.08 -157.76 12.87 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 120.084 1.311 . . . . 0.0 116.0 -171.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -68.93 -25.99 64.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.269 1.4 mp 63.72 167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.213 1.405 . . . . 0.0 113.731 170.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.1 mtm -153.04 -72.74 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.388 -1.445 . . . . 0.0 109.889 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.01 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.538 1.135 . . . . 0.0 113.281 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.7 mt -82.46 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 161.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -135.73 66.12 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.423 1.106 . . . . 0.0 111.074 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 tt -83.19 150.96 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.11 0.964 . . . . 0.0 111.883 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -114.4 -175.98 2.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.379 1.872 . . . . 0.0 111.299 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -79.59 -15.03 58.39 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.03 -10.65 2.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.41 159.2 35.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 112.837 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.03 124.36 5.99 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.427 -0.651 . . . . 0.0 111.584 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -128.62 149.19 50.75 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.829 1.299 . . . . 0.0 111.802 164.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.95 149.33 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 126.617 1.967 . . . . 0.0 107.818 166.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -137.08 100.66 4.34 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.049 0.94 . . . . 0.0 108.631 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -124.19 153.91 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.027 1.731 . . . . 0.0 112.837 -167.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -81.36 155.34 26.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.274 0.629 . . . . 0.0 110.695 166.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 59.99 95.65 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 130.226 3.41 . . . . 0.0 116.333 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -67.26 -18.03 50.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.449 2.766 . . . . 0.0 113.46 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -74.76 -27.83 60.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.433 1.015 . . . . 0.0 111.636 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -75.47 -39.24 58.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.562 0.619 . . . . 0.0 111.914 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.21 -41.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.919 0.487 . . . . 0.0 110.598 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -61.91 -49.16 77.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.307 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -55.7 -41.82 74.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.833 0.742 . . . . 0.0 111.591 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -66.35 -34.34 77.76 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.399 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.2 mt -63.42 -50.49 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.509 1.504 . . . . 0.0 111.025 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.1 -12.49 61.23 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.15 -20.72 17.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.377 1.471 . . . . 0.0 113.241 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -125.48 -29.56 3.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -91.32 -1.53 57.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.766 1.226 . . . . 0.0 112.927 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 108.872 -172.502 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 mt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.5 mt -134.9 140.68 45.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.259 1.824 . . . . 0.0 108.503 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.2 137.75 34.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.98 0.809 . . . . 0.0 112.841 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.81 142.0 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.742 1.217 . . . . 0.0 112.606 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t -143.29 171.6 13.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.723 2.009 . . . . 0.0 109.826 171.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.1 m . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 125.257 1.423 . . . . 0.0 111.268 176.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.536 0.62 0 N-CA-C 112.615 0.198 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.45 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.865 2.066 . . . . 0.0 108.2 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -135.27 123.67 23.32 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.375 1.07 . . . . 0.0 109.75 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -88.48 151.72 22.35 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.842 0.829 . . . . 0.0 112.197 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.38 129.46 53.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.23 1.812 . . . . 0.0 107.541 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -109.86 134.78 51.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.208 1.403 . . . . 0.0 110.555 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.442 ' HB ' ' H ' ' A' ' 40' ' ' GLY . 12.0 mm -94.93 116.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.345 1.058 . . . . 0.0 108.712 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.82 149.51 25.09 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 119.566 -0.575 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -55.32 72.02 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.628 2.771 . . . . 0.0 115.148 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.533 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 94.9 mt -126.19 -37.75 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.911 2.485 . . . . 0.0 113.832 170.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 40.8 Cg_endo -83.8 59.47 6.22 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.782 2.321 . . . . 0.0 112.119 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.126 1.37 . . . . 0.0 113.021 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.93 146.84 45.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.042 1.337 . . . . 0.0 113.43 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.8 t30 35.83 59.82 0.84 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.237 2.215 . . . . 0.0 114.289 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.49 138.34 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.871 0.843 . . . . 0.0 111.789 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -120.08 159.96 23.78 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.862 1.665 . . . . 0.0 110.263 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -17.54 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.05 -1.031 . . . . 0.0 113.173 161.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -74.26 -23.45 59.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.326 1.051 . . . . 0.0 112.999 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.19 -35.95 63.99 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.803 -1.185 . . . . 0.0 110.732 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.32 -43.51 98.65 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.685 -1.26 . . . . 0.0 110.639 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.11 -44.2 96.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.091 0.956 . . . . 0.0 112.554 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -64.0 -36.64 84.65 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.13 -0.981 . . . . 0.0 111.574 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.67 -70.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.154 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.86 125.14 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.136 1.334 . . . . 0.0 111.394 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 17.5 m -158.73 -37.77 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.027 1.731 . . . . 0.0 113.588 164.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.2 Cg_endo -83.84 34.53 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.469 2.113 . . . . 0.0 113.311 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.33 123.35 16.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.643 1.577 . . . . 0.0 110.722 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.35 -160.1 53.93 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.581 0.61 . . . . 0.0 113.487 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -107.24 -5.08 18.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.934 1.294 . . . . 0.0 113.904 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 1.6 mp 67.57 154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.771 2.028 . . . . 0.0 114.404 171.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.5 mmt -151.66 -56.44 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.758 1.623 . . . . 0.0 110.5 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -159.12 148.65 18.78 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.626 1.103 . . . . 0.0 113.645 -170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 147.7 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.191 0.996 . . . . 0.0 111.169 163.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -147.66 101.85 3.37 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.298 0.954 . . . . 0.0 111.688 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.47 149.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.312 -1.493 . . . . 0.0 113.056 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -123.88 156.12 36.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.115 1.366 . . . . 0.0 111.329 167.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -65.39 22.91 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 127.395 2.278 . . . . 0.0 116.941 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.08 -33.11 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.485 1.514 . . . . 0.0 112.667 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -152.82 156.04 38.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.865 1.666 . . . . 0.0 110.217 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 7' ' ' ILE . . . -102.23 152.44 18.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.657 0.646 . . . . 0.0 113.699 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.74 156.21 34.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 123.254 1.502 . . . . 0.0 111.683 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.65 152.86 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.98 2.112 . . . . 0.0 107.334 166.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -136.14 101.27 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -121.52 155.0 35.92 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.943 1.297 . . . . 0.0 112.024 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -75.47 157.01 34.65 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.937 0.495 . . . . 0.0 111.218 164.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 68.34 82.29 0.19 Allowed Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 128.797 2.839 . . . . 0.0 115.517 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -57.93 -37.71 95.07 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.592 2.861 . . . . 0.0 113.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -66.59 -34.31 77.61 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.197 -0.939 . . . . 0.0 112.822 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.7 m -87.06 -21.48 26.04 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -43.98 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.205 0.911 . . . . 0.0 109.836 162.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -63.03 -40.37 97.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.984 0.914 . . . . 0.0 112.461 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.24 -35.96 74.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.263 0.625 . . . . 0.0 112.374 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.64 61.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.611 0.764 . . . . 0.0 112.778 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.66 -53.11 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.485 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -67.02 -9.54 40.17 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.76 -33.13 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.122 1.769 . . . . 0.0 113.966 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -127.83 -15.91 4.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 t -74.97 33.2 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 111.519 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 C--N 1.328 -0.333 0 C-N-CA 128.324 2.65 . . . . 0.0 108.021 -174.645 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 mt -128.92 143.24 50.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.44 1.896 . . . . 0.0 109.057 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -140.09 135.36 32.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.03 0.832 . . . . 0.0 112.59 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.16 144.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.95 0.9 . . . . 0.0 111.095 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.31 129.61 23.84 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.846 1.258 . . . . 0.0 110.46 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 124.207 1.003 . . . . 0.0 112.784 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.546 1.106 0 N-CA-C 115.773 1.413 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt 65.12 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.191 2.597 . . . . 0.0 116.586 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -147.9 172.56 13.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.975 1.71 . . . . 0.0 111.412 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -135.08 161.58 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.153 1.381 . . . . 0.0 113.285 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.19 129.65 31.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.937 1.695 . . . . 0.0 110.309 -171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -111.12 141.69 44.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.781 1.632 . . . . 0.0 111.92 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 mm -101.6 96.76 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.709 1.604 . . . . 0.0 110.291 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 -3.66 84.84 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.409 1.481 . . . . 0.0 115.404 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 68' ' ' ILE . 11.2 p30 -79.62 47.02 0.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.02 1.91 . . . . 0.0 113.664 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 40.93 59.35 8.24 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.392 1.877 . . . . 0.0 113.589 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.45 25.88 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.027 3.818 . . . . 0.0 114.543 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 -12.99 46.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.26 1.424 . . . . 0.0 113.252 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.64 137.16 51.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.837 1.655 . . . . 0.0 112.303 -167.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 50.95 48.65 22.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.304 1.442 . . . . 0.0 114.062 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 m -112.45 146.15 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 122.574 1.178 . . . . 0.0 113.135 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -146.7 166.76 25.61 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 109.694 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 25.2 mmtp -50.45 -32.04 16.79 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.266 -0.896 . . . . 0.0 112.752 172.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.23 -20.66 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.456 1.102 . . . . 0.0 113.459 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.89 -48.26 32.2 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.629 1.104 . . . . 0.0 110.848 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.61 -35.79 79.61 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -71.52 -40.25 70.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.904 0.882 . . . . 0.0 112.989 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -25.53 60.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.627 1.103 . . . . 0.0 112.527 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.38 -74.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 9.4 m-30 -124.14 125.39 44.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.626 1.557 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.421 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 40.6 t -149.62 -54.25 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 161.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 25' ' ' SER . 43.7 Cg_endo -83.06 22.47 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.203 2.602 . . . . 0.0 114.085 -171.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -90.39 -33.03 16.19 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.328 -1.483 . . . . 0.0 114.844 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.07 11.9 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 119.122 0.874 . . . . 0.0 114.16 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.14 -24.56 63.19 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp 66.91 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.36 -59.37 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.622 -1.299 . . . . 0.0 111.019 161.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -145.29 138.98 26.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.148 0.979 . . . . 0.0 111.918 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tt -123.38 127.31 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.74 1.616 . . . . 0.0 110.056 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 5.2 p30 -128.8 152.81 48.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.767 1.227 . . . . 0.0 111.616 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -141.87 154.07 19.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.083 -1.011 . . . . 0.0 112.154 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.538 ' H ' HD13 ' A' ' 35' ' ' ILE . 42.1 tptt -149.38 146.99 27.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.301 1.441 . . . . 0.0 110.91 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -57.34 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 128.539 2.736 . . . . 0.0 116.872 168.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.95 -63.9 0.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.778 1.631 . . . . 0.0 110.669 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -141.46 111.82 6.92 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.985 0.914 . . . . 0.0 110.96 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.72 151.28 33.84 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.549 0.595 . . . . 0.0 112.482 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.37 156.08 46.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.714 1.245 . . . . 0.0 111.83 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.67 143.55 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.942 0.897 . . . . 0.0 109.221 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -127.67 98.44 5.2 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.582 1.153 . . . . 0.0 108.142 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -120.78 151.24 39.83 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.595 1.158 . . . . 0.0 111.672 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.03 159.99 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.756 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 64.74 82.73 0.21 Allowed Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 127.701 2.4 . . . . 0.0 112.818 -160.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.69 -33.05 47.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.14 3.227 . . . . 0.0 113.887 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -77.11 -23.38 51.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.838 0.855 . . . . 0.0 112.942 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -69.91 -41.98 73.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 163.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.76 -43.33 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.047 0.539 . . . . 0.0 110.569 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.97 -43.77 67.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.168 0.895 . . . . 0.0 113.234 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.41 -33.65 75.2 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.37 0.986 . . . . 0.0 111.731 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -67.08 -29.18 68.88 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.287 -0.883 . . . . 0.0 112.97 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.65 -53.0 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.298 1.408 . . . . 0.0 110.4 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.45 -15.92 63.93 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.4 m -84.22 -45.72 12.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.645 1.178 . . . . 0.0 113.68 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -104.0 -29.31 11.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 t -74.89 1.28 13.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.71 0.804 . . . . 0.0 111.598 164.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 CA--C 1.536 0.413 0 O-C-N 120.937 -1.102 . . . . 0.0 110.832 174.606 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.535 ' N ' HD21 ' A' ' 9' ' ' ASN . 48.7 mm . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 mt -127.25 139.96 52.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.542 1.137 . . . . 0.0 109.354 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -131.64 138.13 48.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.451 0.569 . . . . 0.0 112.303 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.07 130.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -133.97 148.79 51.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.151 . . . . 0.0 109.632 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.538 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 N-CA-C 111.409 -0.266 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 134.69 41.7 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.905 0.882 . . . . 0.0 111.554 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -146.87 155.76 42.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.63 1.572 . . . . 0.0 109.304 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -121.14 161.13 22.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.755 0.788 . . . . 0.0 112.663 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.8 121.89 19.04 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.478 1.911 . . . . 0.0 108.291 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -104.35 134.64 47.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.738 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 mm -91.49 132.18 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.742 0.817 . . . . 0.0 108.834 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -155.38 5.63 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.044 0.831 . . . . 0.0 113.104 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.6 83.39 0.43 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.217 -1.166 . . . . 0.0 111.591 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' H ' ' CD ' ' A' ' 11' ' ' PRO . 58.2 tp -139.44 -41.71 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.996 1.718 . . . . 0.0 115.011 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 10' ' ' LEU . 21.4 Cg_endo -93.51 17.75 1.03 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.255 1.97 . . . . 0.0 114.488 -162.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.33 22.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 131.75 27.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.267 2.227 . . . . 0.0 110.754 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 t30 40.15 47.71 2.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.353 1.461 . . . . 0.0 113.728 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.61 125.9 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 123.7 0.8 . . . . 0.0 110.965 -161.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -159.83 151.41 20.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.365 1.466 . . . . 0.0 110.599 -167.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -61.4 -16.73 49.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -69.73 -33.78 72.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.485 0.584 . . . . 0.0 112.345 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.2 -35.78 74.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.207 1.367 . . . . 0.0 112.036 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.42 -39.46 71.07 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -61.95 -38.42 88.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.994 0.918 . . . . 0.0 112.392 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -36.4 82.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.687 0.795 . . . . 0.0 110.938 174.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.36 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -122.53 121.08 35.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.854 1.206 . . . . 0.0 111.717 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.646 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.9 p -150.51 -30.1 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 159.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' A' ' 25' ' ' SER . 44.5 Cg_endo -81.92 26.2 0.63 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.242 2.194 . . . . 0.0 113.265 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -121.62 137.24 54.82 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.592 1.957 . . . . 0.0 110.67 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.1 -159.42 49.7 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 121.841 0.69 . . . . 0.0 114.431 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -100.8 -7.68 23.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.229 1.012 . . . . 0.0 113.543 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 67.85 142.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.025 2.13 . . . . 0.0 115.372 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 mmt -138.73 -81.71 0.31 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.953 1.301 . . . . 0.0 111.018 170.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -137.55 162.18 34.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.301 1.841 . . . . 0.0 113.583 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 tt -149.64 121.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.728 1.211 . . . . 0.0 110.977 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.87 101.92 6.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.472 1.109 . . . . 0.0 111.556 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.16 135.95 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.63 0.772 . . . . 0.0 112.114 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -120.88 165.95 14.48 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.209 1.803 . . . . 0.0 110.38 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -78.15 -18.82 55.1 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 -4.94 9.35 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -164.36 179.54 6.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.25 1.82 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.57 159.02 27.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 120.573 -1.329 . . . . 0.0 114.763 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.36 149.85 51.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.532 1.533 . . . . 0.0 112.084 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.8 150.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 127.024 2.13 . . . . 0.0 108.334 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -132.9 113.99 13.51 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 167.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -125.96 155.54 41.2 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.532 1.158 . . . . 0.0 112.308 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -80.3 144.53 32.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.686 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 80.03 82.03 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.382 3.073 . . . . 0.0 115.155 -170.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.53 -38.68 88.65 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.22 3.28 . . . . 0.0 114.494 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.01 -29.18 67.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.98 -1.075 . . . . 0.0 111.855 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -68.76 -35.0 76.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.49 -40.1 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.437 0.695 . . . . 0.0 109.691 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -65.81 -40.1 91.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.527 170.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.85 -38.34 81.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.2 0.909 . . . . 0.0 111.191 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.41 70.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.529 0.731 . . . . 0.0 112.693 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.27 -50.38 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.265 1.393 . . . . 0.0 110.395 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.22 -12.27 61.53 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.323 0.965 . . . . 0.0 113.393 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -96.86 -28.86 14.04 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -108.53 -56.3 2.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.398 1.479 . . . . 0.0 111.994 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -14.34 58.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.737 1.215 . . . . 0.0 113.151 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 125.802 1.641 . . . . 0.0 112.733 -179.508 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 mt -129.49 148.49 51.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.298 2.239 . . . . 0.0 107.536 166.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -142.42 130.17 21.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.81 138.9 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.406 1.482 . . . . 0.0 112.664 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.3 t -135.38 148.76 49.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 112.766 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 125.169 1.387 . . . . 0.0 112.49 167.624 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.541 0.855 0 CA-C-O 120.102 -0.041 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.66 140.43 40.82 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.117 0.967 . . . . 0.0 113.209 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 141.89 15.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.575 1.55 . . . . 0.0 110.355 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -116.77 145.73 43.3 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.946 0.898 . . . . 0.0 111.717 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.88 124.42 44.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.533 1.533 . . . . 0.0 108.739 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -108.86 135.83 49.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.2 mm -90.72 80.17 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.089 1.356 . . . . 0.0 110.776 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 -4.3 12.28 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.18 1.371 . . . . 0.0 115.164 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.19 -10.81 34.43 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.649 1.98 . . . . 0.0 114.248 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.6 mt 48.53 63.79 9.76 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.066 1.746 . . . . 0.0 113.803 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.99 45.25 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 125.663 4.242 . . . . 0.0 113.679 -173.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -50.43 -23.69 2.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.023 2.129 . . . . 0.0 115.998 -166.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.05 2.8 5.88 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.538 2.335 . . . . 0.0 114.075 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -135.67 61.62 1.65 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 110.8 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.58 117.89 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.789 1.235 . . . . 0.0 110.965 -173.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 t -155.38 151.95 28.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -50.59 -34.09 24.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.549 1.14 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -68.69 -22.38 64.37 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.09 -35.14 64.18 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.339 -1.475 . . . . 0.0 111.24 174.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.55 -40.89 69.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.376 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -69.29 -38.45 78.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.825 0.85 . . . . 0.0 113.184 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -28.1 65.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.68 -77.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.638 1.175 . . . . 0.0 108.526 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -117.53 112.36 20.49 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.693 1.133 . . . . 0.0 111.588 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.525 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 42.8 t -159.95 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.665 1.586 . . . . 0.0 112.294 167.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 25' ' ' SER . 50.4 Cg_endo -87.96 17.15 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 115.358 -171.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -90.29 1.32 56.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.542 1.137 . . . . 0.0 114.043 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.45 19.47 76.32 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.474 1.034 . . . . 0.0 113.905 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -137.75 137.43 38.27 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.595 1.158 . . . . 0.0 110.066 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 tp -158.28 163.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.543 1.137 . . . . 0.0 109.517 -170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.5 tpp -164.59 -67.35 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.668 0.787 . . . . 0.0 110.49 150.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -139.81 144.19 37.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 111.953 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 pt -107.85 141.85 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.107 0.963 . . . . 0.0 110.846 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -145.31 72.36 1.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.684 1.193 . . . . 0.0 110.464 -172.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 tt -90.78 138.11 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.863 -1.148 . . . . 0.0 113.118 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.85 157.0 30.74 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 110.371 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.02 8.53 0.53 Allowed 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -168.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.8 -51.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.349 1.46 . . . . 0.0 111.901 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.73 138.32 23.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.396 1.078 . . . . 0.0 110.738 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.99 160.09 30.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -127.18 152.71 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.898 1.279 . . . . 0.0 111.632 167.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.33 145.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.615 1.566 . . . . 0.0 108.246 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -130.42 87.94 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.633 1.573 . . . . 0.0 107.088 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -115.13 169.68 8.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.619 1.568 . . . . 0.0 112.573 -167.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -91.35 177.52 6.22 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.181 1.393 . . . . 0.0 111.333 168.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 49.15 81.03 0.27 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.741 2.416 . . . . 0.0 114.423 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.29 -29.65 89.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.497 2.798 . . . . 0.0 114.242 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -73.79 -33.94 64.42 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.468 -0.77 . . . . 0.0 111.597 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -70.65 -31.2 68.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.3 0.955 . . . . 0.0 112.622 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.66 -48.1 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.425 0.69 . . . . 0.0 110.518 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -64.66 -44.47 90.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.714 0.688 . . . . 0.0 112.546 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.94 -38.23 72.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.552 1.141 . . . . 0.0 112.322 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.03 -26.22 62.12 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.572 -0.705 . . . . 0.0 112.891 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.39 -51.61 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.045 1.293 . . . . 0.0 110.392 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.89 -17.95 65.01 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.79 -60.11 2.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.312 0.645 . . . . 0.0 111.973 167.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.02 -35.84 20.09 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.322 1.449 . . . . 0.0 114.722 -166.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -85.55 -3.98 59.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.612 1.565 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 124.508 1.123 . . . . 0.0 109.403 163.498 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.62 139.44 53.92 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.92 1.688 . . . . 0.0 108.525 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -132.7 134.77 45.22 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.243 0.929 . . . . 0.0 112.154 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.65 137.92 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.384 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 m -139.67 167.25 22.54 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.089 1.756 . . . . 0.0 110.773 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.468 0.451 0 O-C-N 121.269 -0.895 . . . . 0.0 111.578 -174.712 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 112.914 0.313 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.53 156.02 18.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.307 1.843 . . . . 0.0 111.956 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -159.05 167.04 30.3 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.049 0.939 . . . . 0.0 111.468 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -130.1 165.01 23.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.93 126.11 42.69 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.291 2.236 . . . . 0.0 109.117 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -106.68 143.1 35.26 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.662 1.585 . . . . 0.0 111.498 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.7 101.7 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.668 1.587 . . . . 0.0 110.96 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 7.52 75.59 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.038 1.304 . . . . 0.0 114.909 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -74.29 15.32 0.34 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER 48.25 80.96 0.27 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.373 2.269 . . . . 0.0 112.677 -163.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.39 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.059 3.173 . . . . 0.0 111.892 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 mp 53.15 22.95 2.81 Favored 'General case' 0 CA--C 1.557 1.214 0 O-C-N 120.408 -1.432 . . . . 0.0 113.837 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -150.9 150.11 30.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.341 2.256 . . . . 0.0 110.469 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 m120 45.36 39.67 4.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.291 1.437 . . . . 0.0 113.224 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.77 34.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.739 1.615 . . . . 0.0 113.488 -157.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -90.68 147.53 23.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.898 1.279 . . . . 0.0 110.801 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.33 -32.29 10.88 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -62.97 -12.73 27.67 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.96 -43.71 70.98 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.983 -1.073 . . . . 0.0 111.893 168.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.68 -36.7 65.34 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.641 -0.662 . . . . 0.0 110.73 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.07 -45.52 91.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.491 0.716 . . . . 0.0 112.045 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -28.08 64.09 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.608 -0.682 . . . . 0.0 112.798 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.83 -75.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -123.85 126.58 46.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.843 1.201 . . . . 0.0 111.137 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.614 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 3.7 m -157.78 -20.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 160.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.614 ' CD ' ' H ' ' A' ' 25' ' ' SER . 29.4 Cg_endo -91.85 15.27 1.66 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 123.558 2.306 . . . . 0.0 113.166 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -105.58 154.68 20.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.563 1.145 . . . . 0.0 113.472 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 -146.28 43.43 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.699 1.143 . . . . 0.0 115.761 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.46 -0.6 27.74 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.177 1.391 . . . . 0.0 112.784 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.271 1.3 tp 63.5 171.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 128.376 2.67 . . . . 0.0 116.435 166.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mtm -171.6 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.692 1.597 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -142.63 136.99 29.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.273 1.429 . . . . 0.0 112.457 -164.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tt -85.2 139.31 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.056 0.942 . . . . 0.0 109.929 163.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -143.4 77.83 1.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.921 0.782 . . . . 0.0 111.665 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -88.15 138.71 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 122.076 0.941 . . . . 0.0 111.62 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -130.49 147.22 52.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.679 1.592 . . . . 0.0 108.336 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -75.0 35.86 0.11 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.37 -57.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.103 1.761 . . . . 0.0 109.52 166.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.84 126.58 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.133 1.373 . . . . 0.0 110.22 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.21 149.12 24.77 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 122.604 0.145 . . . . 0.0 112.926 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -134.37 162.41 32.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.324 1.45 . . . . 0.0 111.501 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.95 149.13 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 108.602 167.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -131.98 97.96 4.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.799 1.24 . . . . 0.0 107.936 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.51 145.53 50.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 112.284 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -73.75 154.15 39.71 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 166.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 64.34 86.98 0.13 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.477 2.711 . . . . 0.0 114.638 -166.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.0 -24.48 65.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.753 2.302 . . . . 0.0 114.423 174.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -68.54 -43.38 76.84 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.328 0.967 . . . . 0.0 110.719 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.7 m -72.8 -29.67 63.46 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.19 -46.03 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.873 0.76 . . . . 0.0 109.867 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -63.91 -37.54 87.8 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.288 1.035 . . . . 0.0 112.812 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.15 -45.19 94.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.305 0.642 . . . . 0.0 111.139 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 -31.34 72.45 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.563 -0.711 . . . . 0.0 112.322 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.24 -54.92 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.911 1.232 . . . . 0.0 110.58 172.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -71.67 -16.07 62.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -89.44 -36.17 15.59 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -103.13 -24.29 13.6 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.059 1.344 . . . . 0.0 113.911 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.3 p -68.51 -5.8 21.6 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.129 -1.607 . . . . 0.0 113.221 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.925 1.69 . . . . 0.0 112.84 -170.616 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 121.713 0.768 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -128.79 143.03 50.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.546 2.339 . . . . 0.0 106.623 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -136.19 132.25 35.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.266 1.394 . . . . 0.0 112.446 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.4 144.1 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.021 0.928 . . . . 0.0 110.654 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 t -140.95 147.99 39.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.432 1.093 . . . . 0.0 110.87 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.7 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.407 0.622 . . . . 0.0 111.267 170.544 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 CA--C 1.537 0.66 0 N-CA-C 114.311 0.85 . . . . 0.0 114.311 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.35 148.9 52.22 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.847 2.059 . . . . 0.0 110.006 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 p -162.94 161.68 25.81 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.285 1.434 . . . . 0.0 109.992 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.25 156.24 44.96 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.309 1.043 . . . . 0.0 111.395 160.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.35 117.78 23.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.199 2.199 . . . . 0.0 107.988 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -100.42 147.02 26.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.715 1.206 . . . . 0.0 111.501 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mm -103.29 131.56 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.84 1.256 . . . . 0.0 109.117 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.44 -176.49 4.82 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 121.399 0.444 . . . . 0.0 113.386 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.69 47.51 0.51 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.508 1.523 . . . . 0.0 114.911 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -119.02 -25.28 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 127.261 2.224 . . . . 0.0 115.518 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.9 38.6 0.76 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.92 2.414 . . . . 0.0 112.595 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.7 49.36 1.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.353 1.861 . . . . 0.0 110.183 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.45 37.58 1.69 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.301 1.84 . . . . 0.0 113.168 -161.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 51.36 61.08 3.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.053 1.741 . . . . 0.0 112.399 -172.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.19 149.35 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.089 0.956 . . . . 0.0 113.157 -167.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -138.78 164.43 29.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.109 2.563 . . . . 0.0 109.328 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -49.57 -32.44 12.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.468 1.107 . . . . 0.0 113.136 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -49.55 -36.56 23.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.549 1.539 . . . . 0.0 113.931 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.93 -39.59 50.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 111.94 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.01 -39.67 95.44 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.502 -0.749 . . . . 0.0 110.279 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.12 -36.67 74.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.985 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -69.28 -36.13 76.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.059 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.9 mt -63.1 -77.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.154 0.982 . . . . 0.0 108.871 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -120.3 121.08 37.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.97 1.259 . . . . 0.0 112.304 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.684 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.4 t -152.14 -38.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 112.98 165.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 25' ' ' SER . 47.4 Cg_endo -83.92 46.4 2.01 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.632 2.221 . . . . 0.0 112.18 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.96 145.63 49.72 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.491 1.116 . . . . 0.0 111.51 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.77 -155.4 33.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -97.71 0.89 47.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.686 0.794 . . . . 0.0 112.648 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tp 60.95 175.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.133 2.173 . . . . 0.0 113.7 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 mtm -166.11 -73.56 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.393 1.477 . . . . 0.0 109.051 160.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -144.22 153.53 42.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.663 1.185 . . . . 0.0 112.364 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 tt -122.49 130.93 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 126.292 1.837 . . . . 0.0 109.425 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.06 146.48 50.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.484 1.114 . . . . 0.0 112.316 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.14 148.79 23.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.135 1.374 . . . . 0.0 110.812 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -136.08 -176.44 4.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.639 1.576 . . . . 0.0 109.736 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -65.4 122.95 18.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.65 0.78 . . . . 0.0 110.661 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.44 10.03 0.44 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -157.04 157.64 35.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.529 1.532 . . . . 0.0 110.881 171.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.17 161.7 28.8 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.507 -0.746 . . . . 0.0 113.08 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -140.15 116.93 10.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.833 1.253 . . . . 0.0 110.865 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.98 148.5 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.858 -1.151 . . . . 0.0 108.939 164.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -137.19 98.28 3.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.859 0.864 . . . . 0.0 109.316 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -123.06 153.81 39.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 112.951 -169.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -81.06 153.66 27.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.408 1.083 . . . . 0.0 110.525 164.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 67.81 75.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 128.762 2.825 . . . . 0.0 113.852 -164.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -52.32 -35.77 65.74 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.982 3.121 . . . . 0.0 114.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -64.82 -39.37 93.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.004 0.82 . . . . 0.0 111.857 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -63.86 -31.26 72.38 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 -43.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.944 0.898 . . . . 0.0 109.942 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.74 -45.39 85.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.981 0.81 . . . . 0.0 111.675 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -62.48 -40.03 95.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.722 0.809 . . . . 0.0 112.257 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.04 72.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.379 0.672 . . . . 0.0 112.238 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.66 -51.08 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.517 1.053 . . . . 0.0 110.431 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.61 -15.39 63.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.81 -39.7 15.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.415 1.486 . . . . 0.0 114.141 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.15 -30.95 6.79 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -68.87 -3.16 11.57 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.562 -1.336 . . . . 0.0 113.623 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 . . . . . 0 CA--C 1.546 0.794 0 C-N-CA 128.026 2.531 . . . . 0.0 112.015 178.86 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -129.31 141.78 51.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.438 1.895 . . . . 0.0 109.601 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.36 135.29 30.33 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.2 p -102.18 137.67 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.325 1.05 . . . . 0.0 112.057 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -143.66 141.11 30.41 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.873 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.242 1.017 . . . . 0.0 112.905 173.582 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.532 0.415 0 N-CA-C 113.559 0.561 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.44 118.56 20.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.765 2.026 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -136.42 108.06 7.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.468 1.107 . . . . 0.0 110.118 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -84.98 149.26 25.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.369 0.604 . . . . 0.0 110.855 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.57 120.22 29.05 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.475 1.51 . . . . 0.0 108.117 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -99.18 136.26 39.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.537 1.535 . . . . 0.0 110.744 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -93.13 107.14 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 109.799 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.17 0.83 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.332 1.444 . . . . 0.0 113.947 173.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.65 148.86 39.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.321 1.848 . . . . 0.0 111.207 166.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.9 tp -110.28 90.72 10.35 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.43 1.892 . . . . 0.0 109.341 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.54 -23.62 23.14 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.367 2.711 . . . . 0.0 112.615 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . 0.283 1.6 tt 55.25 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.965 3.306 . . . . 0.0 114.236 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -97.78 -2.69 40.51 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.5 17.99 13.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.572 1.149 . . . . 0.0 113.457 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.12 126.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.786 1.634 . . . . 0.0 113.538 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 t -155.5 142.65 19.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 112.438 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.1 -32.13 71.81 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.754 -0.591 . . . . 0.0 111.019 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.06 -24.57 67.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.557 1.143 . . . . 0.0 112.828 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.09 -41.35 50.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.357 0.98 . . . . 0.0 111.739 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.95 -39.58 87.32 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 110.983 172.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -63.95 -43.79 94.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.172 0.989 . . . . 0.0 112.03 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.714 -1.241 . . . . 0.0 111.397 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.6 mt -58.71 -71.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.402 1.081 . . . . 0.0 109.483 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -124.63 114.56 19.52 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.748 1.158 . . . . 0.0 110.838 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.566 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 33.1 t -155.94 -43.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.566 ' HD2' ' H ' ' A' ' 25' ' ' SER . 89.9 Cg_endo -83.04 11.38 3.29 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.435 2.09 . . . . 0.0 115.521 -173.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -80.07 16.91 1.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.16 -14.63 32.37 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.555 1.074 . . . . 0.0 115.6 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -135.97 141.1 44.39 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.404 1.882 . . . . 0.0 108.64 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 tp -153.37 161.48 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.449 0.699 . . . . 0.0 111.061 -162.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -151.9 -65.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.497 152.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -152.95 153.31 32.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.393 0.997 . . . . 0.0 113.434 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.53 140.2 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.26 1.424 . . . . 0.0 108.891 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -129.84 65.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.735 1.255 . . . . 0.0 110.679 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.35 138.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.821 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -125.82 155.42 41.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.517 1.527 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.83 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -165.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.91 -42.75 0.31 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.943 1.297 . . . . 0.0 112.767 167.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -148.91 146.77 28.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.84 1.256 . . . . 0.0 110.254 171.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.86 164.46 17.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -170.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -130.0 163.65 26.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.496 1.518 . . . . 0.0 110.543 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.96 155.12 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 109.238 166.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -140.93 92.24 2.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.544 1.538 . . . . 0.0 108.28 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -112.33 165.83 11.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.23 1.412 . . . . 0.0 112.815 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.16 163.67 18.6 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.291 1.036 . . . . 0.0 111.062 164.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.41 91.28 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.851 2.46 . . . . 0.0 114.076 -172.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.56 -24.21 75.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.85 1.7 . . . . 0.0 113.969 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -67.28 -35.66 79.94 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.935 0.789 . . . . 0.0 111.587 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.9 m -71.17 -35.73 71.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.336 0.654 . . . . 0.0 112.273 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.34 -41.25 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.889 -0.507 . . . . 0.0 110.424 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -69.53 -36.53 76.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.116 -0.99 . . . . 0.0 112.879 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.33 -35.99 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.212 0.915 . . . . 0.0 111.692 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.02 66.68 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.615 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.14 -52.31 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.475 1.489 . . . . 0.0 110.279 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.14 1.78 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 46.2 t -107.62 -52.69 2.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.23 1.812 . . . . 0.0 112.855 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -88.83 -40.78 12.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.775 1.23 . . . . 0.0 112.501 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -71.09 -3.32 19.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.091 -1.006 . . . . 0.0 112.448 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 128.212 2.605 . . . . 0.0 111.589 179.112 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tp . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 mt -119.98 134.87 55.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.334 1.454 . . . . 0.0 108.001 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.75 128.31 45.12 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.92 142.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.514 1.126 . . . . 0.0 110.598 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 t -141.6 121.05 13.21 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.395 1.078 . . . . 0.0 110.105 171.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 124.781 1.232 . . . . 0.0 111.297 -173.641 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 CA--C 1.547 1.134 0 CA-C-O 121.064 0.36 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.8 123.29 20.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.602 1.161 . . . . 0.0 110.475 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -137.82 114.38 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.855 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -93.0 141.57 28.25 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.703 -0.623 . . . . 0.0 112.529 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.76 133.44 53.98 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.867 2.067 . . . . 0.0 108.36 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -117.57 138.56 51.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.758 2.023 . . . . 0.0 110.773 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -103.13 144.28 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.26 -162.51 1.67 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 122.022 0.79 . . . . 0.0 114.422 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -82.39 19.38 1.25 Allowed 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.601 -1.529 . . . . 0.0 114.675 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.59 -36.83 10.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.619 173.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -72.54 18.08 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.322 3.348 . . . . 0.0 116.696 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.4 mt -71.96 19.61 0.07 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.012 1.325 . . . . 0.0 113.249 170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -126.24 -178.7 4.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 110.409 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -52.16 122.33 8.39 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.311 0.505 . . . . 0.0 111.692 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.11 146.01 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.817 0.818 . . . . 0.0 112.526 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -133.9 168.12 19.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.866 1.667 . . . . 0.0 111.298 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -57.8 -32.51 67.62 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.084 -1.01 . . . . 0.0 111.452 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -64.01 -25.15 67.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.56 -48.19 56.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.624 1.102 . . . . 0.0 110.21 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.27 -38.34 86.39 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.153 -0.967 . . . . 0.0 111.496 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.22 -40.31 93.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.891 1.677 . . . . 0.0 112.16 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -28.4 60.48 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.539 -1.351 . . . . 0.0 113.176 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 ' CE1' ' A' ' 24' ' ' PHE . 20.3 mt -76.0 -45.31 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE1' HG22 ' A' ' 23' ' ' ILE . 77.1 m-85 -137.68 102.26 4.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.178 1.791 . . . . 0.0 111.644 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.562 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.0 t -164.56 -48.56 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.819 1.648 . . . . 0.0 111.923 166.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 25' ' ' SER . 83.8 Cg_endo -78.19 20.23 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.984 2.456 . . . . 0.0 115.679 -169.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.23 15.37 22.96 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.421 1.488 . . . . 0.0 114.217 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.2 5.46 62.52 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.523 1.535 . . . . 0.0 116.422 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -143.57 126.32 16.1 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.981 1.712 . . . . 0.0 109.005 -171.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -151.36 160.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -156.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 40.0 mtm -158.01 -84.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.184 2.194 . . . . 0.0 108.122 152.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -135.05 155.94 49.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.684 1.594 . . . . 0.0 114.073 -168.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -109.64 136.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.699 1.6 . . . . 0.0 110.469 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.58 72.09 1.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.524 1.13 . . . . 0.0 111.114 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.4 134.29 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.615 -1.303 . . . . 0.0 110.099 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -134.93 143.1 46.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.736 1.615 . . . . 0.0 109.011 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.1 46.42 0.4 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.41 -41.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.308 1.443 . . . . 0.0 112.283 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.51 151.2 37.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.208 1.403 . . . . 0.0 109.588 168.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 147.28 18.7 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.392 0.52 . . . . 0.0 113.481 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -125.82 155.34 41.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.825 1.298 . . . . 0.0 111.596 164.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.21 155.41 32.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 107.578 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.22 109.37 7.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 167.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -115.08 161.01 18.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.261 1.824 . . . . 0.0 111.125 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.57 146.37 25.17 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.247 -0.908 . . . . 0.0 110.691 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.74 107.58 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 127.722 2.409 . . . . 0.0 114.969 -171.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.87 -19.0 21.28 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.752 1.635 . . . . 0.0 113.329 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.57 -41.39 98.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.31 1.413 . . . . 0.0 113.103 -172.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -82.45 -18.02 43.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.17 -41.68 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.163 0.892 . . . . 0.0 109.705 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -62.83 -44.31 96.48 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.089 -1.007 . . . . 0.0 111.689 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.81 -41.68 91.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.631 0.65 . . . . 0.0 112.03 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.66 90.35 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.42 -0.8 . . . . 0.0 112.575 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.08 -52.67 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.708 1.14 . . . . 0.0 110.716 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.31 -17.74 56.18 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.6 t -73.53 -49.11 28.18 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.239 1.816 . . . . 0.0 111.976 166.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -101.28 -28.51 12.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -162.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -71.49 -18.32 62.3 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.594 1.088 . . . . 0.0 113.373 173.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 110.33 -172.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.17 133.94 44.81 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.052 2.141 . . . . 0.0 107.94 165.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -144.12 131.88 21.33 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.503 1.047 . . . . 0.0 113.775 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.57 141.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.168 0.587 . . . . 0.0 112.038 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.7 m -133.53 127.14 32.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.83 2.052 . . . . 0.0 108.535 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.672 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.476 0.472 0 CA-C-O 119.706 -0.206 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -114.12 111.84 22.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.45 1.1 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -126.42 100.22 6.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.98 0.912 . . . . 0.0 111.162 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.22 153.88 24.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.53 0.681 . . . . 0.0 111.445 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.07 126.12 29.47 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.765 1.626 . . . . 0.0 108.918 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -103.46 137.98 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.788 1.235 . . . . 0.0 111.633 171.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.78 98.55 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.182 0.993 . . . . 0.0 108.97 168.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.52 176.19 50.69 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.736 0.684 . . . . 0.0 111.571 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.91 40.15 24.37 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.312 -1.111 . . . . 0.0 111.724 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.81 123.47 89.6 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.916 1.287 . . . . 0.0 110.566 -162.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.15 107.3 1.67 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.645 2.897 . . . . 0.0 110.009 168.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.15 7.79 1.97 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.478 -1.389 . . . . 0.0 112.771 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -114.78 128.16 56.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.479 2.311 . . . . 0.0 110.876 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 47.56 35.07 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.98 132.76 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 120.767 -1.208 . . . . 0.0 109.537 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.0 p -133.07 163.23 29.72 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 111.461 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -61.15 -24.63 66.43 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.189 -0.944 . . . . 0.0 112.801 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.33 -31.7 70.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.907 0.883 . . . . 0.0 112.1 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.02 -47.08 84.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.95 0.796 . . . . 0.0 110.42 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.76 -40.66 93.33 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.518 -0.739 . . . . 0.0 111.122 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -68.96 -41.41 78.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.336 1.054 . . . . 0.0 113.327 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -22.36 60.25 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 120.665 -1.272 . . . . 0.0 113.275 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.487 HG22 ' CE1' ' A' ' 24' ' ' PHE . 42.8 mt -83.55 -41.15 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.347 0.659 . . . . 0.0 109.696 170.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CE1' HG22 ' A' ' 23' ' ' ILE . 96.2 m-85 -135.7 91.58 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.534 1.534 . . . . 0.0 111.888 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 26.3 t -157.88 -49.75 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 165.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.3 Cg_endo -78.35 27.67 0.49 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.205 2.603 . . . . 0.0 114.033 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.77 14.87 25.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.718 1.607 . . . . 0.0 113.381 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.18 -101.31 2.71 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.439 1.019 . . . . 0.0 113.479 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -64.1 135.27 56.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.784 0.834 . . . . 0.0 112.747 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 tp -140.5 163.87 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.314 1.046 . . . . 0.0 112.0 -161.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.0 mtm -152.22 -76.9 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.485 1.114 . . . . 0.0 109.79 152.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -142.73 156.61 45.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.738 1.215 . . . . 0.0 113.807 -166.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mt -119.2 137.15 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.962 2.105 . . . . 0.0 109.642 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.96 84.04 2.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.946 1.299 . . . . 0.0 110.075 -175.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -88.33 135.25 26.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 165.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -132.89 147.75 52.29 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.862 2.065 . . . . 0.0 108.432 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -62.48 -9.42 8.49 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.3 -24.43 11.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -152.94 145.41 24.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.335 1.425 . . . . 0.0 114.035 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.46 131.15 10.47 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.862 1.22 . . . . 0.0 113.035 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -137.33 156.07 48.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.632 1.573 . . . . 0.0 111.95 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.82 154.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.535 1.534 . . . . 0.0 109.256 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -136.01 113.37 10.7 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -117.2 158.37 24.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.117 1.767 . . . . 0.0 112.339 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.05 151.56 31.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 109.87 164.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 48.0 t-20 48.8 101.67 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 128.103 2.561 . . . . 0.0 114.439 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 46' ' ' ASN . 34.9 Cg_endo -55.96 -11.84 6.18 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.34 2.694 . . . . 0.0 115.357 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -61.62 -36.0 79.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.599 1.09 . . . . 0.0 113.701 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.6 p -69.49 -39.95 77.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 111.335 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.61 -45.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.385 1.074 . . . . 0.0 110.483 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -63.92 -40.83 97.39 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 111.829 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.71 -35.32 80.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -40.29 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.439 1.096 . . . . 0.0 112.239 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -58.86 -48.65 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 120.207 1.367 . . . . 0.0 110.707 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.67 -15.03 63.1 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.0 t -89.0 -55.37 3.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.429 1.092 . . . . 0.0 111.5 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -87.43 -36.85 17.49 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.124 1.77 . . . . 0.0 113.804 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -67.42 -22.57 65.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.274 1.397 . . . . 0.0 111.879 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 124.413 1.085 . . . . 0.0 112.032 170.216 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mm . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.9 mt -125.03 129.33 50.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.306 0.642 . . . . 0.0 110.991 -171.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -133.06 127.09 33.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.9 144.87 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.704 1.202 . . . . 0.0 110.957 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.3 t -143.03 150.57 39.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.208 1.403 . . . . 0.0 109.293 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 C--O 1.237 0.446 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.983 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 CA-C-O 119.623 -0.24 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.79 120.63 22.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 112.321 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -129.4 159.02 37.54 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.856 1.262 . . . . 0.0 111.533 173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.37 149.34 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.654 1.582 . . . . 0.0 110.247 168.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.64 117.76 19.12 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.691 1.596 . . . . 0.0 107.979 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -97.76 132.5 43.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.677 1.591 . . . . 0.0 110.511 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.36 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.848 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.03 -178.47 0.34 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 123.99 0.805 . . . . 0.0 113.697 166.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -76.75 26.61 0.14 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 120.124 -1.81 . . . . 0.0 113.739 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.19 66.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.468 1.507 . . . . 0.0 112.113 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -63.36 6.32 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.332 3.355 . . . . 0.0 117.604 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.15 -9.05 14.41 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -117.14 -27.02 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.518 1.527 . . . . 0.0 114.241 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.6 127.66 14.63 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.789 1.635 . . . . 0.0 110.259 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.59 89.17 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.201 1.4 . . . . 0.0 111.908 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -139.87 148.74 42.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.486 1.114 . . . . 0.0 109.301 163.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -60.01 -21.01 60.77 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.537 1.062 . . . . 0.0 112.714 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -55.49 -24.33 30.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.72 1.208 . . . . 0.0 113.6 169.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.47 -53.53 7.98 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.043 0.937 . . . . 0.0 111.603 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.16 -36.63 70.98 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.393 -1.442 . . . . 0.0 111.133 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -70.1 -22.84 62.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.438 1.495 . . . . 0.0 114.108 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.13 58.3 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.448 -1.407 . . . . 0.0 111.674 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 24' ' ' PHE . 55.3 mt -80.51 -45.1 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.855 0.862 . . . . 0.0 109.662 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 23' ' ' ILE . 39.5 m-85 -136.89 118.16 14.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.437 1.495 . . . . 0.0 111.251 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.656 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.6 p -154.54 -37.93 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.823 -1.561 . . . . 0.0 114.987 162.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 25' ' ' SER . 82.9 Cg_endo -76.46 -2.28 12.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.155 2.162 . . . . 0.0 113.329 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -93.16 141.55 28.29 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.328 1.051 . . . . 0.0 112.43 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.77 -164.1 43.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 124.643 1.115 . . . . 0.0 114.743 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -87.67 -12.83 44.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.231 1.012 . . . . 0.0 112.776 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 66.57 157.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.188 2.195 . . . . 0.0 113.965 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 38.0 tpp -156.7 -79.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.293 -0.879 . . . . 0.0 111.534 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -138.7 153.27 48.51 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.049 1.295 . . . . 0.0 113.946 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.85 130.73 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.751 1.62 . . . . 0.0 110.625 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -145.32 127.86 16.05 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.819 0.819 . . . . 0.0 113.043 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.33 144.45 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.718 -1.239 . . . . 0.0 112.028 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -128.88 156.07 44.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.356 1.462 . . . . 0.0 110.406 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -72.32 7.44 1.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.23 -35.38 2.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.134 1.333 . . . . 0.0 113.219 163.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -154.22 148.73 26.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.512 1.525 . . . . 0.0 110.448 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.96 165.26 12.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.342 -0.849 . . . . 0.0 114.202 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.33 133.52 51.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.901 1.81 . . . . 0.0 112.683 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 mt -104.88 139.65 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.546 1.538 . . . . 0.0 107.152 167.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -134.61 84.77 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -115.17 153.42 30.85 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.562 1.145 . . . . 0.0 112.489 -169.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.67 151.91 24.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.424 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 65.6 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 128.771 2.828 . . . . 0.0 114.699 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.39 -23.77 58.11 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.242 2.628 . . . . 0.0 114.479 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -64.86 -40.72 95.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 111.182 -175.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 m -73.83 -31.06 63.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.038 0.935 . . . . 0.0 112.631 174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.01 -44.25 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.686 -0.634 . . . . 0.0 109.92 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -65.22 -41.47 94.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.781 0.833 . . . . 0.0 112.152 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -59.51 -38.95 82.3 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.773 0.829 . . . . 0.0 112.198 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.94 58.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.076 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 mt -57.44 -51.52 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 121.007 1.73 . . . . 0.0 109.674 165.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.94 2.54 8.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -105.84 -26.86 11.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.574 1.55 . . . . 0.0 113.526 171.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -127.05 -26.76 3.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.467 1.107 . . . . 0.0 113.309 -166.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -76.57 40.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.185 1.794 . . . . 0.0 112.276 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 128.015 2.526 . . . . 0.0 108.566 -176.562 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -127.0 131.03 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.969 1.708 . . . . 0.0 107.985 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -128.07 122.13 31.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -92.13 141.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.945 0.898 . . . . 0.0 111.225 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.0 t -136.78 150.46 48.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 108.392 166.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 123.567 0.747 . . . . 0.0 110.254 -173.895 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.664 0 CA-C-O 119.385 -0.339 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HE3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -83.16 137.89 33.87 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.004 1.322 . . . . 0.0 112.879 -173.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 t -133.0 162.96 30.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 110.922 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -132.4 161.52 33.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.634 0.73 . . . . 0.0 112.15 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -143.74 130.29 20.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.026 1.73 . . . . 0.0 108.872 -166.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -110.99 141.76 44.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.921 1.688 . . . . 0.0 112.013 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -94.7 100.55 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.093 0.957 . . . . 0.0 111.156 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.96 4.37 53.96 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.047 1.784 . . . . 0.0 115.728 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -82.23 30.15 0.41 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.323 1.449 . . . . 0.0 114.031 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.9 tp 50.71 63.77 9.34 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.71 2.004 . . . . 0.0 114.024 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.89 26.48 0.36 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.365 2.71 . . . . 0.0 115.427 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -78.89 51.2 1.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 109.879 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -147.59 147.07 29.67 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 128.399 2.68 . . . . 0.0 108.544 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -53.75 115.79 2.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.192 0.997 . . . . 0.0 111.573 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.47 148.09 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.308 1.043 . . . . 0.0 111.29 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -118.61 158.97 24.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.0 1.72 . . . . 0.0 111.989 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -52.35 -30.25 27.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.695 1.598 . . . . 0.0 113.819 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.41 -29.61 69.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.002 0.921 . . . . 0.0 113.274 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.89 -43.46 98.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.205 0.911 . . . . 0.0 111.121 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.52 -36.38 63.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.377 1.071 . . . . 0.0 111.612 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.12 -35.53 80.74 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.33 0.652 . . . . 0.0 112.559 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -18.84 59.13 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -72.06 -80.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' CE1' ' HB1' ' A' ' 53' ' ' ALA . 11.2 m-30 -116.34 117.49 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.151 0.977 . . . . 0.0 110.747 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 76.8 p -148.2 -27.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.734 1.613 . . . . 0.0 113.772 158.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 25' ' ' SER . 10.2 Cg_endo -96.46 19.84 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 CA-C-N 122.899 2.071 . . . . 0.0 114.111 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -120.77 143.9 48.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.628 1.571 . . . . 0.0 111.929 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 -152.61 40.85 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.78 -0.575 . . . . 0.0 114.352 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -88.6 -25.77 22.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.024 -0.988 . . . . 0.0 113.257 -171.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mm 64.78 153.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.154 1.782 . . . . 0.0 112.206 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.0 tpp -154.91 -57.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.439 -1.413 . . . . 0.0 113.758 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -156.34 155.69 32.65 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.523 1.129 . . . . 0.0 113.911 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.91 151.89 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.173 1.389 . . . . 0.0 112.281 168.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.25 98.34 3.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.444 1.498 . . . . 0.0 110.525 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tt -106.41 138.84 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -130.64 153.55 48.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.013 1.325 . . . . 0.0 110.371 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -76.78 49.41 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.992 1.317 . . . . 0.0 112.387 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.26 -51.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.744 2.418 . . . . 0.0 110.333 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -149.69 144.39 26.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.521 1.528 . . . . 0.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.14 140.83 15.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.119 0.866 . . . . 0.0 112.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.58 148.69 50.5 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.73 1.253 . . . . 0.0 112.43 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -129.88 138.35 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.745 1.618 . . . . 0.0 107.775 176.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.05 97.68 5.35 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.449 1.1 . . . . 0.0 108.415 175.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -118.53 152.81 35.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.031 0.932 . . . . 0.0 111.655 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.28 162.47 21.14 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.654 167.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 69.88 74.42 0.27 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 127.968 2.507 . . . . 0.0 113.357 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.0 -36.89 97.74 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.659 2.906 . . . . 0.0 114.709 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -62.86 -34.43 77.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.158 1.344 . . . . 0.0 111.817 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.5 m -77.45 -33.88 54.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.72 -42.92 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.178 0.899 . . . . 0.0 109.987 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.01 -39.98 87.18 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.301 1.04 . . . . 0.0 112.711 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.1 -32.23 73.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.994 0.816 . . . . 0.0 112.596 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -73.61 -31.49 63.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.294 0.638 . . . . 0.0 112.05 172.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.67 -54.86 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.956 1.253 . . . . 0.0 110.514 171.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.44 -20.41 63.08 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.601 1.092 . . . . 0.0 112.811 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 t -90.98 -24.44 20.11 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.843 1.257 . . . . 0.0 114.321 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -126.49 -19.18 4.67 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.501 -1.374 . . . . 0.0 113.651 -172.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -86.96 21.3 2.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.382 1.873 . . . . 0.0 112.804 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 CA--C 1.532 0.25 0 C-N-CA 125.083 1.353 . . . . 0.0 109.694 -170.0 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.1 mt . . . . . 0 N--CA 1.461 0.111 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.48 150.89 51.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.785 1.634 . . . . 0.0 109.776 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.13 137.82 31.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.696 -0.627 . . . . 0.0 111.592 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -93.63 145.47 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.042 0.937 . . . . 0.0 111.044 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.4 t -135.67 146.95 48.34 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.587 1.155 . . . . 0.0 110.757 168.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.328 -0.363 0 C-N-CA 123.975 0.91 . . . . 0.0 111.901 175.489 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.535 0.535 0 N-CA-C 112.21 0.042 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 133.47 33.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.207 1.003 . . . . 0.0 112.571 176.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -151.52 155.01 37.62 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.438 0.695 . . . . 0.0 110.833 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -120.59 149.84 41.83 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.304 1.442 . . . . 0.0 111.004 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -120.03 128.17 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.42 1.888 . . . . 0.0 108.459 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -115.49 141.67 47.75 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.754 1.622 . . . . 0.0 111.169 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.69 114.93 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.576 1.15 . . . . 0.0 109.798 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.92 -4.98 86.69 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.716 1.627 . . . . 0.0 114.462 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.554 HD22 ' N ' ' A' ' 68' ' ' ILE . 69.9 m-80 -77.52 31.88 0.16 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.749 1.275 . . . . 0.0 113.466 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt 44.8 76.26 0.56 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.716 2.006 . . . . 0.0 114.188 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.85 26.8 0.18 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.008 3.139 . . . . 0.0 115.419 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -76.2 16.25 0.47 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.133 2.573 . . . . 0.0 112.683 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -127.81 157.62 39.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 129.11 2.964 . . . . 0.0 110.983 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -43.74 120.98 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.045 1.738 . . . . 0.0 112.338 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.96 159.84 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.085 0.954 . . . . 0.0 111.594 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -133.59 161.61 34.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.845 1.658 . . . . 0.0 111.747 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -52.58 -33.86 47.99 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.329 -0.857 . . . . 0.0 111.728 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.62 -21.01 65.41 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.12 -38.04 63.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.911 1.232 . . . . 0.0 112.302 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.96 -37.91 64.37 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.061 -1.024 . . . . 0.0 110.534 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -64.84 -43.85 91.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -29.88 69.75 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.291 0.95 . . . . 0.0 112.145 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.06 -78.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 167.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.16 120.64 35.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.462 1.483 . . . . 0.0 111.752 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 13.3 p -158.1 -33.35 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.219 167.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 25' ' ' SER . 31.5 Cg_endo -91.62 43.1 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.686 2.257 . . . . 0.0 111.201 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -133.33 153.8 51.27 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.215 1.806 . . . . 0.0 110.386 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.18 -157.89 35.38 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 163.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -103.02 -4.76 24.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 65.49 170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.141 1.776 . . . . 0.0 113.941 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.5 mtm -157.65 -75.7 0.09 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.931 -1.106 . . . . 0.0 109.517 163.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -145.42 155.3 43.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.654 1.182 . . . . 0.0 113.995 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 tt -115.6 134.05 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.044 1.738 . . . . 0.0 108.788 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.02 121.44 9.66 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.211 1.005 . . . . 0.0 111.622 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.6 147.07 31.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.879 0.871 . . . . 0.0 111.4 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.64 154.79 43.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.825 1.25 . . . . 0.0 110.211 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -68.8 44.36 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.058 1.743 . . . . 0.0 113.058 171.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.01 -40.71 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.345 2.258 . . . . 0.0 111.993 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -144.97 143.38 30.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.904 1.282 . . . . 0.0 109.923 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.11 136.61 11.73 Favored Glycine 0 N--CA 1.463 0.488 0 C-N-CA 123.884 0.755 . . . . 0.0 112.515 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -139.37 159.58 41.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 123.221 1.486 . . . . 0.0 112.42 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -136.28 148.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.29 1.836 . . . . 0.0 107.523 171.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -134.3 104.84 6.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -124.88 155.27 39.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.493 1.517 . . . . 0.0 112.714 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -90.0 153.5 20.53 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.02 1.328 . . . . 0.0 111.037 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 66.32 79.87 0.23 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.903 2.881 . . . . 0.0 113.705 -159.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -53.11 -33.24 62.9 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.074 3.183 . . . . 0.0 114.635 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -70.58 -35.85 73.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.066 0.848 . . . . 0.0 111.8 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -65.9 -31.75 72.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.88 -38.11 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.697 0.799 . . . . 0.0 110.223 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.39 -42.24 98.79 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.421 -0.799 . . . . 0.0 112.105 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.46 -38.15 90.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.87 0.759 . . . . 0.0 112.239 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.18 77.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.974 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.19 -53.34 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.817 1.19 . . . . 0.0 110.399 171.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.06 -29.7 70.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.306 0.957 . . . . 0.0 112.664 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -77.15 -38.12 52.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -94.87 -26.97 15.96 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 t -72.53 -20.78 61.28 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.152 0.981 . . . . 0.0 112.496 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 125.963 1.705 . . . . 0.0 111.097 170.575 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.554 ' N ' HD22 ' A' ' 9' ' ' ASN . 64.8 mt . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 mt -138.64 139.1 38.39 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.757 1.223 . . . . 0.0 108.922 -165.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -133.74 125.89 29.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.88 139.81 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.096 0.959 . . . . 0.0 111.149 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -143.82 144.57 31.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.744 1.618 . . . . 0.0 110.663 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.468 0.437 0 C-N-CA 124.014 0.926 . . . . 0.0 110.217 178.804 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.539 0.742 0 N-CA-C 113.77 0.642 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 98.59 5.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.079 1.752 . . . . 0.0 109.64 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -128.06 99.82 5.64 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.997 0.919 . . . . 0.0 110.338 -162.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -84.51 154.08 22.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 112.382 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.71 127.76 41.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.003 1.721 . . . . 0.0 108.79 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -104.36 138.74 40.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.376 1.471 . . . . 0.0 112.132 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -97.21 97.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.181 1.392 . . . . 0.0 110.289 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.72 -23.0 65.42 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.147 0.88 . . . . 0.0 115.018 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 68' ' ' ILE . 9.8 p30 -72.96 58.17 0.47 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.212 1.805 . . . . 0.0 115.483 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp 46.37 55.7 15.91 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 127.321 2.248 . . . . 0.0 113.754 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.47 4.42 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.471 3.447 . . . . 0.0 115.112 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.03 1.14 2.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.053 2.141 . . . . 0.0 116.198 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -139.77 -28.95 0.74 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -150.39 99.24 2.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.872 1.269 . . . . 0.0 110.117 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.44 149.52 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.48 0.712 . . . . 0.0 110.621 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -146.22 164.26 32.84 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.699 1.2 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -58.36 -29.76 66.24 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.144 -0.972 . . . . 0.0 112.48 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.34 -18.91 63.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -77.68 -47.18 19.83 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.909 -1.119 . . . . 0.0 109.946 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.15 -41.57 75.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.05 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -68.63 -43.21 76.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.484 1.514 . . . . 0.0 112.905 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -34.6 77.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.182 0.901 . . . . 0.0 111.152 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.93 -70.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.004 1.322 . . . . 0.0 108.747 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -124.2 112.7 17.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 111.168 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 11.8 m -160.57 -22.15 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.364 1.866 . . . . 0.0 113.355 157.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' CD ' ' H ' ' A' ' 25' ' ' SER . 32.5 Cg_exo -73.43 16.22 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.149 2.566 . . . . 0.0 116.4 171.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -134.06 154.95 50.83 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.228 1.411 . . . . 0.0 111.129 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.45 -165.5 31.95 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.334 0.969 . . . . 0.0 115.093 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -91.12 -17.87 25.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.3 mm 64.71 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.785 1.634 . . . . 0.0 112.801 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.5 tpp -153.44 -58.13 0.13 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.3 -0.875 . . . . 0.0 112.466 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -147.8 145.02 28.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.674 1.189 . . . . 0.0 112.967 -171.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -117.68 127.52 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.185 1.794 . . . . 0.0 109.839 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -137.02 87.52 2.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.981 0.896 . . . . 0.0 111.24 -164.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.3 139.43 21.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.078 0.951 . . . . 0.0 110.944 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.31 153.41 46.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.195 2.198 . . . . 0.0 109.082 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -76.81 28.0 0.13 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.53 -41.77 0.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.807 2.043 . . . . 0.0 111.378 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -137.83 146.93 44.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.388 1.075 . . . . 0.0 112.703 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.31 133.33 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 123.976 0.798 . . . . 0.0 112.222 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -131.27 154.83 48.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.25 1.5 . . . . 0.0 112.569 171.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.031 1.732 . . . . 0.0 108.352 167.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -140.72 80.44 1.75 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.383 1.873 . . . . 0.0 108.046 -172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -111.72 165.93 11.62 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.759 -1.213 . . . . 0.0 113.828 -166.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -96.19 153.37 17.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.03 0.932 . . . . 0.0 110.419 166.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 66.95 85.61 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.902 2.881 . . . . 0.0 115.249 -166.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.45 -30.35 72.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.633 2.888 . . . . 0.0 113.331 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -53.91 -41.27 67.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.572 0.624 . . . . 0.0 110.939 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 m -87.47 -23.71 24.36 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.83 -45.86 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.759 1.163 . . . . 0.0 109.105 164.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -65.16 -42.77 93.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.949 0.9 . . . . 0.0 112.755 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.488 1.04 . . . . 0.0 112.197 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.75 -32.58 62.13 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.28 -52.71 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.343 1.429 . . . . 0.0 109.51 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.19 -10.76 60.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -89.06 -23.42 22.55 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.787 -1.196 . . . . 0.0 113.68 170.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -128.96 -37.12 1.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -165.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 t -76.63 -13.2 60.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.826 1.25 . . . . 0.0 113.251 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 123.983 0.913 . . . . 0.0 112.093 178.102 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.555 ' N ' HD21 ' A' ' 9' ' ' ASN . 4.5 mp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -121.92 140.46 52.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.394 1.478 . . . . 0.0 110.45 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.19 140.53 37.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.45 140.81 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.136 1.374 . . . . 0.0 111.136 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.9 t -152.88 153.72 33.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.606 1.162 . . . . 0.0 111.615 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 124.987 1.315 . . . . 0.0 112.07 173.776 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 CA-C-O 120.372 0.072 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.16 50.1 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.335 -0.853 . . . . 0.0 111.739 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -158.27 150.7 22.09 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.918 2.087 . . . . 0.0 108.718 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -126.04 152.33 45.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.591 0.632 . . . . 0.0 112.25 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.68 125.36 41.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.273 1.429 . . . . 0.0 108.904 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -104.14 136.51 43.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.661 1.984 . . . . 0.0 110.262 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.28 137.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.324 1.05 . . . . 0.0 109.561 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.93 -175.1 3.61 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 122.316 0.953 . . . . 0.0 113.194 169.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -83.93 13.24 5.11 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.18 -44.32 99.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.456 1.502 . . . . 0.0 114.723 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.93 21.93 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.914 2.409 . . . . 0.0 113.186 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.59 59.31 1.49 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.532 1.533 . . . . 0.0 110.389 174.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -153.27 31.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.73 2.812 . . . . 0.0 110.795 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 m120 58.42 146.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.431 2.692 . . . . 0.0 114.055 -157.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.16 153.02 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.367 1.067 . . . . 0.0 110.652 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.0 m -135.45 166.06 24.05 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.636 1.974 . . . . 0.0 110.217 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -52.35 -32.94 40.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.194 -0.941 . . . . 0.0 111.465 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.51 -21.7 65.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.181 1.792 . . . . 0.0 115.014 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.83 -47.5 62.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.204 0.911 . . . . 0.0 109.514 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.22 -29.23 62.64 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.497 -1.377 . . . . 0.0 112.051 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -61.82 -46.65 88.58 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.002 0.921 . . . . 0.0 111.687 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.91 -39.1 90.84 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.523 -0.735 . . . . 0.0 110.321 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.73 -76.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 109.113 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -119.52 123.87 45.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.841 1.201 . . . . 0.0 111.747 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.64 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 15.4 m -157.9 -41.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 126.085 1.754 . . . . 0.0 112.846 167.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HD2' ' H ' ' A' ' 25' ' ' SER . 53.9 Cg_endo -81.01 43.44 1.55 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.65 2.233 . . . . 0.0 112.562 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.07 146.15 46.74 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.416 1.486 . . . . 0.0 110.655 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.74 -161.11 28.28 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -96.67 -2.14 45.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.185 0.994 . . . . 0.0 112.95 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp 62.22 167.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 126.803 2.041 . . . . 0.0 114.168 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.9 mtm -152.12 -71.59 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.943 -1.098 . . . . 0.0 110.508 162.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -156.53 155.8 32.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.012 0.925 . . . . 0.0 113.394 -171.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tp -101.75 135.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.737 2.015 . . . . 0.0 110.046 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -127.02 68.85 1.27 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.924 1.289 . . . . 0.0 109.931 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.07 137.67 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 26.0 mmmt -124.14 145.78 49.07 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.639 1.576 . . . . 0.0 108.643 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -70.42 -8.91 54.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -167.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.17 -59.52 1.94 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.756 1.162 . . . . 0.0 110.93 166.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.46 131.97 14.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.998 1.719 . . . . 0.0 110.17 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 36' ' ' LYS . . . -81.82 171.0 52.19 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.81 154.2 39.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.489 1.515 . . . . 0.0 110.972 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.63 151.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.87 1.668 . . . . 0.0 108.58 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.38 108.25 7.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.573 0.749 . . . . 0.0 109.164 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -127.33 158.82 36.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.497 1.519 . . . . 0.0 112.772 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -90.08 147.49 23.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.905 1.282 . . . . 0.0 110.61 170.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 66.6 86.79 0.13 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 129.585 3.154 . . . . 0.0 115.321 -162.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.45 -30.75 93.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.561 2.841 . . . . 0.0 114.851 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.62 -36.15 80.28 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.577 1.081 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -67.85 -37.64 82.12 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.8 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.684 0.793 . . . . 0.0 110.083 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.21 -31.63 72.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.252 1.021 . . . . 0.0 111.664 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.94 68.88 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.147 -0.971 . . . . 0.0 112.534 173.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.1 mt -60.51 -49.53 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.83 1.196 . . . . 0.0 110.594 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.07 -16.81 61.47 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.76 -58.88 3.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.214 1.406 . . . . 0.0 111.27 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.94 -45.09 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.543 -0.723 . . . . 0.0 111.83 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.77 15.97 0.76 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.031 1.332 . . . . 0.0 113.107 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -57.84 140.32 52.1 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.088 -1.007 . . . . 0.0 110.607 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -133.94 130.27 37.47 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.106 0.962 . . . . 0.0 113.549 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.6 ttm -98.29 166.13 11.54 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.267 1.827 . . . . 0.0 110.079 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -75.6 50.57 0.55 Allowed 'General case' 0 CA--C 1.553 1.095 0 O-C-N 120.437 -1.414 . . . . 0.0 114.135 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.35 31.87 5.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.661 2.384 . . . . 0.0 111.326 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.75 -168.96 52.95 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.039 1.304 . . . . 0.0 115.644 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.4 98.69 3.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.08 1.352 . . . . 0.0 111.76 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -105.62 -23.84 12.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.644 1.578 . . . . 0.0 113.904 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -143.55 142.46 31.12 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.477 1.511 . . . . 0.0 110.76 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.55 109.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.359 1.463 . . . . 0.0 109.293 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -130.3 138.96 50.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.282 2.233 . . . . 0.0 108.889 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -141.47 130.96 23.83 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.757 0.823 . . . . 0.0 111.869 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.73 134.45 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.577 -0.702 . . . . 0.0 111.166 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.56 99.46 8.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.791 1.636 . . . . 0.0 108.526 161.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.2 m -77.43 34.18 0.17 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.15 1.38 . . . . 0.0 114.06 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -61.37 102.97 0.26 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.537 1.535 . . . . 0.0 110.756 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.12 37.62 0.32 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.363 1.465 . . . . 0.0 111.795 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.76 145.38 42.37 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.363 2.265 . . . . 0.0 110.344 -173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.221 1.408 . . . . 0.0 112.383 -174.705 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 O4'-C1'-N19 112.172 3.972 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 110.953 2.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.234 1 O4'-C1'-N19 112.569 4.369 . 0.101 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.578 -2.429 1 O4'-C1'-N19 113.3 5.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.539 0.76 0 CA-C-O 120.089 -0.046 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -152.15 145.5 24.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -163.38 168.58 20.18 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.404 1.882 . . . . 0.0 110.01 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -140.63 153.16 45.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 171.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.3 121.35 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 108.435 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -100.66 133.85 44.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.386 1.074 . . . . 0.0 111.311 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.2 mm -90.48 99.43 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.755 0.822 . . . . 0.0 108.831 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.01 156.23 47.82 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.091 0.377 . . . . 0.0 112.663 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -51.03 98.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.15 1.78 . . . . 0.0 112.912 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.8 tm? -150.11 -56.64 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.486 1.514 . . . . 0.0 112.462 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 65.9 Cg_endo -72.94 -48.0 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.931 1.725 . . . . 0.0 113.348 -168.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 mp 57.02 -15.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -129.88 143.98 51.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.216 1.806 . . . . 0.0 111.721 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.61 29.13 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.368 2.267 . . . . 0.0 115.414 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -69.28 138.27 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.015 0.912 . . . . 0.0 111.241 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.9 p -143.71 156.84 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.534 1.133 . . . . 0.0 111.061 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.87 -25.84 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.086 -1.009 . . . . 0.0 111.758 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.83 -28.59 69.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.847 1.259 . . . . 0.0 114.012 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -67.61 -43.11 81.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.99 1.723 . . . . 0.0 111.476 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.01 -45.07 95.22 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.917 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -69.73 -37.92 76.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.494 1.118 . . . . 0.0 113.764 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -31.59 66.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.568 -1.332 . . . . 0.0 111.574 176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -64.14 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.468 1.107 . . . . 0.0 108.727 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -124.5 111.89 16.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.988 1.267 . . . . 0.0 110.71 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.475 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 47.7 t -155.61 -49.76 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 25' ' ' SER . 64.6 Cg_endo -84.47 8.68 4.49 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.024 2.483 . . . . 0.0 115.139 -173.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -84.7 15.05 4.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.848 1.259 . . . . 0.0 113.547 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.14 -15.16 9.13 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.148 -1.595 . . . . 0.0 115.375 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.88 133.91 34.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.319 1.559 . . . . 0.0 111.724 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.45 152.5 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.317 0.647 . . . . 0.0 112.234 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.4 mtm -162.03 -67.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.761 2.024 . . . . 0.0 109.001 151.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -148.43 155.63 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.203 1.401 . . . . 0.0 112.744 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 HG12 ' A' ' 42' ' ' ILE . 16.8 pt -130.04 145.22 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.791 1.236 . . . . 0.0 111.119 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -136.96 157.16 47.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.052 1.341 . . . . 0.0 111.466 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.22 159.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -132.87 167.46 20.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.619 2.368 . . . . 0.0 110.95 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.42 -16.48 36.28 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.43 -10.04 5.16 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -160.64 -177.76 6.41 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.017 1.727 . . . . 0.0 111.132 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.27 170.29 36.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 120.527 -1.358 . . . . 0.0 115.285 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -130.69 128.09 40.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.378 1.471 . . . . 0.0 111.869 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.434 HG12 HG22 ' A' ' 33' ' ' ILE . 1.8 mt -97.74 139.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.724 1.61 . . . . 0.0 108.544 169.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -130.56 94.09 3.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.273 1.429 . . . . 0.0 107.735 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -127.13 154.12 45.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.702 1.601 . . . . 0.0 113.941 -162.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.84 161.87 28.63 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.281 -0.887 . . . . 0.0 111.348 163.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 61.87 78.59 0.3 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.053 2.541 . . . . 0.0 115.639 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -24.28 51.5 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.089 2.526 . . . . 0.0 114.698 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -77.32 -37.09 53.28 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.092 -1.005 . . . . 0.0 112.522 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -70.41 -33.01 70.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.707 0.23 . . . . 0.0 111.091 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.9 t -65.2 -44.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 174.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -58.01 -48.19 80.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 111.419 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.49 -33.53 66.07 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.825 0.85 . . . . 0.0 112.983 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.77 -27.08 36.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -50.4 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 120.692 1.587 . . . . 0.0 110.074 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.0 -4.1 15.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.044 1.338 . . . . 0.0 113.603 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 87.8 m -108.2 -7.93 15.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.502 1.521 . . . . 0.0 113.879 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -137.23 -55.39 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.174 0.897 . . . . 0.0 112.61 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.021 -1.05 . . . . 0.0 112.465 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -113.07 14.75 19.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.811 1.644 . . . . 0.0 112.838 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -79.71 37.29 0.35 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.503 -1.373 . . . . 0.0 112.325 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.16 140.88 19.03 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.234 1.814 . . . . 0.0 107.759 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -116.31 138.29 51.44 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.497 1.119 . . . . 0.0 111.74 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.1 t80 54.03 36.13 23.82 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.851 1.26 . . . . 0.0 113.395 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.9 -145.12 5.78 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.155 -0.966 . . . . 0.0 112.345 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -153.73 158.75 41.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.136 0.974 . . . . 0.0 113.111 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -136.77 -37.7 0.66 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.407 1.883 . . . . 0.0 112.714 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -145.88 172.32 13.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.081 1.353 . . . . 0.0 111.073 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.29 106.41 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.4 mt -119.95 133.96 55.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.595 0.758 . . . . 0.0 110.838 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -134.21 130.58 37.41 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.591 1.156 . . . . 0.0 110.994 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.74 143.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.913 0.885 . . . . 0.0 111.93 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 t -140.38 153.99 46.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.117 1.767 . . . . 0.0 110.849 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m -129.31 29.26 5.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.236 1.414 . . . . 0.0 110.806 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.5 m -75.04 145.94 41.96 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.915 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -138.27 1.69 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.68 1.592 . . . . 0.0 114.152 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.04 159.87 41.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.733 2.013 . . . . 0.0 109.92 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -170.597 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.294 0 O4'-C1'-N19 111.953 3.753 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 O4'-C1'-N19 110.817 2.617 . 0.286 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O5'-C5'-C4' 113.448 2.32 . 0.124 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 O4'-C1'-N19 112.0 3.8 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.533 0.473 0 CA-C-O 121.084 0.368 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.28 146.01 51.83 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -160.98 147.84 15.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.601 1.56 . . . . 0.0 109.634 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -127.23 149.97 49.76 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.777 0.831 . . . . 0.0 110.734 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.57 124.99 31.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -104.26 137.23 42.47 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.755 1.622 . . . . 0.0 111.401 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -95.7 96.3 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.561 1.144 . . . . 0.0 110.281 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -8.51 74.36 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.889 1.233 . . . . 0.0 115.123 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -78.16 30.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.784 2.292 . . . . 0.0 114.179 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 33.14 66.75 1.15 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.595 2.358 . . . . 0.0 114.459 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.44 56.1 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.593 3.529 . . . . 0.0 113.964 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.93 -2.26 11.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.566 2.747 . . . . 0.0 112.985 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.33 150.14 51.7 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.607 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -12.49 96.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.61 3.164 . . . . 0.0 115.349 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 152.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.611 1.564 . . . . 0.0 111.256 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.1 p -137.7 166.72 23.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.543 1.937 . . . . 0.0 110.538 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -55.49 -25.16 35.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.316 0.646 . . . . 0.0 112.172 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -63.01 -27.29 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.303 1.441 . . . . 0.0 113.143 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.83 -48.74 23.55 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.418 -0.801 . . . . 0.0 110.938 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.76 -34.96 79.07 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.609 -1.307 . . . . 0.0 111.329 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -69.2 -35.71 76.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.986 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -37.37 78.77 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.9 1.227 . . . . 0.0 110.887 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.87 -79.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -120.79 108.27 13.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.245 0.93 . . . . 0.0 110.818 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 60.7 p -135.09 -30.46 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.821 -1.561 . . . . 0.0 114.658 160.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 25' ' ' SER . 19.2 Cg_endo -88.65 10.75 3.24 Favored 'Trans proline' 0 C--N 1.356 0.956 0 CA-C-N 122.988 2.103 . . . . 0.0 113.623 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -105.7 142.38 35.53 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.817 1.247 . . . . 0.0 111.332 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.23 -161.24 45.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.967 0.794 . . . . 0.0 114.744 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -98.94 -0.95 41.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.0 0.92 . . . . 0.0 113.387 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 63.56 158.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.744 2.017 . . . . 0.0 115.451 168.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.4 mtm -151.72 -79.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.58 1.152 . . . . 0.0 108.555 162.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -142.0 157.39 44.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -114.68 131.41 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.853 1.661 . . . . 0.0 108.954 168.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -127.1 90.18 3.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.983 1.313 . . . . 0.0 110.415 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.91 138.69 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.626 -0.671 . . . . 0.0 110.354 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -133.56 145.94 50.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.214 1.806 . . . . 0.0 108.693 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.67 25.04 0.81 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.429 1.492 . . . . 0.0 112.827 -168.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 -56.68 0.36 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.568 1.947 . . . . 0.0 110.772 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -142.78 101.16 3.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 110.152 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.34 156.43 48.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.692 0.663 . . . . 0.0 113.77 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.86 152.03 50.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.751 1.262 . . . . 0.0 112.607 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 145.51 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.113 1.765 . . . . 0.0 108.416 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -135.03 90.1 2.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.132 1.773 . . . . 0.0 107.999 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -121.34 160.17 24.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.092 1.357 . . . . 0.0 114.204 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -92.25 156.29 17.4 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.997 1.319 . . . . 0.0 110.229 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 67.63 76.79 0.26 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 129.158 2.983 . . . . 0.0 113.714 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -58.38 -33.85 98.18 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.9 3.066 . . . . 0.0 113.551 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -58.08 -45.26 87.44 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.253 0.933 . . . . 0.0 111.178 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -71.81 -28.37 63.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.53 -42.48 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.733 1.151 . . . . 0.0 110.639 170.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -67.86 -44.06 78.0 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 112.131 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.28 -33.5 69.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.065 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.94 64.06 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.263 -0.898 . . . . 0.0 113.044 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.47 -50.38 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.395 -1.441 . . . . 0.0 109.7 171.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.41 -6.05 32.8 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.4 t -85.23 -50.36 7.44 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.906 1.282 . . . . 0.0 111.982 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -109.0 -47.15 3.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.24 1.016 . . . . 0.0 113.693 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -67.63 -21.42 65.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.13 0.972 . . . . 0.0 112.025 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -118.78 23.6 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.726 2.011 . . . . 0.0 111.811 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.04 146.78 54.57 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.13 14.86 0.26 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.742 1.617 . . . . 0.0 115.26 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -77.28 162.52 27.27 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.523 -1.361 . . . . 0.0 113.461 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -76.86 154.61 33.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.898 1.279 . . . . 0.0 112.203 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.39 -154.39 34.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.321 1.438 . . . . 0.0 112.233 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -69.74 157.68 36.85 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 111.29 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -121.71 151.61 40.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.091 1.356 . . . . 0.0 110.917 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.06 138.16 57.58 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.82 -0.55 . . . . 0.0 110.626 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.1 mt -102.38 106.08 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 mt -126.44 134.91 50.85 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.583 1.153 . . . . 0.0 108.567 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.68 133.5 41.94 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.9 137.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.589 1.556 . . . . 0.0 111.325 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -143.59 168.52 19.68 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.766 2.027 . . . . 0.0 111.004 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.5 m -145.8 136.6 24.41 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.529 1.132 . . . . 0.0 109.539 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -64.73 112.27 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.012 0.824 . . . . 0.0 109.345 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -142.64 134.41 26.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.341 1.056 . . . . 0.0 110.588 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.83 141.09 58.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.565 0.698 . . . . 0.0 112.129 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.878 -1.534 . . . . 0.0 111.47 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.248 0 C5'-C4'-C3' 109.804 -3.798 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 O4'-C1'-N19 111.402 3.202 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 1 O4'-C1'-N19 112.375 4.175 OUTLIER-EPSILON 0.058 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 1 P-O3'-C3' 125.647 4.956 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.636 0.975 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -122.21 97.97 5.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.691 2.396 . . . . 0.0 108.583 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.73 95.35 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.396 1.479 . . . . 0.0 109.332 -164.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -86.57 151.77 23.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.655 0.74 . . . . 0.0 112.241 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.3 126.43 38.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.877 1.671 . . . . 0.0 108.983 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -104.1 136.66 43.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.704 1.602 . . . . 0.0 111.424 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.62 99.01 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.784 0.834 . . . . 0.0 110.245 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.94 -7.26 86.44 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.423 -0.798 . . . . 0.0 114.702 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -77.08 50.07 0.72 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.69 1.596 . . . . 0.0 112.662 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.5 mt 38.45 66.74 2.46 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.334 2.254 . . . . 0.0 113.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.83 15.82 0.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 125.198 3.932 . . . . 0.0 115.262 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.4 32.68 0.34 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.316 1.447 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -127.53 52.0 1.87 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.821 2.048 . . . . 0.0 112.622 -164.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 44.45 55.89 5.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.468 1.507 . . . . 0.0 113.357 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.16 161.15 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.87 0.868 . . . . 0.0 111.606 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -147.06 154.61 41.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 112.377 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -62.31 -29.37 70.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -66.44 -22.08 66.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.29 -38.97 49.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.979 0.912 . . . . 0.0 110.686 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.22 -44.12 80.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.175 0.99 . . . . 0.0 111.205 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.24 -45.08 96.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.064 1.345 . . . . 0.0 111.855 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -29.21 65.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.404 -0.81 . . . . 0.0 112.262 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.36 -73.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -120.87 117.97 28.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.553 1.07 . . . . 0.0 111.923 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 16.5 p -162.48 -31.36 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 163.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' CD ' ' H ' ' A' ' 25' ' ' SER . 30.0 Cg_endo -93.85 0.89 3.21 Favored 'Trans proline' 0 C--N 1.357 1.015 0 CA-C-N 122.932 2.083 . . . . 0.0 114.633 -170.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -78.59 179.45 7.1 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.292 1.837 . . . . 0.0 111.735 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.39 19.34 0.27 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.384 1.468 . . . . 0.0 116.598 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -141.47 140.05 33.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 112.564 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -163.68 153.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.811 2.044 . . . . 0.0 108.672 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.7 tpp -166.08 -57.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.73 1.15 . . . . 0.0 110.897 154.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -156.21 147.12 22.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.96 144.08 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.953 1.301 . . . . 0.0 108.105 169.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.83 86.36 1.93 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 110.498 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tt -103.18 146.29 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -172.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -132.05 149.85 52.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.301 1.84 . . . . 0.0 109.45 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -72.79 39.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.929 1.692 . . . . 0.0 114.3 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.82 -43.64 0.09 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.404 2.282 . . . . 0.0 110.718 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.25 128.67 34.33 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.87 0.868 . . . . 0.0 111.747 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.35 126.55 7.91 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.68 0.657 . . . . 0.0 112.382 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -139.16 150.97 46.23 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.898 1.332 . . . . 0.0 113.84 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 152.86 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.243 2.217 . . . . 0.0 108.978 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -140.14 90.31 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.234 1.414 . . . . 0.0 108.576 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -111.68 164.4 13.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.273 1.429 . . . . 0.0 112.402 -170.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -103.21 148.38 25.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.62 -1.3 . . . . 0.0 110.033 172.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.0 t30 69.69 105.34 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 129.05 2.94 . . . . 0.0 114.438 -156.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.89 -26.9 6.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.496 2.797 . . . . 0.0 113.393 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -65.26 -34.8 79.21 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.235 -0.916 . . . . 0.0 111.996 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.7 m -82.31 -20.07 38.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.77 -1.109 . . . . 0.0 113.578 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.92 -51.64 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.314 1.415 . . . . 0.0 108.979 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -71.25 -28.19 64.0 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.3 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -66.74 -47.95 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.619 1.099 . . . . 0.0 111.761 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.95 66.37 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.947 -1.096 . . . . 0.0 112.328 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.03 -53.33 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.139 0.881 . . . . 0.0 110.198 167.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.96 -18.47 62.62 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.42 1.464 . . . . 0.0 113.532 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.15 -36.62 47.49 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 113.35 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -115.06 -42.38 3.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.503 1.121 . . . . 0.0 113.113 -169.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -72.55 23.53 0.06 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.693 1.997 . . . . 0.0 114.09 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -136.81 8.96 3.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.573 1.949 . . . . 0.0 111.404 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -93.76 116.69 29.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.6 mtt -123.08 141.47 51.92 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.565 1.146 . . . . 0.0 111.859 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -133.05 171.58 13.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.521 1.528 . . . . 0.0 110.099 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.58 119.16 7.04 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.455 -0.778 . . . . 0.0 111.894 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.87 3.26 73.5 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -154.38 152.62 30.42 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.952 1.876 . . . . 0.0 113.968 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -147.43 148.69 31.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.274 1.43 . . . . 0.0 110.719 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.98 134.31 35.67 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.779 0.323 . . . . 0.0 110.571 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.7 mm -132.86 117.8 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.455 1.902 . . . . 0.0 107.701 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 mt -134.63 144.26 47.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.968 1.707 . . . . 0.0 109.74 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.48 138.95 46.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.29 140.79 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.918 1.287 . . . . 0.0 110.481 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -140.43 143.77 35.77 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 167.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.7 p -149.34 142.4 24.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.703 0.764 . . . . 0.0 111.709 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.1 p -154.43 167.99 28.17 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.358 1.063 . . . . 0.0 110.405 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -148.48 141.9 25.28 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.969 0.508 . . . . 0.0 111.555 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.82 10.68 7.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.191 1.796 . . . . 0.0 113.116 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.643 1.577 . . . . 0.0 109.936 168.908 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 1 O4'-C1'-N19 112.312 4.112 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.579 -2.321 1 O4'-C1'-N19 113.042 4.842 . 0.167 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.73 0 P-O3'-C3' 123.804 3.42 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.253 0 O4'-C1'-C2' 102.427 -2.838 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.539 0.764 0 N-CA-C 111.276 -0.317 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 125.82 29.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 111.972 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -138.74 95.02 2.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 109.363 -164.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.01 149.04 43.61 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.442 -0.787 . . . . 0.0 111.183 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.96 122.23 29.7 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.065 1.346 . . . . 0.0 108.93 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t80 -96.44 130.36 43.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.172 1.789 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.84 91.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.181 0.993 . . . . 0.0 109.318 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 6' ' ' PHE . . . -77.93 4.88 56.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.997 1.284 . . . . 0.0 115.397 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -64.48 -162.98 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.58 1.952 . . . . 0.0 111.818 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -119.66 42.11 0.46 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -77.19 54.83 4.81 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.087 3.191 . . . . 0.0 112.318 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.6 50.46 1.32 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.806 2.042 . . . . 0.0 109.376 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -142.49 168.74 19.02 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.086 2.554 . . . . 0.0 109.297 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -61.76 110.01 1.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.395 -0.816 . . . . 0.0 110.205 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.72 155.21 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.082 0.953 . . . . 0.0 112.41 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.1 m -133.55 155.17 50.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.149 1.779 . . . . 0.0 111.333 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.01 -25.68 22.43 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.924 1.29 . . . . 0.0 114.22 -167.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -53.65 -27.32 26.67 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 0.0 113.32 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.13 -49.95 17.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.896 1.225 . . . . 0.0 112.379 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.11 -28.1 69.84 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.045 -1.659 . . . . 0.0 111.514 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.06 -34.95 71.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.31 1.444 . . . . 0.0 113.335 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -35.07 79.52 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.984 1.265 . . . . 0.0 110.91 170.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.26 -77.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.828 1.251 . . . . 0.0 107.96 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -120.53 116.17 24.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.126 1.33 . . . . 0.0 111.122 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.577 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 p -158.66 -29.88 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 162.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 25' ' ' SER . 41.2 Cg_endo -86.82 0.17 7.82 Favored 'Trans proline' 0 C--N 1.357 0.977 0 CA-C-N 123.283 2.208 . . . . 0.0 113.995 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -79.36 171.91 14.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.467 1.507 . . . . 0.0 111.638 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.64 -15.7 80.51 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -87.04 121.21 29.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.873 1.337 . . . . 0.0 111.904 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 tp -154.54 146.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.26 0.624 . . . . 0.0 111.74 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mtm -159.84 -73.09 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.458 1.903 . . . . 0.0 110.129 162.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -143.8 160.63 40.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.965 1.706 . . . . 0.0 114.1 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -133.15 124.67 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.113 1.765 . . . . 0.0 110.105 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -129.28 74.05 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.616 1.167 . . . . 0.0 112.012 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 tt -65.73 146.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.062 -1.024 . . . . 0.0 111.326 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -145.01 147.21 32.37 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.809 2.043 . . . . 0.0 108.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.96 143.35 51.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.785 0.434 . . . . 0.0 110.639 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.87 -53.87 0.31 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.609 1.964 . . . . 0.0 115.84 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -141.32 73.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.049 0.928 . . . . 0.0 112.289 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.93 51.66 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.544 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.77 160.44 38.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 122.839 1.304 . . . . 0.0 112.642 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -122.97 155.84 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.98 1.712 . . . . 0.0 109.024 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -136.3 88.69 2.4 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.941 1.296 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.84 175.0 5.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.819 0.848 . . . . 0.0 111.296 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -117.02 151.89 35.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.145 1.778 . . . . 0.0 109.096 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.9 t30 66.51 92.24 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 127.537 2.335 . . . . 0.0 113.812 -160.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.58 -21.46 45.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.779 2.319 . . . . 0.0 113.34 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.99 -30.97 68.44 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.387 -0.821 . . . . 0.0 112.001 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -89.24 -25.08 21.92 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 117.719 -1.134 . . . . 0.0 113.478 168.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.29 -48.01 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 120.434 1.47 . . . . 0.0 109.274 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.92 -41.65 95.38 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.171 -0.919 . . . . 0.0 113.061 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.12 -38.25 79.17 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.638 1.108 . . . . 0.0 112.479 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -27.5 61.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.66 -58.49 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.598 1.09 . . . . 0.0 109.441 168.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.27 -19.17 65.22 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.42 -44.98 14.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.42 1.888 . . . . 0.0 114.409 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -106.41 -24.74 12.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.79 1.236 . . . . 0.0 113.753 -169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -72.63 35.78 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.328 2.251 . . . . 0.0 112.497 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -153.72 148.92 26.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.982 2.513 . . . . 0.0 109.216 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -135.27 -18.03 1.77 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.847 1.259 . . . . 0.0 111.32 164.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.9 mmt -126.75 162.93 24.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.989 2.515 . . . . 0.0 111.503 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -91.05 13.11 17.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.82 1.248 . . . . 0.0 112.395 168.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -142.02 142.2 32.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.691 1.196 . . . . 0.0 111.141 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.17 -160.27 46.11 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.793 0.711 . . . . 0.0 113.653 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -132.79 132.22 41.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.394 1.478 . . . . 0.0 110.665 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -128.53 -33.27 2.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.179 1.392 . . . . 0.0 112.915 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.93 122.69 36.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 108.71 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.49 109.15 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.351 1.461 . . . . 0.0 108.158 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.14 141.75 47.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.328 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.2 134.91 33.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.807 1.185 . . . . 0.0 113.291 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -90.29 146.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.769 1.228 . . . . 0.0 110.551 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 155.73 44.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.692 0.797 . . . . 0.0 110.276 165.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -103.6 158.66 16.21 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.431 0.692 . . . . 0.0 109.922 166.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -73.16 173.51 9.31 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 112.108 172.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -98.53 14.4 28.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.991 0.916 . . . . 0.0 111.905 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.7 172.53 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.176 1.79 . . . . 0.0 111.873 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 116.859 -1.543 . . . . 0.0 113.677 -176.095 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 111.292 3.092 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.467 0 O4'-C1'-N19 111.44 3.24 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . 0.488 " H3'" H5'' ' B' ' 81' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.154 0 O4'-C1'-N19 111.551 3.351 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . 0.488 H5'' " H3'" ' B' ' 80' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.595 0 O4'-C4'-C3' 108.72 2.3 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 CA--C 1.535 0.531 0 CA-C-O 120.681 0.2 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 142.63 49.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.142 1.377 . . . . 0.0 111.673 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 t -142.93 140.48 31.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.954 1.702 . . . . 0.0 109.184 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -113.59 145.56 41.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.618 0.767 . . . . 0.0 110.31 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -131.72 126.12 33.73 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.644 1.577 . . . . 0.0 109.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.3 132.28 54.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.37 94.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.15 43.25 2.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.708 1.147 . . . . 0.0 112.911 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -114.45 32.92 5.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.586 1.554 . . . . 0.0 113.132 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.8 tp 43.08 72.53 1.14 Allowed Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.885 2.874 . . . . 0.0 113.986 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.5 1.52 6.76 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.67 2.913 . . . . 0.0 113.091 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.18 32.15 0.18 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 114.421 -172.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -146.71 -56.61 0.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.805 -1.184 . . . . 0.0 111.583 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -145.07 134.42 23.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 110.843 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -157.01 149.84 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.208 1.003 . . . . 0.0 111.084 169.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -135.63 155.84 49.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.098 1.759 . . . . 0.0 110.172 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -50.04 -33.8 19.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.154 1.382 . . . . 0.0 114.101 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.3 -23.29 47.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.92 -48.54 58.12 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.017 -1.052 . . . . 0.0 111.581 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.91 -33.62 68.45 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.037 -1.04 . . . . 0.0 111.099 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -61.18 -43.81 98.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -27.23 62.69 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.185 -0.947 . . . . 0.0 111.839 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.22 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.789 0.835 . . . . 0.0 109.525 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -122.1 114.8 21.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.794 1.179 . . . . 0.0 111.037 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.453 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 23.1 t -151.81 -40.54 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.654 170.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' H ' ' A' ' 25' ' ' SER . 22.7 Cg_endo -96.6 15.91 0.79 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.26 2.64 . . . . 0.0 114.125 -172.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.42 22.87 0.32 Allowed 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.455 -1.403 . . . . 0.0 114.4 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.26 -13.93 13.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.476 1.988 . . . . 0.0 116.517 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.51 156.17 49.33 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.114 1.366 . . . . 0.0 110.307 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -165.14 165.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.01 0.924 . . . . 0.0 110.811 -161.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -155.68 -69.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 156.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -143.36 165.04 28.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.451 1.5 . . . . 0.0 113.671 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 tp -113.83 133.84 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.709 2.004 . . . . 0.0 110.018 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -129.9 55.53 1.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 110.416 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.2 tt -70.05 146.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.672 -1.267 . . . . 0.0 111.225 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -134.49 156.52 48.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.797 1.639 . . . . 0.0 110.254 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.51 10.73 0.75 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.766 1.226 . . . . 0.0 113.698 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.68 -60.82 0.44 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.832 1.253 . . . . 0.0 112.238 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -141.89 101.58 3.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.207 1.403 . . . . 0.0 109.457 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.27 152.93 42.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.78 0.705 . . . . 0.0 113.514 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -131.93 157.49 43.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.875 1.27 . . . . 0.0 112.406 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.55 150.38 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.143 1.777 . . . . 0.0 108.53 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -140.15 102.68 4.43 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.226 0.466 . . . . 0.0 110.268 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -119.26 161.01 21.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.249 1.419 . . . . 0.0 112.841 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -78.12 161.86 27.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.745 0.818 . . . . 0.0 109.999 164.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 53.89 90.04 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.769 2.028 . . . . 0.0 113.937 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.99 -25.65 81.87 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.078 2.519 . . . . 0.0 114.523 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -72.69 -25.47 61.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.923 0.783 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -66.73 -42.63 85.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.29 0.95 . . . . 0.0 111.462 167.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.31 -42.79 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.603 1.161 . . . . 0.0 110.952 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -66.49 -45.39 79.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.668 0.787 . . . . 0.0 111.931 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.72 -34.63 74.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.59 0.756 . . . . 0.0 112.357 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.8 -27.62 63.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.68 -48.54 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.958 -1.714 . . . . 0.0 110.505 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.32 2.3 7.8 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.7 t -98.99 -33.05 10.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.877 1.671 . . . . 0.0 112.899 169.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -122.11 -28.26 4.42 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 t -88.08 12.67 12.95 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.954 1.302 . . . . 0.0 112.314 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -147.1 140.82 25.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.693 1.997 . . . . 0.0 110.399 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.19 169.29 20.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 111.73 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttt -136.43 -4.86 2.06 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -118.04 -17.5 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.121 1.768 . . . . 0.0 113.495 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -133.42 134.06 43.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.336 1.454 . . . . 0.0 111.063 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.46 125.45 10.45 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.77 0.7 . . . . 0.0 111.685 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.94 143.62 50.86 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.905 0.882 . . . . 0.0 112.069 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -127.83 12.82 6.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.756 2.022 . . . . 0.0 113.469 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 pp -69.88 154.25 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.382 0.673 . . . . 0.0 111.543 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -124.29 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.593 1.157 . . . . 0.0 109.708 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.8 mt -124.94 138.21 54.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.193 1.397 . . . . 0.0 108.917 165.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -132.36 131.31 41.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.178 0.991 . . . . 0.0 110.799 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.75 140.38 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.214 1.006 . . . . 0.0 111.485 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.1 t -134.99 117.64 15.98 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.354 1.062 . . . . 0.0 110.126 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -151.86 161.69 42.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.866 0.866 . . . . 0.0 112.28 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.6 t -129.15 141.33 51.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.005 0.922 . . . . 0.0 112.22 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -144.28 173.21 11.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.699 1.999 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.32 148.44 48.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.213 1.005 . . . . 0.0 112.129 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.524 1.53 . . . . 0.0 111.162 -176.118 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.254 1 O4'-C1'-N19 112.652 4.452 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.485 1 O4'-C1'-N19 112.489 4.289 . 0.093 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.409 -3.686 0 O4'-C1'-N19 111.169 2.969 . 0.01 4g . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.571 -2.982 1 O4'-C1'-N19 113.398 5.198 . 0.159 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 CA--C 1.533 0.474 0 N-CA-C 112.954 0.328 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 105.06 5.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.227 1.011 . . . . 0.0 110.013 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -128.74 140.39 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.143 0.977 . . . . 0.0 111.294 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -112.25 150.41 30.96 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.952 0.901 . . . . 0.0 112.169 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.07 122.89 35.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.425 1.89 . . . . 0.0 108.707 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -103.59 148.36 26.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.843 1.657 . . . . 0.0 111.524 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.09 135.48 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.537 1.535 . . . . 0.0 110.447 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.41 172.56 2.66 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.568 1.08 . . . . 0.0 113.756 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.67 33.66 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 -161.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.59 -32.97 0.39 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 126.4 1.88 . . . . 0.0 115.307 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.05 -7.23 20.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 123.612 2.326 . . . . 0.0 114.271 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.72 -5.41 8.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.87 1.268 . . . . 0.0 113.254 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -122.68 -38.54 2.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.635 1.974 . . . . 0.0 113.959 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -146.47 127.88 14.95 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.472 1.509 . . . . 0.0 109.113 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.39 127.94 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.438 0.695 . . . . 0.0 111.611 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -152.8 143.32 22.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.093 1.357 . . . . 0.0 109.972 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -57.21 -30.08 64.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.419 1.009 . . . . 0.0 112.426 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.09 -28.95 68.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.896 1.678 . . . . 0.0 113.235 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.43 -45.65 58.65 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.423 1.089 . . . . 0.0 111.514 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.82 -40.93 97.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.496 -0.752 . . . . 0.0 110.252 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.4 -45.28 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.422 1.089 . . . . 0.0 112.424 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.17 82.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.347 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.9 mt -61.02 -74.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.92 1.288 . . . . 0.0 108.494 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 8.8 m-30 -124.53 124.42 42.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.528 1.058 . . . . 0.0 111.444 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.594 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 4.3 m -157.93 -34.31 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 156.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 25' ' ' SER . 56.8 Cg_endo -85.25 5.17 6.33 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 CA-C-N 122.902 2.072 . . . . 0.0 113.686 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.46 -21.34 30.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.08 -157.76 12.87 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 120.084 1.311 . . . . 0.0 116.0 -171.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -68.93 -25.99 64.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.269 1.4 mp 63.72 167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.213 1.405 . . . . 0.0 113.731 170.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.1 mtm -153.04 -72.74 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.388 -1.445 . . . . 0.0 109.889 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.01 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.538 1.135 . . . . 0.0 113.281 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.7 mt -82.46 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 161.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -135.73 66.12 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.423 1.106 . . . . 0.0 111.074 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 tt -83.19 150.96 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.11 0.964 . . . . 0.0 111.883 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -114.4 -175.98 2.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.379 1.872 . . . . 0.0 111.299 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -79.59 -15.03 58.39 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.03 -10.65 2.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.41 159.2 35.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 112.837 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.03 124.36 5.99 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.427 -0.651 . . . . 0.0 111.584 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' CE2' ' C6 ' ' B' ' 80' ' ' ' U' . 7.9 m-85 -128.62 149.19 50.75 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.829 1.299 . . . . 0.0 111.802 164.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.95 149.33 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 126.617 1.967 . . . . 0.0 107.818 166.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -137.08 100.66 4.34 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.049 0.94 . . . . 0.0 108.631 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -124.19 153.91 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.027 1.731 . . . . 0.0 112.837 -167.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -81.36 155.34 26.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.274 0.629 . . . . 0.0 110.695 166.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 59.99 95.65 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 130.226 3.41 . . . . 0.0 116.333 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -67.26 -18.03 50.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.449 2.766 . . . . 0.0 113.46 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -74.76 -27.83 60.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.433 1.015 . . . . 0.0 111.636 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -75.47 -39.24 58.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.562 0.619 . . . . 0.0 111.914 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.21 -41.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.919 0.487 . . . . 0.0 110.598 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -61.91 -49.16 77.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.307 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -55.7 -41.82 74.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.833 0.742 . . . . 0.0 111.591 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -66.35 -34.34 77.76 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.399 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.2 mt -63.42 -50.49 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.509 1.504 . . . . 0.0 111.025 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.1 -12.49 61.23 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.15 -20.72 17.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.377 1.471 . . . . 0.0 113.241 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -125.48 -29.56 3.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -91.32 -1.53 57.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.766 1.226 . . . . 0.0 112.927 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.71 152.09 47.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 108.872 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 56.43 90.19 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.278 1.431 . . . . 0.0 112.896 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -76.12 23.37 0.14 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.567 1.547 . . . . 0.0 113.992 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -130.12 12.75 5.64 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.862 2.465 . . . . 0.0 112.385 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -150.49 -27.38 0.23 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.782 1.633 . . . . 0.0 112.501 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.05 -151.98 12.41 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.046 2.26 . . . . 0.0 111.675 154.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -122.19 165.83 15.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.45 2.3 . . . . 0.0 110.889 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -69.33 10.11 0.37 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.38 131.3 41.7 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.393 1.077 . . . . 0.0 111.088 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.15 129.29 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.5 mt -134.9 140.68 45.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.259 1.824 . . . . 0.0 108.503 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.2 137.75 34.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.98 0.809 . . . . 0.0 112.841 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.81 142.0 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.742 1.217 . . . . 0.0 112.606 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t -143.29 171.6 13.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.723 2.009 . . . . 0.0 109.826 171.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.1 m -142.84 36.89 1.43 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.257 1.423 . . . . 0.0 111.268 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.1 t -146.24 137.89 24.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.094 0.957 . . . . 0.0 113.169 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.77 11.92 35.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.471 1.509 . . . . 0.0 113.519 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.62 158.87 28.32 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.037 -1.039 . . . . 0.0 111.487 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 C--O 1.248 1.017 0 C-N-CA 125.778 1.631 . . . . 0.0 112.024 -175.372 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C3'-C2'-C1' 99.283 -2.463 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.816 0 O4'-C1'-N19 111.514 3.314 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . 0.408 ' C6 ' ' CE2' ' A' ' 41' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.414 1 O4'-C1'-N19 112.276 4.076 . 0.236 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.285 1 O4'-C1'-N19 114.056 5.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.536 0.62 0 N-CA-C 112.615 0.198 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.45 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.865 2.066 . . . . 0.0 108.2 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -135.27 123.67 23.32 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.375 1.07 . . . . 0.0 109.75 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -88.48 151.72 22.35 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.842 0.829 . . . . 0.0 112.197 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.38 129.46 53.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.23 1.812 . . . . 0.0 107.541 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -109.86 134.78 51.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.208 1.403 . . . . 0.0 110.555 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.442 ' HB ' ' H ' ' A' ' 40' ' ' GLY . 12.0 mm -94.93 116.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.345 1.058 . . . . 0.0 108.712 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.82 149.51 25.09 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 119.566 -0.575 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -55.32 72.02 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.628 2.771 . . . . 0.0 115.148 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 94.9 mt -126.19 -37.75 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.911 2.485 . . . . 0.0 113.832 170.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 40.8 Cg_endo -83.8 59.47 6.22 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.782 2.321 . . . . 0.0 112.119 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.126 1.37 . . . . 0.0 113.021 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.93 146.84 45.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.042 1.337 . . . . 0.0 113.43 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.8 t30 35.83 59.82 0.84 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.237 2.215 . . . . 0.0 114.289 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.49 138.34 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.871 0.843 . . . . 0.0 111.789 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -120.08 159.96 23.78 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.862 1.665 . . . . 0.0 110.263 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -17.54 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.05 -1.031 . . . . 0.0 113.173 161.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -74.26 -23.45 59.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.326 1.051 . . . . 0.0 112.999 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.19 -35.95 63.99 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.803 -1.185 . . . . 0.0 110.732 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.32 -43.51 98.65 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.685 -1.26 . . . . 0.0 110.639 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.11 -44.2 96.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.091 0.956 . . . . 0.0 112.554 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -64.0 -36.64 84.65 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.13 -0.981 . . . . 0.0 111.574 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.67 -70.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.154 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.86 125.14 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.136 1.334 . . . . 0.0 111.394 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 17.5 m -158.73 -37.77 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.027 1.731 . . . . 0.0 113.588 164.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.2 Cg_endo -83.84 34.53 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.469 2.113 . . . . 0.0 113.311 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.33 123.35 16.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.643 1.577 . . . . 0.0 110.722 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.35 -160.1 53.93 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.581 0.61 . . . . 0.0 113.487 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -107.24 -5.08 18.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.934 1.294 . . . . 0.0 113.904 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 1.6 mp 67.57 154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.771 2.028 . . . . 0.0 114.404 171.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.5 mmt -151.66 -56.44 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.758 1.623 . . . . 0.0 110.5 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -159.12 148.65 18.78 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.626 1.103 . . . . 0.0 113.645 -170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 147.7 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.191 0.996 . . . . 0.0 111.169 163.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -147.66 101.85 3.37 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.298 0.954 . . . . 0.0 111.688 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.47 149.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.312 -1.493 . . . . 0.0 113.056 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -123.88 156.12 36.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.115 1.366 . . . . 0.0 111.329 167.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -65.39 22.91 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 127.395 2.278 . . . . 0.0 116.941 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.08 -33.11 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.485 1.514 . . . . 0.0 112.667 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -152.82 156.04 38.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.865 1.666 . . . . 0.0 110.217 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 7' ' ' ILE . . . -102.23 152.44 18.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.657 0.646 . . . . 0.0 113.699 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.74 156.21 34.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 123.254 1.502 . . . . 0.0 111.683 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.65 152.86 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.98 2.112 . . . . 0.0 107.334 166.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -136.14 101.27 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -121.52 155.0 35.92 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.943 1.297 . . . . 0.0 112.024 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -75.47 157.01 34.65 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.937 0.495 . . . . 0.0 111.218 164.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 68.34 82.29 0.19 Allowed Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 128.797 2.839 . . . . 0.0 115.517 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -57.93 -37.71 95.07 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.592 2.861 . . . . 0.0 113.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -66.59 -34.31 77.61 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.197 -0.939 . . . . 0.0 112.822 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.7 m -87.06 -21.48 26.04 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -43.98 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.205 0.911 . . . . 0.0 109.836 162.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -63.03 -40.37 97.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.984 0.914 . . . . 0.0 112.461 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.24 -35.96 74.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.263 0.625 . . . . 0.0 112.374 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.64 61.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.611 0.764 . . . . 0.0 112.778 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.66 -53.11 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.485 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -67.02 -9.54 40.17 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.76 -33.13 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.122 1.769 . . . . 0.0 113.966 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -127.83 -15.91 4.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 t -74.97 33.2 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 111.519 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -147.73 143.72 27.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.324 2.65 . . . . 0.0 108.021 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.61 162.75 32.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.501 1.12 . . . . 0.0 109.352 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -58.08 140.82 51.85 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 110.449 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -66.57 103.43 1.07 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.109 0.564 . . . . 0.0 111.888 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -153.77 26.5 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.909 1.684 . . . . 0.0 111.986 -170.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.56 12.13 83.93 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 120.647 -1.283 . . . . 0.0 115.078 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -141.36 151.1 43.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.81 1.644 . . . . 0.0 114.42 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -156.41 136.35 12.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.98 1.712 . . . . 0.0 110.702 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -79.73 142.68 35.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.258 0.935 . . . . 0.0 111.192 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.4 123.82 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.033 1.333 . . . . 0.0 109.317 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 mt -128.92 143.24 50.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.44 1.896 . . . . 0.0 109.057 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -140.09 135.36 32.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.03 0.832 . . . . 0.0 112.59 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.16 144.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.95 0.9 . . . . 0.0 111.095 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.31 129.61 23.84 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.846 1.258 . . . . 0.0 110.46 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -125.13 17.7 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.207 1.003 . . . . 0.0 112.784 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -149.91 151.43 33.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.155 1.382 . . . . 0.0 110.659 170.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -66.92 142.73 57.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.459 1.104 . . . . 0.0 112.955 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.99 21.46 0.88 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.869 1.268 . . . . 0.0 113.342 -168.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 124.871 1.268 . . . . 0.0 112.538 -176.485 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.551 3.351 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 0 O4'-C1'-N19 111.702 3.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O5'-C5'-C4' 114.184 2.846 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.339 0 O4'-C1'-N19 111.358 3.158 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.546 1.106 0 N-CA-C 115.773 1.413 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt 65.12 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.191 2.597 . . . . 0.0 116.586 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -147.9 172.56 13.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.975 1.71 . . . . 0.0 111.412 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -135.08 161.58 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.153 1.381 . . . . 0.0 113.285 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.19 129.65 31.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.937 1.695 . . . . 0.0 110.309 -171.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -111.12 141.69 44.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.781 1.632 . . . . 0.0 111.92 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 mm -101.6 96.76 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.709 1.604 . . . . 0.0 110.291 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 -3.66 84.84 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.409 1.481 . . . . 0.0 115.404 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 47.02 0.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.02 1.91 . . . . 0.0 113.664 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 40.93 59.35 8.24 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.392 1.877 . . . . 0.0 113.589 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.45 25.88 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.027 3.818 . . . . 0.0 114.543 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 -12.99 46.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.26 1.424 . . . . 0.0 113.252 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.64 137.16 51.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.837 1.655 . . . . 0.0 112.303 -167.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 50.95 48.65 22.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.304 1.442 . . . . 0.0 114.062 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 m -112.45 146.15 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 122.574 1.178 . . . . 0.0 113.135 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -146.7 166.76 25.61 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 109.694 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 25.2 mmtp -50.45 -32.04 16.79 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.266 -0.896 . . . . 0.0 112.752 172.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.23 -20.66 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.456 1.102 . . . . 0.0 113.459 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.89 -48.26 32.2 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.629 1.104 . . . . 0.0 110.848 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.61 -35.79 79.61 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -71.52 -40.25 70.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.904 0.882 . . . . 0.0 112.989 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -25.53 60.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.627 1.103 . . . . 0.0 112.527 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.38 -74.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 9.4 m-30 -124.14 125.39 44.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.626 1.557 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.421 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 40.6 t -149.62 -54.25 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 161.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 25' ' ' SER . 43.7 Cg_endo -83.06 22.47 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.203 2.602 . . . . 0.0 114.085 -171.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -90.39 -33.03 16.19 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.328 -1.483 . . . . 0.0 114.844 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.07 11.9 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 119.122 0.874 . . . . 0.0 114.16 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.14 -24.56 63.19 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp 66.91 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.36 -59.37 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.622 -1.299 . . . . 0.0 111.019 161.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -145.29 138.98 26.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.148 0.979 . . . . 0.0 111.918 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tt -123.38 127.31 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.74 1.616 . . . . 0.0 110.056 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 5.2 p30 -128.8 152.81 48.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.767 1.227 . . . . 0.0 111.616 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -141.87 154.07 19.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.083 -1.011 . . . . 0.0 112.154 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.538 ' H ' HD13 ' A' ' 35' ' ' ILE . 42.1 tptt -149.38 146.99 27.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.301 1.441 . . . . 0.0 110.91 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -57.34 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 128.539 2.736 . . . . 0.0 116.872 168.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.95 -63.9 0.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.778 1.631 . . . . 0.0 110.669 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -141.46 111.82 6.92 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.985 0.914 . . . . 0.0 110.96 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.72 151.28 33.84 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.549 0.595 . . . . 0.0 112.482 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.37 156.08 46.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.714 1.245 . . . . 0.0 111.83 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.67 143.55 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.942 0.897 . . . . 0.0 109.221 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -127.67 98.44 5.2 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.582 1.153 . . . . 0.0 108.142 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -120.78 151.24 39.83 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.595 1.158 . . . . 0.0 111.672 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.03 159.99 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.756 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 64.74 82.73 0.21 Allowed Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 127.701 2.4 . . . . 0.0 112.818 -160.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.69 -33.05 47.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.14 3.227 . . . . 0.0 113.887 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -77.11 -23.38 51.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.838 0.855 . . . . 0.0 112.942 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -69.91 -41.98 73.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 163.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.76 -43.33 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.047 0.539 . . . . 0.0 110.569 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.97 -43.77 67.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.168 0.895 . . . . 0.0 113.234 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.41 -33.65 75.2 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.37 0.986 . . . . 0.0 111.731 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -67.08 -29.18 68.88 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.287 -0.883 . . . . 0.0 112.97 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.65 -53.0 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.298 1.408 . . . . 0.0 110.4 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.45 -15.92 63.93 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.4 m -84.22 -45.72 12.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.645 1.178 . . . . 0.0 113.68 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -104.0 -29.31 11.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 t -74.89 1.28 13.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.71 0.804 . . . . 0.0 111.598 164.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.77 128.96 38.06 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.937 -1.102 . . . . 0.0 110.832 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.24 138.12 43.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.499 0.72 . . . . 0.0 111.785 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.0 mtt -140.37 155.67 46.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.613 1.565 . . . . 0.0 111.597 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -65.51 157.78 28.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.811 0.844 . . . . 0.0 111.943 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 57.7 38.11 27.46 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.586 1.954 . . . . 0.0 113.75 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -164.05 19.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -170.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -123.9 138.94 54.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.413 1.885 . . . . 0.0 111.155 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -74.02 115.21 13.22 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.89 146.82 45.89 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.623 0.769 . . . . 0.0 109.219 171.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.4 107.74 19.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 mt -127.25 139.96 52.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.542 1.137 . . . . 0.0 109.354 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -131.64 138.13 48.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.451 0.569 . . . . 0.0 112.303 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.07 130.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -133.97 148.79 51.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.151 . . . . 0.0 109.632 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.2 m -132.63 135.82 46.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 p -101.98 14.1 32.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.731 2.013 . . . . 0.0 112.674 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -69.52 148.54 49.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.592 1.557 . . . . 0.0 110.681 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.27 143.74 56.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.622 -0.674 . . . . 0.0 111.835 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.21 -1.853 . . . . 0.0 111.735 -179.318 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.301 0 O4'-C1'-N19 111.897 3.697 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 0 O4'-C1'-N19 110.815 2.615 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.018 0 C3'-C2'-C1' 99.335 -2.406 . 0.41 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.303 0 O4'-C1'-N19 111.964 3.764 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 N-CA-C 111.409 -0.266 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 134.69 41.7 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.905 0.882 . . . . 0.0 111.554 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -146.87 155.76 42.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.63 1.572 . . . . 0.0 109.304 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -121.14 161.13 22.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.755 0.788 . . . . 0.0 112.663 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.8 121.89 19.04 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.478 1.911 . . . . 0.0 108.291 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -104.35 134.64 47.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.738 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 mm -91.49 132.18 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.742 0.817 . . . . 0.0 108.834 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -155.38 5.63 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.044 0.831 . . . . 0.0 113.104 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.6 83.39 0.43 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.217 -1.166 . . . . 0.0 111.591 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' H ' ' CD ' ' A' ' 11' ' ' PRO . 58.2 tp -139.44 -41.71 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.996 1.718 . . . . 0.0 115.011 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 10' ' ' LEU . 21.4 Cg_endo -93.51 17.75 1.03 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.255 1.97 . . . . 0.0 114.488 -162.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.33 22.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 131.75 27.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.267 2.227 . . . . 0.0 110.754 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 t30 40.15 47.71 2.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.353 1.461 . . . . 0.0 113.728 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.61 125.9 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 123.7 0.8 . . . . 0.0 110.965 -161.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -159.83 151.41 20.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.365 1.466 . . . . 0.0 110.599 -167.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -61.4 -16.73 49.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -69.73 -33.78 72.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.485 0.584 . . . . 0.0 112.345 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.2 -35.78 74.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.207 1.367 . . . . 0.0 112.036 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.42 -39.46 71.07 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -61.95 -38.42 88.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.994 0.918 . . . . 0.0 112.392 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -36.4 82.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.687 0.795 . . . . 0.0 110.938 174.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.36 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -122.53 121.08 35.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.854 1.206 . . . . 0.0 111.717 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.646 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.9 p -150.51 -30.1 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 159.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' A' ' 25' ' ' SER . 44.5 Cg_endo -81.92 26.2 0.63 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.242 2.194 . . . . 0.0 113.265 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -121.62 137.24 54.82 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.592 1.957 . . . . 0.0 110.67 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.1 -159.42 49.7 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 121.841 0.69 . . . . 0.0 114.431 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -100.8 -7.68 23.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.229 1.012 . . . . 0.0 113.543 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 67.85 142.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.025 2.13 . . . . 0.0 115.372 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 mmt -138.73 -81.71 0.31 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.953 1.301 . . . . 0.0 111.018 170.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -137.55 162.18 34.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.301 1.841 . . . . 0.0 113.583 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 tt -149.64 121.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.728 1.211 . . . . 0.0 110.977 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.87 101.92 6.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.472 1.109 . . . . 0.0 111.556 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.16 135.95 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.63 0.772 . . . . 0.0 112.114 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -120.88 165.95 14.48 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.209 1.803 . . . . 0.0 110.38 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -78.15 -18.82 55.1 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 -4.94 9.35 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -164.36 179.54 6.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.25 1.82 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.57 159.02 27.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 120.573 -1.329 . . . . 0.0 114.763 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.36 149.85 51.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.532 1.533 . . . . 0.0 112.084 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.8 150.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 127.024 2.13 . . . . 0.0 108.334 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -132.9 113.99 13.51 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 167.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -125.96 155.54 41.2 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.532 1.158 . . . . 0.0 112.308 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -80.3 144.53 32.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.686 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 80.03 82.03 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.382 3.073 . . . . 0.0 115.155 -170.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.53 -38.68 88.65 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.22 3.28 . . . . 0.0 114.494 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.01 -29.18 67.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.98 -1.075 . . . . 0.0 111.855 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -68.76 -35.0 76.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.49 -40.1 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.437 0.695 . . . . 0.0 109.691 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -65.81 -40.1 91.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.527 170.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.85 -38.34 81.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.2 0.909 . . . . 0.0 111.191 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.41 70.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.529 0.731 . . . . 0.0 112.693 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.27 -50.38 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.265 1.393 . . . . 0.0 110.395 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.22 -12.27 61.53 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.323 0.965 . . . . 0.0 113.393 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -96.86 -28.86 14.04 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -108.53 -56.3 2.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.398 1.479 . . . . 0.0 111.994 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -14.34 58.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.737 1.215 . . . . 0.0 113.151 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.33 10.48 8.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.802 1.641 . . . . 0.0 112.733 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -78.71 137.38 37.75 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.835 -1.165 . . . . 0.0 110.714 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.5 ttt 56.42 34.54 24.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.93 1.292 . . . . 0.0 112.51 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -58.72 -7.66 1.06 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.535 1.934 . . . . 0.0 115.714 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -104.32 -2.9 24.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.642 1.577 . . . . 0.0 113.27 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.18 -27.76 1.08 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.715 1.626 . . . . 0.0 114.898 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -148.96 156.75 42.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.181 2.193 . . . . 0.0 110.551 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -125.8 137.15 53.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 112.572 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.31 137.3 51.89 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.314 1.446 . . . . 0.0 109.993 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.35 114.09 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.487 1.115 . . . . 0.0 108.986 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 mt -129.49 148.49 51.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.298 2.239 . . . . 0.0 107.536 166.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -142.42 130.17 21.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.81 138.9 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.406 1.482 . . . . 0.0 112.664 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.3 t -135.38 148.76 49.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 112.766 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.4 p -133.91 16.97 3.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.169 1.387 . . . . 0.0 112.49 167.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.9 m -94.43 16.17 15.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.304 1.442 . . . . 0.0 113.726 -173.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -93.97 14.6 19.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.379 1.872 . . . . 0.0 112.651 -173.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.83 13.94 7.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.866 1.666 . . . . 0.0 112.024 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 127.182 2.193 . . . . 0.0 113.742 -175.096 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 O4'-C1'-N19 111.061 2.861 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 C5'-C4'-C3' 110.423 -3.385 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.595 1 O4'-C1'-N19 112.522 4.322 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0a' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 O4'-C1'-N19 111.181 2.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.541 0.855 0 CA-C-O 120.102 -0.041 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.66 140.43 40.82 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.117 0.967 . . . . 0.0 113.209 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 141.89 15.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.575 1.55 . . . . 0.0 110.355 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -116.77 145.73 43.3 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.946 0.898 . . . . 0.0 111.717 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.88 124.42 44.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.533 1.533 . . . . 0.0 108.739 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -108.86 135.83 49.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.2 mm -90.72 80.17 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.089 1.356 . . . . 0.0 110.776 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 -4.3 12.28 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.18 1.371 . . . . 0.0 115.164 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.19 -10.81 34.43 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.649 1.98 . . . . 0.0 114.248 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.6 mt 48.53 63.79 9.76 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.066 1.746 . . . . 0.0 113.803 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.99 45.25 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 125.663 4.242 . . . . 0.0 113.679 -173.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -50.43 -23.69 2.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.023 2.129 . . . . 0.0 115.998 -166.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.05 2.8 5.88 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.538 2.335 . . . . 0.0 114.075 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -135.67 61.62 1.65 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 110.8 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.58 117.89 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.789 1.235 . . . . 0.0 110.965 -173.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 t -155.38 151.95 28.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -50.59 -34.09 24.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.549 1.14 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -68.69 -22.38 64.37 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.09 -35.14 64.18 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.339 -1.475 . . . . 0.0 111.24 174.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.55 -40.89 69.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.376 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -69.29 -38.45 78.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.825 0.85 . . . . 0.0 113.184 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -28.1 65.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.68 -77.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.638 1.175 . . . . 0.0 108.526 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -117.53 112.36 20.49 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.693 1.133 . . . . 0.0 111.588 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.525 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 42.8 t -159.95 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.665 1.586 . . . . 0.0 112.294 167.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 25' ' ' SER . 50.4 Cg_endo -87.96 17.15 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 115.358 -171.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -90.29 1.32 56.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.542 1.137 . . . . 0.0 114.043 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.45 19.47 76.32 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.474 1.034 . . . . 0.0 113.905 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -137.75 137.43 38.27 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.595 1.158 . . . . 0.0 110.066 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 tp -158.28 163.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.543 1.137 . . . . 0.0 109.517 -170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.5 tpp -164.59 -67.35 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.668 0.787 . . . . 0.0 110.49 150.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -139.81 144.19 37.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 111.953 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 pt -107.85 141.85 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.107 0.963 . . . . 0.0 110.846 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -145.31 72.36 1.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.684 1.193 . . . . 0.0 110.464 -172.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 tt -90.78 138.11 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.863 -1.148 . . . . 0.0 113.118 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.85 157.0 30.74 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 110.371 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.02 8.53 0.53 Allowed 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -168.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.8 -51.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.349 1.46 . . . . 0.0 111.901 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.73 138.32 23.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.396 1.078 . . . . 0.0 110.738 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.99 160.09 30.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -127.18 152.71 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.898 1.279 . . . . 0.0 111.632 167.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.33 145.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.615 1.566 . . . . 0.0 108.246 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -130.42 87.94 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.633 1.573 . . . . 0.0 107.088 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -115.13 169.68 8.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.619 1.568 . . . . 0.0 112.573 -167.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -91.35 177.52 6.22 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.181 1.393 . . . . 0.0 111.333 168.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 49.15 81.03 0.27 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.741 2.416 . . . . 0.0 114.423 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.29 -29.65 89.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.497 2.798 . . . . 0.0 114.242 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -73.79 -33.94 64.42 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.468 -0.77 . . . . 0.0 111.597 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -70.65 -31.2 68.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.3 0.955 . . . . 0.0 112.622 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.66 -48.1 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.425 0.69 . . . . 0.0 110.518 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -64.66 -44.47 90.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.714 0.688 . . . . 0.0 112.546 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.94 -38.23 72.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.552 1.141 . . . . 0.0 112.322 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.03 -26.22 62.12 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.572 -0.705 . . . . 0.0 112.891 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.39 -51.61 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.045 1.293 . . . . 0.0 110.392 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.89 -17.95 65.01 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.79 -60.11 2.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.312 0.645 . . . . 0.0 111.973 167.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.02 -35.84 20.09 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.322 1.449 . . . . 0.0 114.722 -166.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -85.55 -3.98 59.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.612 1.565 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -75.82 71.88 2.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.508 1.123 . . . . 0.0 109.403 163.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -144.38 138.0 27.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.434 1.894 . . . . 0.0 109.64 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.0 ttp -140.61 139.62 34.94 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.684 1.194 . . . . 0.0 110.538 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -149.0 161.3 42.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 110.73 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.54 53.25 1.05 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.0 -148.13 6.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 128.149 2.785 . . . . 0.0 109.673 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.94 158.5 1.39 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.27 1.028 . . . . 0.0 113.589 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -117.52 144.58 44.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.672 1.989 . . . . 0.0 111.305 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.1 tp -74.57 70.72 1.82 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.409 -0.807 . . . . 0.0 111.324 169.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.31 123.89 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.525 0.73 . . . . 0.0 109.904 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.62 139.44 53.92 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.92 1.688 . . . . 0.0 108.525 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -132.7 134.77 45.22 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.243 0.929 . . . . 0.0 112.154 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.65 137.92 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.384 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 m -139.67 167.25 22.54 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.089 1.756 . . . . 0.0 110.773 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.8 t -153.93 153.07 31.37 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -0.895 . . . . 0.0 111.578 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 m -68.52 -0.5 5.13 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.059 1.344 . . . . 0.0 113.432 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -54.66 112.46 1.02 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.481 1.912 . . . . 0.0 110.83 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.74 49.68 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.211 1.804 . . . . 0.0 111.08 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.551 1.54 . . . . 0.0 113.481 -172.78 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.431 -1.823 1 O4'-C1'-N19 114.462 6.262 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.58 -2.213 0 O4'-C1'-N19 112.17 3.97 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.241 0 C5'-C4'-C3' 110.923 -3.051 . 0.061 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.573 -2.809 0 O4'-C1'-N19 111.961 3.761 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 112.914 0.313 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.53 156.02 18.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.307 1.843 . . . . 0.0 111.956 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -159.05 167.04 30.3 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.049 0.939 . . . . 0.0 111.468 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -130.1 165.01 23.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.93 126.11 42.69 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.291 2.236 . . . . 0.0 109.117 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -106.68 143.1 35.26 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.662 1.585 . . . . 0.0 111.498 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.7 101.7 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.668 1.587 . . . . 0.0 110.96 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 7.52 75.59 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.038 1.304 . . . . 0.0 114.909 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -74.29 15.32 0.34 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER 48.25 80.96 0.27 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.373 2.269 . . . . 0.0 112.677 -163.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.39 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.059 3.173 . . . . 0.0 111.892 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 mp 53.15 22.95 2.81 Favored 'General case' 0 CA--C 1.557 1.214 0 O-C-N 120.408 -1.432 . . . . 0.0 113.837 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -150.9 150.11 30.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.341 2.256 . . . . 0.0 110.469 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 m120 45.36 39.67 4.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.291 1.437 . . . . 0.0 113.224 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.77 34.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.739 1.615 . . . . 0.0 113.488 -157.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -90.68 147.53 23.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.898 1.279 . . . . 0.0 110.801 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.33 -32.29 10.88 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -62.97 -12.73 27.67 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.96 -43.71 70.98 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.983 -1.073 . . . . 0.0 111.893 168.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.68 -36.7 65.34 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.641 -0.662 . . . . 0.0 110.73 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.07 -45.52 91.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.491 0.716 . . . . 0.0 112.045 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -28.08 64.09 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.608 -0.682 . . . . 0.0 112.798 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.83 -75.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -123.85 126.58 46.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.843 1.201 . . . . 0.0 111.137 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.614 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 3.7 m -157.78 -20.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 160.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.614 ' CD ' ' H ' ' A' ' 25' ' ' SER . 29.4 Cg_endo -91.85 15.27 1.66 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 123.558 2.306 . . . . 0.0 113.166 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -105.58 154.68 20.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.563 1.145 . . . . 0.0 113.472 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 -146.28 43.43 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.699 1.143 . . . . 0.0 115.761 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.46 -0.6 27.74 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.177 1.391 . . . . 0.0 112.784 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.271 1.3 tp 63.5 171.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 128.376 2.67 . . . . 0.0 116.435 166.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mtm -171.6 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.692 1.597 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -142.63 136.99 29.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.273 1.429 . . . . 0.0 112.457 -164.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tt -85.2 139.31 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.056 0.942 . . . . 0.0 109.929 163.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -143.4 77.83 1.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.921 0.782 . . . . 0.0 111.665 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -88.15 138.71 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 122.076 0.941 . . . . 0.0 111.62 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -130.49 147.22 52.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.679 1.592 . . . . 0.0 108.336 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -75.0 35.86 0.11 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.37 -57.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.103 1.761 . . . . 0.0 109.52 166.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.84 126.58 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.133 1.373 . . . . 0.0 110.22 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.21 149.12 24.77 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 122.604 0.145 . . . . 0.0 112.926 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -134.37 162.41 32.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.324 1.45 . . . . 0.0 111.501 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.95 149.13 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 108.602 167.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -131.98 97.96 4.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.799 1.24 . . . . 0.0 107.936 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.51 145.53 50.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 112.284 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -73.75 154.15 39.71 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 166.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 64.34 86.98 0.13 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.477 2.711 . . . . 0.0 114.638 -166.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.0 -24.48 65.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.753 2.302 . . . . 0.0 114.423 174.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -68.54 -43.38 76.84 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.328 0.967 . . . . 0.0 110.719 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.7 m -72.8 -29.67 63.46 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.19 -46.03 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.873 0.76 . . . . 0.0 109.867 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -63.91 -37.54 87.8 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.288 1.035 . . . . 0.0 112.812 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.15 -45.19 94.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.305 0.642 . . . . 0.0 111.139 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 -31.34 72.45 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.563 -0.711 . . . . 0.0 112.322 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.24 -54.92 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.911 1.232 . . . . 0.0 110.58 172.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -71.67 -16.07 62.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -89.44 -36.17 15.59 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -103.13 -24.29 13.6 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.059 1.344 . . . . 0.0 113.911 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.3 p -68.51 -5.8 21.6 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.129 -1.607 . . . . 0.0 113.221 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -145.13 23.69 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.925 1.69 . . . . 0.0 112.84 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -82.77 83.5 7.68 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.156 -1.59 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 80.7 mtp 58.96 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.723 1.609 . . . . 0.0 113.716 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -74.26 166.96 22.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.78 1.632 . . . . 0.0 112.873 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.29 160.06 33.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 113.346 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 68.24 -169.68 39.48 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.2 0.905 . . . . 0.0 113.062 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -134.09 18.6 3.76 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -92.18 23.26 3.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.771 1.228 . . . . 0.0 112.594 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -121.51 129.44 52.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.685 1.194 . . . . 0.0 111.23 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 tp -157.28 154.06 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.204 1.002 . . . . 0.0 110.602 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -128.79 143.03 50.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.546 2.339 . . . . 0.0 106.623 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -136.19 132.25 35.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.266 1.394 . . . . 0.0 112.446 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.4 144.1 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.021 0.928 . . . . 0.0 110.654 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 t -140.95 147.99 39.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.432 1.093 . . . . 0.0 110.87 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.7 t -75.69 146.12 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.407 0.622 . . . . 0.0 111.267 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 p -107.34 5.88 27.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.455 1.502 . . . . 0.0 112.386 166.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -141.9 52.67 1.49 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.477 1.911 . . . . 0.0 111.388 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.0 157.62 37.4 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.465 ' NE ' ' H ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.399 0 C-N-CA 126.638 1.975 . . . . 0.0 114.18 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C3'-C2'-C1' 98.996 -2.782 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.375 1 O4'-C1'-N19 112.608 4.408 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.118 0 C3'-C2'-C1' 103.857 2.619 . 0.102 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.031 0 O4'-C1'-N19 111.733 3.533 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 CA--C 1.537 0.66 0 N-CA-C 114.311 0.85 . . . . 0.0 114.311 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.35 148.9 52.22 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.847 2.059 . . . . 0.0 110.006 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 p -162.94 161.68 25.81 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.285 1.434 . . . . 0.0 109.992 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.25 156.24 44.96 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.309 1.043 . . . . 0.0 111.395 160.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.35 117.78 23.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.199 2.199 . . . . 0.0 107.988 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -100.42 147.02 26.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.715 1.206 . . . . 0.0 111.501 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mm -103.29 131.56 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.84 1.256 . . . . 0.0 109.117 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.44 -176.49 4.82 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 121.399 0.444 . . . . 0.0 113.386 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.69 47.51 0.51 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.508 1.523 . . . . 0.0 114.911 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -119.02 -25.28 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 127.261 2.224 . . . . 0.0 115.518 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.9 38.6 0.76 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.92 2.414 . . . . 0.0 112.595 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.7 49.36 1.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.353 1.861 . . . . 0.0 110.183 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.45 37.58 1.69 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.301 1.84 . . . . 0.0 113.168 -161.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 51.36 61.08 3.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.053 1.741 . . . . 0.0 112.399 -172.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.19 149.35 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.089 0.956 . . . . 0.0 113.157 -167.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -138.78 164.43 29.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.109 2.563 . . . . 0.0 109.328 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -49.57 -32.44 12.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.468 1.107 . . . . 0.0 113.136 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -49.55 -36.56 23.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.549 1.539 . . . . 0.0 113.931 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.93 -39.59 50.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 111.94 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.01 -39.67 95.44 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.502 -0.749 . . . . 0.0 110.279 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.12 -36.67 74.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.985 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -69.28 -36.13 76.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.059 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.9 mt -63.1 -77.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.154 0.982 . . . . 0.0 108.871 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -120.3 121.08 37.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.97 1.259 . . . . 0.0 112.304 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.684 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.4 t -152.14 -38.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 112.98 165.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 25' ' ' SER . 47.4 Cg_endo -83.92 46.4 2.01 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.632 2.221 . . . . 0.0 112.18 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.96 145.63 49.72 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.491 1.116 . . . . 0.0 111.51 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.77 -155.4 33.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -97.71 0.89 47.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.686 0.794 . . . . 0.0 112.648 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tp 60.95 175.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.133 2.173 . . . . 0.0 113.7 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 mtm -166.11 -73.56 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.393 1.477 . . . . 0.0 109.051 160.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -144.22 153.53 42.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.663 1.185 . . . . 0.0 112.364 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 tt -122.49 130.93 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 126.292 1.837 . . . . 0.0 109.425 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.06 146.48 50.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.484 1.114 . . . . 0.0 112.316 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.14 148.79 23.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.135 1.374 . . . . 0.0 110.812 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -136.08 -176.44 4.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.639 1.576 . . . . 0.0 109.736 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -65.4 122.95 18.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.65 0.78 . . . . 0.0 110.661 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.44 10.03 0.44 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -157.04 157.64 35.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.529 1.532 . . . . 0.0 110.881 171.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.17 161.7 28.8 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.507 -0.746 . . . . 0.0 113.08 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -140.15 116.93 10.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.833 1.253 . . . . 0.0 110.865 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.98 148.5 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.858 -1.151 . . . . 0.0 108.939 164.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -137.19 98.28 3.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.859 0.864 . . . . 0.0 109.316 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -123.06 153.81 39.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 112.951 -169.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -81.06 153.66 27.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.408 1.083 . . . . 0.0 110.525 164.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 67.81 75.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 128.762 2.825 . . . . 0.0 113.852 -164.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -52.32 -35.77 65.74 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.982 3.121 . . . . 0.0 114.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -64.82 -39.37 93.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.004 0.82 . . . . 0.0 111.857 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -63.86 -31.26 72.38 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 -43.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.944 0.898 . . . . 0.0 109.942 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.74 -45.39 85.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.981 0.81 . . . . 0.0 111.675 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -62.48 -40.03 95.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.722 0.809 . . . . 0.0 112.257 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.04 72.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.379 0.672 . . . . 0.0 112.238 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.66 -51.08 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.517 1.053 . . . . 0.0 110.431 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.61 -15.39 63.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.81 -39.7 15.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.415 1.486 . . . . 0.0 114.141 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.15 -30.95 6.79 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -68.87 -3.16 11.57 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.562 -1.336 . . . . 0.0 113.623 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -115.69 11.12 15.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.026 2.531 . . . . 0.0 112.015 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -57.48 158.48 5.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.036 0.934 . . . . 0.0 112.253 172.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 58.1 mtt -113.28 22.01 14.68 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.48 -40.67 97.72 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.153 -0.967 . . . . 0.0 112.69 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.26 120.55 4.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 112.432 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.78 78.27 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.001 -1.062 . . . . 0.0 114.744 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 54.71 13.29 0.68 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.627 2.371 . . . . 0.0 117.165 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -160.4 140.61 11.47 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.547 1.939 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.3 110.33 12.28 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.29 119.93 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.943 0.897 . . . . 0.0 110.425 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -129.31 141.78 51.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.438 1.895 . . . . 0.0 109.601 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.36 135.29 30.33 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.2 p -102.18 137.67 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.325 1.05 . . . . 0.0 112.057 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -143.66 141.11 30.41 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.873 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 t -130.37 21.89 5.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.242 1.017 . . . . 0.0 112.905 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -149.45 97.99 2.72 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.645 1.178 . . . . 0.0 109.919 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -126.32 10.51 7.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.39 1.476 . . . . 0.0 112.412 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.25 152.86 51.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.665 1.986 . . . . 0.0 110.695 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.846 1.259 . . . . 0.0 109.817 173.759 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 O4'-C1'-N19 111.773 3.573 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.464 0 O4'-C1'-N19 111.863 3.663 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O4'-C1'-N19 111.853 3.653 . 0.072 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.089 1 O4'-C1'-N19 113.954 5.754 . 0.084 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.532 0.415 0 N-CA-C 113.559 0.561 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.44 118.56 20.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.765 2.026 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -136.42 108.06 7.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.468 1.107 . . . . 0.0 110.118 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -84.98 149.26 25.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.369 0.604 . . . . 0.0 110.855 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.57 120.22 29.05 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.475 1.51 . . . . 0.0 108.117 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -99.18 136.26 39.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.537 1.535 . . . . 0.0 110.744 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -93.13 107.14 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 109.799 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.17 0.83 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.332 1.444 . . . . 0.0 113.947 173.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.65 148.86 39.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.321 1.848 . . . . 0.0 111.207 166.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.9 tp -110.28 90.72 10.35 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.43 1.892 . . . . 0.0 109.341 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.54 -23.62 23.14 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.367 2.711 . . . . 0.0 112.615 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . 0.283 1.6 tt 55.25 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.965 3.306 . . . . 0.0 114.236 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -97.78 -2.69 40.51 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.5 17.99 13.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.572 1.149 . . . . 0.0 113.457 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.12 126.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.786 1.634 . . . . 0.0 113.538 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 t -155.5 142.65 19.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 112.438 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.1 -32.13 71.81 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.754 -0.591 . . . . 0.0 111.019 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.06 -24.57 67.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.557 1.143 . . . . 0.0 112.828 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.09 -41.35 50.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.357 0.98 . . . . 0.0 111.739 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.95 -39.58 87.32 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 110.983 172.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -63.95 -43.79 94.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.172 0.989 . . . . 0.0 112.03 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.714 -1.241 . . . . 0.0 111.397 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.6 mt -58.71 -71.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.402 1.081 . . . . 0.0 109.483 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -124.63 114.56 19.52 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.748 1.158 . . . . 0.0 110.838 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.566 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 33.1 t -155.94 -43.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.566 ' HD2' ' H ' ' A' ' 25' ' ' SER . 89.9 Cg_endo -83.04 11.38 3.29 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.435 2.09 . . . . 0.0 115.521 -173.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -80.07 16.91 1.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.16 -14.63 32.37 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.555 1.074 . . . . 0.0 115.6 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -135.97 141.1 44.39 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.404 1.882 . . . . 0.0 108.64 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 tp -153.37 161.48 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.449 0.699 . . . . 0.0 111.061 -162.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -151.9 -65.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.497 152.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -152.95 153.31 32.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.393 0.997 . . . . 0.0 113.434 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.53 140.2 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.26 1.424 . . . . 0.0 108.891 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -129.84 65.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.735 1.255 . . . . 0.0 110.679 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.35 138.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.821 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -125.82 155.42 41.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.517 1.527 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.83 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -165.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.91 -42.75 0.31 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.943 1.297 . . . . 0.0 112.767 167.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -148.91 146.77 28.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.84 1.256 . . . . 0.0 110.254 171.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.86 164.46 17.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -170.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -130.0 163.65 26.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.496 1.518 . . . . 0.0 110.543 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.96 155.12 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 109.238 166.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -140.93 92.24 2.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.544 1.538 . . . . 0.0 108.28 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -112.33 165.83 11.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.23 1.412 . . . . 0.0 112.815 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.16 163.67 18.6 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.291 1.036 . . . . 0.0 111.062 164.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.41 91.28 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.851 2.46 . . . . 0.0 114.076 -172.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.56 -24.21 75.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.85 1.7 . . . . 0.0 113.969 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -67.28 -35.66 79.94 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.935 0.789 . . . . 0.0 111.587 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.9 m -71.17 -35.73 71.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.336 0.654 . . . . 0.0 112.273 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.34 -41.25 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.889 -0.507 . . . . 0.0 110.424 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -69.53 -36.53 76.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.116 -0.99 . . . . 0.0 112.879 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.33 -35.99 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.212 0.915 . . . . 0.0 111.692 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.02 66.68 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.615 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.14 -52.31 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.475 1.489 . . . . 0.0 110.279 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.14 1.78 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 46.2 t -107.62 -52.69 2.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.23 1.812 . . . . 0.0 112.855 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -88.83 -40.78 12.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.775 1.23 . . . . 0.0 112.501 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -71.09 -3.32 19.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.091 -1.006 . . . . 0.0 112.448 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -130.79 27.06 4.96 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.212 2.605 . . . . 0.0 111.589 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.5 157.0 24.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.43 -1.419 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 75.4 mtm -73.91 61.94 0.82 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.963 1.705 . . . . 0.0 113.185 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -135.21 136.97 42.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.749 1.62 . . . . 0.0 110.065 171.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -77.32 140.93 40.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.876 0.846 . . . . 0.0 111.613 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.47 170.04 17.82 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.126 0.87 . . . . 0.0 113.103 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -132.04 15.22 4.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.518 1.927 . . . . 0.0 113.962 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -120.2 6.23 10.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.694 1.998 . . . . 0.0 115.532 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.9 tp -118.4 104.64 10.91 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.47 1.508 . . . . 0.0 109.366 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.433 1.093 . . . . 0.0 109.609 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 mt -119.98 134.87 55.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.334 1.454 . . . . 0.0 108.001 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.75 128.31 45.12 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.92 142.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.514 1.126 . . . . 0.0 110.598 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 t -141.6 121.05 13.21 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.395 1.078 . . . . 0.0 110.105 171.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.8 p -119.54 144.61 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.781 1.232 . . . . 0.0 111.297 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.7 m 53.49 32.5 14.2 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -97.13 154.75 17.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.765 1.226 . . . . 0.0 110.642 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.94 33.4 14.49 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.868 1.667 . . . . 0.0 113.238 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 . . . . . 0 C--O 1.257 1.485 0 C-N-CA 126.982 2.113 . . . . 0.0 112.215 -177.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.008 1 O4'-C1'-N19 115.135 6.935 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.383 1 O4'-C1'-N19 112.607 4.407 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.521 1 O4'-C1'-N19 112.919 4.719 . 0.315 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.228 1 O4'-C1'-N19 112.589 4.389 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 CA--C 1.547 1.134 0 CA-C-O 121.064 0.36 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.8 123.29 20.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.602 1.161 . . . . 0.0 110.475 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -137.82 114.38 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.855 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -93.0 141.57 28.25 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.703 -0.623 . . . . 0.0 112.529 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.76 133.44 53.98 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.867 2.067 . . . . 0.0 108.36 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -117.57 138.56 51.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.758 2.023 . . . . 0.0 110.773 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -103.13 144.28 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.26 -162.51 1.67 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 122.022 0.79 . . . . 0.0 114.422 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -82.39 19.38 1.25 Allowed 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.601 -1.529 . . . . 0.0 114.675 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.59 -36.83 10.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.619 173.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -72.54 18.08 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.322 3.348 . . . . 0.0 116.696 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.4 mt -71.96 19.61 0.07 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.012 1.325 . . . . 0.0 113.249 170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -126.24 -178.7 4.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 110.409 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -52.16 122.33 8.39 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.311 0.505 . . . . 0.0 111.692 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.11 146.01 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.817 0.818 . . . . 0.0 112.526 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -133.9 168.12 19.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.866 1.667 . . . . 0.0 111.298 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -57.8 -32.51 67.62 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.084 -1.01 . . . . 0.0 111.452 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -64.01 -25.15 67.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.56 -48.19 56.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.624 1.102 . . . . 0.0 110.21 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.27 -38.34 86.39 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.153 -0.967 . . . . 0.0 111.496 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.22 -40.31 93.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.891 1.677 . . . . 0.0 112.16 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -28.4 60.48 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.539 -1.351 . . . . 0.0 113.176 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 ' CE1' ' A' ' 24' ' ' PHE . 20.3 mt -76.0 -45.31 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE1' HG22 ' A' ' 23' ' ' ILE . 77.1 m-85 -137.68 102.26 4.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.178 1.791 . . . . 0.0 111.644 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.562 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.0 t -164.56 -48.56 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.819 1.648 . . . . 0.0 111.923 166.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 25' ' ' SER . 83.8 Cg_endo -78.19 20.23 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.984 2.456 . . . . 0.0 115.679 -169.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.23 15.37 22.96 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.421 1.488 . . . . 0.0 114.217 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.2 5.46 62.52 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.523 1.535 . . . . 0.0 116.422 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -143.57 126.32 16.1 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.981 1.712 . . . . 0.0 109.005 -171.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -151.36 160.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -156.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 40.0 mtm -158.01 -84.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.184 2.194 . . . . 0.0 108.122 152.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -135.05 155.94 49.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.684 1.594 . . . . 0.0 114.073 -168.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -109.64 136.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.699 1.6 . . . . 0.0 110.469 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.58 72.09 1.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.524 1.13 . . . . 0.0 111.114 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.4 134.29 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.615 -1.303 . . . . 0.0 110.099 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -134.93 143.1 46.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.736 1.615 . . . . 0.0 109.011 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.1 46.42 0.4 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.41 -41.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.308 1.443 . . . . 0.0 112.283 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.51 151.2 37.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.208 1.403 . . . . 0.0 109.588 168.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 147.28 18.7 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.392 0.52 . . . . 0.0 113.481 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -125.82 155.34 41.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.825 1.298 . . . . 0.0 111.596 164.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.21 155.41 32.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 107.578 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.22 109.37 7.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 167.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -115.08 161.01 18.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.261 1.824 . . . . 0.0 111.125 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.57 146.37 25.17 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.247 -0.908 . . . . 0.0 110.691 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.74 107.58 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 127.722 2.409 . . . . 0.0 114.969 -171.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.87 -19.0 21.28 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.752 1.635 . . . . 0.0 113.329 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.57 -41.39 98.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.31 1.413 . . . . 0.0 113.103 -172.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -82.45 -18.02 43.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.17 -41.68 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.163 0.892 . . . . 0.0 109.705 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -62.83 -44.31 96.48 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.089 -1.007 . . . . 0.0 111.689 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.81 -41.68 91.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.631 0.65 . . . . 0.0 112.03 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.66 90.35 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.42 -0.8 . . . . 0.0 112.575 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.08 -52.67 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.708 1.14 . . . . 0.0 110.716 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.31 -17.74 56.18 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.6 t -73.53 -49.11 28.18 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.239 1.816 . . . . 0.0 111.976 166.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -101.28 -28.51 12.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -162.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -71.49 -18.32 62.3 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.594 1.088 . . . . 0.0 113.373 173.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -122.84 144.09 49.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 110.33 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -148.22 89.25 1.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.807 1.243 . . . . 0.0 111.0 -172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 58.69 12.39 2.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.045 1.738 . . . . 0.0 115.219 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -142.03 163.97 31.45 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.693 1.997 . . . . 0.0 109.747 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -74.68 157.9 34.52 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.075 -1.016 . . . . 0.0 112.618 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.14 -159.83 53.95 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.741 1.162 . . . . 0.0 113.725 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -124.05 129.19 50.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.292 1.437 . . . . 0.0 113.322 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -78.92 -16.23 57.26 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.58 1.552 . . . . 0.0 114.15 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -156.65 162.45 39.84 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.488 1.915 . . . . 0.0 110.506 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mm -87.13 123.34 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.252 1.021 . . . . 0.0 111.068 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.17 133.94 44.81 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.052 2.141 . . . . 0.0 107.94 165.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -144.12 131.88 21.33 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.503 1.047 . . . . 0.0 113.775 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.57 141.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.168 0.587 . . . . 0.0 112.038 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.7 m -133.53 127.14 32.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.83 2.052 . . . . 0.0 108.535 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -147.19 156.95 43.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 3.04 2.82 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 112.972 167.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -114.92 5.4 15.07 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.897 . . . . 0.0 113.214 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.89 154.78 38.32 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.113 -0.992 . . . . 0.0 112.751 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.498 1.919 . . . . 0.0 112.881 175.93 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.362 1 O4'-C1'-N19 113.397 5.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.579 -2.354 0 O4'-C1'-N19 111.998 3.798 . 0.034 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.334 1 C3'-C2'-C1' 105.383 4.315 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0a' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 O4'-C1'-N19 110.265 2.065 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.476 0.472 0 CA-C-O 119.706 -0.206 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -114.12 111.84 22.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.45 1.1 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -126.42 100.22 6.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.98 0.912 . . . . 0.0 111.162 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.22 153.88 24.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.53 0.681 . . . . 0.0 111.445 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.07 126.12 29.47 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.765 1.626 . . . . 0.0 108.918 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -103.46 137.98 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.788 1.235 . . . . 0.0 111.633 171.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.78 98.55 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.182 0.993 . . . . 0.0 108.97 168.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.52 176.19 50.69 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.736 0.684 . . . . 0.0 111.571 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.91 40.15 24.37 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.312 -1.111 . . . . 0.0 111.724 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.81 123.47 89.6 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.916 1.287 . . . . 0.0 110.566 -162.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.15 107.3 1.67 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.645 2.897 . . . . 0.0 110.009 168.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.15 7.79 1.97 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.478 -1.389 . . . . 0.0 112.771 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -114.78 128.16 56.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.479 2.311 . . . . 0.0 110.876 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 47.56 35.07 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.98 132.76 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 120.767 -1.208 . . . . 0.0 109.537 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.0 p -133.07 163.23 29.72 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 111.461 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -61.15 -24.63 66.43 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.189 -0.944 . . . . 0.0 112.801 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.33 -31.7 70.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.907 0.883 . . . . 0.0 112.1 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.02 -47.08 84.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.95 0.796 . . . . 0.0 110.42 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.76 -40.66 93.33 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.518 -0.739 . . . . 0.0 111.122 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -68.96 -41.41 78.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.336 1.054 . . . . 0.0 113.327 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -22.36 60.25 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 120.665 -1.272 . . . . 0.0 113.275 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.487 HG22 ' CE1' ' A' ' 24' ' ' PHE . 42.8 mt -83.55 -41.15 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.347 0.659 . . . . 0.0 109.696 170.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CE1' HG22 ' A' ' 23' ' ' ILE . 96.2 m-85 -135.7 91.58 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.534 1.534 . . . . 0.0 111.888 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 26.3 t -157.88 -49.75 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 165.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.3 Cg_endo -78.35 27.67 0.49 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.205 2.603 . . . . 0.0 114.033 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.77 14.87 25.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.718 1.607 . . . . 0.0 113.381 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.18 -101.31 2.71 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.439 1.019 . . . . 0.0 113.479 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -64.1 135.27 56.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.784 0.834 . . . . 0.0 112.747 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 tp -140.5 163.87 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.314 1.046 . . . . 0.0 112.0 -161.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.0 mtm -152.22 -76.9 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.485 1.114 . . . . 0.0 109.79 152.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -142.73 156.61 45.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.738 1.215 . . . . 0.0 113.807 -166.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mt -119.2 137.15 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.962 2.105 . . . . 0.0 109.642 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.96 84.04 2.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.946 1.299 . . . . 0.0 110.075 -175.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -88.33 135.25 26.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 165.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -132.89 147.75 52.29 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.862 2.065 . . . . 0.0 108.432 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -62.48 -9.42 8.49 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.3 -24.43 11.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -152.94 145.41 24.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.335 1.425 . . . . 0.0 114.035 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.46 131.15 10.47 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.862 1.22 . . . . 0.0 113.035 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -137.33 156.07 48.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.632 1.573 . . . . 0.0 111.95 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.82 154.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.535 1.534 . . . . 0.0 109.256 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -136.01 113.37 10.7 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -117.2 158.37 24.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.117 1.767 . . . . 0.0 112.339 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.05 151.56 31.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 109.87 164.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 48.0 t-20 48.8 101.67 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 128.103 2.561 . . . . 0.0 114.439 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 46' ' ' ASN . 34.9 Cg_endo -55.96 -11.84 6.18 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.34 2.694 . . . . 0.0 115.357 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -61.62 -36.0 79.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.599 1.09 . . . . 0.0 113.701 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.6 p -69.49 -39.95 77.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 111.335 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.61 -45.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.385 1.074 . . . . 0.0 110.483 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -63.92 -40.83 97.39 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 111.829 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.71 -35.32 80.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -40.29 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.439 1.096 . . . . 0.0 112.239 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -58.86 -48.65 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 120.207 1.367 . . . . 0.0 110.707 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.67 -15.03 63.1 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.0 t -89.0 -55.37 3.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.429 1.092 . . . . 0.0 111.5 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -87.43 -36.85 17.49 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.124 1.77 . . . . 0.0 113.804 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -67.42 -22.57 65.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.274 1.397 . . . . 0.0 111.879 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.47 140.21 58.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.413 1.085 . . . . 0.0 112.032 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 13.3 tp10 -145.43 152.28 39.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.943 1.297 . . . . 0.0 111.135 174.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.65 25.98 5.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.209 1.003 . . . . 0.0 111.903 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 60.2 t-20 -129.48 147.65 51.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.63 3.172 . . . . 0.0 108.542 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -79.61 26.32 0.31 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.123 -0.986 . . . . 0.0 113.232 173.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.4 176.71 44.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.885 2.183 . . . . 0.0 111.934 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt 50.12 30.18 4.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.423 1.889 . . . . 0.0 114.149 -174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -85.76 162.4 18.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.169 1.388 . . . . 0.0 112.083 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.71 174.04 11.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.419 1.488 . . . . 0.0 111.376 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mm -133.93 127.55 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.541 1.136 . . . . 0.0 109.169 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.9 mt -125.03 129.33 50.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.306 0.642 . . . . 0.0 110.991 -171.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -133.06 127.09 33.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.9 144.87 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.704 1.202 . . . . 0.0 110.957 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.493 ' HB2' ' H42' ' B' ' 79' ' ' ' C' . 41.3 t -143.03 150.57 39.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.208 1.403 . . . . 0.0 109.293 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 p -138.27 155.35 48.7 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 94.8 p -118.95 153.94 33.81 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 110.367 167.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.02 28.87 2.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.404 1.082 . . . . 0.0 111.58 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.92 10.5 1.34 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.976 1.71 . . . . 0.0 113.591 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 127.686 2.394 . . . . 0.0 109.27 -176.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 1 O4'-C1'-N19 112.345 4.145 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . 0.493 ' H42' ' HB2' ' A' ' 72' ' ' SER . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 O4'-C4'-C3' 108.786 2.347 . 0.023 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.049 0 O4'-C1'-N19 111.62 3.42 . 0.07 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 O4'-C1'-N19 110.879 2.679 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 CA-C-O 119.623 -0.24 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.79 120.63 22.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 112.321 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -129.4 159.02 37.54 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.856 1.262 . . . . 0.0 111.533 173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.37 149.34 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.654 1.582 . . . . 0.0 110.247 168.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.64 117.76 19.12 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.691 1.596 . . . . 0.0 107.979 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -97.76 132.5 43.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.677 1.591 . . . . 0.0 110.511 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.36 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.848 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.03 -178.47 0.34 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 123.99 0.805 . . . . 0.0 113.697 166.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -76.75 26.61 0.14 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 120.124 -1.81 . . . . 0.0 113.739 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.19 66.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.468 1.507 . . . . 0.0 112.113 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -63.36 6.32 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.332 3.355 . . . . 0.0 117.604 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.15 -9.05 14.41 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -117.14 -27.02 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.518 1.527 . . . . 0.0 114.241 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.6 127.66 14.63 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.789 1.635 . . . . 0.0 110.259 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.59 89.17 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.201 1.4 . . . . 0.0 111.908 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -139.87 148.74 42.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.486 1.114 . . . . 0.0 109.301 163.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -60.01 -21.01 60.77 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.537 1.062 . . . . 0.0 112.714 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -55.49 -24.33 30.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.72 1.208 . . . . 0.0 113.6 169.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.47 -53.53 7.98 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.043 0.937 . . . . 0.0 111.603 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.16 -36.63 70.98 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.393 -1.442 . . . . 0.0 111.133 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -70.1 -22.84 62.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.438 1.495 . . . . 0.0 114.108 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.13 58.3 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.448 -1.407 . . . . 0.0 111.674 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 24' ' ' PHE . 55.3 mt -80.51 -45.1 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.855 0.862 . . . . 0.0 109.662 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 23' ' ' ILE . 39.5 m-85 -136.89 118.16 14.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.437 1.495 . . . . 0.0 111.251 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.6 p -154.54 -37.93 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.823 -1.561 . . . . 0.0 114.987 162.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 25' ' ' SER . 82.9 Cg_endo -76.46 -2.28 12.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.155 2.162 . . . . 0.0 113.329 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -93.16 141.55 28.29 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.328 1.051 . . . . 0.0 112.43 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.77 -164.1 43.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 124.643 1.115 . . . . 0.0 114.743 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -87.67 -12.83 44.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.231 1.012 . . . . 0.0 112.776 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 66.57 157.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.188 2.195 . . . . 0.0 113.965 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 38.0 tpp -156.7 -79.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.293 -0.879 . . . . 0.0 111.534 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -138.7 153.27 48.51 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.049 1.295 . . . . 0.0 113.946 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.85 130.73 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.751 1.62 . . . . 0.0 110.625 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -145.32 127.86 16.05 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.819 0.819 . . . . 0.0 113.043 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.33 144.45 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.718 -1.239 . . . . 0.0 112.028 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -128.88 156.07 44.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.356 1.462 . . . . 0.0 110.406 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -72.32 7.44 1.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.23 -35.38 2.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.134 1.333 . . . . 0.0 113.219 163.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -154.22 148.73 26.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.512 1.525 . . . . 0.0 110.448 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.96 165.26 12.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.342 -0.849 . . . . 0.0 114.202 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.33 133.52 51.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.901 1.81 . . . . 0.0 112.683 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 mt -104.88 139.65 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.546 1.538 . . . . 0.0 107.152 167.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -134.61 84.77 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -115.17 153.42 30.85 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.562 1.145 . . . . 0.0 112.489 -169.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.67 151.91 24.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.424 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 65.6 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 128.771 2.828 . . . . 0.0 114.699 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.39 -23.77 58.11 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.242 2.628 . . . . 0.0 114.479 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -64.86 -40.72 95.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 111.182 -175.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 m -73.83 -31.06 63.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.038 0.935 . . . . 0.0 112.631 174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.01 -44.25 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.686 -0.634 . . . . 0.0 109.92 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -65.22 -41.47 94.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.781 0.833 . . . . 0.0 112.152 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -59.51 -38.95 82.3 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.773 0.829 . . . . 0.0 112.198 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.94 58.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.076 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 mt -57.44 -51.52 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 121.007 1.73 . . . . 0.0 109.674 165.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.94 2.54 8.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -105.84 -26.86 11.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.574 1.55 . . . . 0.0 113.526 171.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -127.05 -26.76 3.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.467 1.107 . . . . 0.0 113.309 -166.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -76.57 40.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.185 1.794 . . . . 0.0 112.276 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -142.65 140.73 31.71 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.015 2.526 . . . . 0.0 108.566 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.5 158.67 43.8 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.938 1.295 . . . . 0.0 109.184 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.1 151.8 34.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.59 0.756 . . . . 0.0 111.435 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -79.15 37.17 0.31 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.836 -1.165 . . . . 0.0 112.976 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -87.23 10.28 17.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.058 2.143 . . . . 0.0 112.567 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.89 116.97 1.06 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.657 -1.277 . . . . 0.0 110.544 -164.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.95 153.13 30.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.037 1.335 . . . . 0.0 111.773 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -153.03 13.39 0.51 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.73 133.91 56.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.613 0.765 . . . . 0.0 109.158 168.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 tp -142.23 144.49 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.662 1.185 . . . . 0.0 109.769 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -127.0 131.03 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.969 1.708 . . . . 0.0 107.985 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -128.07 122.13 31.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -92.13 141.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.945 0.898 . . . . 0.0 111.225 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.0 t -136.78 150.46 48.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 108.392 166.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -135.78 144.09 45.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.567 0.747 . . . . 0.0 110.254 -173.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -74.95 154.9 37.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.861 0.464 . . . . 0.0 111.668 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -58.02 126.68 28.49 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.311 0.577 . . . . 0.0 109.598 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.64 157.75 39.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.131 1.373 . . . . 0.0 111.436 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 110.96 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 O4'-C1'-N19 111.959 3.759 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.092 0 O4'-C1'-N19 111.656 3.456 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 O4'-C1'-N19 111.199 2.999 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 O4'-C1'-N19 111.232 3.032 . 0.24 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.664 0 CA-C-O 119.385 -0.339 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HE3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -83.16 137.89 33.87 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.004 1.322 . . . . 0.0 112.879 -173.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 t -133.0 162.96 30.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 110.922 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -132.4 161.52 33.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.634 0.73 . . . . 0.0 112.15 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -143.74 130.29 20.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.026 1.73 . . . . 0.0 108.872 -166.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -110.99 141.76 44.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.921 1.688 . . . . 0.0 112.013 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -94.7 100.55 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.093 0.957 . . . . 0.0 111.156 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.96 4.37 53.96 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.047 1.784 . . . . 0.0 115.728 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -82.23 30.15 0.41 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.323 1.449 . . . . 0.0 114.031 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.9 tp 50.71 63.77 9.34 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.71 2.004 . . . . 0.0 114.024 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.89 26.48 0.36 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.365 2.71 . . . . 0.0 115.427 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -78.89 51.2 1.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 109.879 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -147.59 147.07 29.67 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 128.399 2.68 . . . . 0.0 108.544 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -53.75 115.79 2.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.192 0.997 . . . . 0.0 111.573 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.47 148.09 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.308 1.043 . . . . 0.0 111.29 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -118.61 158.97 24.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.0 1.72 . . . . 0.0 111.989 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -52.35 -30.25 27.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.695 1.598 . . . . 0.0 113.819 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.41 -29.61 69.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.002 0.921 . . . . 0.0 113.274 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.89 -43.46 98.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.205 0.911 . . . . 0.0 111.121 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.52 -36.38 63.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.377 1.071 . . . . 0.0 111.612 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.12 -35.53 80.74 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.33 0.652 . . . . 0.0 112.559 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -18.84 59.13 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -72.06 -80.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' CE1' ' HB1' ' A' ' 53' ' ' ALA . 11.2 m-30 -116.34 117.49 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.151 0.977 . . . . 0.0 110.747 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 76.8 p -148.2 -27.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.734 1.613 . . . . 0.0 113.772 158.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 25' ' ' SER . 10.2 Cg_endo -96.46 19.84 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 CA-C-N 122.899 2.071 . . . . 0.0 114.111 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -120.77 143.9 48.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.628 1.571 . . . . 0.0 111.929 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 -152.61 40.85 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.78 -0.575 . . . . 0.0 114.352 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -88.6 -25.77 22.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.024 -0.988 . . . . 0.0 113.257 -171.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mm 64.78 153.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.154 1.782 . . . . 0.0 112.206 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.0 tpp -154.91 -57.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.439 -1.413 . . . . 0.0 113.758 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -156.34 155.69 32.65 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.523 1.129 . . . . 0.0 113.911 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.91 151.89 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.173 1.389 . . . . 0.0 112.281 168.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.25 98.34 3.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.444 1.498 . . . . 0.0 110.525 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tt -106.41 138.84 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HE2' " H1'" ' B' ' 80' ' ' ' U' . 31.5 mtmt -130.64 153.55 48.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.013 1.325 . . . . 0.0 110.371 169.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -76.78 49.41 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.992 1.317 . . . . 0.0 112.387 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.26 -51.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.744 2.418 . . . . 0.0 110.333 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -149.69 144.39 26.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.521 1.528 . . . . 0.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.14 140.83 15.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.119 0.866 . . . . 0.0 112.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.58 148.69 50.5 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.73 1.253 . . . . 0.0 112.43 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -129.88 138.35 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.745 1.618 . . . . 0.0 107.775 176.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.05 97.68 5.35 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.449 1.1 . . . . 0.0 108.415 175.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -118.53 152.81 35.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.031 0.932 . . . . 0.0 111.655 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.28 162.47 21.14 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.654 167.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 69.88 74.42 0.27 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 127.968 2.507 . . . . 0.0 113.357 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.0 -36.89 97.74 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.659 2.906 . . . . 0.0 114.709 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -62.86 -34.43 77.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.158 1.344 . . . . 0.0 111.817 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.5 m -77.45 -33.88 54.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.72 -42.92 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.178 0.899 . . . . 0.0 109.987 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.01 -39.98 87.18 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.301 1.04 . . . . 0.0 112.711 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.1 -32.23 73.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.994 0.816 . . . . 0.0 112.596 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -73.61 -31.49 63.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.294 0.638 . . . . 0.0 112.05 172.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.67 -54.86 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.956 1.253 . . . . 0.0 110.514 171.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.44 -20.41 63.08 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.601 1.092 . . . . 0.0 112.811 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 t -90.98 -24.44 20.11 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.843 1.257 . . . . 0.0 114.321 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -126.49 -19.18 4.67 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.501 -1.374 . . . . 0.0 113.651 -172.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -86.96 21.3 2.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.382 1.873 . . . . 0.0 112.804 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.11 119.29 9.47 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.083 1.353 . . . . 0.0 109.694 -170.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 21.0 tt0 -148.28 141.7 25.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.567 0.747 . . . . 0.0 111.437 169.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -87.02 -5.43 59.08 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 33.9 m120 -115.36 155.74 26.8 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.786 1.634 . . . . 0.0 110.699 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -78.38 51.2 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.374 0.669 . . . . 0.0 112.327 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.78 -149.59 6.41 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.195 0.902 . . . . 0.0 113.381 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -77.8 41.09 0.33 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.044 1.337 . . . . 0.0 109.757 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -68.82 147.83 51.17 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.114 1.366 . . . . 0.0 111.295 -169.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -127.06 158.53 36.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.695 0.759 . . . . 0.0 112.486 -162.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.1 mt -119.46 126.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 167.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.48 150.89 51.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.785 1.634 . . . . 0.0 109.776 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.13 137.82 31.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.696 -0.627 . . . . 0.0 111.592 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -93.63 145.47 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.042 0.937 . . . . 0.0 111.044 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.4 t -135.67 146.95 48.34 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.587 1.155 . . . . 0.0 110.757 168.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -63.24 156.5 25.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.975 0.91 . . . . 0.0 111.901 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.0 t -125.44 65.76 1.16 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.365 1.079 . . . . 0.0 109.345 164.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.66 137.87 31.93 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.833 -172.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.96 122.06 21.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.143 0.577 . . . . 0.0 110.244 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.17 -176.058 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.671 0 O4'-C1'-N19 111.865 3.665 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 0 O4'-C1'-N19 111.129 2.929 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . 0.463 " H1'" ' HE2' ' A' ' 36' ' ' LYS . . . . . . . . 0 P--O3' 1.572 -2.931 0 O4'-C1'-N19 111.373 3.173 . 0.474 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 N19-C1'-C2' 118.115 2.947 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.535 0.535 0 N-CA-C 112.21 0.042 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 133.47 33.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.207 1.003 . . . . 0.0 112.571 176.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -151.52 155.01 37.62 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.438 0.695 . . . . 0.0 110.833 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -120.59 149.84 41.83 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.304 1.442 . . . . 0.0 111.004 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -120.03 128.17 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.42 1.888 . . . . 0.0 108.459 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -115.49 141.67 47.75 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.754 1.622 . . . . 0.0 111.169 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.69 114.93 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.576 1.15 . . . . 0.0 109.798 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.92 -4.98 86.69 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.716 1.627 . . . . 0.0 114.462 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -77.52 31.88 0.16 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.749 1.275 . . . . 0.0 113.466 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt 44.8 76.26 0.56 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.716 2.006 . . . . 0.0 114.188 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.85 26.8 0.18 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.008 3.139 . . . . 0.0 115.419 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -76.2 16.25 0.47 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.133 2.573 . . . . 0.0 112.683 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -127.81 157.62 39.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 129.11 2.964 . . . . 0.0 110.983 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -43.74 120.98 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.045 1.738 . . . . 0.0 112.338 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.96 159.84 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.085 0.954 . . . . 0.0 111.594 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -133.59 161.61 34.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.845 1.658 . . . . 0.0 111.747 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -52.58 -33.86 47.99 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.329 -0.857 . . . . 0.0 111.728 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.62 -21.01 65.41 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.12 -38.04 63.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.911 1.232 . . . . 0.0 112.302 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.96 -37.91 64.37 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.061 -1.024 . . . . 0.0 110.534 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -64.84 -43.85 91.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -29.88 69.75 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.291 0.95 . . . . 0.0 112.145 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.06 -78.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 167.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.16 120.64 35.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.462 1.483 . . . . 0.0 111.752 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 13.3 p -158.1 -33.35 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.219 167.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 25' ' ' SER . 31.5 Cg_endo -91.62 43.1 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.686 2.257 . . . . 0.0 111.201 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -133.33 153.8 51.27 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.215 1.806 . . . . 0.0 110.386 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.18 -157.89 35.38 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 163.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -103.02 -4.76 24.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 65.49 170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.141 1.776 . . . . 0.0 113.941 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.5 mtm -157.65 -75.7 0.09 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.931 -1.106 . . . . 0.0 109.517 163.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -145.42 155.3 43.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.654 1.182 . . . . 0.0 113.995 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 tt -115.6 134.05 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.044 1.738 . . . . 0.0 108.788 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.02 121.44 9.66 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.211 1.005 . . . . 0.0 111.622 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.6 147.07 31.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.879 0.871 . . . . 0.0 111.4 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.64 154.79 43.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.825 1.25 . . . . 0.0 110.211 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -68.8 44.36 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.058 1.743 . . . . 0.0 113.058 171.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.01 -40.71 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.345 2.258 . . . . 0.0 111.993 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -144.97 143.38 30.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.904 1.282 . . . . 0.0 109.923 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.11 136.61 11.73 Favored Glycine 0 N--CA 1.463 0.488 0 C-N-CA 123.884 0.755 . . . . 0.0 112.515 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -139.37 159.58 41.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 123.221 1.486 . . . . 0.0 112.42 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -136.28 148.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.29 1.836 . . . . 0.0 107.523 171.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -134.3 104.84 6.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -124.88 155.27 39.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.493 1.517 . . . . 0.0 112.714 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -90.0 153.5 20.53 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.02 1.328 . . . . 0.0 111.037 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 66.32 79.87 0.23 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.903 2.881 . . . . 0.0 113.705 -159.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -53.11 -33.24 62.9 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.074 3.183 . . . . 0.0 114.635 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -70.58 -35.85 73.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.066 0.848 . . . . 0.0 111.8 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -65.9 -31.75 72.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.88 -38.11 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.697 0.799 . . . . 0.0 110.223 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.39 -42.24 98.79 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.421 -0.799 . . . . 0.0 112.105 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.46 -38.15 90.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.87 0.759 . . . . 0.0 112.239 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.18 77.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.974 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.19 -53.34 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.817 1.19 . . . . 0.0 110.399 171.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.06 -29.7 70.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.306 0.957 . . . . 0.0 112.664 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -77.15 -38.12 52.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -94.87 -26.97 15.96 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 t -72.53 -20.78 61.28 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.152 0.981 . . . . 0.0 112.496 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -51.69 125.44 14.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.963 1.705 . . . . 0.0 111.097 170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.29 134.8 38.44 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.386 -0.821 . . . . 0.0 110.661 168.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.5 mtm -130.0 172.77 11.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 109.662 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -72.29 8.79 1.2 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -123.63 24.67 8.44 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.834 1.654 . . . . 0.0 113.154 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.46 -150.68 13.86 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.957 -1.089 . . . . 0.0 113.364 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.98 -179.02 4.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.669 1.988 . . . . 0.0 111.993 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -66.19 133.69 51.17 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.82 -0.55 . . . . 0.0 110.235 165.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.2 mt -91.32 142.62 27.5 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.755 166.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.71 115.5 48.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.686 1.595 . . . . 0.0 106.964 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 mt -138.64 139.1 38.39 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.757 1.223 . . . . 0.0 108.922 -165.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -133.74 125.89 29.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.88 139.81 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.096 0.959 . . . . 0.0 111.149 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -143.82 144.57 31.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.744 1.618 . . . . 0.0 110.663 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -114.35 124.78 52.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.014 0.926 . . . . 0.0 110.217 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 m -80.42 147.86 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.363 0.665 . . . . 0.0 112.224 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 53.21 22.07 2.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.46 1.904 . . . . 0.0 113.842 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.66 161.51 29.53 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.755 1.222 . . . . 0.0 113.316 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 127.893 2.477 . . . . 0.0 111.687 -178.677 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.985 0 O4'-C1'-N19 112.055 3.855 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 O4'-C1'-N19 110.838 2.638 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.567 -3.347 0 O4'-C1'-N19 112.035 3.835 . 0.233 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.127 1 O4'-C1'-N19 112.657 4.457 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.539 0.742 0 N-CA-C 113.77 0.642 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 98.59 5.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.079 1.752 . . . . 0.0 109.64 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -128.06 99.82 5.64 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.997 0.919 . . . . 0.0 110.338 -162.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -84.51 154.08 22.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 112.382 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.71 127.76 41.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.003 1.721 . . . . 0.0 108.79 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -104.36 138.74 40.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.376 1.471 . . . . 0.0 112.132 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -97.21 97.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.181 1.392 . . . . 0.0 110.289 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.72 -23.0 65.42 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.147 0.88 . . . . 0.0 115.018 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.96 58.17 0.47 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.212 1.805 . . . . 0.0 115.483 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp 46.37 55.7 15.91 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 127.321 2.248 . . . . 0.0 113.754 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.47 4.42 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.471 3.447 . . . . 0.0 115.112 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.03 1.14 2.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.053 2.141 . . . . 0.0 116.198 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -139.77 -28.95 0.74 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -150.39 99.24 2.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.872 1.269 . . . . 0.0 110.117 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.44 149.52 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.48 0.712 . . . . 0.0 110.621 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -146.22 164.26 32.84 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.699 1.2 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -58.36 -29.76 66.24 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.144 -0.972 . . . . 0.0 112.48 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.34 -18.91 63.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -77.68 -47.18 19.83 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.909 -1.119 . . . . 0.0 109.946 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.15 -41.57 75.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.05 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -68.63 -43.21 76.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.484 1.514 . . . . 0.0 112.905 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -34.6 77.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.182 0.901 . . . . 0.0 111.152 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.93 -70.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.004 1.322 . . . . 0.0 108.747 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -124.2 112.7 17.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 111.168 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 11.8 m -160.57 -22.15 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.364 1.866 . . . . 0.0 113.355 157.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' CD ' ' H ' ' A' ' 25' ' ' SER . 32.5 Cg_exo -73.43 16.22 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.149 2.566 . . . . 0.0 116.4 171.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -134.06 154.95 50.83 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.228 1.411 . . . . 0.0 111.129 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.45 -165.5 31.95 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.334 0.969 . . . . 0.0 115.093 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -91.12 -17.87 25.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.3 mm 64.71 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.785 1.634 . . . . 0.0 112.801 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.5 tpp -153.44 -58.13 0.13 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.3 -0.875 . . . . 0.0 112.466 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -147.8 145.02 28.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.674 1.189 . . . . 0.0 112.967 -171.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -117.68 127.52 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.185 1.794 . . . . 0.0 109.839 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -137.02 87.52 2.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.981 0.896 . . . . 0.0 111.24 -164.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.3 139.43 21.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.078 0.951 . . . . 0.0 110.944 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.31 153.41 46.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.195 2.198 . . . . 0.0 109.082 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -76.81 28.0 0.13 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.53 -41.77 0.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.807 2.043 . . . . 0.0 111.378 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -137.83 146.93 44.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.388 1.075 . . . . 0.0 112.703 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.31 133.33 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 123.976 0.798 . . . . 0.0 112.222 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -131.27 154.83 48.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.25 1.5 . . . . 0.0 112.569 171.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.031 1.732 . . . . 0.0 108.352 167.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -140.72 80.44 1.75 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.383 1.873 . . . . 0.0 108.046 -172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -111.72 165.93 11.62 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.759 -1.213 . . . . 0.0 113.828 -166.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -96.19 153.37 17.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.03 0.932 . . . . 0.0 110.419 166.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 66.95 85.61 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.902 2.881 . . . . 0.0 115.249 -166.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.45 -30.35 72.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.633 2.888 . . . . 0.0 113.331 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -53.91 -41.27 67.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.572 0.624 . . . . 0.0 110.939 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 m -87.47 -23.71 24.36 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.83 -45.86 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.759 1.163 . . . . 0.0 109.105 164.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -65.16 -42.77 93.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.949 0.9 . . . . 0.0 112.755 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.488 1.04 . . . . 0.0 112.197 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.75 -32.58 62.13 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.28 -52.71 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.343 1.429 . . . . 0.0 109.51 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.19 -10.76 60.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -89.06 -23.42 22.55 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.787 -1.196 . . . . 0.0 113.68 170.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -128.96 -37.12 1.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -165.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 t -76.63 -13.2 60.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.826 1.25 . . . . 0.0 113.251 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -73.06 171.06 13.59 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.983 0.913 . . . . 0.0 112.093 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -106.55 138.04 43.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.593 1.157 . . . . 0.0 109.001 171.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -118.41 21.32 12.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.869 1.268 . . . . 0.0 113.855 -170.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 60.39 26.57 16.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.368 2.267 . . . . 0.0 113.711 -169.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -159.77 131.89 6.38 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.371 1.068 . . . . 0.0 111.833 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.95 -174.38 46.61 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.958 1.266 . . . . 0.0 114.927 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.27 158.45 23.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.306 1.042 . . . . 0.0 111.363 168.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -99.83 169.2 9.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.111 0.964 . . . . 0.0 113.48 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.5 mt -108.85 161.14 15.41 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.523 1.529 . . . . 0.0 110.539 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.27 104.22 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -121.92 140.46 52.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.394 1.478 . . . . 0.0 110.45 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.19 140.53 37.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.45 140.81 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.136 1.374 . . . . 0.0 111.136 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.9 t -152.88 153.72 33.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.606 1.162 . . . . 0.0 111.615 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 m -114.02 9.7 17.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.987 1.315 . . . . 0.0 112.07 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -66.5 140.09 57.98 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.24 1.016 . . . . 0.0 109.872 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.39 144.05 28.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.972 -1.08 . . . . 0.0 110.986 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.29 142.84 27.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.297 1.039 . . . . 0.0 110.808 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.376 -1.297 . . . . 0.0 110.811 -179.376 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.154 1 O4'-C1'-N19 112.418 4.218 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 0 O4'-C1'-N19 111.258 3.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 111.933 3.733 . 0.381 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.172 0 O4'-C1'-N19 110.916 2.716 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 CA-C-O 120.372 0.072 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.16 50.1 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.335 -0.853 . . . . 0.0 111.739 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -158.27 150.7 22.09 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.918 2.087 . . . . 0.0 108.718 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -126.04 152.33 45.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.591 0.632 . . . . 0.0 112.25 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.68 125.36 41.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.273 1.429 . . . . 0.0 108.904 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -104.14 136.51 43.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.661 1.984 . . . . 0.0 110.262 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.28 137.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.324 1.05 . . . . 0.0 109.561 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.93 -175.1 3.61 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 122.316 0.953 . . . . 0.0 113.194 169.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -83.93 13.24 5.11 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.18 -44.32 99.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.456 1.502 . . . . 0.0 114.723 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.93 21.93 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.914 2.409 . . . . 0.0 113.186 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.59 59.31 1.49 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.532 1.533 . . . . 0.0 110.389 174.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -153.27 31.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.73 2.812 . . . . 0.0 110.795 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 m120 58.42 146.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.431 2.692 . . . . 0.0 114.055 -157.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.16 153.02 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.367 1.067 . . . . 0.0 110.652 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.0 m -135.45 166.06 24.05 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.636 1.974 . . . . 0.0 110.217 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -52.35 -32.94 40.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.194 -0.941 . . . . 0.0 111.465 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.51 -21.7 65.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.181 1.792 . . . . 0.0 115.014 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.83 -47.5 62.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.204 0.911 . . . . 0.0 109.514 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.22 -29.23 62.64 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.497 -1.377 . . . . 0.0 112.051 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -61.82 -46.65 88.58 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.002 0.921 . . . . 0.0 111.687 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.91 -39.1 90.84 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.523 -0.735 . . . . 0.0 110.321 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.73 -76.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 109.113 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -119.52 123.87 45.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.841 1.201 . . . . 0.0 111.747 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.64 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 15.4 m -157.9 -41.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 126.085 1.754 . . . . 0.0 112.846 167.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HD2' ' H ' ' A' ' 25' ' ' SER . 53.9 Cg_endo -81.01 43.44 1.55 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.65 2.233 . . . . 0.0 112.562 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.07 146.15 46.74 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.416 1.486 . . . . 0.0 110.655 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.74 -161.11 28.28 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -96.67 -2.14 45.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.185 0.994 . . . . 0.0 112.95 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp 62.22 167.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 126.803 2.041 . . . . 0.0 114.168 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.9 mtm -152.12 -71.59 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.943 -1.098 . . . . 0.0 110.508 162.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -156.53 155.8 32.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.012 0.925 . . . . 0.0 113.394 -171.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tp -101.75 135.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.737 2.015 . . . . 0.0 110.046 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -127.02 68.85 1.27 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.924 1.289 . . . . 0.0 109.931 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.07 137.67 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 26.0 mmmt -124.14 145.78 49.07 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.639 1.576 . . . . 0.0 108.643 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -70.42 -8.91 54.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -167.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.17 -59.52 1.94 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.756 1.162 . . . . 0.0 110.93 166.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.46 131.97 14.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.998 1.719 . . . . 0.0 110.17 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 36' ' ' LYS . . . -81.82 171.0 52.19 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.81 154.2 39.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.489 1.515 . . . . 0.0 110.972 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.63 151.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.87 1.668 . . . . 0.0 108.58 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.38 108.25 7.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.573 0.749 . . . . 0.0 109.164 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -127.33 158.82 36.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.497 1.519 . . . . 0.0 112.772 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -90.08 147.49 23.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.905 1.282 . . . . 0.0 110.61 170.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 66.6 86.79 0.13 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 129.585 3.154 . . . . 0.0 115.321 -162.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.45 -30.75 93.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.561 2.841 . . . . 0.0 114.851 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.62 -36.15 80.28 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.577 1.081 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -67.85 -37.64 82.12 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.8 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.684 0.793 . . . . 0.0 110.083 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.21 -31.63 72.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.252 1.021 . . . . 0.0 111.664 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.94 68.88 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.147 -0.971 . . . . 0.0 112.534 173.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.1 mt -60.51 -49.53 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.83 1.196 . . . . 0.0 110.594 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.07 -16.81 61.47 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.76 -58.88 3.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.214 1.406 . . . . 0.0 111.27 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.94 -45.09 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.543 -0.723 . . . . 0.0 111.83 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.77 15.97 0.76 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.031 1.332 . . . . 0.0 113.107 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 121.088 -1.007 . . . . 0.0 110.607 178.197 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -130.3 138.96 50.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.282 2.233 . . . . 0.0 108.889 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -141.47 130.96 23.83 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.757 0.823 . . . . 0.0 111.869 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.73 134.45 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.577 -0.702 . . . . 0.0 111.166 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.56 99.46 8.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.791 1.636 . . . . 0.0 108.526 161.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.473 0.676 0 C-N-CA 125.15 1.38 . . . . 0.0 114.06 -170.138 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.539 0.76 0 CA-C-O 120.089 -0.046 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -152.15 145.5 24.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -163.38 168.58 20.18 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.404 1.882 . . . . 0.0 110.01 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -140.63 153.16 45.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 171.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.3 121.35 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 108.435 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -100.66 133.85 44.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.386 1.074 . . . . 0.0 111.311 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.2 mm -90.48 99.43 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.755 0.822 . . . . 0.0 108.831 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.01 156.23 47.82 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.091 0.377 . . . . 0.0 112.663 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -51.03 98.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.15 1.78 . . . . 0.0 112.912 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.8 tm? -150.11 -56.64 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.486 1.514 . . . . 0.0 112.462 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 65.9 Cg_endo -72.94 -48.0 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.931 1.725 . . . . 0.0 113.348 -168.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 mp 57.02 -15.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -129.88 143.98 51.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.216 1.806 . . . . 0.0 111.721 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.61 29.13 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.368 2.267 . . . . 0.0 115.414 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -69.28 138.27 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.015 0.912 . . . . 0.0 111.241 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.9 p -143.71 156.84 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.534 1.133 . . . . 0.0 111.061 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.87 -25.84 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.086 -1.009 . . . . 0.0 111.758 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.83 -28.59 69.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.847 1.259 . . . . 0.0 114.012 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -67.61 -43.11 81.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.99 1.723 . . . . 0.0 111.476 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.01 -45.07 95.22 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.917 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -69.73 -37.92 76.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.494 1.118 . . . . 0.0 113.764 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -31.59 66.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.568 -1.332 . . . . 0.0 111.574 176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -64.14 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.468 1.107 . . . . 0.0 108.727 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -124.5 111.89 16.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.988 1.267 . . . . 0.0 110.71 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.475 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 47.7 t -155.61 -49.76 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 25' ' ' SER . 64.6 Cg_endo -84.47 8.68 4.49 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.024 2.483 . . . . 0.0 115.139 -173.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -84.7 15.05 4.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.848 1.259 . . . . 0.0 113.547 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.14 -15.16 9.13 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.148 -1.595 . . . . 0.0 115.375 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.88 133.91 34.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.319 1.559 . . . . 0.0 111.724 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.45 152.5 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.317 0.647 . . . . 0.0 112.234 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.4 mtm -162.03 -67.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.761 2.024 . . . . 0.0 109.001 151.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -148.43 155.63 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.203 1.401 . . . . 0.0 112.744 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 HG12 ' A' ' 42' ' ' ILE . 16.8 pt -130.04 145.22 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.791 1.236 . . . . 0.0 111.119 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -136.96 157.16 47.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.052 1.341 . . . . 0.0 111.466 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.22 159.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -132.87 167.46 20.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.619 2.368 . . . . 0.0 110.95 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.42 -16.48 36.28 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.43 -10.04 5.16 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -160.64 -177.76 6.41 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.017 1.727 . . . . 0.0 111.132 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.27 170.29 36.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 120.527 -1.358 . . . . 0.0 115.285 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -130.69 128.09 40.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.378 1.471 . . . . 0.0 111.869 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.434 HG12 HG22 ' A' ' 33' ' ' ILE . 1.8 mt -97.74 139.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.724 1.61 . . . . 0.0 108.544 169.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -130.56 94.09 3.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.273 1.429 . . . . 0.0 107.735 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -127.13 154.12 45.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.702 1.601 . . . . 0.0 113.941 -162.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.84 161.87 28.63 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.281 -0.887 . . . . 0.0 111.348 163.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 61.87 78.59 0.3 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.053 2.541 . . . . 0.0 115.639 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -24.28 51.5 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.089 2.526 . . . . 0.0 114.698 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -77.32 -37.09 53.28 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.092 -1.005 . . . . 0.0 112.522 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -70.41 -33.01 70.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.707 0.23 . . . . 0.0 111.091 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.9 t -65.2 -44.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 174.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -58.01 -48.19 80.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 111.419 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.49 -33.53 66.07 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.825 0.85 . . . . 0.0 112.983 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.77 -27.08 36.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -50.4 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 120.692 1.587 . . . . 0.0 110.074 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.0 -4.1 15.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.044 1.338 . . . . 0.0 113.603 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 87.8 m -108.2 -7.93 15.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.502 1.521 . . . . 0.0 113.879 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -137.23 -55.39 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.174 0.897 . . . . 0.0 112.61 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.021 -1.05 . . . . 0.0 112.465 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 CA--C 1.545 0.785 0 C-N-CA 125.811 1.644 . . . . 0.0 112.838 175.551 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.4 mt -119.95 133.96 55.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.595 0.758 . . . . 0.0 110.838 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -134.21 130.58 37.41 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.591 1.156 . . . . 0.0 110.994 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.74 143.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.913 0.885 . . . . 0.0 111.93 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 t -140.38 153.99 46.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.117 1.767 . . . . 0.0 110.849 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 125.236 1.414 . . . . 0.0 110.806 166.427 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.533 0.473 0 CA-C-O 121.084 0.368 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.28 146.01 51.83 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -160.98 147.84 15.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.601 1.56 . . . . 0.0 109.634 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -127.23 149.97 49.76 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.777 0.831 . . . . 0.0 110.734 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.57 124.99 31.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -104.26 137.23 42.47 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.755 1.622 . . . . 0.0 111.401 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -95.7 96.3 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.561 1.144 . . . . 0.0 110.281 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -8.51 74.36 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.889 1.233 . . . . 0.0 115.123 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -78.16 30.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.784 2.292 . . . . 0.0 114.179 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 33.14 66.75 1.15 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.595 2.358 . . . . 0.0 114.459 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.44 56.1 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.593 3.529 . . . . 0.0 113.964 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.93 -2.26 11.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.566 2.747 . . . . 0.0 112.985 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.33 150.14 51.7 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.607 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -12.49 96.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.61 3.164 . . . . 0.0 115.349 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 152.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.611 1.564 . . . . 0.0 111.256 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.1 p -137.7 166.72 23.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.543 1.937 . . . . 0.0 110.538 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -55.49 -25.16 35.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.316 0.646 . . . . 0.0 112.172 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -63.01 -27.29 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.303 1.441 . . . . 0.0 113.143 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.83 -48.74 23.55 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.418 -0.801 . . . . 0.0 110.938 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.76 -34.96 79.07 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.609 -1.307 . . . . 0.0 111.329 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -69.2 -35.71 76.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.986 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -37.37 78.77 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.9 1.227 . . . . 0.0 110.887 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.87 -79.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -120.79 108.27 13.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.245 0.93 . . . . 0.0 110.818 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 60.7 p -135.09 -30.46 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.821 -1.561 . . . . 0.0 114.658 160.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 25' ' ' SER . 19.2 Cg_endo -88.65 10.75 3.24 Favored 'Trans proline' 0 C--N 1.356 0.956 0 CA-C-N 122.988 2.103 . . . . 0.0 113.623 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -105.7 142.38 35.53 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.817 1.247 . . . . 0.0 111.332 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.23 -161.24 45.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.967 0.794 . . . . 0.0 114.744 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -98.94 -0.95 41.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.0 0.92 . . . . 0.0 113.387 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 63.56 158.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.744 2.017 . . . . 0.0 115.451 168.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.4 mtm -151.72 -79.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.58 1.152 . . . . 0.0 108.555 162.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -142.0 157.39 44.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -114.68 131.41 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.853 1.661 . . . . 0.0 108.954 168.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -127.1 90.18 3.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.983 1.313 . . . . 0.0 110.415 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.91 138.69 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.626 -0.671 . . . . 0.0 110.354 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -133.56 145.94 50.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.214 1.806 . . . . 0.0 108.693 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.67 25.04 0.81 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.429 1.492 . . . . 0.0 112.827 -168.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 -56.68 0.36 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.568 1.947 . . . . 0.0 110.772 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -142.78 101.16 3.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 110.152 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.34 156.43 48.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.692 0.663 . . . . 0.0 113.77 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.86 152.03 50.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.751 1.262 . . . . 0.0 112.607 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 145.51 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.113 1.765 . . . . 0.0 108.416 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -135.03 90.1 2.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.132 1.773 . . . . 0.0 107.999 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -121.34 160.17 24.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.092 1.357 . . . . 0.0 114.204 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -92.25 156.29 17.4 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.997 1.319 . . . . 0.0 110.229 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 67.63 76.79 0.26 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 129.158 2.983 . . . . 0.0 113.714 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -58.38 -33.85 98.18 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.9 3.066 . . . . 0.0 113.551 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -58.08 -45.26 87.44 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.253 0.933 . . . . 0.0 111.178 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -71.81 -28.37 63.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.53 -42.48 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.733 1.151 . . . . 0.0 110.639 170.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -67.86 -44.06 78.0 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 112.131 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.28 -33.5 69.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.065 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.94 64.06 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.263 -0.898 . . . . 0.0 113.044 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.47 -50.38 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.395 -1.441 . . . . 0.0 109.7 171.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.41 -6.05 32.8 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.4 t -85.23 -50.36 7.44 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.906 1.282 . . . . 0.0 111.982 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -109.0 -47.15 3.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.24 1.016 . . . . 0.0 113.693 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -67.63 -21.42 65.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.13 0.972 . . . . 0.0 112.025 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 126.726 2.011 . . . . 0.0 111.811 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 mt -126.44 134.91 50.85 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.583 1.153 . . . . 0.0 108.567 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.68 133.5 41.94 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.9 137.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.589 1.556 . . . . 0.0 111.325 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -143.59 168.52 19.68 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.766 2.027 . . . . 0.0 111.004 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 124.529 1.132 . . . . 0.0 109.539 178.089 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.636 0.975 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -122.21 97.97 5.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.691 2.396 . . . . 0.0 108.583 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.73 95.35 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.396 1.479 . . . . 0.0 109.332 -164.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -86.57 151.77 23.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.655 0.74 . . . . 0.0 112.241 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.3 126.43 38.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.877 1.671 . . . . 0.0 108.983 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -104.1 136.66 43.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.704 1.602 . . . . 0.0 111.424 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.62 99.01 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.784 0.834 . . . . 0.0 110.245 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.94 -7.26 86.44 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.423 -0.798 . . . . 0.0 114.702 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -77.08 50.07 0.72 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.69 1.596 . . . . 0.0 112.662 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.5 mt 38.45 66.74 2.46 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.334 2.254 . . . . 0.0 113.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.83 15.82 0.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 125.198 3.932 . . . . 0.0 115.262 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.4 32.68 0.34 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.316 1.447 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -127.53 52.0 1.87 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.821 2.048 . . . . 0.0 112.622 -164.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 44.45 55.89 5.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.468 1.507 . . . . 0.0 113.357 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.16 161.15 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.87 0.868 . . . . 0.0 111.606 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -147.06 154.61 41.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 112.377 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -62.31 -29.37 70.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -66.44 -22.08 66.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.29 -38.97 49.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.979 0.912 . . . . 0.0 110.686 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.22 -44.12 80.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.175 0.99 . . . . 0.0 111.205 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.24 -45.08 96.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.064 1.345 . . . . 0.0 111.855 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -29.21 65.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.404 -0.81 . . . . 0.0 112.262 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.36 -73.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -120.87 117.97 28.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.553 1.07 . . . . 0.0 111.923 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 16.5 p -162.48 -31.36 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 163.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' CD ' ' H ' ' A' ' 25' ' ' SER . 30.0 Cg_endo -93.85 0.89 3.21 Favored 'Trans proline' 0 C--N 1.357 1.015 0 CA-C-N 122.932 2.083 . . . . 0.0 114.633 -170.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -78.59 179.45 7.1 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.292 1.837 . . . . 0.0 111.735 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.39 19.34 0.27 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.384 1.468 . . . . 0.0 116.598 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -141.47 140.05 33.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 112.564 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -163.68 153.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.811 2.044 . . . . 0.0 108.672 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.7 tpp -166.08 -57.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.73 1.15 . . . . 0.0 110.897 154.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -156.21 147.12 22.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.96 144.08 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.953 1.301 . . . . 0.0 108.105 169.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.83 86.36 1.93 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 110.498 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tt -103.18 146.29 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -172.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -132.05 149.85 52.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.301 1.84 . . . . 0.0 109.45 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -72.79 39.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.929 1.692 . . . . 0.0 114.3 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.82 -43.64 0.09 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.404 2.282 . . . . 0.0 110.718 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.25 128.67 34.33 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.87 0.868 . . . . 0.0 111.747 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.35 126.55 7.91 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.68 0.657 . . . . 0.0 112.382 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -139.16 150.97 46.23 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.898 1.332 . . . . 0.0 113.84 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 152.86 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.243 2.217 . . . . 0.0 108.978 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -140.14 90.31 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.234 1.414 . . . . 0.0 108.576 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -111.68 164.4 13.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.273 1.429 . . . . 0.0 112.402 -170.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -103.21 148.38 25.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.62 -1.3 . . . . 0.0 110.033 172.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.0 t30 69.69 105.34 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 129.05 2.94 . . . . 0.0 114.438 -156.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.89 -26.9 6.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.496 2.797 . . . . 0.0 113.393 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -65.26 -34.8 79.21 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.235 -0.916 . . . . 0.0 111.996 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.7 m -82.31 -20.07 38.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.77 -1.109 . . . . 0.0 113.578 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.92 -51.64 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.314 1.415 . . . . 0.0 108.979 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -71.25 -28.19 64.0 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.3 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -66.74 -47.95 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.619 1.099 . . . . 0.0 111.761 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.95 66.37 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.947 -1.096 . . . . 0.0 112.328 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.03 -53.33 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.139 0.881 . . . . 0.0 110.198 167.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.96 -18.47 62.62 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.42 1.464 . . . . 0.0 113.532 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.15 -36.62 47.49 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 113.35 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -115.06 -42.38 3.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.503 1.121 . . . . 0.0 113.113 -169.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -72.55 23.53 0.06 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.693 1.997 . . . . 0.0 114.09 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 126.573 1.949 . . . . 0.0 111.404 175.395 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 mt -134.63 144.26 47.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.968 1.707 . . . . 0.0 109.74 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.48 138.95 46.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.29 140.79 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.918 1.287 . . . . 0.0 110.481 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -140.43 143.77 35.77 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 167.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.7 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.703 0.764 . . . . 0.0 111.709 -172.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.539 0.764 0 N-CA-C 111.276 -0.317 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 125.82 29.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 111.972 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -138.74 95.02 2.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 109.363 -164.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.01 149.04 43.61 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.442 -0.787 . . . . 0.0 111.183 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.96 122.23 29.7 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.065 1.346 . . . . 0.0 108.93 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t80 -96.44 130.36 43.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.172 1.789 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.84 91.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.181 0.993 . . . . 0.0 109.318 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 6' ' ' PHE . . . -77.93 4.88 56.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.997 1.284 . . . . 0.0 115.397 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -64.48 -162.98 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.58 1.952 . . . . 0.0 111.818 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -119.66 42.11 0.46 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -77.19 54.83 4.81 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.087 3.191 . . . . 0.0 112.318 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.6 50.46 1.32 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.806 2.042 . . . . 0.0 109.376 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -142.49 168.74 19.02 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.086 2.554 . . . . 0.0 109.297 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -61.76 110.01 1.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.395 -0.816 . . . . 0.0 110.205 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.72 155.21 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.082 0.953 . . . . 0.0 112.41 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.1 m -133.55 155.17 50.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.149 1.779 . . . . 0.0 111.333 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.01 -25.68 22.43 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.924 1.29 . . . . 0.0 114.22 -167.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -53.65 -27.32 26.67 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 0.0 113.32 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.13 -49.95 17.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.896 1.225 . . . . 0.0 112.379 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.11 -28.1 69.84 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.045 -1.659 . . . . 0.0 111.514 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.06 -34.95 71.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.31 1.444 . . . . 0.0 113.335 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -35.07 79.52 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.984 1.265 . . . . 0.0 110.91 170.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.26 -77.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.828 1.251 . . . . 0.0 107.96 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -120.53 116.17 24.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.126 1.33 . . . . 0.0 111.122 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.577 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 p -158.66 -29.88 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 162.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 25' ' ' SER . 41.2 Cg_endo -86.82 0.17 7.82 Favored 'Trans proline' 0 C--N 1.357 0.977 0 CA-C-N 123.283 2.208 . . . . 0.0 113.995 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -79.36 171.91 14.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.467 1.507 . . . . 0.0 111.638 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.64 -15.7 80.51 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -87.04 121.21 29.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.873 1.337 . . . . 0.0 111.904 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 tp -154.54 146.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.26 0.624 . . . . 0.0 111.74 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mtm -159.84 -73.09 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.458 1.903 . . . . 0.0 110.129 162.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -143.8 160.63 40.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.965 1.706 . . . . 0.0 114.1 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -133.15 124.67 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.113 1.765 . . . . 0.0 110.105 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -129.28 74.05 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.616 1.167 . . . . 0.0 112.012 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 tt -65.73 146.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.062 -1.024 . . . . 0.0 111.326 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -145.01 147.21 32.37 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.809 2.043 . . . . 0.0 108.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.96 143.35 51.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.785 0.434 . . . . 0.0 110.639 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.87 -53.87 0.31 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.609 1.964 . . . . 0.0 115.84 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -141.32 73.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.049 0.928 . . . . 0.0 112.289 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.93 51.66 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.544 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.77 160.44 38.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 122.839 1.304 . . . . 0.0 112.642 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -122.97 155.84 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.98 1.712 . . . . 0.0 109.024 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -136.3 88.69 2.4 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.941 1.296 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.84 175.0 5.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.819 0.848 . . . . 0.0 111.296 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -117.02 151.89 35.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.145 1.778 . . . . 0.0 109.096 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.9 t30 66.51 92.24 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 127.537 2.335 . . . . 0.0 113.812 -160.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.58 -21.46 45.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.779 2.319 . . . . 0.0 113.34 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.99 -30.97 68.44 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.387 -0.821 . . . . 0.0 112.001 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -89.24 -25.08 21.92 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 117.719 -1.134 . . . . 0.0 113.478 168.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.29 -48.01 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 120.434 1.47 . . . . 0.0 109.274 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.92 -41.65 95.38 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.171 -0.919 . . . . 0.0 113.061 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.12 -38.25 79.17 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.638 1.108 . . . . 0.0 112.479 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -27.5 61.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.66 -58.49 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.598 1.09 . . . . 0.0 109.441 168.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.27 -19.17 65.22 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.42 -44.98 14.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.42 1.888 . . . . 0.0 114.409 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -106.41 -24.74 12.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.79 1.236 . . . . 0.0 113.753 -169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -72.63 35.78 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.328 2.251 . . . . 0.0 112.497 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 127.982 2.513 . . . . 0.0 109.216 -175.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.14 141.75 47.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.328 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.2 134.91 33.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.807 1.185 . . . . 0.0 113.291 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -90.29 146.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.769 1.228 . . . . 0.0 110.551 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 155.73 44.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.692 0.797 . . . . 0.0 110.276 165.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 123.431 0.692 . . . . 0.0 109.922 166.062 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 CA--C 1.535 0.531 0 CA-C-O 120.681 0.2 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 142.63 49.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.142 1.377 . . . . 0.0 111.673 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 t -142.93 140.48 31.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.954 1.702 . . . . 0.0 109.184 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -113.59 145.56 41.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.618 0.767 . . . . 0.0 110.31 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -131.72 126.12 33.73 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.644 1.577 . . . . 0.0 109.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.3 132.28 54.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.37 94.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.15 43.25 2.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.708 1.147 . . . . 0.0 112.911 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -114.45 32.92 5.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.586 1.554 . . . . 0.0 113.132 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.8 tp 43.08 72.53 1.14 Allowed Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.885 2.874 . . . . 0.0 113.986 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.5 1.52 6.76 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.67 2.913 . . . . 0.0 113.091 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.18 32.15 0.18 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 114.421 -172.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -146.71 -56.61 0.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.805 -1.184 . . . . 0.0 111.583 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -145.07 134.42 23.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 110.843 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -157.01 149.84 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.208 1.003 . . . . 0.0 111.084 169.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -135.63 155.84 49.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.098 1.759 . . . . 0.0 110.172 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -50.04 -33.8 19.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.154 1.382 . . . . 0.0 114.101 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.3 -23.29 47.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.92 -48.54 58.12 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.017 -1.052 . . . . 0.0 111.581 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.91 -33.62 68.45 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.037 -1.04 . . . . 0.0 111.099 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -61.18 -43.81 98.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -27.23 62.69 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.185 -0.947 . . . . 0.0 111.839 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.22 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.789 0.835 . . . . 0.0 109.525 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -122.1 114.8 21.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.794 1.179 . . . . 0.0 111.037 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.453 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 23.1 t -151.81 -40.54 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.654 170.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' H ' ' A' ' 25' ' ' SER . 22.7 Cg_endo -96.6 15.91 0.79 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.26 2.64 . . . . 0.0 114.125 -172.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.42 22.87 0.32 Allowed 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.455 -1.403 . . . . 0.0 114.4 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.26 -13.93 13.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.476 1.988 . . . . 0.0 116.517 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.51 156.17 49.33 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.114 1.366 . . . . 0.0 110.307 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -165.14 165.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.01 0.924 . . . . 0.0 110.811 -161.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -155.68 -69.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 156.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -143.36 165.04 28.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.451 1.5 . . . . 0.0 113.671 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 tp -113.83 133.84 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.709 2.004 . . . . 0.0 110.018 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -129.9 55.53 1.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 110.416 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.2 tt -70.05 146.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.672 -1.267 . . . . 0.0 111.225 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -134.49 156.52 48.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.797 1.639 . . . . 0.0 110.254 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.51 10.73 0.75 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.766 1.226 . . . . 0.0 113.698 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.68 -60.82 0.44 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.832 1.253 . . . . 0.0 112.238 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -141.89 101.58 3.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.207 1.403 . . . . 0.0 109.457 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.27 152.93 42.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.78 0.705 . . . . 0.0 113.514 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -131.93 157.49 43.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.875 1.27 . . . . 0.0 112.406 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.55 150.38 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.143 1.777 . . . . 0.0 108.53 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -140.15 102.68 4.43 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.226 0.466 . . . . 0.0 110.268 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -119.26 161.01 21.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.249 1.419 . . . . 0.0 112.841 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -78.12 161.86 27.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.745 0.818 . . . . 0.0 109.999 164.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 53.89 90.04 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.769 2.028 . . . . 0.0 113.937 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.99 -25.65 81.87 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.078 2.519 . . . . 0.0 114.523 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -72.69 -25.47 61.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.923 0.783 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -66.73 -42.63 85.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.29 0.95 . . . . 0.0 111.462 167.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.31 -42.79 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.603 1.161 . . . . 0.0 110.952 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -66.49 -45.39 79.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.668 0.787 . . . . 0.0 111.931 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.72 -34.63 74.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.59 0.756 . . . . 0.0 112.357 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.8 -27.62 63.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.68 -48.54 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.958 -1.714 . . . . 0.0 110.505 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.32 2.3 7.8 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.7 t -98.99 -33.05 10.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.877 1.671 . . . . 0.0 112.899 169.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -122.11 -28.26 4.42 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 t -88.08 12.67 12.95 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.954 1.302 . . . . 0.0 112.314 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 126.693 1.997 . . . . 0.0 110.399 177.548 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.8 mt -124.94 138.21 54.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.193 1.397 . . . . 0.0 108.917 165.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -132.36 131.31 41.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.178 0.991 . . . . 0.0 110.799 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.75 140.38 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.214 1.006 . . . . 0.0 111.485 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.1 t -134.99 117.64 15.98 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.354 1.062 . . . . 0.0 110.126 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 123.866 0.866 . . . . 0.0 112.28 178.619 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 CA--C 1.533 0.474 0 N-CA-C 112.954 0.328 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 105.06 5.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.227 1.011 . . . . 0.0 110.013 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -128.74 140.39 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.143 0.977 . . . . 0.0 111.294 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -112.25 150.41 30.96 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.952 0.901 . . . . 0.0 112.169 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.07 122.89 35.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.425 1.89 . . . . 0.0 108.707 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -103.59 148.36 26.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.843 1.657 . . . . 0.0 111.524 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.09 135.48 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.537 1.535 . . . . 0.0 110.447 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.41 172.56 2.66 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.568 1.08 . . . . 0.0 113.756 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.67 33.66 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 -161.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.59 -32.97 0.39 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 126.4 1.88 . . . . 0.0 115.307 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.05 -7.23 20.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 123.612 2.326 . . . . 0.0 114.271 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.72 -5.41 8.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.87 1.268 . . . . 0.0 113.254 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -122.68 -38.54 2.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.635 1.974 . . . . 0.0 113.959 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -146.47 127.88 14.95 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.472 1.509 . . . . 0.0 109.113 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.39 127.94 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.438 0.695 . . . . 0.0 111.611 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -152.8 143.32 22.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.093 1.357 . . . . 0.0 109.972 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -57.21 -30.08 64.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.419 1.009 . . . . 0.0 112.426 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.09 -28.95 68.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.896 1.678 . . . . 0.0 113.235 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.43 -45.65 58.65 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.423 1.089 . . . . 0.0 111.514 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.82 -40.93 97.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.496 -0.752 . . . . 0.0 110.252 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.4 -45.28 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.422 1.089 . . . . 0.0 112.424 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.17 82.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.347 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.9 mt -61.02 -74.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.92 1.288 . . . . 0.0 108.494 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 8.8 m-30 -124.53 124.42 42.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.528 1.058 . . . . 0.0 111.444 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.594 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 4.3 m -157.93 -34.31 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 156.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 25' ' ' SER . 56.8 Cg_endo -85.25 5.17 6.33 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 CA-C-N 122.902 2.072 . . . . 0.0 113.686 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.46 -21.34 30.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.08 -157.76 12.87 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 120.084 1.311 . . . . 0.0 116.0 -171.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -68.93 -25.99 64.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.269 1.4 mp 63.72 167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.213 1.405 . . . . 0.0 113.731 170.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.1 mtm -153.04 -72.74 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.388 -1.445 . . . . 0.0 109.889 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.01 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.538 1.135 . . . . 0.0 113.281 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.7 mt -82.46 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 161.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -135.73 66.12 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.423 1.106 . . . . 0.0 111.074 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 tt -83.19 150.96 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.11 0.964 . . . . 0.0 111.883 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -114.4 -175.98 2.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.379 1.872 . . . . 0.0 111.299 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -79.59 -15.03 58.39 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.03 -10.65 2.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.41 159.2 35.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 112.837 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.03 124.36 5.99 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.427 -0.651 . . . . 0.0 111.584 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -128.62 149.19 50.75 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.829 1.299 . . . . 0.0 111.802 164.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.95 149.33 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 126.617 1.967 . . . . 0.0 107.818 166.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -137.08 100.66 4.34 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.049 0.94 . . . . 0.0 108.631 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -124.19 153.91 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.027 1.731 . . . . 0.0 112.837 -167.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -81.36 155.34 26.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.274 0.629 . . . . 0.0 110.695 166.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 59.99 95.65 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 130.226 3.41 . . . . 0.0 116.333 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -67.26 -18.03 50.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.449 2.766 . . . . 0.0 113.46 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -74.76 -27.83 60.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.433 1.015 . . . . 0.0 111.636 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -75.47 -39.24 58.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.562 0.619 . . . . 0.0 111.914 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.21 -41.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.919 0.487 . . . . 0.0 110.598 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -61.91 -49.16 77.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.307 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -55.7 -41.82 74.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.833 0.742 . . . . 0.0 111.591 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -66.35 -34.34 77.76 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.399 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.2 mt -63.42 -50.49 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.509 1.504 . . . . 0.0 111.025 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.1 -12.49 61.23 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.15 -20.72 17.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.377 1.471 . . . . 0.0 113.241 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -125.48 -29.56 3.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -91.32 -1.53 57.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.766 1.226 . . . . 0.0 112.927 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 108.872 -172.502 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 mt . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.5 mt -134.9 140.68 45.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.259 1.824 . . . . 0.0 108.503 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.2 137.75 34.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.98 0.809 . . . . 0.0 112.841 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.81 142.0 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.742 1.217 . . . . 0.0 112.606 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t -143.29 171.6 13.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.723 2.009 . . . . 0.0 109.826 171.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.1 m . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 125.257 1.423 . . . . 0.0 111.268 176.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.536 0.62 0 N-CA-C 112.615 0.198 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.45 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.865 2.066 . . . . 0.0 108.2 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -135.27 123.67 23.32 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.375 1.07 . . . . 0.0 109.75 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -88.48 151.72 22.35 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.842 0.829 . . . . 0.0 112.197 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.38 129.46 53.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.23 1.812 . . . . 0.0 107.541 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -109.86 134.78 51.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.208 1.403 . . . . 0.0 110.555 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.442 ' HB ' ' H ' ' A' ' 40' ' ' GLY . 12.0 mm -94.93 116.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.345 1.058 . . . . 0.0 108.712 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.82 149.51 25.09 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 119.566 -0.575 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -55.32 72.02 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.628 2.771 . . . . 0.0 115.148 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.533 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 94.9 mt -126.19 -37.75 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.911 2.485 . . . . 0.0 113.832 170.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 40.8 Cg_endo -83.8 59.47 6.22 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.782 2.321 . . . . 0.0 112.119 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.126 1.37 . . . . 0.0 113.021 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.93 146.84 45.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.042 1.337 . . . . 0.0 113.43 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.8 t30 35.83 59.82 0.84 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.237 2.215 . . . . 0.0 114.289 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.49 138.34 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.871 0.843 . . . . 0.0 111.789 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -120.08 159.96 23.78 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.862 1.665 . . . . 0.0 110.263 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -17.54 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.05 -1.031 . . . . 0.0 113.173 161.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -74.26 -23.45 59.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.326 1.051 . . . . 0.0 112.999 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.19 -35.95 63.99 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.803 -1.185 . . . . 0.0 110.732 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.32 -43.51 98.65 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.685 -1.26 . . . . 0.0 110.639 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.11 -44.2 96.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.091 0.956 . . . . 0.0 112.554 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -64.0 -36.64 84.65 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.13 -0.981 . . . . 0.0 111.574 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.67 -70.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.154 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.86 125.14 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.136 1.334 . . . . 0.0 111.394 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 17.5 m -158.73 -37.77 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.027 1.731 . . . . 0.0 113.588 164.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.2 Cg_endo -83.84 34.53 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.469 2.113 . . . . 0.0 113.311 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.33 123.35 16.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.643 1.577 . . . . 0.0 110.722 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.35 -160.1 53.93 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.581 0.61 . . . . 0.0 113.487 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -107.24 -5.08 18.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.934 1.294 . . . . 0.0 113.904 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 1.6 mp 67.57 154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.771 2.028 . . . . 0.0 114.404 171.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.5 mmt -151.66 -56.44 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.758 1.623 . . . . 0.0 110.5 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -159.12 148.65 18.78 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.626 1.103 . . . . 0.0 113.645 -170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 147.7 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.191 0.996 . . . . 0.0 111.169 163.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -147.66 101.85 3.37 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.298 0.954 . . . . 0.0 111.688 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.47 149.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.312 -1.493 . . . . 0.0 113.056 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -123.88 156.12 36.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.115 1.366 . . . . 0.0 111.329 167.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -65.39 22.91 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 127.395 2.278 . . . . 0.0 116.941 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.08 -33.11 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.485 1.514 . . . . 0.0 112.667 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -152.82 156.04 38.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.865 1.666 . . . . 0.0 110.217 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 7' ' ' ILE . . . -102.23 152.44 18.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.657 0.646 . . . . 0.0 113.699 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.74 156.21 34.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 123.254 1.502 . . . . 0.0 111.683 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.65 152.86 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.98 2.112 . . . . 0.0 107.334 166.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -136.14 101.27 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -121.52 155.0 35.92 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.943 1.297 . . . . 0.0 112.024 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -75.47 157.01 34.65 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.937 0.495 . . . . 0.0 111.218 164.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 68.34 82.29 0.19 Allowed Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 128.797 2.839 . . . . 0.0 115.517 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -57.93 -37.71 95.07 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.592 2.861 . . . . 0.0 113.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -66.59 -34.31 77.61 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.197 -0.939 . . . . 0.0 112.822 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.7 m -87.06 -21.48 26.04 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -43.98 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.205 0.911 . . . . 0.0 109.836 162.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -63.03 -40.37 97.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.984 0.914 . . . . 0.0 112.461 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.24 -35.96 74.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.263 0.625 . . . . 0.0 112.374 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.64 61.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.611 0.764 . . . . 0.0 112.778 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.66 -53.11 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.485 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -67.02 -9.54 40.17 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.76 -33.13 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.122 1.769 . . . . 0.0 113.966 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -127.83 -15.91 4.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 t -74.97 33.2 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 111.519 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 C--N 1.328 -0.333 0 C-N-CA 128.324 2.65 . . . . 0.0 108.021 -174.645 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 mt -128.92 143.24 50.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.44 1.896 . . . . 0.0 109.057 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -140.09 135.36 32.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.03 0.832 . . . . 0.0 112.59 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.16 144.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.95 0.9 . . . . 0.0 111.095 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.31 129.61 23.84 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.846 1.258 . . . . 0.0 110.46 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 124.207 1.003 . . . . 0.0 112.784 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.546 1.106 0 N-CA-C 115.773 1.413 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt 65.12 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.191 2.597 . . . . 0.0 116.586 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -147.9 172.56 13.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.975 1.71 . . . . 0.0 111.412 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -135.08 161.58 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.153 1.381 . . . . 0.0 113.285 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.19 129.65 31.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.937 1.695 . . . . 0.0 110.309 -171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -111.12 141.69 44.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.781 1.632 . . . . 0.0 111.92 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 mm -101.6 96.76 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.709 1.604 . . . . 0.0 110.291 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 -3.66 84.84 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.409 1.481 . . . . 0.0 115.404 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 47.02 0.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.02 1.91 . . . . 0.0 113.664 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 40.93 59.35 8.24 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.392 1.877 . . . . 0.0 113.589 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.45 25.88 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.027 3.818 . . . . 0.0 114.543 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 -12.99 46.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.26 1.424 . . . . 0.0 113.252 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.64 137.16 51.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.837 1.655 . . . . 0.0 112.303 -167.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 50.95 48.65 22.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.304 1.442 . . . . 0.0 114.062 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 m -112.45 146.15 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 122.574 1.178 . . . . 0.0 113.135 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -146.7 166.76 25.61 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 109.694 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 25.2 mmtp -50.45 -32.04 16.79 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.266 -0.896 . . . . 0.0 112.752 172.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.23 -20.66 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.456 1.102 . . . . 0.0 113.459 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.89 -48.26 32.2 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.629 1.104 . . . . 0.0 110.848 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.61 -35.79 79.61 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -71.52 -40.25 70.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.904 0.882 . . . . 0.0 112.989 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -25.53 60.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.627 1.103 . . . . 0.0 112.527 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.38 -74.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 9.4 m-30 -124.14 125.39 44.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.626 1.557 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.421 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 40.6 t -149.62 -54.25 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 161.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 25' ' ' SER . 43.7 Cg_endo -83.06 22.47 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.203 2.602 . . . . 0.0 114.085 -171.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -90.39 -33.03 16.19 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.328 -1.483 . . . . 0.0 114.844 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.07 11.9 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 119.122 0.874 . . . . 0.0 114.16 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.14 -24.56 63.19 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp 66.91 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.36 -59.37 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.622 -1.299 . . . . 0.0 111.019 161.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -145.29 138.98 26.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.148 0.979 . . . . 0.0 111.918 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tt -123.38 127.31 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.74 1.616 . . . . 0.0 110.056 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 5.2 p30 -128.8 152.81 48.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.767 1.227 . . . . 0.0 111.616 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -141.87 154.07 19.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.083 -1.011 . . . . 0.0 112.154 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.538 ' H ' HD13 ' A' ' 35' ' ' ILE . 42.1 tptt -149.38 146.99 27.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.301 1.441 . . . . 0.0 110.91 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -57.34 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 128.539 2.736 . . . . 0.0 116.872 168.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.95 -63.9 0.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.778 1.631 . . . . 0.0 110.669 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -141.46 111.82 6.92 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.985 0.914 . . . . 0.0 110.96 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.72 151.28 33.84 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.549 0.595 . . . . 0.0 112.482 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.37 156.08 46.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.714 1.245 . . . . 0.0 111.83 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.67 143.55 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.942 0.897 . . . . 0.0 109.221 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -127.67 98.44 5.2 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.582 1.153 . . . . 0.0 108.142 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -120.78 151.24 39.83 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.595 1.158 . . . . 0.0 111.672 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.03 159.99 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.756 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 64.74 82.73 0.21 Allowed Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 127.701 2.4 . . . . 0.0 112.818 -160.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.69 -33.05 47.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.14 3.227 . . . . 0.0 113.887 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -77.11 -23.38 51.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.838 0.855 . . . . 0.0 112.942 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -69.91 -41.98 73.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 163.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.76 -43.33 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.047 0.539 . . . . 0.0 110.569 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.97 -43.77 67.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.168 0.895 . . . . 0.0 113.234 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.41 -33.65 75.2 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.37 0.986 . . . . 0.0 111.731 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -67.08 -29.18 68.88 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.287 -0.883 . . . . 0.0 112.97 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.65 -53.0 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.298 1.408 . . . . 0.0 110.4 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.45 -15.92 63.93 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.4 m -84.22 -45.72 12.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.645 1.178 . . . . 0.0 113.68 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -104.0 -29.31 11.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 t -74.89 1.28 13.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.71 0.804 . . . . 0.0 111.598 164.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 CA--C 1.536 0.413 0 O-C-N 120.937 -1.102 . . . . 0.0 110.832 174.606 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 mt -127.25 139.96 52.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.542 1.137 . . . . 0.0 109.354 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -131.64 138.13 48.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.451 0.569 . . . . 0.0 112.303 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.07 130.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -133.97 148.79 51.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.151 . . . . 0.0 109.632 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.538 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 N-CA-C 111.409 -0.266 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 134.69 41.7 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.905 0.882 . . . . 0.0 111.554 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -146.87 155.76 42.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.63 1.572 . . . . 0.0 109.304 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -121.14 161.13 22.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.755 0.788 . . . . 0.0 112.663 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.8 121.89 19.04 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.478 1.911 . . . . 0.0 108.291 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -104.35 134.64 47.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.738 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 mm -91.49 132.18 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.742 0.817 . . . . 0.0 108.834 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -155.38 5.63 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.044 0.831 . . . . 0.0 113.104 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.6 83.39 0.43 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.217 -1.166 . . . . 0.0 111.591 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' H ' ' CD ' ' A' ' 11' ' ' PRO . 58.2 tp -139.44 -41.71 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.996 1.718 . . . . 0.0 115.011 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 10' ' ' LEU . 21.4 Cg_endo -93.51 17.75 1.03 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.255 1.97 . . . . 0.0 114.488 -162.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.33 22.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 131.75 27.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.267 2.227 . . . . 0.0 110.754 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 t30 40.15 47.71 2.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.353 1.461 . . . . 0.0 113.728 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.61 125.9 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 123.7 0.8 . . . . 0.0 110.965 -161.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -159.83 151.41 20.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.365 1.466 . . . . 0.0 110.599 -167.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -61.4 -16.73 49.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -69.73 -33.78 72.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.485 0.584 . . . . 0.0 112.345 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.2 -35.78 74.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.207 1.367 . . . . 0.0 112.036 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.42 -39.46 71.07 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -61.95 -38.42 88.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.994 0.918 . . . . 0.0 112.392 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -36.4 82.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.687 0.795 . . . . 0.0 110.938 174.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.36 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -122.53 121.08 35.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.854 1.206 . . . . 0.0 111.717 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.646 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.9 p -150.51 -30.1 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 159.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' A' ' 25' ' ' SER . 44.5 Cg_endo -81.92 26.2 0.63 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.242 2.194 . . . . 0.0 113.265 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -121.62 137.24 54.82 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.592 1.957 . . . . 0.0 110.67 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.1 -159.42 49.7 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 121.841 0.69 . . . . 0.0 114.431 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -100.8 -7.68 23.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.229 1.012 . . . . 0.0 113.543 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 67.85 142.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.025 2.13 . . . . 0.0 115.372 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 mmt -138.73 -81.71 0.31 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.953 1.301 . . . . 0.0 111.018 170.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -137.55 162.18 34.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.301 1.841 . . . . 0.0 113.583 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 tt -149.64 121.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.728 1.211 . . . . 0.0 110.977 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.87 101.92 6.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.472 1.109 . . . . 0.0 111.556 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.16 135.95 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.63 0.772 . . . . 0.0 112.114 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -120.88 165.95 14.48 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.209 1.803 . . . . 0.0 110.38 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -78.15 -18.82 55.1 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 -4.94 9.35 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -164.36 179.54 6.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.25 1.82 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.57 159.02 27.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 120.573 -1.329 . . . . 0.0 114.763 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.36 149.85 51.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.532 1.533 . . . . 0.0 112.084 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.8 150.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 127.024 2.13 . . . . 0.0 108.334 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -132.9 113.99 13.51 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 167.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -125.96 155.54 41.2 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.532 1.158 . . . . 0.0 112.308 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -80.3 144.53 32.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.686 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 80.03 82.03 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.382 3.073 . . . . 0.0 115.155 -170.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.53 -38.68 88.65 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.22 3.28 . . . . 0.0 114.494 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.01 -29.18 67.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.98 -1.075 . . . . 0.0 111.855 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -68.76 -35.0 76.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.49 -40.1 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.437 0.695 . . . . 0.0 109.691 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -65.81 -40.1 91.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.527 170.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.85 -38.34 81.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.2 0.909 . . . . 0.0 111.191 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.41 70.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.529 0.731 . . . . 0.0 112.693 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.27 -50.38 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.265 1.393 . . . . 0.0 110.395 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.22 -12.27 61.53 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.323 0.965 . . . . 0.0 113.393 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -96.86 -28.86 14.04 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -108.53 -56.3 2.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.398 1.479 . . . . 0.0 111.994 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -14.34 58.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.737 1.215 . . . . 0.0 113.151 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 CA--C 1.544 0.713 0 C-N-CA 125.802 1.641 . . . . 0.0 112.733 -179.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 mt -129.49 148.49 51.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.298 2.239 . . . . 0.0 107.536 166.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -142.42 130.17 21.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.81 138.9 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.406 1.482 . . . . 0.0 112.664 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.3 t -135.38 148.76 49.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 112.766 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 125.169 1.387 . . . . 0.0 112.49 167.624 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.541 0.855 0 CA-C-O 120.102 -0.041 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.66 140.43 40.82 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.117 0.967 . . . . 0.0 113.209 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 141.89 15.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.575 1.55 . . . . 0.0 110.355 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -116.77 145.73 43.3 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.946 0.898 . . . . 0.0 111.717 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.88 124.42 44.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.533 1.533 . . . . 0.0 108.739 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -108.86 135.83 49.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.2 mm -90.72 80.17 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.089 1.356 . . . . 0.0 110.776 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 -4.3 12.28 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.18 1.371 . . . . 0.0 115.164 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.19 -10.81 34.43 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.649 1.98 . . . . 0.0 114.248 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.6 mt 48.53 63.79 9.76 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.066 1.746 . . . . 0.0 113.803 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.99 45.25 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 125.663 4.242 . . . . 0.0 113.679 -173.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -50.43 -23.69 2.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.023 2.129 . . . . 0.0 115.998 -166.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.05 2.8 5.88 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.538 2.335 . . . . 0.0 114.075 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -135.67 61.62 1.65 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 110.8 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.58 117.89 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.789 1.235 . . . . 0.0 110.965 -173.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 t -155.38 151.95 28.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -50.59 -34.09 24.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.549 1.14 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -68.69 -22.38 64.37 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.09 -35.14 64.18 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.339 -1.475 . . . . 0.0 111.24 174.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.55 -40.89 69.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.376 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -69.29 -38.45 78.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.825 0.85 . . . . 0.0 113.184 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -28.1 65.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.68 -77.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.638 1.175 . . . . 0.0 108.526 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -117.53 112.36 20.49 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.693 1.133 . . . . 0.0 111.588 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.525 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 42.8 t -159.95 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.665 1.586 . . . . 0.0 112.294 167.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 25' ' ' SER . 50.4 Cg_endo -87.96 17.15 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 115.358 -171.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -90.29 1.32 56.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.542 1.137 . . . . 0.0 114.043 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.45 19.47 76.32 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.474 1.034 . . . . 0.0 113.905 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -137.75 137.43 38.27 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.595 1.158 . . . . 0.0 110.066 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 tp -158.28 163.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.543 1.137 . . . . 0.0 109.517 -170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.5 tpp -164.59 -67.35 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.668 0.787 . . . . 0.0 110.49 150.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -139.81 144.19 37.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 111.953 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 pt -107.85 141.85 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.107 0.963 . . . . 0.0 110.846 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -145.31 72.36 1.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.684 1.193 . . . . 0.0 110.464 -172.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 tt -90.78 138.11 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.863 -1.148 . . . . 0.0 113.118 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.85 157.0 30.74 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 110.371 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.02 8.53 0.53 Allowed 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -168.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.8 -51.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.349 1.46 . . . . 0.0 111.901 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.73 138.32 23.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.396 1.078 . . . . 0.0 110.738 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.99 160.09 30.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -127.18 152.71 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.898 1.279 . . . . 0.0 111.632 167.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.33 145.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.615 1.566 . . . . 0.0 108.246 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -130.42 87.94 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.633 1.573 . . . . 0.0 107.088 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -115.13 169.68 8.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.619 1.568 . . . . 0.0 112.573 -167.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -91.35 177.52 6.22 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.181 1.393 . . . . 0.0 111.333 168.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 49.15 81.03 0.27 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.741 2.416 . . . . 0.0 114.423 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.29 -29.65 89.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.497 2.798 . . . . 0.0 114.242 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -73.79 -33.94 64.42 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.468 -0.77 . . . . 0.0 111.597 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -70.65 -31.2 68.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.3 0.955 . . . . 0.0 112.622 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.66 -48.1 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.425 0.69 . . . . 0.0 110.518 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -64.66 -44.47 90.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.714 0.688 . . . . 0.0 112.546 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.94 -38.23 72.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.552 1.141 . . . . 0.0 112.322 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.03 -26.22 62.12 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.572 -0.705 . . . . 0.0 112.891 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.39 -51.61 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.045 1.293 . . . . 0.0 110.392 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.89 -17.95 65.01 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.79 -60.11 2.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.312 0.645 . . . . 0.0 111.973 167.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.02 -35.84 20.09 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.322 1.449 . . . . 0.0 114.722 -166.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -85.55 -3.98 59.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.612 1.565 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 124.508 1.123 . . . . 0.0 109.403 163.498 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.0 mt . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.62 139.44 53.92 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.92 1.688 . . . . 0.0 108.525 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -132.7 134.77 45.22 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.243 0.929 . . . . 0.0 112.154 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.65 137.92 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.384 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 m -139.67 167.25 22.54 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.089 1.756 . . . . 0.0 110.773 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.468 0.451 0 O-C-N 121.269 -0.895 . . . . 0.0 111.578 -174.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 112.914 0.313 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.53 156.02 18.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.307 1.843 . . . . 0.0 111.956 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -159.05 167.04 30.3 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.049 0.939 . . . . 0.0 111.468 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -130.1 165.01 23.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.93 126.11 42.69 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.291 2.236 . . . . 0.0 109.117 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -106.68 143.1 35.26 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.662 1.585 . . . . 0.0 111.498 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.7 101.7 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.668 1.587 . . . . 0.0 110.96 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 7.52 75.59 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.038 1.304 . . . . 0.0 114.909 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -74.29 15.32 0.34 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER 48.25 80.96 0.27 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.373 2.269 . . . . 0.0 112.677 -163.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.39 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.059 3.173 . . . . 0.0 111.892 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 mp 53.15 22.95 2.81 Favored 'General case' 0 CA--C 1.557 1.214 0 O-C-N 120.408 -1.432 . . . . 0.0 113.837 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -150.9 150.11 30.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.341 2.256 . . . . 0.0 110.469 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 m120 45.36 39.67 4.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.291 1.437 . . . . 0.0 113.224 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.77 34.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.739 1.615 . . . . 0.0 113.488 -157.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -90.68 147.53 23.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.898 1.279 . . . . 0.0 110.801 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.33 -32.29 10.88 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -62.97 -12.73 27.67 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.96 -43.71 70.98 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.983 -1.073 . . . . 0.0 111.893 168.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.68 -36.7 65.34 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.641 -0.662 . . . . 0.0 110.73 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.07 -45.52 91.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.491 0.716 . . . . 0.0 112.045 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -28.08 64.09 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.608 -0.682 . . . . 0.0 112.798 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.83 -75.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -123.85 126.58 46.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.843 1.201 . . . . 0.0 111.137 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.614 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 3.7 m -157.78 -20.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 160.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.614 ' CD ' ' H ' ' A' ' 25' ' ' SER . 29.4 Cg_endo -91.85 15.27 1.66 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 123.558 2.306 . . . . 0.0 113.166 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -105.58 154.68 20.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.563 1.145 . . . . 0.0 113.472 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 -146.28 43.43 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.699 1.143 . . . . 0.0 115.761 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.46 -0.6 27.74 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.177 1.391 . . . . 0.0 112.784 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.271 1.3 tp 63.5 171.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 128.376 2.67 . . . . 0.0 116.435 166.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mtm -171.6 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.692 1.597 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -142.63 136.99 29.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.273 1.429 . . . . 0.0 112.457 -164.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tt -85.2 139.31 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.056 0.942 . . . . 0.0 109.929 163.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -143.4 77.83 1.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.921 0.782 . . . . 0.0 111.665 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -88.15 138.71 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 122.076 0.941 . . . . 0.0 111.62 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -130.49 147.22 52.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.679 1.592 . . . . 0.0 108.336 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -75.0 35.86 0.11 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.37 -57.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.103 1.761 . . . . 0.0 109.52 166.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.84 126.58 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.133 1.373 . . . . 0.0 110.22 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.21 149.12 24.77 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 122.604 0.145 . . . . 0.0 112.926 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -134.37 162.41 32.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.324 1.45 . . . . 0.0 111.501 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.95 149.13 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 108.602 167.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -131.98 97.96 4.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.799 1.24 . . . . 0.0 107.936 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.51 145.53 50.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 112.284 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -73.75 154.15 39.71 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 166.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 64.34 86.98 0.13 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.477 2.711 . . . . 0.0 114.638 -166.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.0 -24.48 65.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.753 2.302 . . . . 0.0 114.423 174.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -68.54 -43.38 76.84 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.328 0.967 . . . . 0.0 110.719 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.7 m -72.8 -29.67 63.46 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.19 -46.03 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.873 0.76 . . . . 0.0 109.867 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -63.91 -37.54 87.8 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.288 1.035 . . . . 0.0 112.812 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.15 -45.19 94.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.305 0.642 . . . . 0.0 111.139 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 -31.34 72.45 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.563 -0.711 . . . . 0.0 112.322 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.24 -54.92 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.911 1.232 . . . . 0.0 110.58 172.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -71.67 -16.07 62.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -89.44 -36.17 15.59 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -103.13 -24.29 13.6 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.059 1.344 . . . . 0.0 113.911 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.3 p -68.51 -5.8 21.6 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.129 -1.607 . . . . 0.0 113.221 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.925 1.69 . . . . 0.0 112.84 -170.616 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 121.713 0.768 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -128.79 143.03 50.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.546 2.339 . . . . 0.0 106.623 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -136.19 132.25 35.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.266 1.394 . . . . 0.0 112.446 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.4 144.1 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.021 0.928 . . . . 0.0 110.654 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 t -140.95 147.99 39.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.432 1.093 . . . . 0.0 110.87 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.7 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.407 0.622 . . . . 0.0 111.267 170.544 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 CA--C 1.537 0.66 0 N-CA-C 114.311 0.85 . . . . 0.0 114.311 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.35 148.9 52.22 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.847 2.059 . . . . 0.0 110.006 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 p -162.94 161.68 25.81 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.285 1.434 . . . . 0.0 109.992 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.25 156.24 44.96 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.309 1.043 . . . . 0.0 111.395 160.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.35 117.78 23.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.199 2.199 . . . . 0.0 107.988 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -100.42 147.02 26.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.715 1.206 . . . . 0.0 111.501 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mm -103.29 131.56 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.84 1.256 . . . . 0.0 109.117 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.44 -176.49 4.82 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 121.399 0.444 . . . . 0.0 113.386 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.69 47.51 0.51 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.508 1.523 . . . . 0.0 114.911 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -119.02 -25.28 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 127.261 2.224 . . . . 0.0 115.518 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.9 38.6 0.76 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.92 2.414 . . . . 0.0 112.595 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.7 49.36 1.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.353 1.861 . . . . 0.0 110.183 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.45 37.58 1.69 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.301 1.84 . . . . 0.0 113.168 -161.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 51.36 61.08 3.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.053 1.741 . . . . 0.0 112.399 -172.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.19 149.35 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.089 0.956 . . . . 0.0 113.157 -167.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -138.78 164.43 29.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.109 2.563 . . . . 0.0 109.328 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -49.57 -32.44 12.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.468 1.107 . . . . 0.0 113.136 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -49.55 -36.56 23.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.549 1.539 . . . . 0.0 113.931 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.93 -39.59 50.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 111.94 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.01 -39.67 95.44 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.502 -0.749 . . . . 0.0 110.279 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.12 -36.67 74.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.985 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -69.28 -36.13 76.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.059 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.9 mt -63.1 -77.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.154 0.982 . . . . 0.0 108.871 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -120.3 121.08 37.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.97 1.259 . . . . 0.0 112.304 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.684 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.4 t -152.14 -38.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 112.98 165.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 25' ' ' SER . 47.4 Cg_endo -83.92 46.4 2.01 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.632 2.221 . . . . 0.0 112.18 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.96 145.63 49.72 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.491 1.116 . . . . 0.0 111.51 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.77 -155.4 33.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -97.71 0.89 47.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.686 0.794 . . . . 0.0 112.648 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tp 60.95 175.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.133 2.173 . . . . 0.0 113.7 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 mtm -166.11 -73.56 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.393 1.477 . . . . 0.0 109.051 160.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -144.22 153.53 42.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.663 1.185 . . . . 0.0 112.364 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 tt -122.49 130.93 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 126.292 1.837 . . . . 0.0 109.425 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.06 146.48 50.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.484 1.114 . . . . 0.0 112.316 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.14 148.79 23.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.135 1.374 . . . . 0.0 110.812 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -136.08 -176.44 4.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.639 1.576 . . . . 0.0 109.736 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -65.4 122.95 18.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.65 0.78 . . . . 0.0 110.661 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.44 10.03 0.44 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -157.04 157.64 35.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.529 1.532 . . . . 0.0 110.881 171.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.17 161.7 28.8 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.507 -0.746 . . . . 0.0 113.08 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -140.15 116.93 10.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.833 1.253 . . . . 0.0 110.865 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.98 148.5 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.858 -1.151 . . . . 0.0 108.939 164.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -137.19 98.28 3.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.859 0.864 . . . . 0.0 109.316 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -123.06 153.81 39.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 112.951 -169.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -81.06 153.66 27.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.408 1.083 . . . . 0.0 110.525 164.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 67.81 75.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 128.762 2.825 . . . . 0.0 113.852 -164.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -52.32 -35.77 65.74 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.982 3.121 . . . . 0.0 114.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -64.82 -39.37 93.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.004 0.82 . . . . 0.0 111.857 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -63.86 -31.26 72.38 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 -43.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.944 0.898 . . . . 0.0 109.942 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.74 -45.39 85.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.981 0.81 . . . . 0.0 111.675 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -62.48 -40.03 95.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.722 0.809 . . . . 0.0 112.257 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.04 72.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.379 0.672 . . . . 0.0 112.238 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.66 -51.08 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.517 1.053 . . . . 0.0 110.431 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.61 -15.39 63.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.81 -39.7 15.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.415 1.486 . . . . 0.0 114.141 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.15 -30.95 6.79 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -68.87 -3.16 11.57 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.562 -1.336 . . . . 0.0 113.623 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 . . . . . 0 CA--C 1.546 0.794 0 C-N-CA 128.026 2.531 . . . . 0.0 112.015 178.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -129.31 141.78 51.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.438 1.895 . . . . 0.0 109.601 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.36 135.29 30.33 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.2 p -102.18 137.67 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.325 1.05 . . . . 0.0 112.057 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -143.66 141.11 30.41 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.873 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.242 1.017 . . . . 0.0 112.905 173.582 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.532 0.415 0 N-CA-C 113.559 0.561 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' HE22 ' A' ' 43' ' ' GLN . 0.6 OUTLIER -131.44 118.56 20.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.765 2.026 . . . . 0.0 109.506 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -136.42 108.06 7.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.468 1.107 . . . . 0.0 110.118 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -84.98 149.26 25.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.369 0.604 . . . . 0.0 110.855 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.57 120.22 29.05 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.475 1.51 . . . . 0.0 108.117 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -99.18 136.26 39.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.537 1.535 . . . . 0.0 110.744 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -93.13 107.14 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 109.799 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.17 0.83 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.332 1.444 . . . . 0.0 113.947 173.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.65 148.86 39.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.321 1.848 . . . . 0.0 111.207 166.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.9 tp -110.28 90.72 10.35 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.43 1.892 . . . . 0.0 109.341 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.54 -23.62 23.14 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.367 2.711 . . . . 0.0 112.615 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . 0.283 1.6 tt 55.25 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.965 3.306 . . . . 0.0 114.236 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -97.78 -2.69 40.51 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.5 17.99 13.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.572 1.149 . . . . 0.0 113.457 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.12 126.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.786 1.634 . . . . 0.0 113.538 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 t -155.5 142.65 19.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 112.438 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.1 -32.13 71.81 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.754 -0.591 . . . . 0.0 111.019 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.06 -24.57 67.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.557 1.143 . . . . 0.0 112.828 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.09 -41.35 50.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.357 0.98 . . . . 0.0 111.739 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.95 -39.58 87.32 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 110.983 172.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -63.95 -43.79 94.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.172 0.989 . . . . 0.0 112.03 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.714 -1.241 . . . . 0.0 111.397 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.6 mt -58.71 -71.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.402 1.081 . . . . 0.0 109.483 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -124.63 114.56 19.52 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.748 1.158 . . . . 0.0 110.838 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.566 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 33.1 t -155.94 -43.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.566 ' HD2' ' H ' ' A' ' 25' ' ' SER . 89.9 Cg_endo -83.04 11.38 3.29 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.435 2.09 . . . . 0.0 115.521 -173.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -80.07 16.91 1.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.16 -14.63 32.37 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.555 1.074 . . . . 0.0 115.6 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.528 ' CE1' HD22 ' A' ' 46' ' ' ASN . 47.8 m-70 -135.97 141.1 44.39 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.404 1.882 . . . . 0.0 108.64 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 tp -153.37 161.48 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.449 0.699 . . . . 0.0 111.061 -162.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -151.9 -65.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.497 152.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -152.95 153.31 32.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.393 0.997 . . . . 0.0 113.434 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.53 140.2 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.26 1.424 . . . . 0.0 108.891 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -129.84 65.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.735 1.255 . . . . 0.0 110.679 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.35 138.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.821 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -125.82 155.42 41.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.517 1.527 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.83 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -165.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.91 -42.75 0.31 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.943 1.297 . . . . 0.0 112.767 167.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -148.91 146.77 28.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.84 1.256 . . . . 0.0 110.254 171.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.86 164.46 17.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -170.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -130.0 163.65 26.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.496 1.518 . . . . 0.0 110.543 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.96 155.12 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 109.238 166.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.415 HE22 ' HB3' ' A' ' 2' ' ' LYS . 42.3 tp60 -140.93 92.24 2.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.544 1.538 . . . . 0.0 108.28 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -112.33 165.83 11.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.23 1.412 . . . . 0.0 112.815 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.16 163.67 18.6 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.291 1.036 . . . . 0.0 111.062 164.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.528 HD22 ' CE1' ' A' ' 29' ' ' HIS . 56.5 t-20 51.41 91.28 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.851 2.46 . . . . 0.0 114.076 -172.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.56 -24.21 75.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.85 1.7 . . . . 0.0 113.969 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -67.28 -35.66 79.94 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.935 0.789 . . . . 0.0 111.587 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.9 m -71.17 -35.73 71.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.336 0.654 . . . . 0.0 112.273 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.34 -41.25 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.889 -0.507 . . . . 0.0 110.424 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -69.53 -36.53 76.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.116 -0.99 . . . . 0.0 112.879 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.33 -35.99 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.212 0.915 . . . . 0.0 111.692 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.02 66.68 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.615 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.14 -52.31 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.475 1.489 . . . . 0.0 110.279 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.14 1.78 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 46.2 t -107.62 -52.69 2.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.23 1.812 . . . . 0.0 112.855 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -88.83 -40.78 12.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.775 1.23 . . . . 0.0 112.501 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -71.09 -3.32 19.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.091 -1.006 . . . . 0.0 112.448 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 128.212 2.605 . . . . 0.0 111.589 179.112 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tp . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 mt -119.98 134.87 55.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.334 1.454 . . . . 0.0 108.001 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.75 128.31 45.12 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.92 142.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.514 1.126 . . . . 0.0 110.598 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 t -141.6 121.05 13.21 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.395 1.078 . . . . 0.0 110.105 171.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 124.781 1.232 . . . . 0.0 111.297 -173.641 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 CA--C 1.547 1.134 0 CA-C-O 121.064 0.36 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.8 123.29 20.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.602 1.161 . . . . 0.0 110.475 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -137.82 114.38 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.855 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -93.0 141.57 28.25 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.703 -0.623 . . . . 0.0 112.529 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.76 133.44 53.98 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.867 2.067 . . . . 0.0 108.36 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -117.57 138.56 51.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.758 2.023 . . . . 0.0 110.773 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -103.13 144.28 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.26 -162.51 1.67 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 122.022 0.79 . . . . 0.0 114.422 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -82.39 19.38 1.25 Allowed 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.601 -1.529 . . . . 0.0 114.675 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.59 -36.83 10.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.619 173.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -72.54 18.08 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.322 3.348 . . . . 0.0 116.696 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.4 mt -71.96 19.61 0.07 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.012 1.325 . . . . 0.0 113.249 170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -126.24 -178.7 4.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 110.409 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -52.16 122.33 8.39 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.311 0.505 . . . . 0.0 111.692 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.11 146.01 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.817 0.818 . . . . 0.0 112.526 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -133.9 168.12 19.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.866 1.667 . . . . 0.0 111.298 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -57.8 -32.51 67.62 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.084 -1.01 . . . . 0.0 111.452 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -64.01 -25.15 67.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.56 -48.19 56.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.624 1.102 . . . . 0.0 110.21 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.27 -38.34 86.39 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.153 -0.967 . . . . 0.0 111.496 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.22 -40.31 93.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.891 1.677 . . . . 0.0 112.16 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -28.4 60.48 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.539 -1.351 . . . . 0.0 113.176 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 ' CE1' ' A' ' 24' ' ' PHE . 20.3 mt -76.0 -45.31 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE1' HG22 ' A' ' 23' ' ' ILE . 77.1 m-85 -137.68 102.26 4.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.178 1.791 . . . . 0.0 111.644 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.562 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.0 t -164.56 -48.56 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.819 1.648 . . . . 0.0 111.923 166.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 25' ' ' SER . 83.8 Cg_endo -78.19 20.23 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.984 2.456 . . . . 0.0 115.679 -169.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.23 15.37 22.96 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.421 1.488 . . . . 0.0 114.217 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.2 5.46 62.52 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.523 1.535 . . . . 0.0 116.422 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -143.57 126.32 16.1 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.981 1.712 . . . . 0.0 109.005 -171.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -151.36 160.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -156.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 40.0 mtm -158.01 -84.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.184 2.194 . . . . 0.0 108.122 152.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -135.05 155.94 49.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.684 1.594 . . . . 0.0 114.073 -168.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -109.64 136.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.699 1.6 . . . . 0.0 110.469 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.58 72.09 1.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.524 1.13 . . . . 0.0 111.114 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.4 134.29 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.615 -1.303 . . . . 0.0 110.099 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -134.93 143.1 46.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.736 1.615 . . . . 0.0 109.011 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.1 46.42 0.4 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.41 -41.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.308 1.443 . . . . 0.0 112.283 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.51 151.2 37.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.208 1.403 . . . . 0.0 109.588 168.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 147.28 18.7 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.392 0.52 . . . . 0.0 113.481 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -125.82 155.34 41.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.825 1.298 . . . . 0.0 111.596 164.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.21 155.41 32.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 107.578 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.22 109.37 7.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 167.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -115.08 161.01 18.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.261 1.824 . . . . 0.0 111.125 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.57 146.37 25.17 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.247 -0.908 . . . . 0.0 110.691 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.74 107.58 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 127.722 2.409 . . . . 0.0 114.969 -171.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.87 -19.0 21.28 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.752 1.635 . . . . 0.0 113.329 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.57 -41.39 98.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.31 1.413 . . . . 0.0 113.103 -172.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -82.45 -18.02 43.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.17 -41.68 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.163 0.892 . . . . 0.0 109.705 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -62.83 -44.31 96.48 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.089 -1.007 . . . . 0.0 111.689 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.81 -41.68 91.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.631 0.65 . . . . 0.0 112.03 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.66 90.35 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.42 -0.8 . . . . 0.0 112.575 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.08 -52.67 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.708 1.14 . . . . 0.0 110.716 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.31 -17.74 56.18 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.6 t -73.53 -49.11 28.18 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.239 1.816 . . . . 0.0 111.976 166.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -101.28 -28.51 12.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -162.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -71.49 -18.32 62.3 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.594 1.088 . . . . 0.0 113.373 173.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 110.33 -172.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 119.687 -0.197 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.17 133.94 44.81 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.052 2.141 . . . . 0.0 107.94 165.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -144.12 131.88 21.33 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.503 1.047 . . . . 0.0 113.775 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.57 141.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.168 0.587 . . . . 0.0 112.038 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.7 m -133.53 127.14 32.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.83 2.052 . . . . 0.0 108.535 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.672 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.476 0.472 0 CA-C-O 119.706 -0.206 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -114.12 111.84 22.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.45 1.1 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -126.42 100.22 6.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.98 0.912 . . . . 0.0 111.162 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.22 153.88 24.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.53 0.681 . . . . 0.0 111.445 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.07 126.12 29.47 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.765 1.626 . . . . 0.0 108.918 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -103.46 137.98 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.788 1.235 . . . . 0.0 111.633 171.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.78 98.55 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.182 0.993 . . . . 0.0 108.97 168.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.52 176.19 50.69 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.736 0.684 . . . . 0.0 111.571 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.91 40.15 24.37 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.312 -1.111 . . . . 0.0 111.724 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.81 123.47 89.6 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.916 1.287 . . . . 0.0 110.566 -162.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.15 107.3 1.67 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.645 2.897 . . . . 0.0 110.009 168.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.15 7.79 1.97 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.478 -1.389 . . . . 0.0 112.771 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -114.78 128.16 56.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.479 2.311 . . . . 0.0 110.876 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 47.56 35.07 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.98 132.76 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 120.767 -1.208 . . . . 0.0 109.537 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.0 p -133.07 163.23 29.72 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 111.461 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -61.15 -24.63 66.43 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.189 -0.944 . . . . 0.0 112.801 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.33 -31.7 70.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.907 0.883 . . . . 0.0 112.1 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.02 -47.08 84.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.95 0.796 . . . . 0.0 110.42 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.76 -40.66 93.33 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.518 -0.739 . . . . 0.0 111.122 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -68.96 -41.41 78.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.336 1.054 . . . . 0.0 113.327 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -22.36 60.25 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 120.665 -1.272 . . . . 0.0 113.275 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.487 HG22 ' CE1' ' A' ' 24' ' ' PHE . 42.8 mt -83.55 -41.15 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.347 0.659 . . . . 0.0 109.696 170.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CE1' HG22 ' A' ' 23' ' ' ILE . 96.2 m-85 -135.7 91.58 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.534 1.534 . . . . 0.0 111.888 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 26.3 t -157.88 -49.75 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 165.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.3 Cg_endo -78.35 27.67 0.49 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.205 2.603 . . . . 0.0 114.033 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.77 14.87 25.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.718 1.607 . . . . 0.0 113.381 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.18 -101.31 2.71 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.439 1.019 . . . . 0.0 113.479 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -64.1 135.27 56.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.784 0.834 . . . . 0.0 112.747 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 tp -140.5 163.87 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.314 1.046 . . . . 0.0 112.0 -161.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.0 mtm -152.22 -76.9 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.485 1.114 . . . . 0.0 109.79 152.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -142.73 156.61 45.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.738 1.215 . . . . 0.0 113.807 -166.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mt -119.2 137.15 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.962 2.105 . . . . 0.0 109.642 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.96 84.04 2.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.946 1.299 . . . . 0.0 110.075 -175.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -88.33 135.25 26.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 165.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -132.89 147.75 52.29 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.862 2.065 . . . . 0.0 108.432 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -62.48 -9.42 8.49 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.3 -24.43 11.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -152.94 145.41 24.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.335 1.425 . . . . 0.0 114.035 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.46 131.15 10.47 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.862 1.22 . . . . 0.0 113.035 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -137.33 156.07 48.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.632 1.573 . . . . 0.0 111.95 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.82 154.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.535 1.534 . . . . 0.0 109.256 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -136.01 113.37 10.7 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -117.2 158.37 24.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.117 1.767 . . . . 0.0 112.339 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.05 151.56 31.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 109.87 164.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 48.0 t-20 48.8 101.67 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 128.103 2.561 . . . . 0.0 114.439 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 46' ' ' ASN . 34.9 Cg_endo -55.96 -11.84 6.18 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.34 2.694 . . . . 0.0 115.357 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -61.62 -36.0 79.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.599 1.09 . . . . 0.0 113.701 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.6 p -69.49 -39.95 77.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 111.335 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.61 -45.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.385 1.074 . . . . 0.0 110.483 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -63.92 -40.83 97.39 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 111.829 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.71 -35.32 80.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -40.29 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.439 1.096 . . . . 0.0 112.239 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -58.86 -48.65 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 120.207 1.367 . . . . 0.0 110.707 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.67 -15.03 63.1 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.0 t -89.0 -55.37 3.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.429 1.092 . . . . 0.0 111.5 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -87.43 -36.85 17.49 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.124 1.77 . . . . 0.0 113.804 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -67.42 -22.57 65.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.274 1.397 . . . . 0.0 111.879 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 124.413 1.085 . . . . 0.0 112.032 170.216 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mm . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.9 mt -125.03 129.33 50.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.306 0.642 . . . . 0.0 110.991 -171.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -133.06 127.09 33.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.9 144.87 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.704 1.202 . . . . 0.0 110.957 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.3 t -143.03 150.57 39.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.208 1.403 . . . . 0.0 109.293 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 p . . . . . 0 C--O 1.237 0.446 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 CA-C-O 119.623 -0.24 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.79 120.63 22.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 112.321 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -129.4 159.02 37.54 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.856 1.262 . . . . 0.0 111.533 173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.37 149.34 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.654 1.582 . . . . 0.0 110.247 168.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.64 117.76 19.12 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.691 1.596 . . . . 0.0 107.979 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -97.76 132.5 43.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.677 1.591 . . . . 0.0 110.511 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.36 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.848 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.03 -178.47 0.34 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 123.99 0.805 . . . . 0.0 113.697 166.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -76.75 26.61 0.14 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 120.124 -1.81 . . . . 0.0 113.739 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.19 66.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.468 1.507 . . . . 0.0 112.113 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -63.36 6.32 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.332 3.355 . . . . 0.0 117.604 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.15 -9.05 14.41 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -117.14 -27.02 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.518 1.527 . . . . 0.0 114.241 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.6 127.66 14.63 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.789 1.635 . . . . 0.0 110.259 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.59 89.17 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.201 1.4 . . . . 0.0 111.908 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -139.87 148.74 42.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.486 1.114 . . . . 0.0 109.301 163.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -60.01 -21.01 60.77 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.537 1.062 . . . . 0.0 112.714 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -55.49 -24.33 30.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.72 1.208 . . . . 0.0 113.6 169.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.47 -53.53 7.98 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.043 0.937 . . . . 0.0 111.603 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.16 -36.63 70.98 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.393 -1.442 . . . . 0.0 111.133 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -70.1 -22.84 62.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.438 1.495 . . . . 0.0 114.108 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.13 58.3 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.448 -1.407 . . . . 0.0 111.674 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 24' ' ' PHE . 55.3 mt -80.51 -45.1 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.855 0.862 . . . . 0.0 109.662 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 23' ' ' ILE . 39.5 m-85 -136.89 118.16 14.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.437 1.495 . . . . 0.0 111.251 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.656 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.6 p -154.54 -37.93 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.823 -1.561 . . . . 0.0 114.987 162.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 25' ' ' SER . 82.9 Cg_endo -76.46 -2.28 12.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.155 2.162 . . . . 0.0 113.329 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -93.16 141.55 28.29 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.328 1.051 . . . . 0.0 112.43 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.77 -164.1 43.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 124.643 1.115 . . . . 0.0 114.743 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -87.67 -12.83 44.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.231 1.012 . . . . 0.0 112.776 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 66.57 157.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.188 2.195 . . . . 0.0 113.965 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 38.0 tpp -156.7 -79.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.293 -0.879 . . . . 0.0 111.534 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -138.7 153.27 48.51 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.049 1.295 . . . . 0.0 113.946 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.85 130.73 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.751 1.62 . . . . 0.0 110.625 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -145.32 127.86 16.05 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.819 0.819 . . . . 0.0 113.043 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.33 144.45 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.718 -1.239 . . . . 0.0 112.028 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -128.88 156.07 44.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.356 1.462 . . . . 0.0 110.406 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -72.32 7.44 1.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.23 -35.38 2.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.134 1.333 . . . . 0.0 113.219 163.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -154.22 148.73 26.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.512 1.525 . . . . 0.0 110.448 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.96 165.26 12.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.342 -0.849 . . . . 0.0 114.202 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.33 133.52 51.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.901 1.81 . . . . 0.0 112.683 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 mt -104.88 139.65 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.546 1.538 . . . . 0.0 107.152 167.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -134.61 84.77 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -115.17 153.42 30.85 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.562 1.145 . . . . 0.0 112.489 -169.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.67 151.91 24.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.424 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 65.6 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 128.771 2.828 . . . . 0.0 114.699 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.39 -23.77 58.11 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.242 2.628 . . . . 0.0 114.479 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -64.86 -40.72 95.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 111.182 -175.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 m -73.83 -31.06 63.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.038 0.935 . . . . 0.0 112.631 174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.01 -44.25 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.686 -0.634 . . . . 0.0 109.92 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -65.22 -41.47 94.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.781 0.833 . . . . 0.0 112.152 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -59.51 -38.95 82.3 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.773 0.829 . . . . 0.0 112.198 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.94 58.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.076 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 mt -57.44 -51.52 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 121.007 1.73 . . . . 0.0 109.674 165.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.94 2.54 8.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -105.84 -26.86 11.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.574 1.55 . . . . 0.0 113.526 171.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -127.05 -26.76 3.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.467 1.107 . . . . 0.0 113.309 -166.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -76.57 40.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.185 1.794 . . . . 0.0 112.276 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 128.015 2.526 . . . . 0.0 108.566 -176.562 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 tp . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -127.0 131.03 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.969 1.708 . . . . 0.0 107.985 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -128.07 122.13 31.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -92.13 141.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.945 0.898 . . . . 0.0 111.225 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.0 t -136.78 150.46 48.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 108.392 166.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 123.567 0.747 . . . . 0.0 110.254 -173.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.664 0 CA-C-O 119.385 -0.339 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HE3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -83.16 137.89 33.87 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.004 1.322 . . . . 0.0 112.879 -173.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 t -133.0 162.96 30.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 110.922 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -132.4 161.52 33.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.634 0.73 . . . . 0.0 112.15 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -143.74 130.29 20.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.026 1.73 . . . . 0.0 108.872 -166.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -110.99 141.76 44.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.921 1.688 . . . . 0.0 112.013 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -94.7 100.55 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.093 0.957 . . . . 0.0 111.156 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.96 4.37 53.96 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.047 1.784 . . . . 0.0 115.728 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -82.23 30.15 0.41 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.323 1.449 . . . . 0.0 114.031 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.9 tp 50.71 63.77 9.34 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.71 2.004 . . . . 0.0 114.024 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.89 26.48 0.36 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.365 2.71 . . . . 0.0 115.427 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -78.89 51.2 1.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 109.879 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -147.59 147.07 29.67 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 128.399 2.68 . . . . 0.0 108.544 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -53.75 115.79 2.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.192 0.997 . . . . 0.0 111.573 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.47 148.09 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.308 1.043 . . . . 0.0 111.29 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -118.61 158.97 24.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.0 1.72 . . . . 0.0 111.989 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -52.35 -30.25 27.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.695 1.598 . . . . 0.0 113.819 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.41 -29.61 69.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.002 0.921 . . . . 0.0 113.274 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.89 -43.46 98.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.205 0.911 . . . . 0.0 111.121 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.52 -36.38 63.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.377 1.071 . . . . 0.0 111.612 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.12 -35.53 80.74 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.33 0.652 . . . . 0.0 112.559 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -18.84 59.13 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -72.06 -80.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' CE1' ' HB1' ' A' ' 53' ' ' ALA . 11.2 m-30 -116.34 117.49 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.151 0.977 . . . . 0.0 110.747 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 76.8 p -148.2 -27.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.734 1.613 . . . . 0.0 113.772 158.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 25' ' ' SER . 10.2 Cg_endo -96.46 19.84 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 CA-C-N 122.899 2.071 . . . . 0.0 114.111 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -120.77 143.9 48.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.628 1.571 . . . . 0.0 111.929 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 -152.61 40.85 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.78 -0.575 . . . . 0.0 114.352 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -88.6 -25.77 22.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.024 -0.988 . . . . 0.0 113.257 -171.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mm 64.78 153.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.154 1.782 . . . . 0.0 112.206 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.0 tpp -154.91 -57.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.439 -1.413 . . . . 0.0 113.758 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -156.34 155.69 32.65 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.523 1.129 . . . . 0.0 113.911 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.91 151.89 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.173 1.389 . . . . 0.0 112.281 168.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.25 98.34 3.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.444 1.498 . . . . 0.0 110.525 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tt -106.41 138.84 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -130.64 153.55 48.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.013 1.325 . . . . 0.0 110.371 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -76.78 49.41 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.992 1.317 . . . . 0.0 112.387 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.26 -51.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.744 2.418 . . . . 0.0 110.333 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -149.69 144.39 26.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.521 1.528 . . . . 0.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.14 140.83 15.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.119 0.866 . . . . 0.0 112.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.58 148.69 50.5 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.73 1.253 . . . . 0.0 112.43 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -129.88 138.35 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.745 1.618 . . . . 0.0 107.775 176.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.05 97.68 5.35 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.449 1.1 . . . . 0.0 108.415 175.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -118.53 152.81 35.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.031 0.932 . . . . 0.0 111.655 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.28 162.47 21.14 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.654 167.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 69.88 74.42 0.27 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 127.968 2.507 . . . . 0.0 113.357 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.0 -36.89 97.74 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.659 2.906 . . . . 0.0 114.709 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -62.86 -34.43 77.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.158 1.344 . . . . 0.0 111.817 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.5 m -77.45 -33.88 54.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.72 -42.92 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.178 0.899 . . . . 0.0 109.987 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.01 -39.98 87.18 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.301 1.04 . . . . 0.0 112.711 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.1 -32.23 73.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.994 0.816 . . . . 0.0 112.596 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -73.61 -31.49 63.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.294 0.638 . . . . 0.0 112.05 172.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.67 -54.86 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.956 1.253 . . . . 0.0 110.514 171.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.44 -20.41 63.08 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.601 1.092 . . . . 0.0 112.811 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 t -90.98 -24.44 20.11 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.843 1.257 . . . . 0.0 114.321 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -126.49 -19.18 4.67 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.501 -1.374 . . . . 0.0 113.651 -172.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -86.96 21.3 2.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.382 1.873 . . . . 0.0 112.804 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 CA--C 1.532 0.25 0 C-N-CA 125.083 1.353 . . . . 0.0 109.694 -170.0 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.1 mt . . . . . 0 N--CA 1.461 0.111 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.48 150.89 51.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.785 1.634 . . . . 0.0 109.776 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.13 137.82 31.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.696 -0.627 . . . . 0.0 111.592 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -93.63 145.47 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.042 0.937 . . . . 0.0 111.044 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.4 t -135.67 146.95 48.34 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.587 1.155 . . . . 0.0 110.757 168.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.328 -0.363 0 C-N-CA 123.975 0.91 . . . . 0.0 111.901 175.489 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.535 0.535 0 N-CA-C 112.21 0.042 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 133.47 33.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.207 1.003 . . . . 0.0 112.571 176.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -151.52 155.01 37.62 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.438 0.695 . . . . 0.0 110.833 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -120.59 149.84 41.83 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.304 1.442 . . . . 0.0 111.004 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -120.03 128.17 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.42 1.888 . . . . 0.0 108.459 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -115.49 141.67 47.75 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.754 1.622 . . . . 0.0 111.169 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.69 114.93 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.576 1.15 . . . . 0.0 109.798 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.92 -4.98 86.69 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.716 1.627 . . . . 0.0 114.462 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -77.52 31.88 0.16 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.749 1.275 . . . . 0.0 113.466 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt 44.8 76.26 0.56 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.716 2.006 . . . . 0.0 114.188 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.85 26.8 0.18 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.008 3.139 . . . . 0.0 115.419 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -76.2 16.25 0.47 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.133 2.573 . . . . 0.0 112.683 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -127.81 157.62 39.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 129.11 2.964 . . . . 0.0 110.983 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -43.74 120.98 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.045 1.738 . . . . 0.0 112.338 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.96 159.84 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.085 0.954 . . . . 0.0 111.594 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -133.59 161.61 34.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.845 1.658 . . . . 0.0 111.747 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -52.58 -33.86 47.99 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.329 -0.857 . . . . 0.0 111.728 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.62 -21.01 65.41 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.12 -38.04 63.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.911 1.232 . . . . 0.0 112.302 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.96 -37.91 64.37 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.061 -1.024 . . . . 0.0 110.534 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -64.84 -43.85 91.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -29.88 69.75 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.291 0.95 . . . . 0.0 112.145 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.06 -78.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 167.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.16 120.64 35.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.462 1.483 . . . . 0.0 111.752 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 13.3 p -158.1 -33.35 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.219 167.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 25' ' ' SER . 31.5 Cg_endo -91.62 43.1 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.686 2.257 . . . . 0.0 111.201 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -133.33 153.8 51.27 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.215 1.806 . . . . 0.0 110.386 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.18 -157.89 35.38 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 163.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -103.02 -4.76 24.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 65.49 170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.141 1.776 . . . . 0.0 113.941 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.5 mtm -157.65 -75.7 0.09 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.931 -1.106 . . . . 0.0 109.517 163.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -145.42 155.3 43.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.654 1.182 . . . . 0.0 113.995 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 tt -115.6 134.05 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.044 1.738 . . . . 0.0 108.788 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.02 121.44 9.66 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.211 1.005 . . . . 0.0 111.622 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.6 147.07 31.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.879 0.871 . . . . 0.0 111.4 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.64 154.79 43.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.825 1.25 . . . . 0.0 110.211 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -68.8 44.36 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.058 1.743 . . . . 0.0 113.058 171.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.01 -40.71 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.345 2.258 . . . . 0.0 111.993 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -144.97 143.38 30.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.904 1.282 . . . . 0.0 109.923 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.11 136.61 11.73 Favored Glycine 0 N--CA 1.463 0.488 0 C-N-CA 123.884 0.755 . . . . 0.0 112.515 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -139.37 159.58 41.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 123.221 1.486 . . . . 0.0 112.42 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -136.28 148.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.29 1.836 . . . . 0.0 107.523 171.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -134.3 104.84 6.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -124.88 155.27 39.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.493 1.517 . . . . 0.0 112.714 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -90.0 153.5 20.53 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.02 1.328 . . . . 0.0 111.037 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 66.32 79.87 0.23 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.903 2.881 . . . . 0.0 113.705 -159.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -53.11 -33.24 62.9 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.074 3.183 . . . . 0.0 114.635 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -70.58 -35.85 73.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.066 0.848 . . . . 0.0 111.8 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -65.9 -31.75 72.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.88 -38.11 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.697 0.799 . . . . 0.0 110.223 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.39 -42.24 98.79 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.421 -0.799 . . . . 0.0 112.105 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.46 -38.15 90.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.87 0.759 . . . . 0.0 112.239 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.18 77.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.974 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.19 -53.34 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.817 1.19 . . . . 0.0 110.399 171.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.06 -29.7 70.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.306 0.957 . . . . 0.0 112.664 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -77.15 -38.12 52.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -94.87 -26.97 15.96 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 t -72.53 -20.78 61.28 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.152 0.981 . . . . 0.0 112.496 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 . . . . . 0 N--CA 1.469 0.494 0 C-N-CA 125.963 1.705 . . . . 0.0 111.097 170.575 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 mt -138.64 139.1 38.39 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.757 1.223 . . . . 0.0 108.922 -165.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -133.74 125.89 29.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.88 139.81 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.096 0.959 . . . . 0.0 111.149 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -143.82 144.57 31.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.744 1.618 . . . . 0.0 110.663 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.468 0.437 0 C-N-CA 124.014 0.926 . . . . 0.0 110.217 178.804 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.539 0.742 0 N-CA-C 113.77 0.642 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 98.59 5.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.079 1.752 . . . . 0.0 109.64 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -128.06 99.82 5.64 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.997 0.919 . . . . 0.0 110.338 -162.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -84.51 154.08 22.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 112.382 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.71 127.76 41.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.003 1.721 . . . . 0.0 108.79 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -104.36 138.74 40.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.376 1.471 . . . . 0.0 112.132 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -97.21 97.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.181 1.392 . . . . 0.0 110.289 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.72 -23.0 65.42 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.147 0.88 . . . . 0.0 115.018 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.96 58.17 0.47 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.212 1.805 . . . . 0.0 115.483 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp 46.37 55.7 15.91 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 127.321 2.248 . . . . 0.0 113.754 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.47 4.42 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.471 3.447 . . . . 0.0 115.112 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.03 1.14 2.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.053 2.141 . . . . 0.0 116.198 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -139.77 -28.95 0.74 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -150.39 99.24 2.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.872 1.269 . . . . 0.0 110.117 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.44 149.52 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.48 0.712 . . . . 0.0 110.621 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -146.22 164.26 32.84 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.699 1.2 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -58.36 -29.76 66.24 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.144 -0.972 . . . . 0.0 112.48 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.34 -18.91 63.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -77.68 -47.18 19.83 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.909 -1.119 . . . . 0.0 109.946 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.15 -41.57 75.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.05 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -68.63 -43.21 76.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.484 1.514 . . . . 0.0 112.905 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -34.6 77.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.182 0.901 . . . . 0.0 111.152 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.93 -70.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.004 1.322 . . . . 0.0 108.747 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -124.2 112.7 17.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 111.168 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 11.8 m -160.57 -22.15 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.364 1.866 . . . . 0.0 113.355 157.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' CD ' ' H ' ' A' ' 25' ' ' SER . 32.5 Cg_exo -73.43 16.22 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.149 2.566 . . . . 0.0 116.4 171.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -134.06 154.95 50.83 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.228 1.411 . . . . 0.0 111.129 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.45 -165.5 31.95 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.334 0.969 . . . . 0.0 115.093 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -91.12 -17.87 25.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.3 mm 64.71 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.785 1.634 . . . . 0.0 112.801 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.5 tpp -153.44 -58.13 0.13 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.3 -0.875 . . . . 0.0 112.466 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -147.8 145.02 28.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.674 1.189 . . . . 0.0 112.967 -171.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -117.68 127.52 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.185 1.794 . . . . 0.0 109.839 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -137.02 87.52 2.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.981 0.896 . . . . 0.0 111.24 -164.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.3 139.43 21.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.078 0.951 . . . . 0.0 110.944 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.31 153.41 46.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.195 2.198 . . . . 0.0 109.082 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -76.81 28.0 0.13 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.53 -41.77 0.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.807 2.043 . . . . 0.0 111.378 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -137.83 146.93 44.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.388 1.075 . . . . 0.0 112.703 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.31 133.33 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 123.976 0.798 . . . . 0.0 112.222 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -131.27 154.83 48.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.25 1.5 . . . . 0.0 112.569 171.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.031 1.732 . . . . 0.0 108.352 167.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -140.72 80.44 1.75 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.383 1.873 . . . . 0.0 108.046 -172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -111.72 165.93 11.62 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.759 -1.213 . . . . 0.0 113.828 -166.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -96.19 153.37 17.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.03 0.932 . . . . 0.0 110.419 166.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 66.95 85.61 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.902 2.881 . . . . 0.0 115.249 -166.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.45 -30.35 72.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.633 2.888 . . . . 0.0 113.331 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -53.91 -41.27 67.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.572 0.624 . . . . 0.0 110.939 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 m -87.47 -23.71 24.36 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.83 -45.86 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.759 1.163 . . . . 0.0 109.105 164.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -65.16 -42.77 93.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.949 0.9 . . . . 0.0 112.755 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.488 1.04 . . . . 0.0 112.197 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.75 -32.58 62.13 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.28 -52.71 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.343 1.429 . . . . 0.0 109.51 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.19 -10.76 60.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -89.06 -23.42 22.55 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.787 -1.196 . . . . 0.0 113.68 170.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -128.96 -37.12 1.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -165.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 t -76.63 -13.2 60.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.826 1.25 . . . . 0.0 113.251 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 123.983 0.913 . . . . 0.0 112.093 178.102 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -121.92 140.46 52.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.394 1.478 . . . . 0.0 110.45 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.19 140.53 37.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.45 140.81 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.136 1.374 . . . . 0.0 111.136 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.9 t -152.88 153.72 33.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.606 1.162 . . . . 0.0 111.615 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 124.987 1.315 . . . . 0.0 112.07 173.776 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.957 0 CA-C-O 120.372 0.072 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.16 50.1 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.335 -0.853 . . . . 0.0 111.739 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -158.27 150.7 22.09 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.918 2.087 . . . . 0.0 108.718 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -126.04 152.33 45.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.591 0.632 . . . . 0.0 112.25 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.68 125.36 41.71 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.273 1.429 . . . . 0.0 108.904 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -104.14 136.51 43.62 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.661 1.984 . . . . 0.0 110.262 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.28 137.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.324 1.05 . . . . 0.0 109.561 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.93 -175.1 3.61 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-O 122.316 0.953 . . . . 0.0 113.194 169.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -83.93 13.24 5.11 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.18 -44.32 99.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.456 1.502 . . . . 0.0 114.723 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -81.93 21.93 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.914 2.409 . . . . 0.0 113.186 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.59 59.31 1.49 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.532 1.533 . . . . 0.0 110.389 174.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -153.27 31.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.73 2.812 . . . . 0.0 110.795 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 m120 58.42 146.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.431 2.692 . . . . 0.0 114.055 -157.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.16 153.02 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.367 1.067 . . . . 0.0 110.652 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.0 m -135.45 166.06 24.05 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.636 1.974 . . . . 0.0 110.217 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -52.35 -32.94 40.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.194 -0.941 . . . . 0.0 111.465 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.51 -21.7 65.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.181 1.792 . . . . 0.0 115.014 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.83 -47.5 62.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.204 0.911 . . . . 0.0 109.514 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.22 -29.23 62.64 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.497 -1.377 . . . . 0.0 112.051 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -61.82 -46.65 88.58 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.002 0.921 . . . . 0.0 111.687 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.91 -39.1 90.84 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.523 -0.735 . . . . 0.0 110.321 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.73 -76.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 109.113 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -119.52 123.87 45.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.841 1.201 . . . . 0.0 111.747 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.64 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 15.4 m -157.9 -41.47 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 126.085 1.754 . . . . 0.0 112.846 167.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HD2' ' H ' ' A' ' 25' ' ' SER . 53.9 Cg_endo -81.01 43.44 1.55 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.65 2.233 . . . . 0.0 112.562 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.07 146.15 46.74 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.416 1.486 . . . . 0.0 110.655 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.74 -161.11 28.28 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 116.404 1.322 . . . . 0.0 116.404 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -96.67 -2.14 45.22 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.185 0.994 . . . . 0.0 112.95 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp 62.22 167.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 126.803 2.041 . . . . 0.0 114.168 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.9 mtm -152.12 -71.59 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.943 -1.098 . . . . 0.0 110.508 162.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -156.53 155.8 32.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.012 0.925 . . . . 0.0 113.394 -171.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 tp -101.75 135.31 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.737 2.015 . . . . 0.0 110.046 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -127.02 68.85 1.27 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.924 1.289 . . . . 0.0 109.931 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.07 137.67 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.447 -0.783 . . . . 0.0 110.775 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 26.0 mmmt -124.14 145.78 49.07 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.639 1.576 . . . . 0.0 108.643 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -70.42 -8.91 54.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -167.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.17 -59.52 1.94 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.756 1.162 . . . . 0.0 110.93 166.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.46 131.97 14.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.998 1.719 . . . . 0.0 110.17 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 36' ' ' LYS . . . -81.82 171.0 52.19 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -123.81 154.2 39.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.489 1.515 . . . . 0.0 110.972 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.63 151.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.87 1.668 . . . . 0.0 108.58 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -136.38 108.25 7.1 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.573 0.749 . . . . 0.0 109.164 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -127.33 158.82 36.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.497 1.519 . . . . 0.0 112.772 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -90.08 147.49 23.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.905 1.282 . . . . 0.0 110.61 170.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 66.6 86.79 0.13 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 129.585 3.154 . . . . 0.0 115.321 -162.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.45 -30.75 93.38 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.561 2.841 . . . . 0.0 114.851 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.62 -36.15 80.28 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.577 1.081 . . . . 0.0 111.13 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -67.85 -37.64 82.12 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.8 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.684 0.793 . . . . 0.0 110.083 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 tpt85 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.21 -31.63 72.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.252 1.021 . . . . 0.0 111.664 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.94 68.88 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.147 -0.971 . . . . 0.0 112.534 173.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.1 mt -60.51 -49.53 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.83 1.196 . . . . 0.0 110.594 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.07 -16.81 61.47 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.76 -58.88 3.03 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.214 1.406 . . . . 0.0 111.27 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.94 -45.09 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.543 -0.723 . . . . 0.0 111.83 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.77 15.97 0.76 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.031 1.332 . . . . 0.0 113.107 176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -57.84 140.32 52.1 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.088 -1.007 . . . . 0.0 110.607 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -133.94 130.27 37.47 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.106 0.962 . . . . 0.0 113.549 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 32.6 ttm -98.29 166.13 11.54 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.267 1.827 . . . . 0.0 110.079 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -75.6 50.57 0.55 Allowed 'General case' 0 CA--C 1.553 1.095 0 O-C-N 120.437 -1.414 . . . . 0.0 114.135 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.35 31.87 5.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.661 2.384 . . . . 0.0 111.326 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.75 -168.96 52.95 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.039 1.304 . . . . 0.0 115.644 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -74.4 98.69 3.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.08 1.352 . . . . 0.0 111.76 179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -105.62 -23.84 12.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.644 1.578 . . . . 0.0 113.904 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -143.55 142.46 31.12 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.477 1.511 . . . . 0.0 110.76 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.55 109.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.359 1.463 . . . . 0.0 109.293 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 mt -130.3 138.96 50.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.282 2.233 . . . . 0.0 108.889 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -141.47 130.96 23.83 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.757 0.823 . . . . 0.0 111.869 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.73 134.45 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.577 -0.702 . . . . 0.0 111.166 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.56 99.46 8.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.791 1.636 . . . . 0.0 108.526 161.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.2 m -77.43 34.18 0.17 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.15 1.38 . . . . 0.0 114.06 -170.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.0 m -61.37 102.97 0.26 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.537 1.535 . . . . 0.0 110.756 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -79.12 37.62 0.32 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.363 1.465 . . . . 0.0 111.795 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.76 145.38 42.37 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.363 2.265 . . . . 0.0 110.344 -173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.221 1.408 . . . . 0.0 112.383 -174.705 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 O4'-C1'-N19 112.172 3.972 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 110.953 2.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.234 1 O4'-C1'-N19 112.569 4.369 . 0.101 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.578 -2.429 1 O4'-C1'-N19 113.3 5.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 CA--C 1.539 0.76 0 CA-C-O 120.089 -0.046 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -152.15 145.5 24.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -163.38 168.58 20.18 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.404 1.882 . . . . 0.0 110.01 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -140.63 153.16 45.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 171.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.3 121.35 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 108.435 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -100.66 133.85 44.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.386 1.074 . . . . 0.0 111.311 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.2 mm -90.48 99.43 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.755 0.822 . . . . 0.0 108.831 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.01 156.23 47.82 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.091 0.377 . . . . 0.0 112.663 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -51.03 98.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.15 1.78 . . . . 0.0 112.912 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.8 tm? -150.11 -56.64 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.486 1.514 . . . . 0.0 112.462 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 65.9 Cg_endo -72.94 -48.0 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 CA-C-N 121.931 1.725 . . . . 0.0 113.348 -168.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 mp 57.02 -15.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 173.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -129.88 143.98 51.08 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.216 1.806 . . . . 0.0 111.721 -171.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.61 29.13 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.368 2.267 . . . . 0.0 115.414 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 m -69.28 138.27 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.015 0.912 . . . . 0.0 111.241 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.9 p -143.71 156.84 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.534 1.133 . . . . 0.0 111.061 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -58.87 -25.84 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.086 -1.009 . . . . 0.0 111.758 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -64.83 -28.59 69.66 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.847 1.259 . . . . 0.0 114.012 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -67.61 -43.11 81.22 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.99 1.723 . . . . 0.0 111.476 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.01 -45.07 95.22 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.917 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -69.73 -37.92 76.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.494 1.118 . . . . 0.0 113.764 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -31.59 66.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.568 -1.332 . . . . 0.0 111.574 176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -64.14 -75.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.468 1.107 . . . . 0.0 108.727 169.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -124.5 111.89 16.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.988 1.267 . . . . 0.0 110.71 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.475 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 47.7 t -155.61 -49.76 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 25' ' ' SER . 64.6 Cg_endo -84.47 8.68 4.49 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.024 2.483 . . . . 0.0 115.139 -173.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -84.7 15.05 4.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.848 1.259 . . . . 0.0 113.547 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.14 -15.16 9.13 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.148 -1.595 . . . . 0.0 115.375 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -83.88 133.91 34.71 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.319 1.559 . . . . 0.0 111.724 168.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.45 152.5 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.317 0.647 . . . . 0.0 112.234 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.4 mtm -162.03 -67.56 0.05 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.761 2.024 . . . . 0.0 109.001 151.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -148.43 155.63 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.203 1.401 . . . . 0.0 112.744 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 HG12 ' A' ' 42' ' ' ILE . 16.8 pt -130.04 145.22 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.791 1.236 . . . . 0.0 111.119 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -136.96 157.16 47.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.052 1.341 . . . . 0.0 111.466 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.7 tt -141.22 159.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -132.87 167.46 20.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.619 2.368 . . . . 0.0 110.95 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -60.42 -16.48 36.28 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.43 -10.04 5.16 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -160.64 -177.76 6.41 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.017 1.727 . . . . 0.0 111.132 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.27 170.29 36.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 120.527 -1.358 . . . . 0.0 115.285 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -130.69 128.09 40.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.378 1.471 . . . . 0.0 111.869 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.434 HG12 HG22 ' A' ' 33' ' ' ILE . 1.8 mt -97.74 139.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.724 1.61 . . . . 0.0 108.544 169.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -130.56 94.09 3.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.273 1.429 . . . . 0.0 107.735 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -127.13 154.12 45.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.702 1.601 . . . . 0.0 113.941 -162.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.84 161.87 28.63 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.281 -0.887 . . . . 0.0 111.348 163.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 61.87 78.59 0.3 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.053 2.541 . . . . 0.0 115.639 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -24.28 51.5 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.089 2.526 . . . . 0.0 114.698 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -77.32 -37.09 53.28 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.092 -1.005 . . . . 0.0 112.522 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -70.41 -33.01 70.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.707 0.23 . . . . 0.0 111.091 167.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.9 t -65.2 -44.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 174.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -58.01 -48.19 80.77 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 111.419 168.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.49 -33.53 66.07 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.825 0.85 . . . . 0.0 112.983 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.77 -27.08 36.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 -50.4 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 120.692 1.587 . . . . 0.0 110.074 175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.0 -4.1 15.54 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.044 1.338 . . . . 0.0 113.603 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 87.8 m -108.2 -7.93 15.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.502 1.521 . . . . 0.0 113.879 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -137.23 -55.39 0.7 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.174 0.897 . . . . 0.0 112.61 -171.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -65.02 -20.89 66.72 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.021 -1.05 . . . . 0.0 112.465 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -113.07 14.75 19.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.811 1.644 . . . . 0.0 112.838 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -79.71 37.29 0.35 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.503 -1.373 . . . . 0.0 112.325 173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.16 140.88 19.03 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.234 1.814 . . . . 0.0 107.759 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -116.31 138.29 51.44 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.497 1.119 . . . . 0.0 111.74 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.1 t80 54.03 36.13 23.82 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.851 1.26 . . . . 0.0 113.395 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.9 -145.12 5.78 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.155 -0.966 . . . . 0.0 112.345 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -153.73 158.75 41.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.136 0.974 . . . . 0.0 113.111 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -136.77 -37.7 0.66 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.407 1.883 . . . . 0.0 112.714 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.2 mt -145.88 172.32 13.52 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.081 1.353 . . . . 0.0 111.073 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.7 mt -131.29 106.41 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.4 mt -119.95 133.96 55.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.595 0.758 . . . . 0.0 110.838 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -134.21 130.58 37.41 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.591 1.156 . . . . 0.0 110.994 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.74 143.5 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.913 0.885 . . . . 0.0 111.93 173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.8 t -140.38 153.99 46.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.117 1.767 . . . . 0.0 110.849 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m -129.31 29.26 5.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.236 1.414 . . . . 0.0 110.806 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.5 m -75.04 145.94 41.96 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.915 172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -138.27 1.69 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.68 1.592 . . . . 0.0 114.152 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.04 159.87 41.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.733 2.013 . . . . 0.0 109.92 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -170.597 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.294 0 O4'-C1'-N19 111.953 3.753 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 O4'-C1'-N19 110.817 2.617 . 0.286 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O5'-C5'-C4' 113.448 2.32 . 0.124 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.16 0 O4'-C1'-N19 112.0 3.8 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 CA--C 1.533 0.473 0 CA-C-O 121.084 0.368 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.28 146.01 51.83 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 175.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -160.98 147.84 15.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.601 1.56 . . . . 0.0 109.634 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -127.23 149.97 49.76 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.777 0.831 . . . . 0.0 110.734 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.57 124.99 31.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.789 1.235 . . . . 0.0 108.822 -173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -104.26 137.23 42.47 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.755 1.622 . . . . 0.0 111.401 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -95.7 96.3 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.561 1.144 . . . . 0.0 110.281 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -8.51 74.36 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.889 1.233 . . . . 0.0 115.123 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -78.16 30.7 0.17 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.784 2.292 . . . . 0.0 114.179 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 33.14 66.75 1.15 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.595 2.358 . . . . 0.0 114.459 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.44 56.1 1.64 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.593 3.529 . . . . 0.0 113.964 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.6 mt -69.93 -2.26 11.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.566 2.747 . . . . 0.0 112.985 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -130.33 150.14 51.7 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.607 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -12.49 96.4 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 129.61 3.164 . . . . 0.0 115.349 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.75 152.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.611 1.564 . . . . 0.0 111.256 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.1 p -137.7 166.72 23.26 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.543 1.937 . . . . 0.0 110.538 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -55.49 -25.16 35.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.316 0.646 . . . . 0.0 112.172 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -63.01 -27.29 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.303 1.441 . . . . 0.0 113.143 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.83 -48.74 23.55 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.418 -0.801 . . . . 0.0 110.938 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.76 -34.96 79.07 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.609 -1.307 . . . . 0.0 111.329 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -69.2 -35.71 76.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.986 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -37.37 78.77 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.9 1.227 . . . . 0.0 110.887 172.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.87 -79.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.418 1.087 . . . . 0.0 108.917 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -120.79 108.27 13.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.245 0.93 . . . . 0.0 110.818 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 60.7 p -135.09 -30.46 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 116.821 -1.561 . . . . 0.0 114.658 160.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' A' ' 25' ' ' SER . 19.2 Cg_endo -88.65 10.75 3.24 Favored 'Trans proline' 0 C--N 1.356 0.956 0 CA-C-N 122.988 2.103 . . . . 0.0 113.623 -176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -105.7 142.38 35.53 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.817 1.247 . . . . 0.0 111.332 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.23 -161.24 45.11 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.967 0.794 . . . . 0.0 114.744 169.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -98.94 -0.95 41.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.0 0.92 . . . . 0.0 113.387 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 63.56 158.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.744 2.017 . . . . 0.0 115.451 168.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.4 mtm -151.72 -79.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.58 1.152 . . . . 0.0 108.555 162.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -142.0 157.39 44.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -114.68 131.41 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.853 1.661 . . . . 0.0 108.954 168.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -127.1 90.18 3.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.983 1.313 . . . . 0.0 110.415 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.91 138.69 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.626 -0.671 . . . . 0.0 110.354 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -133.56 145.94 50.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.214 1.806 . . . . 0.0 108.693 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.67 25.04 0.81 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.429 1.492 . . . . 0.0 112.827 -168.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.46 -56.68 0.36 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.568 1.947 . . . . 0.0 110.772 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -142.78 101.16 3.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 110.152 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.34 156.43 48.54 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.692 0.663 . . . . 0.0 113.77 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.86 152.03 50.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.751 1.262 . . . . 0.0 112.607 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 145.51 20.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.113 1.765 . . . . 0.0 108.416 168.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -135.03 90.1 2.6 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.132 1.773 . . . . 0.0 107.999 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -121.34 160.17 24.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.092 1.357 . . . . 0.0 114.204 -167.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -92.25 156.29 17.4 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.997 1.319 . . . . 0.0 110.229 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 67.63 76.79 0.26 Allowed Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 129.158 2.983 . . . . 0.0 113.714 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -58.38 -33.85 98.18 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.9 3.066 . . . . 0.0 113.551 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -58.08 -45.26 87.44 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.253 0.933 . . . . 0.0 111.178 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -71.81 -28.37 63.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.53 -42.48 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.733 1.151 . . . . 0.0 110.639 170.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -67.86 -44.06 78.0 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 112.131 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.28 -33.5 69.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.412 1.085 . . . . 0.0 112.065 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.94 64.06 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.263 -0.898 . . . . 0.0 113.044 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.47 -50.38 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.395 -1.441 . . . . 0.0 109.7 171.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.41 -6.05 32.8 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.4 t -85.23 -50.36 7.44 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.906 1.282 . . . . 0.0 111.982 166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -109.0 -47.15 3.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.24 1.016 . . . . 0.0 113.693 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -67.63 -21.42 65.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.13 0.972 . . . . 0.0 112.025 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -118.78 23.6 11.35 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.726 2.011 . . . . 0.0 111.811 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.04 146.78 54.57 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.13 14.86 0.26 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.742 1.617 . . . . 0.0 115.26 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -77.28 162.52 27.27 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.523 -1.361 . . . . 0.0 113.461 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -76.86 154.61 33.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.898 1.279 . . . . 0.0 112.203 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.39 -154.39 34.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.321 1.438 . . . . 0.0 112.233 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -69.74 157.68 36.85 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 111.29 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -121.71 151.61 40.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.091 1.356 . . . . 0.0 110.917 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.06 138.16 57.58 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.82 -0.55 . . . . 0.0 110.626 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.1 mt -102.38 106.08 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 mt -126.44 134.91 50.85 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.583 1.153 . . . . 0.0 108.567 -172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.68 133.5 41.94 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.9 137.65 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.589 1.556 . . . . 0.0 111.325 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 m -143.59 168.52 19.68 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.766 2.027 . . . . 0.0 111.004 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.5 m -145.8 136.6 24.41 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.529 1.132 . . . . 0.0 109.539 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -64.73 112.27 3.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.012 0.824 . . . . 0.0 109.345 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -142.64 134.41 26.84 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.341 1.056 . . . . 0.0 110.588 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.83 141.09 58.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.565 0.698 . . . . 0.0 112.129 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.878 -1.534 . . . . 0.0 111.47 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.248 0 C5'-C4'-C3' 109.804 -3.798 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 O4'-C1'-N19 111.402 3.202 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 1 O4'-C1'-N19 112.375 4.175 OUTLIER-EPSILON 0.058 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 1 P-O3'-C3' 125.647 4.956 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.636 0.975 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -122.21 97.97 5.72 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.691 2.396 . . . . 0.0 108.583 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.73 95.35 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.396 1.479 . . . . 0.0 109.332 -164.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -86.57 151.77 23.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.655 0.74 . . . . 0.0 112.241 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.3 126.43 38.98 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.877 1.671 . . . . 0.0 108.983 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -104.1 136.66 43.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.704 1.602 . . . . 0.0 111.424 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.62 99.01 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.784 0.834 . . . . 0.0 110.245 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.94 -7.26 86.44 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.423 -0.798 . . . . 0.0 114.702 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -77.08 50.07 0.72 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.69 1.596 . . . . 0.0 112.662 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.5 mt 38.45 66.74 2.46 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.334 2.254 . . . . 0.0 113.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.83 15.82 0.44 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 125.198 3.932 . . . . 0.0 115.262 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.4 32.68 0.34 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.316 1.447 . . . . 0.0 111.764 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -127.53 52.0 1.87 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.821 2.048 . . . . 0.0 112.622 -164.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 44.45 55.89 5.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.468 1.507 . . . . 0.0 113.357 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.16 161.15 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.87 0.868 . . . . 0.0 111.606 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -147.06 154.61 41.37 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.502 1.121 . . . . 0.0 112.377 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -62.31 -29.37 70.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -66.44 -22.08 66.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.29 -38.97 49.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.979 0.912 . . . . 0.0 110.686 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.22 -44.12 80.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.175 0.99 . . . . 0.0 111.205 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -61.24 -45.08 96.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.064 1.345 . . . . 0.0 111.855 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -29.21 65.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.404 -0.81 . . . . 0.0 112.262 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.36 -73.19 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 168.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -120.87 117.97 28.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.553 1.07 . . . . 0.0 111.923 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 16.5 p -162.48 -31.36 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 163.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' CD ' ' H ' ' A' ' 25' ' ' SER . 30.0 Cg_endo -93.85 0.89 3.21 Favored 'Trans proline' 0 C--N 1.357 1.015 0 CA-C-N 122.932 2.083 . . . . 0.0 114.633 -170.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -78.59 179.45 7.1 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.292 1.837 . . . . 0.0 111.735 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.39 19.34 0.27 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.384 1.468 . . . . 0.0 116.598 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -141.47 140.05 33.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.938 1.695 . . . . 0.0 112.564 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -163.68 153.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.811 2.044 . . . . 0.0 108.672 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.7 tpp -166.08 -57.88 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.73 1.15 . . . . 0.0 110.897 154.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -156.21 147.12 22.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.96 144.08 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.953 1.301 . . . . 0.0 108.105 169.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.83 86.36 1.93 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 110.498 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 tt -103.18 146.29 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -172.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -132.05 149.85 52.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.301 1.84 . . . . 0.0 109.45 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -72.79 39.5 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.929 1.692 . . . . 0.0 114.3 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.82 -43.64 0.09 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.404 2.282 . . . . 0.0 110.718 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.25 128.67 34.33 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.87 0.868 . . . . 0.0 111.747 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.35 126.55 7.91 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.68 0.657 . . . . 0.0 112.382 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -139.16 150.97 46.23 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 122.898 1.332 . . . . 0.0 113.84 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 152.86 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 127.243 2.217 . . . . 0.0 108.978 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -140.14 90.31 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.234 1.414 . . . . 0.0 108.576 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -111.68 164.4 13.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.273 1.429 . . . . 0.0 112.402 -170.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -103.21 148.38 25.87 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.62 -1.3 . . . . 0.0 110.033 172.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.0 t30 69.69 105.34 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 129.05 2.94 . . . . 0.0 114.438 -156.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.89 -26.9 6.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.496 2.797 . . . . 0.0 113.393 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -65.26 -34.8 79.21 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.235 -0.916 . . . . 0.0 111.996 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.7 m -82.31 -20.07 38.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.77 -1.109 . . . . 0.0 113.578 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.92 -51.64 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.314 1.415 . . . . 0.0 108.979 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -71.25 -28.19 64.0 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 117.936 -1.03 . . . . 0.0 113.3 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -66.74 -47.95 70.68 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.619 1.099 . . . . 0.0 111.761 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.21 -25.95 66.37 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.947 -1.096 . . . . 0.0 112.328 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.03 -53.33 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.139 0.881 . . . . 0.0 110.198 167.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.96 -18.47 62.62 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.42 1.464 . . . . 0.0 113.532 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 74.4 m -78.15 -36.62 47.49 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 113.35 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -115.06 -42.38 3.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.503 1.121 . . . . 0.0 113.113 -169.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -72.55 23.53 0.06 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.693 1.997 . . . . 0.0 114.09 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -136.81 8.96 3.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.573 1.949 . . . . 0.0 111.404 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -93.76 116.69 29.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.434 1.494 . . . . 0.0 110.351 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.6 mtt -123.08 141.47 51.92 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.565 1.146 . . . . 0.0 111.859 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -133.05 171.58 13.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.521 1.528 . . . . 0.0 110.099 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.58 119.16 7.04 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.455 -0.778 . . . . 0.0 111.894 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.87 3.26 73.5 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -154.38 152.62 30.42 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 119.952 1.876 . . . . 0.0 113.968 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -147.43 148.69 31.55 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.274 1.43 . . . . 0.0 110.719 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.98 134.31 35.67 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.779 0.323 . . . . 0.0 110.571 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.7 mm -132.86 117.8 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.455 1.902 . . . . 0.0 107.701 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 mt -134.63 144.26 47.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.968 1.707 . . . . 0.0 109.74 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.48 138.95 46.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.29 140.79 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.918 1.287 . . . . 0.0 110.481 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -140.43 143.77 35.77 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.693 0.797 . . . . 0.0 109.9 167.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.7 p -149.34 142.4 24.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.703 0.764 . . . . 0.0 111.709 -172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.1 p -154.43 167.99 28.17 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.358 1.063 . . . . 0.0 110.405 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -148.48 141.9 25.28 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.969 0.508 . . . . 0.0 111.555 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.82 10.68 7.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.191 1.796 . . . . 0.0 113.116 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 . . . . . 0 C--O 1.249 1.07 0 C-N-CA 125.643 1.577 . . . . 0.0 109.936 168.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 1 O4'-C1'-N19 112.312 4.112 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.579 -2.321 1 O4'-C1'-N19 113.042 4.842 . 0.167 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.73 0 P-O3'-C3' 123.804 3.42 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.253 0 O4'-C1'-C2' 102.427 -2.838 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.539 0.764 0 N-CA-C 111.276 -0.317 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 125.82 29.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.164 0.986 . . . . 0.0 111.972 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -138.74 95.02 2.9 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 109.363 -164.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.01 149.04 43.61 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.442 -0.787 . . . . 0.0 111.183 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.96 122.23 29.7 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.065 1.346 . . . . 0.0 108.93 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t80 -96.44 130.36 43.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.172 1.789 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.84 91.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.181 0.993 . . . . 0.0 109.318 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 6' ' ' PHE . . . -77.93 4.88 56.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.997 1.284 . . . . 0.0 115.397 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -64.48 -162.98 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.58 1.952 . . . . 0.0 111.818 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -119.66 42.11 0.46 Allowed Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -77.19 54.83 4.81 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.087 3.191 . . . . 0.0 112.318 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.6 50.46 1.32 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.806 2.042 . . . . 0.0 109.376 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -142.49 168.74 19.02 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.086 2.554 . . . . 0.0 109.297 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -61.76 110.01 1.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.395 -0.816 . . . . 0.0 110.205 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.72 155.21 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.082 0.953 . . . . 0.0 112.41 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.1 m -133.55 155.17 50.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.149 1.779 . . . . 0.0 111.333 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -54.01 -25.68 22.43 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.924 1.29 . . . . 0.0 114.22 -167.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -53.65 -27.32 26.67 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.876 1.67 . . . . 0.0 113.32 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -75.13 -49.95 17.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.896 1.225 . . . . 0.0 112.379 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 mp -63.11 -28.1 69.84 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.045 -1.659 . . . . 0.0 111.514 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.06 -34.95 71.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.31 1.444 . . . . 0.0 113.335 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -35.07 79.52 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.984 1.265 . . . . 0.0 110.91 170.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.26 -77.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.828 1.251 . . . . 0.0 107.96 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -120.53 116.17 24.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.126 1.33 . . . . 0.0 111.122 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.577 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 p -158.66 -29.88 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 162.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 25' ' ' SER . 41.2 Cg_endo -86.82 0.17 7.82 Favored 'Trans proline' 0 C--N 1.357 0.977 0 CA-C-N 123.283 2.208 . . . . 0.0 113.995 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -79.36 171.91 14.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.467 1.507 . . . . 0.0 111.638 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.64 -15.7 80.51 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -87.04 121.21 29.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.873 1.337 . . . . 0.0 111.904 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 tp -154.54 146.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.26 0.624 . . . . 0.0 111.74 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mtm -159.84 -73.09 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.458 1.903 . . . . 0.0 110.129 162.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -143.8 160.63 40.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.965 1.706 . . . . 0.0 114.1 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 tt -133.15 124.67 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.113 1.765 . . . . 0.0 110.105 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -129.28 74.05 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.616 1.167 . . . . 0.0 112.012 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.3 tt -65.73 146.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.062 -1.024 . . . . 0.0 111.326 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -145.01 147.21 32.37 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 126.809 2.043 . . . . 0.0 108.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.96 143.35 51.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.785 0.434 . . . . 0.0 110.639 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 64.87 -53.87 0.31 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.609 1.964 . . . . 0.0 115.84 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -141.32 73.5 1.42 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.049 0.928 . . . . 0.0 112.289 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.72 160.93 51.66 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.544 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.77 160.44 38.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 122.839 1.304 . . . . 0.0 112.642 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -122.97 155.84 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.98 1.712 . . . . 0.0 109.024 169.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -136.3 88.69 2.4 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.941 1.296 . . . . 0.0 109.477 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.84 175.0 5.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.819 0.848 . . . . 0.0 111.296 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -117.02 151.89 35.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.145 1.778 . . . . 0.0 109.096 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.9 t30 66.51 92.24 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 127.537 2.335 . . . . 0.0 113.812 -160.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.58 -21.46 45.9 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.779 2.319 . . . . 0.0 113.34 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.99 -30.97 68.44 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.387 -0.821 . . . . 0.0 112.001 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.2 m -89.24 -25.08 21.92 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 117.719 -1.134 . . . . 0.0 113.478 168.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.29 -48.01 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 120.434 1.47 . . . . 0.0 109.274 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.92 -41.65 95.38 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.171 -0.919 . . . . 0.0 113.061 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.12 -38.25 79.17 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.638 1.108 . . . . 0.0 112.479 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -27.5 61.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.66 -58.49 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.598 1.09 . . . . 0.0 109.441 168.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.27 -19.17 65.22 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.42 -44.98 14.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.42 1.888 . . . . 0.0 114.409 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -106.41 -24.74 12.15 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.79 1.236 . . . . 0.0 113.753 -169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 t -72.63 35.78 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.328 2.251 . . . . 0.0 112.497 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -153.72 148.92 26.94 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.982 2.513 . . . . 0.0 109.216 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -135.27 -18.03 1.77 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.847 1.259 . . . . 0.0 111.32 164.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.9 mmt -126.75 162.93 24.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.989 2.515 . . . . 0.0 111.503 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -91.05 13.11 17.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.82 1.248 . . . . 0.0 112.395 168.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -142.02 142.2 32.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.691 1.196 . . . . 0.0 111.141 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.17 -160.27 46.11 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.793 0.711 . . . . 0.0 113.653 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -132.79 132.22 41.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.394 1.478 . . . . 0.0 110.665 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -128.53 -33.27 2.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.179 1.392 . . . . 0.0 112.915 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -125.93 122.69 36.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.062 1.345 . . . . 0.0 108.71 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.49 109.15 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.351 1.461 . . . . 0.0 108.158 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.14 141.75 47.58 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.328 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -139.2 134.91 33.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.807 1.185 . . . . 0.0 113.291 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -90.29 146.43 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.769 1.228 . . . . 0.0 110.551 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 155.73 44.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.692 0.797 . . . . 0.0 110.276 165.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -103.6 158.66 16.21 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.431 0.692 . . . . 0.0 109.922 166.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -73.16 173.51 9.31 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 112.108 172.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -98.53 14.4 28.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.991 0.916 . . . . 0.0 111.905 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.7 172.53 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.176 1.79 . . . . 0.0 111.873 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 116.859 -1.543 . . . . 0.0 113.677 -176.095 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 111.292 3.092 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.467 0 O4'-C1'-N19 111.44 3.24 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . 0.488 " H3'" H5'' ' B' ' 81' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.154 0 O4'-C1'-N19 111.551 3.351 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . 0.488 H5'' " H3'" ' B' ' 80' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.595 0 O4'-C4'-C3' 108.72 2.3 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 CA--C 1.535 0.531 0 CA-C-O 120.681 0.2 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 142.63 49.28 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.142 1.377 . . . . 0.0 111.673 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 t -142.93 140.48 31.16 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.954 1.702 . . . . 0.0 109.184 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -113.59 145.56 41.07 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.618 0.767 . . . . 0.0 110.31 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -131.72 126.12 33.73 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.644 1.577 . . . . 0.0 109.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.3 132.28 54.31 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.37 94.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.15 43.25 2.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.708 1.147 . . . . 0.0 112.911 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -114.45 32.92 5.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.586 1.554 . . . . 0.0 113.132 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.8 tp 43.08 72.53 1.14 Allowed Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.885 2.874 . . . . 0.0 113.986 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.5 1.52 6.76 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.67 2.913 . . . . 0.0 113.091 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.18 32.15 0.18 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 114.421 -172.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -146.71 -56.61 0.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.805 -1.184 . . . . 0.0 111.583 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -145.07 134.42 23.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 110.843 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -157.01 149.84 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.208 1.003 . . . . 0.0 111.084 169.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 m -135.63 155.84 49.79 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.098 1.759 . . . . 0.0 110.172 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -50.04 -33.8 19.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.154 1.382 . . . . 0.0 114.101 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.3 -23.29 47.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.92 -48.54 58.12 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.017 -1.052 . . . . 0.0 111.581 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.91 -33.62 68.45 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.037 -1.04 . . . . 0.0 111.099 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -61.18 -43.81 98.29 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 171.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -27.23 62.69 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.185 -0.947 . . . . 0.0 111.839 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.22 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.789 0.835 . . . . 0.0 109.525 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -122.1 114.8 21.4 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.794 1.179 . . . . 0.0 111.037 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.453 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 23.1 t -151.81 -40.54 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 117.239 -1.362 . . . . 0.0 114.654 170.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' H ' ' A' ' 25' ' ' SER . 22.7 Cg_endo -96.6 15.91 0.79 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.26 2.64 . . . . 0.0 114.125 -172.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -78.42 22.87 0.32 Allowed 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.455 -1.403 . . . . 0.0 114.4 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.26 -13.93 13.61 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.476 1.988 . . . . 0.0 116.517 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.51 156.17 49.33 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.114 1.366 . . . . 0.0 110.307 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -165.14 165.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.01 0.924 . . . . 0.0 110.811 -161.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -155.68 -69.24 0.12 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 156.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -143.36 165.04 28.6 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.451 1.5 . . . . 0.0 113.671 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 tp -113.83 133.84 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.709 2.004 . . . . 0.0 110.018 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -129.9 55.53 1.78 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 110.416 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.2 tt -70.05 146.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.672 -1.267 . . . . 0.0 111.225 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -134.49 156.52 48.46 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.797 1.639 . . . . 0.0 110.254 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.51 10.73 0.75 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.766 1.226 . . . . 0.0 113.698 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.68 -60.82 0.44 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.832 1.253 . . . . 0.0 112.238 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -141.89 101.58 3.98 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.207 1.403 . . . . 0.0 109.457 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.27 152.93 42.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.78 0.705 . . . . 0.0 113.514 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -131.93 157.49 43.87 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.875 1.27 . . . . 0.0 112.406 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mt -115.55 150.38 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.143 1.777 . . . . 0.0 108.53 165.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -140.15 102.68 4.43 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.226 0.466 . . . . 0.0 110.268 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -119.26 161.01 21.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.249 1.419 . . . . 0.0 112.841 -169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -78.12 161.86 27.07 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.745 0.818 . . . . 0.0 109.999 164.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 53.89 90.04 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.769 2.028 . . . . 0.0 113.937 -172.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.99 -25.65 81.87 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.078 2.519 . . . . 0.0 114.523 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -72.69 -25.47 61.25 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.923 0.783 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -66.73 -42.63 85.95 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.29 0.95 . . . . 0.0 111.462 167.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -68.31 -42.79 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.603 1.161 . . . . 0.0 110.952 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -66.49 -45.39 79.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.668 0.787 . . . . 0.0 111.931 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.72 -34.63 74.69 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.59 0.756 . . . . 0.0 112.357 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.8 -27.62 63.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.68 -48.54 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.958 -1.714 . . . . 0.0 110.505 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.32 2.3 7.8 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.7 t -98.99 -33.05 10.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.877 1.671 . . . . 0.0 112.899 169.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -122.11 -28.26 4.42 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 t -88.08 12.67 12.95 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.954 1.302 . . . . 0.0 112.314 170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -147.1 140.82 25.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.693 1.997 . . . . 0.0 110.399 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.19 169.29 20.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 111.73 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttt -136.43 -4.86 2.06 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -118.04 -17.5 9.65 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.121 1.768 . . . . 0.0 113.495 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -133.42 134.06 43.14 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.336 1.454 . . . . 0.0 111.063 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.46 125.45 10.45 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.77 0.7 . . . . 0.0 111.685 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -130.94 143.62 50.86 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.905 0.882 . . . . 0.0 112.069 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -127.83 12.82 6.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.756 2.022 . . . . 0.0 113.469 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 pp -69.88 154.25 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.382 0.673 . . . . 0.0 111.543 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -124.29 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.593 1.157 . . . . 0.0 109.708 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.8 mt -124.94 138.21 54.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.193 1.397 . . . . 0.0 108.917 165.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -132.36 131.31 41.76 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.178 0.991 . . . . 0.0 110.799 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.75 140.38 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.214 1.006 . . . . 0.0 111.485 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.1 t -134.99 117.64 15.98 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.354 1.062 . . . . 0.0 110.126 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -151.86 161.69 42.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.866 0.866 . . . . 0.0 112.28 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.6 t -129.15 141.33 51.21 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.005 0.922 . . . . 0.0 112.22 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -144.28 173.21 11.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.699 1.999 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.32 148.44 48.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.213 1.005 . . . . 0.0 112.129 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.524 1.53 . . . . 0.0 111.162 -176.118 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.254 1 O4'-C1'-N19 112.652 4.452 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.485 1 O4'-C1'-N19 112.489 4.289 . 0.093 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.409 -3.686 0 O4'-C1'-N19 111.169 2.969 . 0.01 4g . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.571 -2.982 1 O4'-C1'-N19 113.398 5.198 . 0.159 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo . . . . . 0 CA--C 1.533 0.474 0 N-CA-C 112.954 0.328 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 105.06 5.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.227 1.011 . . . . 0.0 110.013 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 t -128.74 140.39 51.75 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.143 0.977 . . . . 0.0 111.294 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -112.25 150.41 30.96 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.952 0.901 . . . . 0.0 112.169 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.07 122.89 35.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.425 1.89 . . . . 0.0 108.707 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -103.59 148.36 26.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.843 1.657 . . . . 0.0 111.524 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.09 135.48 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.537 1.535 . . . . 0.0 110.447 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.41 172.56 2.66 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.568 1.08 . . . . 0.0 113.756 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -69.67 33.66 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 118.292 2.701 . . . . 0.0 118.292 -161.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.59 -32.97 0.39 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 126.4 1.88 . . . . 0.0 115.307 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.05 -7.23 20.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 123.612 2.326 . . . . 0.0 114.271 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.72 -5.41 8.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.87 1.268 . . . . 0.0 113.254 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -122.68 -38.54 2.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.635 1.974 . . . . 0.0 113.959 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -146.47 127.88 14.95 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.472 1.509 . . . . 0.0 109.113 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.39 127.94 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.438 0.695 . . . . 0.0 111.611 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -152.8 143.32 22.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.093 1.357 . . . . 0.0 109.972 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -57.21 -30.08 64.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.419 1.009 . . . . 0.0 112.426 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.09 -28.95 68.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.896 1.678 . . . . 0.0 113.235 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.43 -45.65 58.65 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.423 1.089 . . . . 0.0 111.514 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.82 -40.93 97.79 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 121.496 -0.752 . . . . 0.0 110.252 173.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.4 -45.28 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.422 1.089 . . . . 0.0 112.424 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.17 82.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.347 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.9 mt -61.02 -74.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 124.92 1.288 . . . . 0.0 108.494 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 8.8 m-30 -124.53 124.42 42.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.528 1.058 . . . . 0.0 111.444 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.594 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 4.3 m -157.93 -34.31 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 156.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 25' ' ' SER . 56.8 Cg_endo -85.25 5.17 6.33 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 CA-C-N 122.902 2.072 . . . . 0.0 113.686 -176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.46 -21.34 30.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.08 -157.76 12.87 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 120.084 1.311 . . . . 0.0 116.0 -171.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -68.93 -25.99 64.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.269 1.4 mp 63.72 167.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.213 1.405 . . . . 0.0 113.731 170.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.1 mtm -153.04 -72.74 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.388 -1.445 . . . . 0.0 109.889 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.01 150.21 32.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.538 1.135 . . . . 0.0 113.281 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.7 mt -82.46 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 161.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -135.73 66.12 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.423 1.106 . . . . 0.0 111.074 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.1 tt -83.19 150.96 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.11 0.964 . . . . 0.0 111.883 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -114.4 -175.98 2.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.379 1.872 . . . . 0.0 111.299 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -79.59 -15.03 58.39 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.03 -10.65 2.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 171.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.41 159.2 35.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 112.837 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.03 124.36 5.99 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.427 -0.651 . . . . 0.0 111.584 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' CE2' ' C6 ' ' B' ' 80' ' ' ' U' . 7.9 m-85 -128.62 149.19 50.75 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.829 1.299 . . . . 0.0 111.802 164.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.95 149.33 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 126.617 1.967 . . . . 0.0 107.818 166.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -137.08 100.66 4.34 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.049 0.94 . . . . 0.0 108.631 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -124.19 153.91 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.027 1.731 . . . . 0.0 112.837 -167.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -81.36 155.34 26.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.274 0.629 . . . . 0.0 110.695 166.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 59.99 95.65 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 130.226 3.41 . . . . 0.0 116.333 -167.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -67.26 -18.03 50.23 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.449 2.766 . . . . 0.0 113.46 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -74.76 -27.83 60.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.433 1.015 . . . . 0.0 111.636 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 m -75.47 -39.24 58.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.562 0.619 . . . . 0.0 111.914 170.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.21 -41.99 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.919 0.487 . . . . 0.0 110.598 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -61.91 -49.16 77.29 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.199 -0.905 . . . . 0.0 112.307 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -55.7 -41.82 74.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.833 0.742 . . . . 0.0 111.591 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -66.35 -34.34 77.76 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.399 177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.2 mt -63.42 -50.49 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.509 1.504 . . . . 0.0 111.025 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.1 -12.49 61.23 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.15 -20.72 17.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.377 1.471 . . . . 0.0 113.241 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -125.48 -29.56 3.2 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -91.32 -1.53 57.62 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.766 1.226 . . . . 0.0 112.927 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -138.71 152.09 47.7 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.661 1.984 . . . . 0.0 108.872 -172.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 56.43 90.19 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.278 1.431 . . . . 0.0 112.896 -169.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -76.12 23.37 0.14 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.567 1.547 . . . . 0.0 113.992 -173.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -130.12 12.75 5.64 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.862 2.465 . . . . 0.0 112.385 169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -150.49 -27.38 0.23 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.782 1.633 . . . . 0.0 112.501 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.05 -151.98 12.41 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.046 2.26 . . . . 0.0 111.675 154.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -122.19 165.83 15.54 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.45 2.3 . . . . 0.0 110.889 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -69.33 10.11 0.37 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -73.38 131.3 41.7 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.393 1.077 . . . . 0.0 111.088 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.15 129.29 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.5 mt -134.9 140.68 45.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.259 1.824 . . . . 0.0 108.503 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.2 137.75 34.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.98 0.809 . . . . 0.0 112.841 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.81 142.0 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.742 1.217 . . . . 0.0 112.606 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t -143.29 171.6 13.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.723 2.009 . . . . 0.0 109.826 171.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.1 m -142.84 36.89 1.43 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.257 1.423 . . . . 0.0 111.268 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.1 t -146.24 137.89 24.8 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.094 0.957 . . . . 0.0 113.169 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.77 11.92 35.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.471 1.509 . . . . 0.0 113.519 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.62 158.87 28.32 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.037 -1.039 . . . . 0.0 111.487 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 C--O 1.248 1.017 0 C-N-CA 125.778 1.631 . . . . 0.0 112.024 -175.372 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C3'-C2'-C1' 99.283 -2.463 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.816 0 O4'-C1'-N19 111.514 3.314 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . 0.408 ' C6 ' ' CE2' ' A' ' 41' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.414 1 O4'-C1'-N19 112.276 4.076 . 0.236 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.285 1 O4'-C1'-N19 114.056 5.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.536 0.62 0 N-CA-C 112.615 0.198 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.45 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.865 2.066 . . . . 0.0 108.2 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -135.27 123.67 23.32 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.375 1.07 . . . . 0.0 109.75 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -88.48 151.72 22.35 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.842 0.829 . . . . 0.0 112.197 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.38 129.46 53.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.23 1.812 . . . . 0.0 107.541 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -109.86 134.78 51.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.208 1.403 . . . . 0.0 110.555 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.442 ' HB ' ' H ' ' A' ' 40' ' ' GLY . 12.0 mm -94.93 116.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.345 1.058 . . . . 0.0 108.712 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.82 149.51 25.09 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 119.566 -0.575 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -55.32 72.02 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.628 2.771 . . . . 0.0 115.148 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.533 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 94.9 mt -126.19 -37.75 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 127.911 2.485 . . . . 0.0 113.832 170.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 40.8 Cg_endo -83.8 59.47 6.22 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.782 2.321 . . . . 0.0 112.119 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.126 1.37 . . . . 0.0 113.021 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.93 146.84 45.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.042 1.337 . . . . 0.0 113.43 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.8 t30 35.83 59.82 0.84 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.237 2.215 . . . . 0.0 114.289 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.49 138.34 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.871 0.843 . . . . 0.0 111.789 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -120.08 159.96 23.78 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.862 1.665 . . . . 0.0 110.263 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.42 -17.54 2.01 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.05 -1.031 . . . . 0.0 113.173 161.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -74.26 -23.45 59.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.326 1.051 . . . . 0.0 112.999 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.19 -35.95 63.99 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.803 -1.185 . . . . 0.0 110.732 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.32 -43.51 98.65 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.685 -1.26 . . . . 0.0 110.639 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.11 -44.2 96.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.091 0.956 . . . . 0.0 112.554 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -64.0 -36.64 84.65 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.13 -0.981 . . . . 0.0 111.574 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.5 mt -63.67 -70.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.154 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.86 125.14 45.76 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 120.136 1.334 . . . . 0.0 111.394 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 17.5 m -158.73 -37.77 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 126.027 1.731 . . . . 0.0 113.588 164.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.2 Cg_endo -83.84 34.53 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.469 2.113 . . . . 0.0 113.311 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.33 123.35 16.61 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.643 1.577 . . . . 0.0 110.722 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.35 -160.1 53.93 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.581 0.61 . . . . 0.0 113.487 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -107.24 -5.08 18.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.934 1.294 . . . . 0.0 113.904 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 1.6 mp 67.57 154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.771 2.028 . . . . 0.0 114.404 171.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.5 mmt -151.66 -56.44 0.15 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.758 1.623 . . . . 0.0 110.5 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -159.12 148.65 18.78 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.626 1.103 . . . . 0.0 113.645 -170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 147.7 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 124.191 0.996 . . . . 0.0 111.169 163.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -147.66 101.85 3.37 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.298 0.954 . . . . 0.0 111.688 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.47 149.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.312 -1.493 . . . . 0.0 113.056 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -123.88 156.12 36.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.115 1.366 . . . . 0.0 111.329 167.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -65.39 22.91 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 127.395 2.278 . . . . 0.0 116.941 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.08 -33.11 0.12 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.485 1.514 . . . . 0.0 112.667 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -152.82 156.04 38.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.865 1.666 . . . . 0.0 110.217 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 7' ' ' ILE . . . -102.23 152.44 18.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.657 0.646 . . . . 0.0 113.699 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -122.74 156.21 34.91 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 123.254 1.502 . . . . 0.0 111.683 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.65 152.86 34.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.98 2.112 . . . . 0.0 107.334 166.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -136.14 101.27 4.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -121.52 155.0 35.92 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.943 1.297 . . . . 0.0 112.024 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -75.47 157.01 34.65 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 122.937 0.495 . . . . 0.0 111.218 164.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 68.34 82.29 0.19 Allowed Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 128.797 2.839 . . . . 0.0 115.517 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -57.93 -37.71 95.07 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.592 2.861 . . . . 0.0 113.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -66.59 -34.31 77.61 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.197 -0.939 . . . . 0.0 112.822 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.7 m -87.06 -21.48 26.04 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -43.98 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.205 0.911 . . . . 0.0 109.836 162.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -63.03 -40.37 97.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.984 0.914 . . . . 0.0 112.461 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.24 -35.96 74.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.263 0.625 . . . . 0.0 112.374 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.64 61.78 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.611 0.764 . . . . 0.0 112.778 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.1 mt -64.66 -53.11 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 120.94 -1.1 . . . . 0.0 109.485 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -67.02 -9.54 40.17 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -94.76 -33.13 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.122 1.769 . . . . 0.0 113.966 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -127.83 -15.91 4.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 t -74.97 33.2 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 111.519 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -147.73 143.72 27.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.324 2.65 . . . . 0.0 108.021 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.61 162.75 32.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.501 1.12 . . . . 0.0 109.352 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -58.08 140.82 51.85 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.324 0.65 . . . . 0.0 110.449 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -66.57 103.43 1.07 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.109 0.564 . . . . 0.0 111.888 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -153.77 26.5 0.5 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.909 1.684 . . . . 0.0 111.986 -170.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.56 12.13 83.93 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 120.647 -1.283 . . . . 0.0 115.078 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -141.36 151.1 43.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.81 1.644 . . . . 0.0 114.42 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -156.41 136.35 12.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.98 1.712 . . . . 0.0 110.702 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -79.73 142.68 35.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.258 0.935 . . . . 0.0 111.192 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.4 123.82 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.033 1.333 . . . . 0.0 109.317 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 mt -128.92 143.24 50.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.44 1.896 . . . . 0.0 109.057 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -140.09 135.36 32.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.03 0.832 . . . . 0.0 112.59 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.16 144.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.95 0.9 . . . . 0.0 111.095 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.31 129.61 23.84 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.846 1.258 . . . . 0.0 110.46 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -125.13 17.7 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.207 1.003 . . . . 0.0 112.784 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -149.91 151.43 33.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.155 1.382 . . . . 0.0 110.659 170.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -66.92 142.73 57.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.459 1.104 . . . . 0.0 112.955 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.99 21.46 0.88 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.869 1.268 . . . . 0.0 113.342 -168.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 124.871 1.268 . . . . 0.0 112.538 -176.485 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.551 3.351 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 0 O4'-C1'-N19 111.702 3.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O5'-C5'-C4' 114.184 2.846 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.339 0 O4'-C1'-N19 111.358 3.158 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.546 1.106 0 N-CA-C 115.773 1.413 . . . . 0.0 115.773 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt 65.12 124.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.191 2.597 . . . . 0.0 116.586 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -147.9 172.56 13.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.975 1.71 . . . . 0.0 111.412 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -135.08 161.58 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.153 1.381 . . . . 0.0 113.285 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.19 129.65 31.97 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.937 1.695 . . . . 0.0 110.309 -171.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -111.12 141.69 44.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.781 1.632 . . . . 0.0 111.92 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 mm -101.6 96.76 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.709 1.604 . . . . 0.0 110.291 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 -3.66 84.84 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.409 1.481 . . . . 0.0 115.404 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 47.02 0.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.02 1.91 . . . . 0.0 113.664 177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 40.93 59.35 8.24 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 126.392 1.877 . . . . 0.0 113.589 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.45 25.88 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.027 3.818 . . . . 0.0 114.543 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.25 -12.99 46.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.26 1.424 . . . . 0.0 113.252 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.64 137.16 51.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.837 1.655 . . . . 0.0 112.303 -167.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 50.95 48.65 22.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.304 1.442 . . . . 0.0 114.062 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 m -112.45 146.15 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 122.574 1.178 . . . . 0.0 113.135 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -146.7 166.76 25.61 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 109.694 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 25.2 mmtp -50.45 -32.04 16.79 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.266 -0.896 . . . . 0.0 112.752 172.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -69.23 -20.66 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.456 1.102 . . . . 0.0 113.459 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.89 -48.26 32.2 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.629 1.104 . . . . 0.0 110.848 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.61 -35.79 79.61 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -71.52 -40.25 70.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.904 0.882 . . . . 0.0 112.989 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -25.53 60.78 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.627 1.103 . . . . 0.0 112.527 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.38 -74.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 9.4 m-30 -124.14 125.39 44.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.626 1.557 . . . . 0.0 112.13 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.421 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 40.6 t -149.62 -54.25 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.509 1.299 . . . . 0.0 114.509 161.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 25' ' ' SER . 43.7 Cg_endo -83.06 22.47 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.203 2.602 . . . . 0.0 114.085 -171.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -90.39 -33.03 16.19 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 120.328 -1.483 . . . . 0.0 114.844 -172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.1 -161.07 11.9 Favored Glycine 0 N--CA 1.469 0.882 0 CA-C-N 119.122 0.874 . . . . 0.0 114.16 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.14 -24.56 63.19 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 mp 66.91 161.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.83 1.252 . . . . 0.0 113.25 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.36 -59.37 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.622 -1.299 . . . . 0.0 111.019 161.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -145.29 138.98 26.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.148 0.979 . . . . 0.0 111.918 -169.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tt -123.38 127.31 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.74 1.616 . . . . 0.0 110.056 172.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 5.2 p30 -128.8 152.81 48.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.767 1.227 . . . . 0.0 111.616 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -141.87 154.07 19.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 121.083 -1.011 . . . . 0.0 112.154 -178.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.538 ' H ' HD13 ' A' ' 35' ' ' ILE . 42.1 tptt -149.38 146.99 27.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.301 1.441 . . . . 0.0 110.91 -171.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -57.34 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 128.539 2.736 . . . . 0.0 116.872 168.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.95 -63.9 0.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.778 1.631 . . . . 0.0 110.669 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -141.46 111.82 6.92 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.985 0.914 . . . . 0.0 110.96 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.72 151.28 33.84 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.549 0.595 . . . . 0.0 112.482 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.37 156.08 46.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.714 1.245 . . . . 0.0 111.83 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.67 143.55 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.942 0.897 . . . . 0.0 109.221 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -127.67 98.44 5.2 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.582 1.153 . . . . 0.0 108.142 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -120.78 151.24 39.83 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.595 1.158 . . . . 0.0 111.672 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.03 159.99 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.756 168.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 64.74 82.73 0.21 Allowed Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 127.701 2.4 . . . . 0.0 112.818 -160.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -51.69 -33.05 47.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.14 3.227 . . . . 0.0 113.887 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -77.11 -23.38 51.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.838 0.855 . . . . 0.0 112.942 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.1 m -69.91 -41.98 73.97 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 163.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.76 -43.33 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.047 0.539 . . . . 0.0 110.569 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.97 -43.77 67.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.168 0.895 . . . . 0.0 113.234 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.41 -33.65 75.2 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.37 0.986 . . . . 0.0 111.731 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -67.08 -29.18 68.88 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.287 -0.883 . . . . 0.0 112.97 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.65 -53.0 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.298 1.408 . . . . 0.0 110.4 170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.45 -15.92 63.93 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.4 m -84.22 -45.72 12.6 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.645 1.178 . . . . 0.0 113.68 168.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -104.0 -29.31 11.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 t -74.89 1.28 13.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.71 0.804 . . . . 0.0 111.598 164.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.77 128.96 38.06 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.937 -1.102 . . . . 0.0 110.832 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.24 138.12 43.46 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.499 0.72 . . . . 0.0 111.785 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.0 mtt -140.37 155.67 46.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.613 1.565 . . . . 0.0 111.597 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -65.51 157.78 28.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.811 0.844 . . . . 0.0 111.943 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 57.7 38.11 27.46 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.586 1.954 . . . . 0.0 113.75 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -164.05 19.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 -170.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -123.9 138.94 54.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.413 1.885 . . . . 0.0 111.155 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -74.02 115.21 13.22 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.89 146.82 45.89 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.623 0.769 . . . . 0.0 109.219 171.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.4 107.74 19.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -170.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 mt -127.25 139.96 52.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.542 1.137 . . . . 0.0 109.354 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -131.64 138.13 48.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.451 0.569 . . . . 0.0 112.303 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.07 130.61 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.2 t -133.97 148.79 51.19 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.151 . . . . 0.0 109.632 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.2 m -132.63 135.82 46.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 p -101.98 14.1 32.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.731 2.013 . . . . 0.0 112.674 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -69.52 148.54 49.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.592 1.557 . . . . 0.0 110.681 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.27 143.74 56.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.622 -0.674 . . . . 0.0 111.835 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.21 -1.853 . . . . 0.0 111.735 -179.318 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.301 0 O4'-C1'-N19 111.897 3.697 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 0 O4'-C1'-N19 110.815 2.615 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.018 0 C3'-C2'-C1' 99.335 -2.406 . 0.41 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.303 0 O4'-C1'-N19 111.964 3.764 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 N-CA-C 111.409 -0.266 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.52 134.69 41.7 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.905 0.882 . . . . 0.0 111.554 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -146.87 155.76 42.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.63 1.572 . . . . 0.0 109.304 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -121.14 161.13 22.35 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.755 0.788 . . . . 0.0 112.663 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.8 121.89 19.04 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.478 1.911 . . . . 0.0 108.291 -174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -104.35 134.64 47.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.738 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 mm -91.49 132.18 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.742 0.817 . . . . 0.0 108.834 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -155.38 5.63 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.044 0.831 . . . . 0.0 113.104 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.6 83.39 0.43 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.217 -1.166 . . . . 0.0 111.591 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' H ' ' CD ' ' A' ' 11' ' ' PRO . 58.2 tp -139.44 -41.71 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.996 1.718 . . . . 0.0 115.011 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 10' ' ' LEU . 21.4 Cg_endo -93.51 17.75 1.03 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.255 1.97 . . . . 0.0 114.488 -162.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.33 22.83 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 131.75 27.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.267 2.227 . . . . 0.0 110.754 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 t30 40.15 47.71 2.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.353 1.461 . . . . 0.0 113.728 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.61 125.9 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 123.7 0.8 . . . . 0.0 110.965 -161.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.2 t -159.83 151.41 20.01 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.365 1.466 . . . . 0.0 110.599 -167.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -61.4 -16.73 49.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -69.73 -33.78 72.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.485 0.584 . . . . 0.0 112.345 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.2 -35.78 74.14 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.207 1.367 . . . . 0.0 112.036 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.42 -39.46 71.07 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -61.95 -38.42 88.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.994 0.918 . . . . 0.0 112.392 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -36.4 82.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.687 0.795 . . . . 0.0 110.938 174.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.36 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -122.53 121.08 35.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.854 1.206 . . . . 0.0 111.717 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.646 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.9 p -150.51 -30.1 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 159.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' A' ' 25' ' ' SER . 44.5 Cg_endo -81.92 26.2 0.63 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.242 2.194 . . . . 0.0 113.265 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -121.62 137.24 54.82 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.592 1.957 . . . . 0.0 110.67 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.1 -159.42 49.7 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 121.841 0.69 . . . . 0.0 114.431 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -100.8 -7.68 23.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.229 1.012 . . . . 0.0 113.543 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 67.85 142.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.025 2.13 . . . . 0.0 115.372 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 mmt -138.73 -81.71 0.31 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.953 1.301 . . . . 0.0 111.018 170.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -137.55 162.18 34.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.301 1.841 . . . . 0.0 113.583 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 tt -149.64 121.64 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.728 1.211 . . . . 0.0 110.977 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -127.87 101.92 6.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.472 1.109 . . . . 0.0 111.556 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 tp -89.16 135.95 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.63 0.772 . . . . 0.0 112.114 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -120.88 165.95 14.48 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.209 1.803 . . . . 0.0 110.38 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -78.15 -18.82 55.1 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 -4.94 9.35 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -164.36 179.54 6.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.25 1.82 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.57 159.02 27.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 120.573 -1.329 . . . . 0.0 114.763 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.36 149.85 51.85 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.532 1.533 . . . . 0.0 112.084 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.8 150.27 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 127.024 2.13 . . . . 0.0 108.334 171.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -132.9 113.99 13.51 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 167.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -125.96 155.54 41.2 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.532 1.158 . . . . 0.0 112.308 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -80.3 144.53 32.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.686 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 80.03 82.03 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.382 3.073 . . . . 0.0 115.155 -170.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -58.53 -38.68 88.65 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.22 3.28 . . . . 0.0 114.494 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.01 -29.18 67.32 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.98 -1.075 . . . . 0.0 111.855 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -68.76 -35.0 76.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.49 -40.1 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.437 0.695 . . . . 0.0 109.691 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -65.81 -40.1 91.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.527 170.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.85 -38.34 81.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.2 0.909 . . . . 0.0 111.191 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -32.41 70.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.529 0.731 . . . . 0.0 112.693 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.27 -50.38 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.265 1.393 . . . . 0.0 110.395 170.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.22 -12.27 61.53 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.323 0.965 . . . . 0.0 113.393 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -96.86 -28.86 14.04 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -108.53 -56.3 2.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.398 1.479 . . . . 0.0 111.994 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.72 -14.34 58.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.737 1.215 . . . . 0.0 113.151 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.33 10.48 8.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.802 1.641 . . . . 0.0 112.733 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -78.71 137.38 37.75 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.835 -1.165 . . . . 0.0 110.714 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.5 ttt 56.42 34.54 24.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.93 1.292 . . . . 0.0 112.51 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -58.72 -7.66 1.06 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.535 1.934 . . . . 0.0 115.714 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -104.32 -2.9 24.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.642 1.577 . . . . 0.0 113.27 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.18 -27.76 1.08 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.715 1.626 . . . . 0.0 114.898 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -148.96 156.75 42.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.181 2.193 . . . . 0.0 110.551 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -125.8 137.15 53.77 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 112.572 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.31 137.3 51.89 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.314 1.446 . . . . 0.0 109.993 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -111.35 114.09 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.487 1.115 . . . . 0.0 108.986 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 mt -129.49 148.49 51.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.298 2.239 . . . . 0.0 107.536 166.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -142.42 130.17 21.6 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.81 138.9 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.406 1.482 . . . . 0.0 112.664 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.3 t -135.38 148.76 49.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 112.766 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.4 p -133.91 16.97 3.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.169 1.387 . . . . 0.0 112.49 167.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.9 m -94.43 16.17 15.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.304 1.442 . . . . 0.0 113.726 -173.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -93.97 14.6 19.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.379 1.872 . . . . 0.0 112.651 -173.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.83 13.94 7.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.866 1.666 . . . . 0.0 112.024 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 127.182 2.193 . . . . 0.0 113.742 -175.096 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 O4'-C1'-N19 111.061 2.861 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 C5'-C4'-C3' 110.423 -3.385 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.595 1 O4'-C1'-N19 112.522 4.322 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0a' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 O4'-C1'-N19 111.181 2.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.541 0.855 0 CA-C-O 120.102 -0.041 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.66 140.43 40.82 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.117 0.967 . . . . 0.0 113.209 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 141.89 15.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.575 1.55 . . . . 0.0 110.355 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -116.77 145.73 43.3 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.946 0.898 . . . . 0.0 111.717 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.88 124.42 44.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 125.533 1.533 . . . . 0.0 108.739 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -108.86 135.83 49.42 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.2 mm -90.72 80.17 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.089 1.356 . . . . 0.0 110.776 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.4 -4.3 12.28 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.18 1.371 . . . . 0.0 115.164 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -65.19 -10.81 34.43 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.649 1.98 . . . . 0.0 114.248 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.6 mt 48.53 63.79 9.76 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.066 1.746 . . . . 0.0 113.803 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.99 45.25 1.75 Allowed 'Trans proline' 0 CA--C 1.547 1.133 1 C-N-CA 125.663 4.242 . . . . 0.0 113.679 -173.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -50.43 -23.69 2.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.023 2.129 . . . . 0.0 115.998 -166.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.05 2.8 5.88 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.538 2.335 . . . . 0.0 114.075 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -135.67 61.62 1.65 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 110.8 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -124.58 117.89 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.789 1.235 . . . . 0.0 110.965 -173.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.1 t -155.38 151.95 28.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.87 2.068 . . . . 0.0 109.785 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -50.59 -34.09 24.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.549 1.14 . . . . 0.0 112.99 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -68.69 -22.38 64.37 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.09 -35.14 64.18 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.339 -1.475 . . . . 0.0 111.24 174.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -71.55 -40.89 69.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.376 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -69.29 -38.45 78.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.825 0.85 . . . . 0.0 113.184 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -28.1 65.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.031 -1.043 . . . . 0.0 112.217 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.68 -77.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.638 1.175 . . . . 0.0 108.526 168.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -117.53 112.36 20.49 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.693 1.133 . . . . 0.0 111.588 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.525 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 42.8 t -159.95 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.665 1.586 . . . . 0.0 112.294 167.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 25' ' ' SER . 50.4 Cg_endo -87.96 17.15 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 115.358 -171.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -90.29 1.32 56.65 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.542 1.137 . . . . 0.0 114.043 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.45 19.47 76.32 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 119.474 1.034 . . . . 0.0 113.905 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -137.75 137.43 38.27 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.595 1.158 . . . . 0.0 110.066 171.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 tp -158.28 163.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.543 1.137 . . . . 0.0 109.517 -170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 37.5 tpp -164.59 -67.35 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.668 0.787 . . . . 0.0 110.49 150.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -139.81 144.19 37.22 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.889 1.676 . . . . 0.0 111.953 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 pt -107.85 141.85 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.107 0.963 . . . . 0.0 110.846 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -145.31 72.36 1.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.684 1.193 . . . . 0.0 110.464 -172.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 tt -90.78 138.11 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.863 -1.148 . . . . 0.0 113.118 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.85 157.0 30.74 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 110.371 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.02 8.53 0.53 Allowed 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -168.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.8 -51.33 0.67 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.349 1.46 . . . . 0.0 111.901 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -147.73 138.32 23.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.396 1.078 . . . . 0.0 110.738 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.99 160.09 30.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -127.18 152.71 47.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.898 1.279 . . . . 0.0 111.632 167.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.33 145.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.615 1.566 . . . . 0.0 108.246 165.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -130.42 87.94 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.633 1.573 . . . . 0.0 107.088 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -115.13 169.68 8.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.619 1.568 . . . . 0.0 112.573 -167.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -91.35 177.52 6.22 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.181 1.393 . . . . 0.0 111.333 168.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 49.15 81.03 0.27 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.741 2.416 . . . . 0.0 114.423 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.29 -29.65 89.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.497 2.798 . . . . 0.0 114.242 -173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -73.79 -33.94 64.42 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.468 -0.77 . . . . 0.0 111.597 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -70.65 -31.2 68.04 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.3 0.955 . . . . 0.0 112.622 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.66 -48.1 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.425 0.69 . . . . 0.0 110.518 167.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -64.66 -44.47 90.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.714 0.688 . . . . 0.0 112.546 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.94 -38.23 72.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.552 1.141 . . . . 0.0 112.322 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.03 -26.22 62.12 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.572 -0.705 . . . . 0.0 112.891 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.39 -51.61 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.045 1.293 . . . . 0.0 110.392 172.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -65.89 -17.95 65.01 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 77.3 m -80.79 -60.11 2.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.312 0.645 . . . . 0.0 111.973 167.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.02 -35.84 20.09 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.322 1.449 . . . . 0.0 114.722 -166.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -85.55 -3.98 59.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.612 1.565 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -75.82 71.88 2.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.508 1.123 . . . . 0.0 109.403 163.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -144.38 138.0 27.48 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.434 1.894 . . . . 0.0 109.64 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.0 ttp -140.61 139.62 34.94 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.684 1.194 . . . . 0.0 110.538 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -149.0 161.3 42.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.668 1.587 . . . . 0.0 110.73 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.54 53.25 1.05 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.0 -148.13 6.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 128.149 2.785 . . . . 0.0 109.673 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -52.94 158.5 1.39 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.27 1.028 . . . . 0.0 113.589 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -117.52 144.58 44.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.672 1.989 . . . . 0.0 111.305 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.1 tp -74.57 70.72 1.82 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.409 -0.807 . . . . 0.0 111.324 169.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 88.0 mt -76.31 123.89 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.525 0.73 . . . . 0.0 109.904 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.62 139.44 53.92 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.92 1.688 . . . . 0.0 108.525 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -132.7 134.77 45.22 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.243 0.929 . . . . 0.0 112.154 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.65 137.92 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.384 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 m -139.67 167.25 22.54 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.089 1.756 . . . . 0.0 110.773 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.8 t -153.93 153.07 31.37 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.269 -0.895 . . . . 0.0 111.578 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 m -68.52 -0.5 5.13 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.059 1.344 . . . . 0.0 113.432 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -54.66 112.46 1.02 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.481 1.912 . . . . 0.0 110.83 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.74 49.68 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.211 1.804 . . . . 0.0 111.08 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.551 1.54 . . . . 0.0 113.481 -172.78 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.431 -1.823 1 O4'-C1'-N19 114.462 6.262 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.58 -2.213 0 O4'-C1'-N19 112.17 3.97 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.241 0 C5'-C4'-C3' 110.923 -3.051 . 0.061 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.573 -2.809 0 O4'-C1'-N19 111.961 3.761 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 112.914 0.313 . . . . 0.0 112.914 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.53 156.02 18.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.307 1.843 . . . . 0.0 111.956 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.5 p -159.05 167.04 30.3 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.049 0.939 . . . . 0.0 111.468 172.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -130.1 165.01 23.16 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.93 126.11 42.69 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 127.291 2.236 . . . . 0.0 109.117 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -106.68 143.1 35.26 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.662 1.585 . . . . 0.0 111.498 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.7 101.7 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.668 1.587 . . . . 0.0 110.96 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 7.52 75.59 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.038 1.304 . . . . 0.0 114.909 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -74.29 15.32 0.34 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER 48.25 80.96 0.27 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 127.373 2.269 . . . . 0.0 112.677 -163.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.39 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.059 3.173 . . . . 0.0 111.892 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.3 mp 53.15 22.95 2.81 Favored 'General case' 0 CA--C 1.557 1.214 0 O-C-N 120.408 -1.432 . . . . 0.0 113.837 -169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -150.9 150.11 30.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.341 2.256 . . . . 0.0 110.469 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 m120 45.36 39.67 4.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.291 1.437 . . . . 0.0 113.224 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.77 34.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.739 1.615 . . . . 0.0 113.488 -157.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -90.68 147.53 23.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.898 1.279 . . . . 0.0 110.801 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.33 -32.29 10.88 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -62.97 -12.73 27.67 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.96 -43.71 70.98 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.983 -1.073 . . . . 0.0 111.893 168.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.68 -36.7 65.34 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.641 -0.662 . . . . 0.0 110.73 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.07 -45.52 91.78 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.491 0.716 . . . . 0.0 112.045 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -28.08 64.09 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.608 -0.682 . . . . 0.0 112.798 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.83 -75.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -123.85 126.58 46.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.843 1.201 . . . . 0.0 111.137 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.614 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 3.7 m -157.78 -20.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 160.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.614 ' CD ' ' H ' ' A' ' 25' ' ' SER . 29.4 Cg_endo -91.85 15.27 1.66 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 CA-C-N 123.558 2.306 . . . . 0.0 113.166 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -105.58 154.68 20.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.563 1.145 . . . . 0.0 113.472 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.23 -146.28 43.43 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.699 1.143 . . . . 0.0 115.761 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -104.46 -0.6 27.74 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.177 1.391 . . . . 0.0 112.784 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.271 1.3 tp 63.5 171.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 128.376 2.67 . . . . 0.0 116.435 166.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mtm -171.6 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.692 1.597 . . . . 0.0 110.953 165.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -142.63 136.99 29.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.273 1.429 . . . . 0.0 112.457 -164.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 tt -85.2 139.31 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.056 0.942 . . . . 0.0 109.929 163.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -143.4 77.83 1.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.921 0.782 . . . . 0.0 111.665 -176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 tt -88.15 138.71 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 122.076 0.941 . . . . 0.0 111.62 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -130.49 147.22 52.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.679 1.592 . . . . 0.0 108.336 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -75.0 35.86 0.11 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.37 -57.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.103 1.761 . . . . 0.0 109.52 166.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.84 126.58 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.133 1.373 . . . . 0.0 110.22 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.21 149.12 24.77 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 122.604 0.145 . . . . 0.0 112.926 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -134.37 162.41 32.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.324 1.45 . . . . 0.0 111.501 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.95 149.13 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 108.602 167.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -131.98 97.96 4.31 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.799 1.24 . . . . 0.0 107.936 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -126.51 145.53 50.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.015 1.326 . . . . 0.0 112.284 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -73.75 154.15 39.71 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 166.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 64.34 86.98 0.13 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.477 2.711 . . . . 0.0 114.638 -166.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.0 -24.48 65.71 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.753 2.302 . . . . 0.0 114.423 174.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -68.54 -43.38 76.84 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.328 0.967 . . . . 0.0 110.719 -176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.7 m -72.8 -29.67 63.46 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.19 -46.03 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 118.873 0.76 . . . . 0.0 109.867 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -63.91 -37.54 87.8 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.288 1.035 . . . . 0.0 112.812 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.15 -45.19 94.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.305 0.642 . . . . 0.0 111.139 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 -31.34 72.45 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.563 -0.711 . . . . 0.0 112.322 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.24 -54.92 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.911 1.232 . . . . 0.0 110.58 172.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -71.67 -16.07 62.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -89.44 -36.17 15.59 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -103.13 -24.29 13.6 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.059 1.344 . . . . 0.0 113.911 -173.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.3 p -68.51 -5.8 21.6 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.129 -1.607 . . . . 0.0 113.221 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -145.13 23.69 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.925 1.69 . . . . 0.0 112.84 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -82.77 83.5 7.68 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.156 -1.59 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 80.7 mtp 58.96 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.723 1.609 . . . . 0.0 113.716 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -74.26 166.96 22.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.78 1.632 . . . . 0.0 112.873 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -128.29 160.06 33.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.483 1.113 . . . . 0.0 113.346 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 68.24 -169.68 39.48 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.2 0.905 . . . . 0.0 113.062 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -134.09 18.6 3.76 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -92.18 23.26 3.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.771 1.228 . . . . 0.0 112.594 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -121.51 129.44 52.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.685 1.194 . . . . 0.0 111.23 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.5 tp -157.28 154.06 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.204 1.002 . . . . 0.0 110.602 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -128.79 143.03 50.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.546 2.339 . . . . 0.0 106.623 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -136.19 132.25 35.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.266 1.394 . . . . 0.0 112.446 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.4 144.1 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.021 0.928 . . . . 0.0 110.654 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 t -140.95 147.99 39.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.432 1.093 . . . . 0.0 110.87 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.7 t -75.69 146.12 40.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.407 0.622 . . . . 0.0 111.267 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 p -107.34 5.88 27.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.455 1.502 . . . . 0.0 112.386 166.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -141.9 52.67 1.49 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.477 1.911 . . . . 0.0 111.388 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.0 157.62 37.4 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.465 ' NE ' ' H ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.399 0 C-N-CA 126.638 1.975 . . . . 0.0 114.18 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 C3'-C2'-C1' 98.996 -2.782 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.375 1 O4'-C1'-N19 112.608 4.408 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.118 0 C3'-C2'-C1' 103.857 2.619 . 0.102 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.031 0 O4'-C1'-N19 111.733 3.533 . 0.01 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 CA--C 1.537 0.66 0 N-CA-C 114.311 0.85 . . . . 0.0 114.311 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.35 148.9 52.22 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.847 2.059 . . . . 0.0 110.006 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 p -162.94 161.68 25.81 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.285 1.434 . . . . 0.0 109.992 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.25 156.24 44.96 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.309 1.043 . . . . 0.0 111.395 160.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.35 117.78 23.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.199 2.199 . . . . 0.0 107.988 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -100.42 147.02 26.3 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.715 1.206 . . . . 0.0 111.501 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mm -103.29 131.56 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.84 1.256 . . . . 0.0 109.117 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.44 -176.49 4.82 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 121.399 0.444 . . . . 0.0 113.386 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -76.69 47.51 0.51 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.508 1.523 . . . . 0.0 114.911 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -119.02 -25.28 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 127.261 2.224 . . . . 0.0 115.518 -171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.9 38.6 0.76 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.92 2.414 . . . . 0.0 112.595 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mp -80.7 49.36 1.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.353 1.861 . . . . 0.0 110.183 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -141.45 37.58 1.69 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.301 1.84 . . . . 0.0 113.168 -161.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 51.36 61.08 3.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.053 1.741 . . . . 0.0 112.399 -172.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.19 149.35 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.089 0.956 . . . . 0.0 113.157 -167.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.5 m -138.78 164.43 29.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.109 2.563 . . . . 0.0 109.328 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -49.57 -32.44 12.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.468 1.107 . . . . 0.0 113.136 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -49.55 -36.56 23.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.549 1.539 . . . . 0.0 113.931 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.93 -39.59 50.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 111.94 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.01 -39.67 95.44 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.502 -0.749 . . . . 0.0 110.279 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.12 -36.67 74.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.218 1.407 . . . . 0.0 112.985 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -69.28 -36.13 76.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.498 -0.751 . . . . 0.0 111.059 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 86.9 mt -63.1 -77.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.154 0.982 . . . . 0.0 108.871 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -120.3 121.08 37.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.97 1.259 . . . . 0.0 112.304 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.684 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.4 t -152.14 -38.49 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 112.98 165.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 25' ' ' SER . 47.4 Cg_endo -83.92 46.4 2.01 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.632 2.221 . . . . 0.0 112.18 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.96 145.63 49.72 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.491 1.116 . . . . 0.0 111.51 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.77 -155.4 33.89 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 167.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -97.71 0.89 47.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.686 0.794 . . . . 0.0 112.648 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tp 60.95 175.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 127.133 2.173 . . . . 0.0 113.7 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 mtm -166.11 -73.56 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.393 1.477 . . . . 0.0 109.051 160.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -144.22 153.53 42.17 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.663 1.185 . . . . 0.0 112.364 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.3 tt -122.49 130.93 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 126.292 1.837 . . . . 0.0 109.425 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.06 146.48 50.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.484 1.114 . . . . 0.0 112.316 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.14 148.79 23.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.135 1.374 . . . . 0.0 110.812 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -136.08 -176.44 4.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.639 1.576 . . . . 0.0 109.736 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -65.4 122.95 18.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.65 0.78 . . . . 0.0 110.661 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 55.44 10.03 0.44 Allowed 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -157.04 157.64 35.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.529 1.532 . . . . 0.0 110.881 171.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.17 161.7 28.8 Favored Glycine 0 N--CA 1.468 0.81 0 O-C-N 121.507 -0.746 . . . . 0.0 113.08 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -140.15 116.93 10.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.833 1.253 . . . . 0.0 110.865 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.98 148.5 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.858 -1.151 . . . . 0.0 108.939 164.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -137.19 98.28 3.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.859 0.864 . . . . 0.0 109.316 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -123.06 153.81 39.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.105 1.362 . . . . 0.0 112.951 -169.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -81.06 153.66 27.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.408 1.083 . . . . 0.0 110.525 164.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 67.81 75.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 128.762 2.825 . . . . 0.0 113.852 -164.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -52.32 -35.77 65.74 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.982 3.121 . . . . 0.0 114.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -64.82 -39.37 93.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.004 0.82 . . . . 0.0 111.857 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -63.86 -31.26 72.38 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 -43.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.944 0.898 . . . . 0.0 109.942 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.74 -45.39 85.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.981 0.81 . . . . 0.0 111.675 169.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -62.48 -40.03 95.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.722 0.809 . . . . 0.0 112.257 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.31 -32.04 72.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.379 0.672 . . . . 0.0 112.238 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.66 -51.08 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.517 1.053 . . . . 0.0 110.431 173.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -68.61 -15.39 63.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.81 -39.7 15.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.415 1.486 . . . . 0.0 114.141 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.15 -30.95 6.79 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -68.87 -3.16 11.57 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.562 -1.336 . . . . 0.0 113.623 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -115.69 11.12 15.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 128.026 2.531 . . . . 0.0 112.015 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -57.48 158.48 5.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.036 0.934 . . . . 0.0 112.253 172.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 58.1 mtt -113.28 22.01 14.68 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.48 -40.67 97.72 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.153 -0.967 . . . . 0.0 112.69 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.26 120.55 4.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.074 0.95 . . . . 0.0 112.432 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.78 78.27 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.001 -1.062 . . . . 0.0 114.744 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 54.71 13.29 0.68 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.627 2.371 . . . . 0.0 117.165 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -160.4 140.61 11.47 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.547 1.939 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.3 110.33 12.28 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 163.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.29 119.93 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.943 0.897 . . . . 0.0 110.425 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -129.31 141.78 51.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.438 1.895 . . . . 0.0 109.601 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.36 135.29 30.33 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.2 p -102.18 137.67 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.325 1.05 . . . . 0.0 112.057 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -143.66 141.11 30.41 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.66 1.184 . . . . 0.0 112.873 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 t -130.37 21.89 5.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.242 1.017 . . . . 0.0 112.905 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.0 t -149.45 97.99 2.72 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.645 1.178 . . . . 0.0 109.919 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -126.32 10.51 7.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.39 1.476 . . . . 0.0 112.412 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.25 152.86 51.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.665 1.986 . . . . 0.0 110.695 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.846 1.259 . . . . 0.0 109.817 173.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 O4'-C1'-N19 111.773 3.573 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.464 0 O4'-C1'-N19 111.863 3.663 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O4'-C1'-N19 111.853 3.653 . 0.072 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.089 1 O4'-C1'-N19 113.954 5.754 . 0.084 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.532 0.415 0 N-CA-C 113.559 0.561 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' HE22 ' A' ' 43' ' ' GLN . 0.6 OUTLIER -131.44 118.56 20.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.765 2.026 . . . . 0.0 109.506 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -136.42 108.06 7.0 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.468 1.107 . . . . 0.0 110.118 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -84.98 149.26 25.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.369 0.604 . . . . 0.0 110.855 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.57 120.22 29.05 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.475 1.51 . . . . 0.0 108.117 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -99.18 136.26 39.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.537 1.535 . . . . 0.0 110.744 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -93.13 107.14 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 109.799 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.17 0.83 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.332 1.444 . . . . 0.0 113.947 173.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.65 148.86 39.83 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.321 1.848 . . . . 0.0 111.207 166.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.9 tp -110.28 90.72 10.35 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.43 1.892 . . . . 0.0 109.341 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.54 -23.62 23.14 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.367 2.711 . . . . 0.0 112.615 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . 0.283 1.6 tt 55.25 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.965 3.306 . . . . 0.0 114.236 175.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -97.78 -2.69 40.51 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.5 17.99 13.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.572 1.149 . . . . 0.0 113.457 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.12 126.59 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.786 1.634 . . . . 0.0 113.538 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 t -155.5 142.65 19.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.018 0.927 . . . . 0.0 112.438 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.1 -32.13 71.81 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.754 -0.591 . . . . 0.0 111.019 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.06 -24.57 67.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.557 1.143 . . . . 0.0 112.828 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.09 -41.35 50.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.357 0.98 . . . . 0.0 111.739 175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.95 -39.58 87.32 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 110.983 172.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -63.95 -43.79 94.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.172 0.989 . . . . 0.0 112.03 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.714 -1.241 . . . . 0.0 111.397 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.6 mt -58.71 -71.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.402 1.081 . . . . 0.0 109.483 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -124.63 114.56 19.52 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.748 1.158 . . . . 0.0 110.838 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.566 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 33.1 t -155.94 -43.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 170.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.566 ' HD2' ' H ' ' A' ' 25' ' ' SER . 89.9 Cg_endo -83.04 11.38 3.29 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 122.435 2.09 . . . . 0.0 115.521 -173.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -80.07 16.91 1.09 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.16 -14.63 32.37 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.555 1.074 . . . . 0.0 115.6 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.528 ' CE1' HD22 ' A' ' 46' ' ' ASN . 47.8 m-70 -135.97 141.1 44.39 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 126.404 1.882 . . . . 0.0 108.64 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 tp -153.37 161.48 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.449 0.699 . . . . 0.0 111.061 -162.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -151.9 -65.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.497 152.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -152.95 153.31 32.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.393 0.997 . . . . 0.0 113.434 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.53 140.2 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.26 1.424 . . . . 0.0 108.891 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -129.84 65.62 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.735 1.255 . . . . 0.0 110.679 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.35 138.69 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.821 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -125.82 155.42 41.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.517 1.527 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -70.83 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -165.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.91 -42.75 0.31 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.943 1.297 . . . . 0.0 112.767 167.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -148.91 146.77 28.04 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.84 1.256 . . . . 0.0 110.254 171.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.86 164.46 17.36 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -170.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -130.0 163.65 26.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.496 1.518 . . . . 0.0 110.543 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.96 155.12 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 109.238 166.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.415 HE22 ' HB3' ' A' ' 2' ' ' LYS . 42.3 tp60 -140.93 92.24 2.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.544 1.538 . . . . 0.0 108.28 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -112.33 165.83 11.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.23 1.412 . . . . 0.0 112.815 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.16 163.67 18.6 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.291 1.036 . . . . 0.0 111.062 164.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.528 HD22 ' CE1' ' A' ' 29' ' ' HIS . 56.5 t-20 51.41 91.28 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 127.851 2.46 . . . . 0.0 114.076 -172.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.56 -24.21 75.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 121.85 1.7 . . . . 0.0 113.969 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -67.28 -35.66 79.94 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.935 0.789 . . . . 0.0 111.587 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.9 m -71.17 -35.73 71.73 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.336 0.654 . . . . 0.0 112.273 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -63.34 -41.25 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.889 -0.507 . . . . 0.0 110.424 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -69.53 -36.53 76.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.116 -0.99 . . . . 0.0 112.879 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.33 -35.99 80.8 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.212 0.915 . . . . 0.0 111.692 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.4 -29.02 66.68 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.615 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.7 mt -64.14 -52.31 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 120.475 1.489 . . . . 0.0 110.279 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -72.14 1.78 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 46.2 t -107.62 -52.69 2.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.23 1.812 . . . . 0.0 112.855 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -88.83 -40.78 12.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.775 1.23 . . . . 0.0 112.501 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -71.09 -3.32 19.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.091 -1.006 . . . . 0.0 112.448 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -130.79 27.06 4.96 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.212 2.605 . . . . 0.0 111.589 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.5 157.0 24.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.43 -1.419 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 75.4 mtm -73.91 61.94 0.82 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.963 1.705 . . . . 0.0 113.185 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -135.21 136.97 42.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.749 1.62 . . . . 0.0 110.065 171.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -77.32 140.93 40.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.876 0.846 . . . . 0.0 111.613 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.47 170.04 17.82 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.126 0.87 . . . . 0.0 113.103 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -132.04 15.22 4.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.518 1.927 . . . . 0.0 113.962 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -120.2 6.23 10.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.694 1.998 . . . . 0.0 115.532 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.9 tp -118.4 104.64 10.91 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.47 1.508 . . . . 0.0 109.366 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.433 1.093 . . . . 0.0 109.609 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.4 mt -119.98 134.87 55.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.334 1.454 . . . . 0.0 108.001 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.75 128.31 45.12 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.92 142.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.514 1.126 . . . . 0.0 110.598 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 t -141.6 121.05 13.21 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.395 1.078 . . . . 0.0 110.105 171.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.8 p -119.54 144.61 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.781 1.232 . . . . 0.0 111.297 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.7 m 53.49 32.5 14.2 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -97.13 154.75 17.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.765 1.226 . . . . 0.0 110.642 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.94 33.4 14.49 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.868 1.667 . . . . 0.0 113.238 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 . . . . . 0 C--O 1.257 1.485 0 C-N-CA 126.982 2.113 . . . . 0.0 112.215 -177.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.008 1 O4'-C1'-N19 115.135 6.935 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.383 1 O4'-C1'-N19 112.607 4.407 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.577 -2.521 1 O4'-C1'-N19 112.919 4.719 . 0.315 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.228 1 O4'-C1'-N19 112.589 4.389 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 CA--C 1.547 1.134 0 CA-C-O 121.064 0.36 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -68.8 123.29 20.53 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.602 1.161 . . . . 0.0 110.475 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -137.82 114.38 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 110.855 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -93.0 141.57 28.25 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.703 -0.623 . . . . 0.0 112.529 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.76 133.44 53.98 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.867 2.067 . . . . 0.0 108.36 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -117.57 138.56 51.84 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.758 2.023 . . . . 0.0 110.773 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mm -103.13 144.28 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.26 -162.51 1.67 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 122.022 0.79 . . . . 0.0 114.422 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -82.39 19.38 1.25 Allowed 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.601 -1.529 . . . . 0.0 114.675 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.59 -36.83 10.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.619 173.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -72.54 18.08 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.322 3.348 . . . . 0.0 116.696 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.4 mt -71.96 19.61 0.07 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.012 1.325 . . . . 0.0 113.249 170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -126.24 -178.7 4.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 110.409 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -52.16 122.33 8.39 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.311 0.505 . . . . 0.0 111.692 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.11 146.01 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.817 0.818 . . . . 0.0 112.526 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 m -133.9 168.12 19.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.866 1.667 . . . . 0.0 111.298 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -57.8 -32.51 67.62 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.084 -1.01 . . . . 0.0 111.452 172.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -64.01 -25.15 67.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.56 -48.19 56.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.624 1.102 . . . . 0.0 110.21 170.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.27 -38.34 86.39 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.153 -0.967 . . . . 0.0 111.496 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.22 -40.31 93.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.891 1.677 . . . . 0.0 112.16 175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -28.4 60.48 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.539 -1.351 . . . . 0.0 113.176 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 ' CE1' ' A' ' 24' ' ' PHE . 20.3 mt -76.0 -45.31 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CE1' HG22 ' A' ' 23' ' ' ILE . 77.1 m-85 -137.68 102.26 4.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.178 1.791 . . . . 0.0 111.644 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.562 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 34.0 t -164.56 -48.56 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.819 1.648 . . . . 0.0 111.923 166.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 25' ' ' SER . 83.8 Cg_endo -78.19 20.23 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.984 2.456 . . . . 0.0 115.679 -169.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.23 15.37 22.96 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.421 1.488 . . . . 0.0 114.217 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.2 5.46 62.52 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.523 1.535 . . . . 0.0 116.422 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -143.57 126.32 16.1 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.981 1.712 . . . . 0.0 109.005 -171.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -151.36 160.88 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -156.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 40.0 mtm -158.01 -84.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.184 2.194 . . . . 0.0 108.122 152.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -135.05 155.94 49.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.684 1.594 . . . . 0.0 114.073 -168.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -109.64 136.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.699 1.6 . . . . 0.0 110.469 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.58 72.09 1.32 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.524 1.13 . . . . 0.0 111.114 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.4 134.29 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.615 -1.303 . . . . 0.0 110.099 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -134.93 143.1 46.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.736 1.615 . . . . 0.0 109.011 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -76.1 46.42 0.4 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.41 -41.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.308 1.443 . . . . 0.0 112.283 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -145.51 151.2 37.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.208 1.403 . . . . 0.0 109.588 168.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 147.28 18.7 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.392 0.52 . . . . 0.0 113.481 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -125.82 155.34 41.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.825 1.298 . . . . 0.0 111.596 164.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.21 155.41 32.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 107.578 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.22 109.37 7.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 167.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -115.08 161.01 18.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.261 1.824 . . . . 0.0 111.125 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.57 146.37 25.17 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.247 -0.908 . . . . 0.0 110.691 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.74 107.58 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 127.722 2.409 . . . . 0.0 114.969 -171.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.87 -19.0 21.28 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.752 1.635 . . . . 0.0 113.329 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.57 -41.39 98.9 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.31 1.413 . . . . 0.0 113.103 -172.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -82.45 -18.02 43.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.17 -41.68 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.163 0.892 . . . . 0.0 109.705 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -62.83 -44.31 96.48 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.089 -1.007 . . . . 0.0 111.689 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -59.81 -41.68 91.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.631 0.65 . . . . 0.0 112.03 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.66 90.35 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.42 -0.8 . . . . 0.0 112.575 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.08 -52.67 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.708 1.14 . . . . 0.0 110.716 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.31 -17.74 56.18 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.6 t -73.53 -49.11 28.18 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.239 1.816 . . . . 0.0 111.976 166.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -101.28 -28.51 12.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -162.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.2 p -71.49 -18.32 62.3 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.594 1.088 . . . . 0.0 113.373 173.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -122.84 144.09 49.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.758 2.023 . . . . 0.0 110.33 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -148.22 89.25 1.71 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.807 1.243 . . . . 0.0 111.0 -172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 58.69 12.39 2.18 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.045 1.738 . . . . 0.0 115.219 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -142.03 163.97 31.45 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.693 1.997 . . . . 0.0 109.747 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -74.68 157.9 34.52 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.075 -1.016 . . . . 0.0 112.618 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.14 -159.83 53.95 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.741 1.162 . . . . 0.0 113.725 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -124.05 129.19 50.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.292 1.437 . . . . 0.0 113.322 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -78.92 -16.23 57.26 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.58 1.552 . . . . 0.0 114.15 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -156.65 162.45 39.84 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.488 1.915 . . . . 0.0 110.506 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mm -87.13 123.34 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 124.252 1.021 . . . . 0.0 111.068 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 mt -132.17 133.94 44.81 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.052 2.141 . . . . 0.0 107.94 165.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -144.12 131.88 21.33 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.503 1.047 . . . . 0.0 113.775 -173.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 p -100.57 141.29 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.168 0.587 . . . . 0.0 112.038 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.7 m -133.53 127.14 32.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.83 2.052 . . . . 0.0 108.535 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.0 p -147.19 156.95 43.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 3.04 2.82 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.938 0.895 . . . . 0.0 112.972 167.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -114.92 5.4 15.07 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.897 . . . . 0.0 113.214 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.89 154.78 38.32 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.113 -0.992 . . . . 0.0 112.751 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.498 1.919 . . . . 0.0 112.881 175.93 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.362 1 O4'-C1'-N19 113.397 5.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.579 -2.354 0 O4'-C1'-N19 111.998 3.798 . 0.034 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.334 1 C3'-C2'-C1' 105.383 4.315 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0a' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.79 0 O4'-C1'-N19 110.265 2.065 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 N--CA 1.476 0.472 0 CA-C-O 119.706 -0.206 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -114.12 111.84 22.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.45 1.1 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -126.42 100.22 6.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.98 0.912 . . . . 0.0 111.162 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.22 153.88 24.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.53 0.681 . . . . 0.0 111.445 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.07 126.12 29.47 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.765 1.626 . . . . 0.0 108.918 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -103.46 137.98 40.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.788 1.235 . . . . 0.0 111.633 171.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.78 98.55 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.182 0.993 . . . . 0.0 108.97 168.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.52 176.19 50.69 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.736 0.684 . . . . 0.0 111.571 164.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.91 40.15 24.37 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.312 -1.111 . . . . 0.0 111.724 -172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.81 123.47 89.6 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.916 1.287 . . . . 0.0 110.566 -162.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.15 107.3 1.67 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.645 2.897 . . . . 0.0 110.009 168.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.15 7.79 1.97 Allowed 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.478 -1.389 . . . . 0.0 112.771 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -114.78 128.16 56.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.479 2.311 . . . . 0.0 110.876 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 t30 47.56 35.07 3.94 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -85.98 132.76 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 120.767 -1.208 . . . . 0.0 109.537 169.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.0 p -133.07 163.23 29.72 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 111.461 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -61.15 -24.63 66.43 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.189 -0.944 . . . . 0.0 112.801 173.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.33 -31.7 70.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.907 0.883 . . . . 0.0 112.1 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -63.02 -47.08 84.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.95 0.796 . . . . 0.0 110.42 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.76 -40.66 93.33 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.518 -0.739 . . . . 0.0 111.122 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -68.96 -41.41 78.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.336 1.054 . . . . 0.0 113.327 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -22.36 60.25 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 120.665 -1.272 . . . . 0.0 113.275 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.487 HG22 ' CE1' ' A' ' 24' ' ' PHE . 42.8 mt -83.55 -41.15 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.347 0.659 . . . . 0.0 109.696 170.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.487 ' CE1' HG22 ' A' ' 23' ' ' ILE . 96.2 m-85 -135.7 91.58 2.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.534 1.534 . . . . 0.0 111.888 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 26.3 t -157.88 -49.75 0.01 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 165.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 25' ' ' SER . 65.3 Cg_endo -78.35 27.67 0.49 Allowed 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.205 2.603 . . . . 0.0 114.033 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.77 14.87 25.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.718 1.607 . . . . 0.0 113.381 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.18 -101.31 2.71 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.439 1.019 . . . . 0.0 113.479 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -64.1 135.27 56.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.784 0.834 . . . . 0.0 112.747 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 tp -140.5 163.87 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.314 1.046 . . . . 0.0 112.0 -161.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.0 mtm -152.22 -76.9 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.485 1.114 . . . . 0.0 109.79 152.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -142.73 156.61 45.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.738 1.215 . . . . 0.0 113.807 -166.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mt -119.2 137.15 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.962 2.105 . . . . 0.0 109.642 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.96 84.04 2.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.946 1.299 . . . . 0.0 110.075 -175.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -88.33 135.25 26.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 O-C-N 121.228 -0.92 . . . . 0.0 110.111 165.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -132.89 147.75 52.29 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.862 2.065 . . . . 0.0 108.432 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -62.48 -9.42 8.49 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.3 -24.43 11.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -152.94 145.41 24.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.335 1.425 . . . . 0.0 114.035 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.46 131.15 10.47 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.862 1.22 . . . . 0.0 113.035 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -137.33 156.07 48.67 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.632 1.573 . . . . 0.0 111.95 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.82 154.32 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.535 1.534 . . . . 0.0 109.256 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -136.01 113.37 10.7 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -117.2 158.37 24.4 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.117 1.767 . . . . 0.0 112.339 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.05 151.56 31.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 109.87 164.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 48.0 t-20 48.8 101.67 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 128.103 2.561 . . . . 0.0 114.439 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 46' ' ' ASN . 34.9 Cg_endo -55.96 -11.84 6.18 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.34 2.694 . . . . 0.0 115.357 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -61.62 -36.0 79.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.599 1.09 . . . . 0.0 113.701 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.6 p -69.49 -39.95 77.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.563 1.074 . . . . 0.0 111.335 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.61 -45.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.385 1.074 . . . . 0.0 110.483 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -63.92 -40.83 97.39 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 111.829 174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.71 -35.32 80.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -40.29 66.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.439 1.096 . . . . 0.0 112.239 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.5 mt -58.86 -48.65 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 120.207 1.367 . . . . 0.0 110.707 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.67 -15.03 63.1 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.0 t -89.0 -55.37 3.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.429 1.092 . . . . 0.0 111.5 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -87.43 -36.85 17.49 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.124 1.77 . . . . 0.0 113.804 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -67.42 -22.57 65.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.274 1.397 . . . . 0.0 111.879 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -64.47 140.21 58.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.413 1.085 . . . . 0.0 112.032 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 13.3 tp10 -145.43 152.28 39.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.943 1.297 . . . . 0.0 111.135 174.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.65 25.98 5.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.209 1.003 . . . . 0.0 111.903 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' H ' ' HG3' ' A' ' 60' ' ' GLU . 60.2 t-20 -129.48 147.65 51.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.63 3.172 . . . . 0.0 108.542 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -79.61 26.32 0.31 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 121.123 -0.986 . . . . 0.0 113.232 173.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.4 176.71 44.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.885 2.183 . . . . 0.0 111.934 -173.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt 50.12 30.18 4.05 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.423 1.889 . . . . 0.0 114.149 -174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -85.76 162.4 18.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.169 1.388 . . . . 0.0 112.083 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.71 174.04 11.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.419 1.488 . . . . 0.0 111.376 174.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.9 mm -133.93 127.55 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.541 1.136 . . . . 0.0 109.169 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.9 mt -125.03 129.33 50.07 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.306 0.642 . . . . 0.0 110.991 -171.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -133.06 127.09 33.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.9 144.87 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.704 1.202 . . . . 0.0 110.957 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.493 ' HB2' ' H42' ' B' ' 79' ' ' ' C' . 41.3 t -143.03 150.57 39.76 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.208 1.403 . . . . 0.0 109.293 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 p -138.27 155.35 48.7 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 94.8 p -118.95 153.94 33.81 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.257 1.423 . . . . 0.0 110.367 167.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -140.02 28.87 2.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.404 1.082 . . . . 0.0 111.58 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.92 10.5 1.34 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.976 1.71 . . . . 0.0 113.591 -174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 . . . . . 0 C--O 1.247 0.936 0 C-N-CA 127.686 2.394 . . . . 0.0 109.27 -176.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 1 O4'-C1'-N19 112.345 4.145 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . 0.493 ' H42' ' HB2' ' A' ' 72' ' ' SER . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 O4'-C4'-C3' 108.786 2.347 . 0.023 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.049 0 O4'-C1'-N19 111.62 3.42 . 0.07 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 O4'-C1'-N19 110.879 2.679 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 CA-C-O 119.623 -0.24 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.79 120.63 22.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 112.321 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -129.4 159.02 37.54 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.856 1.262 . . . . 0.0 111.533 173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.5 ptm85 -137.37 149.34 46.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.654 1.582 . . . . 0.0 110.247 168.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -131.64 117.76 19.12 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 125.691 1.596 . . . . 0.0 107.979 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -97.76 132.5 43.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.677 1.591 . . . . 0.0 110.511 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.36 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.848 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.03 -178.47 0.34 Allowed Glycine 0 CA--C 1.54 1.628 0 C-N-CA 123.99 0.805 . . . . 0.0 113.697 166.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -76.75 26.61 0.14 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 120.124 -1.81 . . . . 0.0 113.739 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.19 66.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.468 1.507 . . . . 0.0 112.113 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -63.36 6.32 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.332 3.355 . . . . 0.0 117.604 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.15 -9.05 14.41 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -117.14 -27.02 6.61 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.518 1.527 . . . . 0.0 114.241 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.6 127.66 14.63 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.789 1.635 . . . . 0.0 110.259 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.59 89.17 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.201 1.4 . . . . 0.0 111.908 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -139.87 148.74 42.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.486 1.114 . . . . 0.0 109.301 163.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -60.01 -21.01 60.77 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.537 1.062 . . . . 0.0 112.714 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -55.49 -24.33 30.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.72 1.208 . . . . 0.0 113.6 169.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.47 -53.53 7.98 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.043 0.937 . . . . 0.0 111.603 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.16 -36.63 70.98 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.393 -1.442 . . . . 0.0 111.133 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -70.1 -22.84 62.99 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.438 1.495 . . . . 0.0 114.108 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -32.13 58.3 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.448 -1.407 . . . . 0.0 111.674 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 24' ' ' PHE . 55.3 mt -80.51 -45.1 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.855 0.862 . . . . 0.0 109.662 -177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 23' ' ' ILE . 39.5 m-85 -136.89 118.16 14.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.437 1.495 . . . . 0.0 111.251 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 14.6 p -154.54 -37.93 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 CA-C-O 116.823 -1.561 . . . . 0.0 114.987 162.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 25' ' ' SER . 82.9 Cg_endo -76.46 -2.28 12.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 CA-C-N 123.155 2.162 . . . . 0.0 113.329 176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -93.16 141.55 28.29 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.328 1.051 . . . . 0.0 112.43 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.77 -164.1 43.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 124.643 1.115 . . . . 0.0 114.743 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -87.67 -12.83 44.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.231 1.012 . . . . 0.0 112.776 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 66.57 157.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.188 2.195 . . . . 0.0 113.965 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 38.0 tpp -156.7 -79.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.293 -0.879 . . . . 0.0 111.534 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -138.7 153.27 48.51 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.049 1.295 . . . . 0.0 113.946 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.85 130.73 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.751 1.62 . . . . 0.0 110.625 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -145.32 127.86 16.05 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.819 0.819 . . . . 0.0 113.043 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.6 tt -114.33 144.45 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.718 -1.239 . . . . 0.0 112.028 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -128.88 156.07 44.26 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.356 1.462 . . . . 0.0 110.406 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -72.32 7.44 1.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.23 -35.38 2.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.134 1.333 . . . . 0.0 113.219 163.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -154.22 148.73 26.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.512 1.525 . . . . 0.0 110.448 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.96 165.26 12.35 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 121.342 -0.849 . . . . 0.0 114.202 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -126.33 133.52 51.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 123.901 1.81 . . . . 0.0 112.683 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 mt -104.88 139.65 25.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.546 1.538 . . . . 0.0 107.152 167.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -134.61 84.77 2.13 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -115.17 153.42 30.85 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.562 1.145 . . . . 0.0 112.489 -169.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.67 151.91 24.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.424 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 65.6 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 128.771 2.828 . . . . 0.0 114.699 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.39 -23.77 58.11 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.242 2.628 . . . . 0.0 114.479 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -64.86 -40.72 95.59 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 111.182 -175.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 m -73.83 -31.06 63.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.038 0.935 . . . . 0.0 112.631 174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.01 -44.25 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.686 -0.634 . . . . 0.0 109.92 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -65.22 -41.47 94.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.781 0.833 . . . . 0.0 112.152 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -59.51 -38.95 82.3 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.773 0.829 . . . . 0.0 112.198 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.96 -28.94 58.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.076 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 mt -57.44 -51.52 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 121.007 1.73 . . . . 0.0 109.674 165.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.94 2.54 8.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.8 t -105.84 -26.86 11.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.574 1.55 . . . . 0.0 113.526 171.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -127.05 -26.76 3.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.467 1.107 . . . . 0.0 113.309 -166.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -76.57 40.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.185 1.794 . . . . 0.0 112.276 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -142.65 140.73 31.71 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.015 2.526 . . . . 0.0 108.566 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.5 158.67 43.8 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.938 1.295 . . . . 0.0 109.184 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.1 151.8 34.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.59 0.756 . . . . 0.0 111.435 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -79.15 37.17 0.31 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.836 -1.165 . . . . 0.0 112.976 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -87.23 10.28 17.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.058 2.143 . . . . 0.0 112.567 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.89 116.97 1.06 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 120.657 -1.277 . . . . 0.0 110.544 -164.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.95 153.13 30.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.037 1.335 . . . . 0.0 111.773 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -153.03 13.39 0.51 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.73 133.91 56.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.613 0.765 . . . . 0.0 109.158 168.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 tp -142.23 144.49 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.662 1.185 . . . . 0.0 109.769 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -127.0 131.03 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.969 1.708 . . . . 0.0 107.985 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -128.07 122.13 31.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -92.13 141.29 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.945 0.898 . . . . 0.0 111.225 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.0 t -136.78 150.46 48.38 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.541 1.536 . . . . 0.0 108.392 166.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -135.78 144.09 45.59 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.567 0.747 . . . . 0.0 110.254 -173.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -74.95 154.9 37.92 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.861 0.464 . . . . 0.0 111.668 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -58.02 126.68 28.49 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.311 0.577 . . . . 0.0 109.598 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.64 157.75 39.4 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.131 1.373 . . . . 0.0 111.436 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 110.96 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 O4'-C1'-N19 111.959 3.759 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.092 0 O4'-C1'-N19 111.656 3.456 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 O4'-C1'-N19 111.199 2.999 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.826 0 O4'-C1'-N19 111.232 3.032 . 0.24 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.664 0 CA-C-O 119.385 -0.339 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' H ' ' HE3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -83.16 137.89 33.87 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.004 1.322 . . . . 0.0 112.879 -173.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 t -133.0 162.96 30.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 110.922 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -132.4 161.52 33.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.634 0.73 . . . . 0.0 112.15 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -143.74 130.29 20.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.026 1.73 . . . . 0.0 108.872 -166.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -110.99 141.76 44.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.921 1.688 . . . . 0.0 112.013 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mm -94.7 100.55 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.093 0.957 . . . . 0.0 111.156 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.96 4.37 53.96 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.047 1.784 . . . . 0.0 115.728 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -82.23 30.15 0.41 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.323 1.449 . . . . 0.0 114.031 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.9 tp 50.71 63.77 9.34 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.71 2.004 . . . . 0.0 114.024 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.89 26.48 0.36 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.365 2.71 . . . . 0.0 115.427 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 mp -78.89 51.2 1.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.485 1.514 . . . . 0.0 109.879 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -147.59 147.07 29.67 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 128.399 2.68 . . . . 0.0 108.544 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -53.75 115.79 2.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.192 0.997 . . . . 0.0 111.573 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.47 148.09 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.308 1.043 . . . . 0.0 111.29 -170.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.1 m -118.61 158.97 24.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.0 1.72 . . . . 0.0 111.989 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -52.35 -30.25 27.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.695 1.598 . . . . 0.0 113.819 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.41 -29.61 69.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.002 0.921 . . . . 0.0 113.274 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.89 -43.46 98.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.205 0.911 . . . . 0.0 111.121 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.52 -36.38 63.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.377 1.071 . . . . 0.0 111.612 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.12 -35.53 80.74 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.33 0.652 . . . . 0.0 112.559 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -18.84 59.13 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -72.06 -80.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 166.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' CE1' ' HB1' ' A' ' 53' ' ' ALA . 11.2 m-30 -116.34 117.49 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.151 0.977 . . . . 0.0 110.747 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.62 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 76.8 p -148.2 -27.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.734 1.613 . . . . 0.0 113.772 158.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 25' ' ' SER . 10.2 Cg_endo -96.46 19.84 0.5 Allowed 'Trans proline' 0 CA--C 1.547 1.133 0 CA-C-N 122.899 2.071 . . . . 0.0 114.111 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -120.77 143.9 48.57 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.628 1.571 . . . . 0.0 111.929 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 -152.61 40.85 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.78 -0.575 . . . . 0.0 114.352 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -88.6 -25.77 22.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 118.024 -0.988 . . . . 0.0 113.257 -171.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mm 64.78 153.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 126.154 1.782 . . . . 0.0 112.206 -175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.0 tpp -154.91 -57.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.439 -1.413 . . . . 0.0 113.758 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -156.34 155.69 32.65 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.523 1.129 . . . . 0.0 113.911 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.91 151.89 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.173 1.389 . . . . 0.0 112.281 168.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.25 98.34 3.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.444 1.498 . . . . 0.0 110.525 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tt -106.41 138.84 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HE2' " H1'" ' B' ' 80' ' ' ' U' . 31.5 mtmt -130.64 153.55 48.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.013 1.325 . . . . 0.0 110.371 169.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -76.78 49.41 0.63 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.992 1.317 . . . . 0.0 112.387 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.26 -51.29 0.07 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.744 2.418 . . . . 0.0 110.333 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -149.69 144.39 26.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.521 1.528 . . . . 0.0 109.359 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.14 140.83 15.63 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.119 0.866 . . . . 0.0 112.381 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.58 148.69 50.5 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.73 1.253 . . . . 0.0 112.43 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -129.88 138.35 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.745 1.618 . . . . 0.0 107.775 176.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.05 97.68 5.35 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.449 1.1 . . . . 0.0 108.415 175.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -118.53 152.81 35.28 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.031 0.932 . . . . 0.0 111.655 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.28 162.47 21.14 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.654 167.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 69.88 74.42 0.27 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 127.968 2.507 . . . . 0.0 113.357 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.0 -36.89 97.74 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.659 2.906 . . . . 0.0 114.709 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -62.86 -34.43 77.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.158 1.344 . . . . 0.0 111.817 177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.5 m -77.45 -33.88 54.65 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.72 -42.92 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.178 0.899 . . . . 0.0 109.987 170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -67.01 -39.98 87.18 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.301 1.04 . . . . 0.0 112.711 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.1 -32.23 73.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.994 0.816 . . . . 0.0 112.596 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 24' ' ' PHE . . . -73.61 -31.49 63.58 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.294 0.638 . . . . 0.0 112.05 172.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.67 -54.86 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.956 1.253 . . . . 0.0 110.514 171.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.44 -20.41 63.08 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.601 1.092 . . . . 0.0 112.811 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.0 t -90.98 -24.44 20.11 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.843 1.257 . . . . 0.0 114.321 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -126.49 -19.18 4.67 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.501 -1.374 . . . . 0.0 113.651 -172.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -86.96 21.3 2.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.382 1.873 . . . . 0.0 112.804 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.11 119.29 9.47 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.083 1.353 . . . . 0.0 109.694 -170.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 21.0 tt0 -148.28 141.7 25.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.567 0.747 . . . . 0.0 111.437 169.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -87.02 -5.43 59.08 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 33.9 m120 -115.36 155.74 26.8 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.786 1.634 . . . . 0.0 110.699 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -78.38 51.2 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.374 0.669 . . . . 0.0 112.327 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.78 -149.59 6.41 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.195 0.902 . . . . 0.0 113.381 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -77.8 41.09 0.33 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.044 1.337 . . . . 0.0 109.757 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -68.82 147.83 51.17 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.114 1.366 . . . . 0.0 111.295 -169.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -127.06 158.53 36.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.695 0.759 . . . . 0.0 112.486 -162.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 93.1 mt -119.46 126.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 167.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.48 150.89 51.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.785 1.634 . . . . 0.0 109.776 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.13 137.82 31.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.696 -0.627 . . . . 0.0 111.592 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -93.63 145.47 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.042 0.937 . . . . 0.0 111.044 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.4 t -135.67 146.95 48.34 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.587 1.155 . . . . 0.0 110.757 168.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -63.24 156.5 25.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.975 0.91 . . . . 0.0 111.901 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.0 t -125.44 65.76 1.16 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 122.365 1.079 . . . . 0.0 109.345 164.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.66 137.87 31.93 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.833 -172.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.96 122.06 21.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.143 0.577 . . . . 0.0 110.244 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.17 -176.058 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.671 0 O4'-C1'-N19 111.865 3.665 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 0 O4'-C1'-N19 111.129 2.929 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . 0.463 " H1'" ' HE2' ' A' ' 36' ' ' LYS . . . . . . . . 0 P--O3' 1.572 -2.931 0 O4'-C1'-N19 111.373 3.173 . 0.474 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 N19-C1'-C2' 118.115 2.947 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.535 0.535 0 N-CA-C 112.21 0.042 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 133.47 33.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.207 1.003 . . . . 0.0 112.571 176.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.0 p -151.52 155.01 37.62 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.438 0.695 . . . . 0.0 110.833 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -120.59 149.84 41.83 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.304 1.442 . . . . 0.0 111.004 171.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -120.03 128.17 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.42 1.888 . . . . 0.0 108.459 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -115.49 141.67 47.75 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.754 1.622 . . . . 0.0 111.169 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.69 114.93 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.576 1.15 . . . . 0.0 109.798 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.92 -4.98 86.69 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.716 1.627 . . . . 0.0 114.462 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -77.52 31.88 0.16 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.749 1.275 . . . . 0.0 113.466 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.0 mt 44.8 76.26 0.56 Allowed Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.716 2.006 . . . . 0.0 114.188 174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -69.85 26.8 0.18 Allowed 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.008 3.139 . . . . 0.0 115.419 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -76.2 16.25 0.47 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.133 2.573 . . . . 0.0 112.683 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -127.81 157.62 39.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 129.11 2.964 . . . . 0.0 110.983 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -43.74 120.98 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.045 1.738 . . . . 0.0 112.338 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.96 159.84 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.085 0.954 . . . . 0.0 111.594 -172.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.7 p -133.59 161.61 34.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.845 1.658 . . . . 0.0 111.747 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -52.58 -33.86 47.99 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.329 -0.857 . . . . 0.0 111.728 172.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.62 -21.01 65.41 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -74.12 -38.04 63.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.911 1.232 . . . . 0.0 112.302 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.96 -37.91 64.37 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.061 -1.024 . . . . 0.0 110.534 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -64.84 -43.85 91.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -29.88 69.75 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.291 0.95 . . . . 0.0 112.145 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.06 -78.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 167.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -121.16 120.64 35.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.462 1.483 . . . . 0.0 111.752 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.522 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 13.3 p -158.1 -33.35 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.219 167.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 25' ' ' SER . 31.5 Cg_endo -91.62 43.1 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.686 2.257 . . . . 0.0 111.201 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -133.33 153.8 51.27 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.215 1.806 . . . . 0.0 110.386 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.18 -157.89 35.38 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 163.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -103.02 -4.76 24.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 65.49 170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.141 1.776 . . . . 0.0 113.941 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.5 mtm -157.65 -75.7 0.09 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.931 -1.106 . . . . 0.0 109.517 163.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -145.42 155.3 43.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.654 1.182 . . . . 0.0 113.995 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 tt -115.6 134.05 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.044 1.738 . . . . 0.0 108.788 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -147.02 121.44 9.66 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.211 1.005 . . . . 0.0 111.622 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.6 147.07 31.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.879 0.871 . . . . 0.0 111.4 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -126.64 154.79 43.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.825 1.25 . . . . 0.0 110.211 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -68.8 44.36 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.058 1.743 . . . . 0.0 113.058 171.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.01 -40.71 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.345 2.258 . . . . 0.0 111.993 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -144.97 143.38 30.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.904 1.282 . . . . 0.0 109.923 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.11 136.61 11.73 Favored Glycine 0 N--CA 1.463 0.488 0 C-N-CA 123.884 0.755 . . . . 0.0 112.515 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -139.37 159.58 41.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 123.221 1.486 . . . . 0.0 112.42 -174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -136.28 148.05 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.29 1.836 . . . . 0.0 107.523 171.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -134.3 104.84 6.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -124.88 155.27 39.77 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.493 1.517 . . . . 0.0 112.714 -169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -90.0 153.5 20.53 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.02 1.328 . . . . 0.0 111.037 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 66.32 79.87 0.23 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 128.903 2.881 . . . . 0.0 113.705 -159.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -53.11 -33.24 62.9 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.074 3.183 . . . . 0.0 114.635 174.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -70.58 -35.85 73.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.066 0.848 . . . . 0.0 111.8 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 p -65.9 -31.75 72.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.88 -38.11 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.697 0.799 . . . . 0.0 110.223 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -63.39 -42.24 98.79 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.421 -0.799 . . . . 0.0 112.105 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.46 -38.15 90.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.87 0.759 . . . . 0.0 112.239 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.18 77.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.974 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.19 -53.34 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.817 1.19 . . . . 0.0 110.399 171.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.06 -29.7 70.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.306 0.957 . . . . 0.0 112.664 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 78.0 m -77.15 -38.12 52.54 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -94.87 -26.97 15.96 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 t -72.53 -20.78 61.28 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.152 0.981 . . . . 0.0 112.496 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -51.69 125.44 14.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.963 1.705 . . . . 0.0 111.097 170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -77.29 134.8 38.44 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.386 -0.821 . . . . 0.0 110.661 168.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.5 mtm -130.0 172.77 11.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 109.662 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -72.29 8.79 1.2 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -123.63 24.67 8.44 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.834 1.654 . . . . 0.0 113.154 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.46 -150.68 13.86 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.957 -1.089 . . . . 0.0 113.364 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -122.98 -179.02 4.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.669 1.988 . . . . 0.0 111.993 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -66.19 133.69 51.17 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.82 -0.55 . . . . 0.0 110.235 165.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.2 mt -91.32 142.62 27.5 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.755 166.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.71 115.5 48.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.686 1.595 . . . . 0.0 106.964 -176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 mt -138.64 139.1 38.39 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.757 1.223 . . . . 0.0 108.922 -165.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -133.74 125.89 29.53 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.88 139.81 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.096 0.959 . . . . 0.0 111.149 174.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -143.82 144.57 31.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.744 1.618 . . . . 0.0 110.663 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -114.35 124.78 52.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.014 0.926 . . . . 0.0 110.217 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 m -80.42 147.86 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.363 0.665 . . . . 0.0 112.224 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 53.21 22.07 2.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.46 1.904 . . . . 0.0 113.842 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.66 161.51 29.53 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.755 1.222 . . . . 0.0 113.316 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 127.893 2.477 . . . . 0.0 111.687 -178.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.985 0 O4'-C1'-N19 112.055 3.855 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 O4'-C1'-N19 110.838 2.638 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O3' 1.567 -3.347 0 O4'-C1'-N19 112.035 3.835 . 0.233 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.127 1 O4'-C1'-N19 112.657 4.457 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 CA--C 1.539 0.742 0 N-CA-C 113.77 0.642 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 98.59 5.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.079 1.752 . . . . 0.0 109.64 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -128.06 99.82 5.64 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.997 0.919 . . . . 0.0 110.338 -162.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -84.51 154.08 22.91 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.434 0.635 . . . . 0.0 112.382 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.71 127.76 41.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.003 1.721 . . . . 0.0 108.79 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -104.36 138.74 40.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.376 1.471 . . . . 0.0 112.132 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -97.21 97.46 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.181 1.392 . . . . 0.0 110.289 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.72 -23.0 65.42 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.147 0.88 . . . . 0.0 115.018 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.96 58.17 0.47 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.212 1.805 . . . . 0.0 115.483 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp 46.37 55.7 15.91 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 127.321 2.248 . . . . 0.0 113.754 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.47 4.42 2.08 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.471 3.447 . . . . 0.0 115.112 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.03 1.14 2.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.053 2.141 . . . . 0.0 116.198 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -139.77 -28.95 0.74 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -150.39 99.24 2.76 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.872 1.269 . . . . 0.0 110.117 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.44 149.52 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.48 0.712 . . . . 0.0 110.621 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 t -146.22 164.26 32.84 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.699 1.2 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -58.36 -29.76 66.24 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.144 -0.972 . . . . 0.0 112.48 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.34 -18.91 63.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -77.68 -47.18 19.83 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.909 -1.119 . . . . 0.0 109.946 169.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.15 -41.57 75.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.05 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -68.63 -43.21 76.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.484 1.514 . . . . 0.0 112.905 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -34.6 77.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.182 0.901 . . . . 0.0 111.152 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.93 -70.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.004 1.322 . . . . 0.0 108.747 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -124.2 112.7 17.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 111.168 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 26' ' ' PRO . 11.8 m -160.57 -22.15 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 126.364 1.866 . . . . 0.0 113.355 157.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' CD ' ' H ' ' A' ' 25' ' ' SER . 32.5 Cg_exo -73.43 16.22 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.149 2.566 . . . . 0.0 116.4 171.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -134.06 154.95 50.83 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.228 1.411 . . . . 0.0 111.129 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.45 -165.5 31.95 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.334 0.969 . . . . 0.0 115.093 170.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -91.12 -17.87 25.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.284 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.3 mm 64.71 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.785 1.634 . . . . 0.0 112.801 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.5 tpp -153.44 -58.13 0.13 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.3 -0.875 . . . . 0.0 112.466 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -147.8 145.02 28.6 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.674 1.189 . . . . 0.0 112.967 -171.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 tt -117.68 127.52 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.185 1.794 . . . . 0.0 109.839 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -137.02 87.52 2.29 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.981 0.896 . . . . 0.0 111.24 -164.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.3 139.43 21.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 124.078 0.951 . . . . 0.0 110.944 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.31 153.41 46.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.195 2.198 . . . . 0.0 109.082 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -76.81 28.0 0.13 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.53 -41.77 0.29 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.807 2.043 . . . . 0.0 111.378 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -137.83 146.93 44.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.388 1.075 . . . . 0.0 112.703 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.31 133.33 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 123.976 0.798 . . . . 0.0 112.222 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -131.27 154.83 48.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.25 1.5 . . . . 0.0 112.569 171.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.031 1.732 . . . . 0.0 108.352 167.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -140.72 80.44 1.75 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.383 1.873 . . . . 0.0 108.046 -172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -111.72 165.93 11.62 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.759 -1.213 . . . . 0.0 113.828 -166.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -96.19 153.37 17.83 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.03 0.932 . . . . 0.0 110.419 166.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 66.95 85.61 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 128.902 2.881 . . . . 0.0 115.249 -166.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.45 -30.35 72.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.633 2.888 . . . . 0.0 113.331 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -53.91 -41.27 67.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.572 0.624 . . . . 0.0 110.939 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 m -87.47 -23.71 24.36 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.83 -45.86 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.759 1.163 . . . . 0.0 109.105 164.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -65.16 -42.77 93.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.949 0.9 . . . . 0.0 112.755 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.488 1.04 . . . . 0.0 112.197 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.75 -32.58 62.13 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.28 -52.71 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.343 1.429 . . . . 0.0 109.51 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.19 -10.76 60.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -89.06 -23.42 22.55 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.787 -1.196 . . . . 0.0 113.68 170.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -128.96 -37.12 1.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -165.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 t -76.63 -13.2 60.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.826 1.25 . . . . 0.0 113.251 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -73.06 171.06 13.59 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.983 0.913 . . . . 0.0 112.093 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -106.55 138.04 43.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.593 1.157 . . . . 0.0 109.001 171.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -118.41 21.32 12.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.869 1.268 . . . . 0.0 113.855 -170.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 60.39 26.57 16.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.368 2.267 . . . . 0.0 113.711 -169.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -159.77 131.89 6.38 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.371 1.068 . . . . 0.0 111.833 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.95 -174.38 46.61 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.958 1.266 . . . . 0.0 114.927 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -82.27 158.45 23.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.306 1.042 . . . . 0.0 111.363 168.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -99.83 169.2 9.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.111 0.964 . . . . 0.0 113.48 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.5 mt -108.85 161.14 15.41 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.523 1.529 . . . . 0.0 110.539 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.27 104.22 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -121.92 140.46 52.41 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.394 1.478 . . . . 0.0 110.45 -169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.19 140.53 37.83 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.45 140.81 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.136 1.374 . . . . 0.0 111.136 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.9 t -152.88 153.72 33.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.606 1.162 . . . . 0.0 111.615 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.8 m -114.02 9.7 17.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.987 1.315 . . . . 0.0 112.07 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -66.5 140.09 57.98 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.24 1.016 . . . . 0.0 109.872 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -85.39 144.05 28.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.972 -1.08 . . . . 0.0 110.986 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.29 142.84 27.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.297 1.039 . . . . 0.0 110.808 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.376 -1.297 . . . . 0.0 110.811 -179.376 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.154 1 O4'-C1'-N19 112.418 4.218 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 0 O4'-C1'-N19 111.258 3.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 111.933 3.733 . 0.381 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.172 0 O4'-C1'-N19 110.916 2.716 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_